Form 8-K
8-K — ARC Group Acquisition I Corp.
Accession: 0001493152-26-042241
Filed: 2026-09-10
Period: 2026-09-10
CIK: 0002073515
SIC: 6770 (BLANK CHECKS)
Item: Entry into a Material Definitive Agreement
Item: Regulation FD Disclosure
Item: Financial Statements and Exhibits
Documents
8-K — form8-k.htm (Primary)
EX-2.1 (ex2-1.htm)
EX-10.1 (ex10-1.htm)
EX-10.2 (ex10-2.htm)
EX-10.3 (ex10-3.htm)
EX-10.4 (ex10-4.htm)
EX-10.5 (ex10-5.htm)
EX-10.6 (ex10-6.htm)
EX-10.7 (ex10-7.htm)
EX-10.8 (ex10-8.htm)
EX-99.1 (ex99-1.htm)
GRAPHIC (ex99-1_001.jpg)
GRAPHIC (ex99-1_002.jpg)
XML — IDEA: XBRL DOCUMENT (R1.htm)
8-K
8-K (Primary)
Filename: form8-k.htm · Sequence: 1
false
0002073515
0002073515
2026-09-10
2026-09-10
0002073515
ARCLU:UnitsEachConsistingOfOneClassOrdinaryShareParValue0.0001PerShareOneWarrantAndOneRightToAcquire14Member
2026-09-10
2026-09-10
0002073515
ARCLU:ClassOrdinarySharesIncludedAsPartOfUnitsMember
2026-09-10
2026-09-10
0002073515
ARCLU:RightsIncludedAsPartOfUnitsMember
2026-09-10
2026-09-10
0002073515
ARCLU:WarrantsEachWarrantExercisableForOneClassOrdinaryShareAtExercisePriceOf11.50PerShareMember
2026-09-10
2026-09-10
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of
the
Securities Exchange Act of 1934
Date
of Report (Date of earliest event reported): September 10, 2026
ARC
Group Acquisition I Corp
(Exact
name of registrant as specified in its charter)
British
Virgin Islands
001-43253
N/A
00-0000000
(State
or other jurisdiction of
incorporation
or organization)
(Commission
File
Number)
(I.R.S.
Employer
Identification
Number)
398
S Mill Avenue, Suite 306, Tempe, AZ 85284
(Address
of principal executive offices, including zip code)
(928)
625-0928
(Registrant’s
telephone number, including area code)
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under
any of the following provisions
☐
Written communications
pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐
Soliciting material pursuant
to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐
Pre-commencement communications
pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐
Pre-commencement communications
pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities
registered pursuant to Section 12(b) of the Act:
Title
of each class
Trading
Symbol(s)
Name
of each exchange on which registered
Units, each consisting of
one Class A ordinary share, par value $0.0001 per share, one warrant, and one right to acquire 1/4th of one Class A ordinary
share
ARCLU
The Nasdaq Stock Market
LLC
Class A ordinary shares
included as part of the Units
ARCL
The Nasdaq Stock Market
LLC
Rights included as part
of the Units
ARCLR
The Nasdaq Stock Market
LLC
Warrants, each warrant exercisable
for one Class A ordinary share at an exercise price of $11.50 per share
ARCLW
The Nasdaq Stock Market
LLC
Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2
of the Securities Exchange Act of 1934.
Emerging
growth company ☒
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item
1.01. Entry into Material Definitive Agreement
Share
Purchase Agreement
On
September 10, 2026, ARC Group Acquisition I Corp, a British Virgin Islands business company (“we,” “our,” or
“Purchaser”), Firstborn Top Capital Sdn. Bhd., a Malaysian private limited company (“Firstborn”), the holders
of all of the ordinary shares (the “Firstborn Shares”) of Firstborn (the “Selling Shareholders”), Datuk Dr. Doris
Wong in the capacity as the representative from and after the Closing (as defined below) for the shareholders of Purchaser (other than
the Selling Shareholders as of immediately prior to the Closing and their successors and assigns), and Ow Ruey Shen, in the capacity
as the representative for the Selling Shareholders from and after the Closing, entered into a share purchase agreement (as it may be
amended, supplemented or otherwise modified from time to time, the “Share Purchase Agreement”): each Selling Shareholder
shall sell, transfer, assign, convey and deliver to Purchaser, and Purchaser shall purchase, acquire and accept from each Selling Shareholder,
their Firstborn Shares, respectively, free and clear of any and all liens and encumbrances, such that all of the issued and outstanding
Firstborn Shares at the Closing shall be sold to and purchased by Purchaser (the transactions contemplated by the foregoing clause the
“Business Combination,” and together with the other transactions contemplated by the Share Purchase Agreement, the “Transactions”).
The
terms of the Share Purchase Agreement, which contains customary representations and warranties, covenants, closing conditions and other
terms relating to the Business Combination and the other Transactions contemplated thereby, are summarized below. Capitalized terms used
in this Current Report on Form 8-K but not otherwise defined herein have the meanings ascribed to them in the Share Purchase Agreement.
General
Effects of the Business Combination
Subject
to the terms and conditions of the Share Purchase Agreement, at the Closing the Business Combination will result in, among other things,
the following:
● all
of the issued and outstanding Firstborn Shares will be exchanged for Class A ordinary shares
of Purchaser (“Purchaser Class A Ordinary Shares”);
● Firstborn
will become a wholly-owned subsidiary of Purchaser; and
● Purchaser
will change its name to “BlueCrest Investment, Inc.”
Transaction
Consideration
The
aggregate consideration to be paid in the Transactions to the Selling Shareholders will consist of: (A) $1,000,000,000, (B) minus the
Closing Net Indebtedness, (C) plus or minus, as applicable, the Working Capital Adjustment, and (D) minus the amount of any unpaid transaction
bonuses and other transaction-related compensation payable in connection with the Transactions, with the resulting amount divided by
the Redemption Price (the “Consideration Shares”). The Working Capital Adjustment shall equal the Net Working Capital Amount
minus the Target Net Working Capital Amount of $618,000, such that the Transaction Consideration shall be increased dollar-for-dollar
to the extent the Net Working Capital Amount exceeds the Target Net Working Capital Amount and decreased dollar-for-dollar to the extent
the Target Net Working Capital Amount exceeds the Net Working Capital Amount. There is no minimum cash condition or minimum cash consideration
in connection with the Closing. Each Selling Shareholder shall have the right to receive at the Closing, a number of Purchaser
Class A Ordinary Shares equal to the aggregate Consideration Shares divided by the number of Firstborn Shares outstanding immediately
prior to the Closing, multiplied by the number of Firstborn Shares held by such Selling Shareholder (the “Conversion Ratio”).
Redemptions
Pursuant
to our charter and the Trust Agreement (defined below), eligible holders of Purchaser Class A Ordinary Shares may elect to redeem all
or a portion of such holder’s Purchaser Class A Ordinary Shares (the “SPAC Share Redemptions”), at the per-share price,
payable in cash, equal to such holder’s pro rata share of Purchaser’s trust account, by tendering the Purchaser Class A Ordinary
Shares of such holder for redemption not later than 5:00 p.m. Eastern Time on the date that is two Business Days prior to the date of
the Extraordinary General Meeting of the holders of Purchaser Class A Ordinary Shares and Class B ordinary shares of Purchaser to be
called for the purpose of voting on proposals related to the Transactions (the “Shareholder Meeting”).
PIPE
Investment
During
the Interim Period, Purchaser and Firstborn shall reasonably cooperate to seek a PIPE Investment pursuant to customary and binding subscription
agreements (the “Subscription Agreements”) with certain investors (the “PIPE Investors”) agreed by Purchaser
and Firstborn, and shall use their respective commercially reasonable efforts to cause the PIPE Investment to close concurrently with
the Closing (the “PIPE Investment”). The terms of the PIPE Investment shall be negotiated and agreed by Purchaser and Firstborn
consistent with market terms, and Purchaser and Firstborn shall negotiate and agree on the choice of placement agent, fees, approach
and target investor universe. Firstborn’s senior management shall participate in any investor meetings and roadshows as reasonably
requested by Purchaser.
Stock
Exchange Listing
Purchaser
Class A Ordinary Shares and warrants to purchase Class A ordinary shares of Purchaser are expected to be listed on The Nasdaq Stock Market
LLC (the “Nasdaq”).
Representations
and Warranties and Covenants
Each
of the parties to the Share Purchase Agreement have made representations, warranties and covenants in the Share Purchase Agreement that
are customary for transactions of this nature.
Conditions
to Each Party’s Obligations
Consummation
of the Transactions is subject to customary conditions of the respective parties, and conditions customary to special purpose
acquisition companies, including the approval of Purchaser’s shareholders and Firstborn’s shareholders. In addition, consummation
of the Transactions is subject to other Closing conditions, including, among others: (a) if required, the expiration of the waiting
period (or extension thereof) under any applicable antitrust laws, (b) the absence of any order, writ, judgment, injunction, temporary
restraining order, stipulation, determination, decree or award entered by or with or under the authority of any governmental entity or
arbitral institution in effect enjoining or prohibiting the consummation of the Transactions, and the absence of any law that makes consummation
of the Transactions illegal or otherwise prohibited, (c) approval by Purchaser shareholders at the Shareholder Meeting of the
Transactions, including, the issuance of any shares in connection with the PIPE Investment, the adoption of an amended and restated memorandum
and articles of association of Purchaser, the adoption of an incentive equity plan, and the appointment of members of Purchaser
board of directors, (d) after giving effect to all SPAC Share Redemptions and the PIPE Investment, Purchaser shall have consolidated
net tangible assets of at least $5,000,001 (as calculated and determined in accordance with Rule 3a51-1(g)(1) of the Securities Exchange
Act) either immediately prior to or upon the Closing after giving effect to the Transactions, (e) the Purchaser Proxy/Registration
Statement shall have become effective, no stop order shall have been issued by the SEC and remain in effect and no proceeding seeking
such a stop order shall have been threatened or initiated by the SEC and remain pending, (f) receipt of approval for listing on Nasdaq
for the Purchaser Class A Ordinary Shares to be issued in connection with the Transactions, and (g) delivery by the other parties of
all Closing deliveries, documents and other items required to be delivered by such parties as required by the Share Purchase Agreement.
Termination
The
Share Purchase Agreement may be terminated under certain customary and limited circumstances at any time prior to the Closing, including,
among others, (i) by the mutual written consent of Purchaser and Firstborn, if the Closing has not occurred by January 31, 2027, subject
to extension if Purchaser secures one or more extensions of the deadline under its organizational documents and IPO prospectus to complete
its initial business combination, (ii) by Purchaser or Firstborn if the Transaction is prohibited by a governmental authority, (iii)
by Purchaser or Firstborn after an uncured breach by a party of the representations, warranties, covenants, or agreements contained in
the Share Purchase Agreement, (iv) by Purchaser or Firstborn after a material adverse effect on Purchaser or Firstborn, respectively,
or (v) by Purchaser if Purchaser’s shareholders do not approve the Transactions.
A
copy of the Share Purchase Agreement is filed with this Current Report on Form 8-K as Exhibit 2.1 and is incorporated herein by reference,
and the foregoing description of the Share Purchase Agreement is qualified in its entirety by reference thereto. The Share Purchase Agreement
contains representations, warranties and covenants that the respective parties made to each other as of the date of the Share Purchase
Agreement or other specific dates. The assertions embodied in those representations, warranties and covenants were made for purposes
of the contract among the respective parties and are subject to important qualifications and limitations agreed to by the parties in
connection with negotiating such agreement. The representations, warranties and covenants in the Share Purchase Agreement are also modified
in important part by the underlying disclosure schedules which are not filed publicly and which are subject to a contractual standard
of materiality different from that generally applicable to shareholders and were used for the purpose of allocating risk among the parties
rather than establishing matters as facts. We do not believe that these schedules contain information that is material to an investment
decision.
Certain
Related Agreements
Sponsor
Support Agreement
Concurrently
with the execution of the Share Purchase Agreement, certain of Purchaser’s Affiliates and MFH 2, LLC, a Delaware limited liability
company (the “Sponsor”), entered into a support agreement (the “Sponsor Support Agreement”), pursuant to which
each such parties agreed to, among other things, (i) appear at the Shareholder Meeting and vote all of its Purchaser Ordinary Shares
it holds or has the power to vote (including any acquired in future) in favor of the Share Purchase Agreement and the Transactions, (ii) be bound by certain transfer restrictions with respect to its Purchaser Securities, and (iii) not redeem any of its Purchaser
Securities and waive any anti-dilution rights with respect to any equity issuance, including the PIPE Investment, on the terms and subject
to the conditions set forth in the Sponsor Support Agreement.
The
foregoing description of the Sponsor Support Agreement does not purport to be complete and is qualified in its entirety by the terms
and conditions of the Sponsor Support Agreement, a form of which is attached hereto as Exhibit 10.1 and is incorporated herein by reference.
Company
Support Agreement
Concurrently
with the execution of the Share Purchase Agreement, the directors, officers and holders of five percent (5%) or more of the voting stock
of Firstborn entered into a support agreement (the “Company Support Agreement”), pursuant to which each such parties agreed
to, vote in favor of the Transactions and against any Alternative Transaction.
The
foregoing description of the Company Support Agreement does not purport to be complete and is qualified in its entirety by the terms
and conditions of the Company Support Agreement, a form of which is attached hereto as Exhibit 10.2 and is incorporated herein by reference.
Registration
Rights Agreement
In
connection with the consummation of the Transactions, Purchaser will enter into a Registration Rights Agreement (the “RRA”)
with certain shareholders of Purchaser and Firstborn. The RRA includes, among other things, the following provisions:
Purchaser
will be required to file a resale shelf registration statement on behalf of Purchaser and Firstborn shareholders party to the agreement
within 30 days after the closing of the Transactions. The RRA also provides certain demand rights and piggyback rights to such
shareholders, subject to certain specified underwriter cutbacks and issuer blackout periods. Purchaser will bear all costs and expenses
incurred in connection with the resale shelf registration statement, any demand registration statement, any underwritten takedown, any
block trade, any piggyback registration statement prior to its withdrawal and all expenses incurred in performing or complying with its
other obligations under the RRA, whether or not the registration statement becomes effective.
The
RRA will terminate with respect to any holder party thereto, on the date that such holder party no longer holds any registrable securities.
The
foregoing description of the RRA does not purport to be complete and is qualified in its entirety by the terms and conditions of the
RRA, a form of which is attached hereto as Exhibit 10.3 and is incorporated herein by reference.
Lock-Up
Agreement
In
connection with the consummation of the Transactions, directors, officers and significant shareholders of Firstborn will enter
into a Lock-Up Agreement (the “Lock-Up Agreement”) with Purchaser, with respect to the Purchaser Class A Ordinary Shares
that will be issued as consideration under the Share Purchase Agreement. The Lock-Up Agreement includes, among other things, the following
provisions:
Signatories
will not be able to transfer any Purchaser Class A Ordinary Shares beneficially owned or otherwise held by them for the same period applicable
to the Sponsor’s lock-up agreement with respect to its founder shares.
The
foregoing description of the Lock-Up Agreement does not purport to be complete and is qualified in its entirety by the terms and conditions
of the Lock-Up Agreement, a form of which is attached hereto as Exhibit 10.4 and is incorporated herein by reference.
Restrictive
Covenant Agreement
In
connection with the consummation of the Transactions, directors, officers and significant shareholders of Firstborn will
enter into a Restrictive Covenant Agreement (the “Restrictive Covenant Agreement”) with Purchaser, providing for, among other
things, non-solicitation and non-competition restrictions for a period of 2 to 4 years from the Closing Date.
The
foregoing description of the Restrictive Covenant Agreement does not purport to be complete and is qualified in its entirety by the terms
and conditions of the Restrictive Covenant Agreement, a form of which is attached hereto as Exhibit 10.5 and is incorporated herein by
reference.
Indemnification
Agreement
In
connection with the consummation of the Transactions, existing and newly appointed directors and officers of Purchaser and Firstborn
will enter into an Indemnification Agreement (the “Indemnification Agreement”) with Purchaser, providing for, among other
things, holding harmless, advancing costs and indemnifying such persons to the fullest extent permitted by applicable law and the Purchaser’s
charter.
The
foregoing description of the Indemnification Agreement does not purport to be complete and is qualified in its entirety by the terms
and conditions of the Indemnification Agreement, a form of which is attached hereto as Exhibit 10.6 and is incorporated herein by reference.
Incentive
Equity Plan
At
or prior to the Closing, Purchaser will adopt an incentive equity plan (the “Incentive Equity Plan”) that will provide for
the grant of equity incentives of Purchaser Class A Ordinary Shares to the directors, officers, employees, consultants and advisors (and
prospective directors, officers, employees, consultants and advisors) following the Closing. Within 30 days after the Closing, Purchaser
will file a registration statement on Form S-8 with respect to the Purchaser Class A Ordinary Shares issuable under the Incentive Equity
Plan, and Purchaser will use reasonable efforts to maintain the effectiveness of the registration statement and maintain the current
status of the prospectus contained therein for so long as awards granted pursuant to the Incentive Equity Plan remain outstanding.
The
foregoing description of the Incentive Equity Plan does not purport to be complete and is qualified in its entirety by the terms
and conditions of the Incentive Equity Plan, a form of which is attached hereto as Exhibit 10.7 and is incorporated herein by
reference.
Executive
Employment Agreement
In
connection with the consummation of the Transactions, each continuing executive officer of Firstborn will enter into an Executive
Employment Agreement (the “Employment Agreement”) with Firstborn with an effective date as of the Closing Date. The Employment
Agreement contains customary terms and conditions, including among others, salary, duties, termination, severance, non-solicitation and
confidentiality provisions.
The
foregoing description of the Employment Agreement does not purport to be complete and is qualified in its entirety by the terms and conditions
of the Employment Agreement, a form of which is attached hereto as Exhibit 10.8 and is incorporated herein by reference.
Item
7.01 Regulation FD Disclosure
On
September 10, 2026, Purchaser issued a press release announcing the execution of the Share Purchase Agreement. The press release is attached
hereto as Exhibit 99.1 and incorporated by reference herein.
The
foregoing Exhibit 99.1 is being furnished pursuant to Item 7.01 and will not be deemed to be filed for purposes of Section 18 of the
Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise be subject to the liabilities of that section,
nor will it be deemed to be incorporated by reference in any filing under the Securities Act or the Exchange Act.
Additional
Information
In
connection with the proposed Business Combination, Purchaser intends to file a registration statement on Form S-4 (as it may be amended
from time to time, the “Form S-4”) with the SEC. The Form S-4 will include a proxy statement/prospectus of Purchaser and
a preliminary prospectus of Purchaser. The definitive proxy statement/prospectus will be sent to all Purchaser shareholders after it
is declared effective by the SEC. Additionally, Purchaser will file other relevant materials with the SEC in connection with the proposed
Business Combination. Copies of the Form S-4, the proxy statement/prospectus and all other relevant materials filed or that will be filed
with the SEC may be obtained free of charge at the SEC’s website at www.sec.gov. The information contained in, or that may be accessed
through, the websites referenced in this press release is not incorporated by reference into, and is not a part of, this press release.
Before making any voting or investment decision, investors and security holders of Purchaser are urged to read the Form S-4, the proxy
statement/prospectus and all other relevant materials filed or that will be filed with the SEC in connection with the proposed Business
Combination because they will contain important information about the proposed Business Combination and the parties to the proposed Business
Combination.
Participants
in the Solicitation
Under
SEC rules, Purchaser and Firstborn and their respective directors and executive officers may be deemed to be participants in the solicitation
of proxies of Purchaser’s shareholders in connection with the proposed Business Combination. Investors and security holders may
obtain more detailed information regarding the names and interests in the proposed Business Combination of Purchaser’s directors
and officers in Purchaser’s filings with the SEC, including Purchaser’s initial public offering final prospectus, which was
filed with the SEC on April 30, 2026, and Purchaser’s subsequent quarterly reports on Form 10-Q and current reports on Form 8-K.
Information regarding the persons who may, under SEC rules, be deemed participants in the solicitation of proxies to Purchaser’s
shareholders in connection with the proposed Business Combination will be included in the proxy statement/prospectus relating to the
proposed Business Combination when it becomes available. You may obtain free copies of these documents as described in the preceding
paragraph.
Forward
Looking Statements
This
Current Report includes “forward-looking statements” within the meaning of the “safe harbor” provisions of the
Private Securities Litigation Reform Act of 1995 with respect to the proposed Business Combination between Purchaser and Firstborn. Words
such as “expect,” “estimate,” “project,” “budget,” “forecast,” “anticipate,”
“intend,” “plan,” “may,” “will,” “could,” “should,” “believe,”
“predict,” “potential,” “continue,” “strategy,” “future,” “opportunity,”
“would,” “seem, “ “seek,” “outlook” and similar expressions are intended to identify
such forward-looking statements. Forward-looking statements are predictions, projections and other statements about future events that
are based on current expectations and assumptions and, as a result, are subject to risks and uncertainties that could cause the actual
results to differ materially from the expected results. These statements are based on various assumptions, whether or not identified
in this Current Report. These forward-looking statements are provided for illustrative purposes only and are not intended to serve as,
and must not be relied on by an investor as, a guarantee, an assurance, a prediction or a definitive statement of fact or probability.
Actual events and circumstances are difficult or impossible to predict and will differ from assumptions. These forward-looking statements
include, without limitation, Firstborn’s and Purchaser’s expectations with respect to anticipated financial impacts of the
proposed Business Combination, the satisfaction of closing conditions to the proposed Business Combination, and the timing of the completion
of the proposed Business Combination.
You
should carefully consider the risks and uncertainties described in the “Risk Factors” section of Purchaser’s initial
public offering prospectus, and its subsequent quarterly reports on Form 10-Q and current reports on Form 8-K. In addition, there will
be risks and uncertainties described in the Form S-4 and other documents filed by Purchaser from time to time with the SEC. These filings
will identify and address other important risks and uncertainties that could cause actual events and results to differ materially from
those contained in the forward-looking statements. Many of these factors are outside Firstborn’s and Purchaser’s control
and are difficult to predict. Many factors could cause actual future events to differ from the forward-looking statements in this Current
Report, including but not limited to: (1) the outcome of any legal proceedings that may be instituted against Purchaser or Firstborn
following the announcement of the proposed Business Combination; (2) the inability to complete the proposed Business Combination, including
due to the inability to concurrently close the Business Combination and related transactions, including any private placement of ordinary
shares or due to failure to obtain approval of the shareholders of Purchaser; (3) the risk that the proposed Business Combination may
not be completed by Purchaser’s Business Combination deadline and the potential failure to obtain an extension of the Business
Combination deadline if sought by Purchaser; (4) the failure to satisfy the conditions to the consummation of the proposed Business Combination,
including the approval by the shareholders of Purchaser, and the receipt of certain governmental and regulatory approvals; (5) delays
in obtaining, adverse conditions contained in, or the inability to obtain necessary regulatory approvals or complete regulatory reviews
required to complete the proposed Business Combination; (6) the occurrence of any event, change or other circumstance that could give
rise to the termination of the Share Purchase Agreement; (7) volatility in the price of Purchaser’s or the combined company’s
securities; (8) the risk that the proposed Business Combination disrupts current plans and operations as a result of the announcement
and consummation of the Business Combination; (9) the inability to recognize the anticipated benefits of the proposed Business Combination,
which may be affected by, among other things, competition, the ability of the combined company to grow and manage growth profitably,
maintain relationships with customers and suppliers and retain key employees; (10) costs related to the proposed Business Combination;
(11) changes in the applicable laws or regulations; (12) the possibility that the combined company may be adversely affected by other
economic, business, and/or competitive factors; (13) the risk of downturns and a changing regulatory landscape in the highly competitive
industry in which Firstborn operates; (14) the impact of the conflicts in the Middles East and Ukraine; (15) the potential inability
of the combined company to raise additional capital needed to pursue its business objectives or to achieve efficiencies regarding other
costs; (16) the enforceability of Firstborn’s intellectual property, including its licenses and related patents, and the potential
infringement on the intellectual property rights of others, cyber security risks or potential breaches of data security; and (17) other
risks and uncertainties described in Purchaser’s initial public offering prospectus, and its subsequent quarterly reports on Form
10-Q, current reports on Form 8-K and to be described in the Form S-4 and other documents to be filed by Purchaser from time to time
with the SEC. These risks and uncertainties may be amplified by the conflicts in the Middle East and Ukraine, which have caused significant
economic uncertainty.
Firstborn
and Purchaser caution that the foregoing list of factors is not exclusive or exhaustive and not to place undue reliance upon any forward-looking
statements, including projections, which speak only as of the date made. None of Firstborn or Purchaser gives any assurance that Firstborn
or Purchaser will achieve its expectations. None of Firstborn or Purchaser undertakes or accepts any obligation to publicly provide revisions
or updates to any forward-looking statements, whether as a result of new information, future developments or otherwise, or should circumstances
change, except as otherwise required by securities and other applicable laws.
Disclaimer
This
Current Report is for informational purposes only and is neither an offer to purchase, nor a solicitation of an offer to sell, subscribe
for or buy any securities or the solicitation of any vote in any jurisdiction pursuant to the proposed transactions or otherwise, nor
shall there be any sale, issuance or transfer or securities in any jurisdiction in contravention of applicable law. No offer of securities
shall be made except by means of a prospectus meeting the requirements of Section 10 of the Securities Act.
Item
9.01 Financial Statements and Exhibits.
(d)
Exhibits.
Exhibit
No.
Description
2.1*
Share Purchase Agreement, dated September 10, 2026, by and among ARC Group Acquisition I Corp, Firstborn Top Capital Sdn. Bhd., shareholders of Firstborn Top Capital Sdn. Bhd. and certain representatives.
10.1*
Form of Sponsor Support Agreement.
10.2*
Form of Company Support Agreement.
10.3
Form of Registration Rights Agreement.
10.4
Form of Lock-Up Agreement.
10.5
Form of Restrictive Covenant Agreement.
10.6
Form of Indemnification Agreement.
10.7
Form of Incentive Equity Plan.
10.8
Form of Executive Employment Agreement.
99.1
Joint Press Release of ARC Group Acquisition I Corp. and Firstborn Top Capital Sdn. Bhd., dated September 10, 2026.
104
Cover
Page Interactive Data File (embedded within the Inline XBRL document).
*The
schedules to this Exhibit have been omitted in accordance with Regulation S-K Item 601(b)(2). Purchaser agrees to furnish supplementally
a copy of any omitted schedule to the SEC upon its request; provided, however, that Purchaser may request confidential treatment for
any such schedules so furnished.
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.
Dated: September 10, 2026
ARC Group Acquisition I Corp
By:
/s/
Datuk Dr. Doris Wong Sing Ee
Name:
Datuk Dr. Doris Wong Sing Ee
Title:
Chief Executive Officer and Director
EX-2.1
EX-2.1
Filename: ex2-1.htm · Sequence: 2
Exhibit
2.1
SHARE
PURCHASE AGREEMENT
DATED
AS OF SEPTEMBER 10, 2026
BY
AND AMONG
ARC
GROUP ACQUISITION I CORP.,
THE
PURCHASER REPRESENTATIVE,
FIRSTBORN
TOP CAPITAL SDN. BHD.,
THE
SELLING SHAREHOLDERS
AND
THE
SHAREHOLDER REPRESENTATIVE
TABLE
OF CONTENTS
Article
I SALE AND PURCHASE OF SHARES
6
1.1
Sale
and Purchase of Company Shares
6
1.2
Rights
Cease to Exist
6
Article
II CONSIDERATION
7
2.1
Transaction
Consideration.
7
2.2
Closing
Statement.
7
2.3
Allocation
Statement.
9
2.4
Fractional
Shares.
9
2.5
Tax
Withholding.
9
Article
III CLOSING
9
3.1
Closing.
9
3.2
Surrender
of Company Shares and Disbursement of Transaction Consideration.
9
3.3
Closing
Transactions.
10
Article
IV REPRESENTATIONS AND WARRANTIES OF THE COMPANY
10
4.1
Organization;
Standing and Power.
10
4.2
Authorization;
Binding Agreement.
10
4.3
Capitalization.
11
4.4
Subsidiaries.
12
4.5
Governmental
Approvals.
12
4.6
Non-Contravention.
12
4.7
Financial
Statements; Internal Controls.
12
4.8
Absence
of Certain Changes.
14
4.9
Compliance
with Laws.
16
4.10
Company
Permits.
17
4.11
Litigation.
17
4.12
Material
Contracts.
17
4.13
Intellectual
Property.
19
4.14
Taxes
Returns and Audits.
21
4.15
Real
Property.
22
4.16
Personal
Property.
23
4.17
Title
to and Sufficiency of Assets.
23
4.18
Employee
Matters.
23
4.19
Benefit
Plans.
24
4.20
Environmental
Matters.
25
4.21
Transactions
with Related Persons.
26
4.22
Insurance.
26
4.23
Books
and Records.
27
4.24
Top
Customers and Suppliers.
27
4.25
Certain
Business Practices.
28
4.26
Compliance
with Privacy Laws, Privacy Policies and Certain Contracts.
29
4.27
Investment
Company Act.
29
4.28
Finders
and Brokers.
29
4.29
Restrictions
on Business Activities.
29
4.30
Fairness
Opinion.
30
4.31
Independent
Investigation.
30
4.32
Information
Supplied.
30
4.33
Disclosure.
30
ii
Article
V REPRESENTATIONS AND WARRANTIES OF THE SELLING SHAREHOLDERS
31
5.1
Authorization
of Agreement; Enforceability.
31
5.2
Conflicts;
Consents of Third Parties.
31
5.3
Ownership
and Transfer of Company Shares.
31
5.4
Litigation.
32
5.5
Financial
Advisors.
32
Article
VI REPRESENTATIONS AND WARRANTIES OF PURCHASER
32
6.1
Organization
and Standing.
32
6.2
Authorization;
Binding Agreement.
32
6.3
Governmental
Approvals.
33
6.4
Non-Contravention.
33
6.5
Capitalization.
33
6.6
SEC
Filings and Purchaser Financials.
34
6.7
Absence
of Certain Changes.
35
6.8
Compliance
with Laws.
35
6.9
Actions;
Orders; Permits.
35
6.10
Taxes
and Returns.
35
6.11
Employees
and Employee Benefit Plans.
36
6.12
Properties.
36
6.13
Material
Contracts.
36
6.14
Transactions
with Affiliates.
36
6.15
Investment
Company Act.
37
6.16
Finders
and Brokers.
37
6.17
Ownership
of Transaction Consideration.
37
6.18
Certain
Business Practices.
37
6.19
Insurance.
37
6.20
Purchaser
Trust Account.
38
6.21
Independent
Investigation.
38
Article
VII COVENANTS
38
7.1
Access
and Information.
38
7.2
Conduct
of Business of the Company.
39
7.3
Conduct
of Business of Purchaser.
42
7.4
Annual
and Interim Financial Statements.
44
7.5
Purchaser
Public Filings.
44
7.6
No
Solicitation.
44
7.7
No
Trading.
45
7.8
Notification
of Certain Matters.
45
7.9
Efforts.
46
7.10
Further
Assurances.
47
7.11
The
Registration Statement.
48
7.12
Public
Announcements.
50
7.13
Confidential
Information.
50
7.14
Documents
and Information.
51
7.15
Post-Closing
Board of Directors and Executive Officers.
52
7.16
Indemnification
of Directors and Officers; Tail Insurance.
52
7.17
Trust
Account Proceeds.
52
7.18
PIPE
Investment.
53
7.19
Incentive
Equity Plan.
53
7.20
Tax
Matters.
53
7.21
Related
Party Matters.
55
iii
Article
VIII NO SURVIVAL
55
8.1
No
Survival.
55
Article
IX CONDITIONS TO CLOSING
56
9.1
Conditions
to Each Party’s Obligations.
56
9.2
Conditions
to Obligations of Purchaser.
56
9.3
Conditions
to Obligations of the Company
58
9.4
Frustration
of Closing Conditions.
59
Article
X TERMINATION AND EXPENSES
59
10.1
Termination
of Agreement.
59
10.2
Effect
of Termination.
60
10.3
Fees
and Expenses.
61
Article
XI WAIVERS AND RELEASES
61
11.1
Waiver
of Claims Against Trust.
61
Article
XII MISCELLANEOUS
62
12.1
Notices.
62
12.2
Binding
Effect; Assignment.
63
12.3
Third
Parties.
63
12.4
Reserved..
63
12.5
Governing
Law; Jurisdiction.
63
12.6
WAIVER
OF JURY TRIAL.
63
12.7
Specific
Performance.
63
12.8
Severability.
63
12.9
Amendment.
64
12.10
Waiver.
64
12.11
Entire
Agreement.
64
12.12
Interpretation.
64
12.13
Counterparts.
65
12.14
Purchaser
Representative.
65
12.15
Shareholder
Representative.
66
12.16
Legal
Representation.
67
Article
XIII RESERVED
68
Article
XIV DEFINITIONS
68
14.1
Certain Definitions.
68
Exhibits
Exhibit
A-1 – Selling Shareholders
Exhibit
A-2 – Allocation Schedule
Exhibit
B – Form of Registration Rights Agreement
Exhibit
C – Form of Executive Employment Agreement
Exhibit
D – Form of Incentive Equity Plan
Exhibit
E – Form of Indemnification Agreement
Exhibit
F – Form of Sponsor Support Agreement
Exhibit
G – Form of Company Support Agreement
Exhibit
H – Form of Lock-Up Agreement
Exhibit
I – Form of Restrictive Covenant Agreement
iv
SHARE
PURCHASE AGREEMENT
THIS
SHARE PURCHASE AGREEMENT (this “Agreement”), dated as of September 10, 2026 (the “Agreement Date”),
is entered into by and among ARC Group Acquisition I Corp., a British Virgin Islands business company (“Purchaser”),
Datuk Dr. Doris Wong in the capacity as the representative from and after the Closing (as defined below) for the shareholders of Purchaser
(other than the Company Security Holders (as defined below) as of immediately prior to the Closing and their successors and assigns)
in accordance with the terms and conditions of this Agreement (the “Purchaser Representative”), Firstborn Top Capital
Sdn. Bhd., a Malaysian private limited company (the “Company”), the holders of Company Shares identified on Exhibit
A-1 hereto (each, a “Selling Shareholder” and collectively, the “Selling Shareholders”), and
Ow Ruey Shen, in the capacity as the representative for the Selling Shareholders (the “Shareholder Representative”).
W
I T N E S S E T H :
WHEREAS,
the Company operates a licensed money lending business committed to providing transparent and accessible financial solutions to individuals
and businesses across Malaysia;
WHEREAS,
Purchaser is a blank check special purpose acquisition company incorporated for the purpose of entering into a merger, share exchange,
asset acquisition, share purchase, recapitalization, reorganization, or other similar business combination with one or more operating
businesses or entities through a business combination;
WHEREAS,
the Selling Shareholders own all of the issued and outstanding securities of the Company (the “Company Shares”);
WHEREAS,
the Selling Shareholders desire to sell, transfer, assign, convey and deliver to Purchaser, and Purchaser desires to purchase, acquire
and accept from the Selling Shareholders, all of the Company Shares, for the Transaction Consideration, upon the terms and conditions
set forth herein;
WHEREAS,
the board of directors of the Company and Purchaser have (i) determined that the transactions are fair, advisable and in the best interests
of their respective companies and shareholders, (ii) approved this Agreement, the documents attached as Exhibits hereto (the “Ancillary
Documents”), and the transactions contemplated hereby and thereby, upon the terms and subject to the conditions set forth herein
and therein, and (iii) determined to recommend to their respective shareholders the approval and adoption of this Agreement, the Ancillary
Documents, and the transactions contemplated hereby and thereby;
WHEREAS,
as a condition and inducement to the Company’s willingness to enter into this Agreement, simultaneously with the execution and
delivery of this Agreement, in connection with the transactions contemplated hereby, certain of the Purchaser’s Affiliates and
MFH 2, LLC, a Delaware limited liability company (the “Sponsor”) are entering into the Sponsor Support Agreement in
the form attached as Exhibit F (the “Sponsor Support Agreement”), providing that, among other things, each
such Person shall (i) vote its Purchaser Ordinary Shares in favor of the adoption and approval of this Agreement and the transactions
contemplated hereby and against any Alternative Transaction, (ii) waive any right to redeem any Purchaser Securities it holds and any
anti-dilution rights with respect to any equity issuance, including the PIPE Investment, and (iii) subject its Purchaser Securities to
a lock-up, in each case subject to the limited exceptions set forth therein;
5
WHEREAS,
as a condition and inducement to Purchaser’s willingness to enter into this Agreement, simultaneously with the execution and delivery
of this Agreement, in connection with the transactions contemplated hereby, the directors, officers and holders of five percent (5%)
or more of the voting stock of the Company are entering into a Company Support Agreement in the form attached hereto as Exhibit G
(the “Company Support Agreement”), providing that, among other things, each such Person shall irrevocably agree to
vote in favor of the transactions contemplated hereby and against any Alternative Transaction;
WHEREAS,
in connection with the Closing of the transactions contemplated by this Agreement, certain Key Executives shall have entered into mutually
acceptable Executive Employment Agreements with Purchaser, in substantially the form attached as Exhibit C hereto (each, an “Employment
Agreement”), each of which agreements will become effective as of the Closing;
WHEREAS,
prior to and effective as of the Closing of the transactions contemplated by this Agreement, the officers and directors of Purchaser
and the Company who shall serve in such capacities from and after the Closing shall have been duly elected or appointed thereby, and
shall each have entered into an Indemnification Agreement, the form of which is attached as Exhibit E hereto (the “Indemnification
Agreement”), each of which agreements shall become effective as of the Closing;
WHEREAS,
at the Closing, directors, officers and significant shareholders of the Company as of immediately prior to the Closing Date shall enter
into Lock-Up Agreements with Purchaser in substantially the form attached as Exhibit H hereto (each, a “Lock-Up Agreement”),
subjecting their Purchaser Securities to a lock-up for a period substantially identical to the lock-up applicable to the Sponsor with
respect to its founder shares, and shall enter into Restrictive Covenant Agreements with Purchaser in the form attached as Exhibit
I hereto (each, a “Restrictive Covenant Agreement”), providing for, among other things, non-solicitation and non-competition
restrictions for a period of two (2) to four (4) years from the Closing Date;
WHEREAS,
in connection with the execution and delivery of this Agreement, Purchaser and the Company shall reasonably cooperate to seek to enter
into customary and binding subscription agreements (the “Subscription Agreements”) with certain investors (the “PIPE
Investors”) pursuant to which such PIPE Investors, upon the terms and subject to the conditions set forth therein, may purchase
Purchaser Class A Ordinary Shares at a purchase price of Ten U.S. Dollars ($10.00) per share (the “Private Placement Amount”),
in a private placement or placements (the “Private Placements”) to be consummated concurrently with the Closing (collectively,
the “PIPE Investment”); and
WHEREAS,
certain terms used in this Agreement are defined in Section 14.1.
NOW,
THEREFORE, in consideration of the premises and the mutual covenants and agreements hereinafter contained and for other good and valuable
consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereby agree as follows:
Article
I
SALE
AND PURCHASE OF SHARES
1.1
Sale and Purchase of Company Shares. Upon the terms and subject to the conditions contained herein, on the Closing Date, each
Selling Shareholder shall sell, transfer, assign, convey and deliver to Purchaser, and Purchaser shall purchase, acquire and accept from
each Selling Shareholder, that number of Company Shares set forth opposite the name of each Selling Shareholder on Exhibit A-1
hereto, free and clear of any and all Liens and Encumbrances, such that all of the issued and outstanding Company Shares at the Closing
shall be sold to and purchased by Purchaser.
1.2
Rights Cease to Exist. At the Closing, upon payment of the Transaction Consideration to the Selling Shareholders, respectively,
the Selling Shareholders shall cease to have any rights with respect to the Company Shares, except the rights set forth in this Agreement.
That portion of the Transaction Consideration paid to each Selling Shareholder in accordance with the terms hereof shall be deemed to
have been issued in full satisfaction of all rights pertaining to the Company Shares held by each such Selling Shareholder.
6
Article
II
CONSIDERATION
2.1
Transaction Consideration. Subject to the terms and conditions of this Agreement, the total consideration for the purchase of
all issued and outstanding Company Shares (the “Transaction Consideration”) shall be the number of Purchaser Class
A Ordinary Shares (the “Consideration Shares”) equal to: (A) One Billion U.S. Dollars ($1,000,000,000), (B) minus
the Closing Net Indebtedness, (C) plus or minus, as applicable, the Working Capital Adjustment, and (D) minus the amount of any unpaid
transaction bonuses and other transaction-related compensation payable in connection with the transactions contemplated hereby, in each
case as set forth in the Closing Statement, with the resulting amount divided by the Redemption Price. The Working Capital Adjustment
shall equal the Net Working Capital Amount minus the Target Net Working Capital Amount, such that the Transaction Consideration shall
be increased dollar-for-dollar to the extent the Net Working Capital Amount exceeds the Target Net Working Capital Amount and decreased
dollar-for-dollar to the extent the Target Net Working Capital Amount exceeds the Net Working Capital Amount. The Transaction Consideration
may include earn-out shares expressly agreed by Purchaser and the Company in writing and reflected in the Allocation Statement and applicable
Ancillary Documents. For the avoidance of doubt, there is no minimum cash condition or minimum cash consideration in connection with
the Closing. Each Selling Shareholder shall have the right to receive at the Closing a number of Purchaser Class A Ordinary Shares equal
to the aggregate Consideration Shares divided by the number of Company Shares outstanding immediately prior to the Closing, multiplied
by the number of Company Shares held by such Selling Shareholder (the “Conversion Ratio”). All currency amounts in
this Agreement are designated in U.S. Dollars.
2.2
Closing Statement.
(a)
No later than three (3) Business Days prior to the Closing Date (the date of such calculation, the “Calculation Date”),
the Company shall deliver to Purchaser a statement setting forth (A) the Company Closing Cash, (B) the Closing Net Indebtedness, (C)
the Net Working Capital Amount, (D) the amount of unpaid transaction bonuses and other transaction-related compensation payable in connection
with the transactions contemplated hereby, (E) the amount of Transaction Expenses to be paid by the post-Closing combined company, and
(F) a detailed calculation of each of the foregoing, in each case determined in accordance with the Accounting Principles and accompanied
by reasonable supporting schedules and work papers, certified by the Company’s Director (the “Closing Statement”).
The amounts set forth in the Closing Statement shall be estimates for purposes of the Closing and shall be subject to a post-Closing
true-up.
(b)
Within ninety (90) Business Days after the Closing, Purchaser or the Company shall deliver a final true-up statement (the “Preliminary
Final Closing Statement”). Upon receipt of the Preliminary Final Closing Statement, the Shareholder Representative will have
thirty (30) days (the “Review Period”) to review such Preliminary Final Closing Statement and related computations.
In connection with the review of the Preliminary Final Closing Statement, Purchaser will reasonably cooperate with and give, and will
cause the Company to reasonably cooperate with and give, to the Shareholder Representative and its authorized Representatives, reasonable
access during normal business hours to the books and records of the Company, and work papers used in the preparation of the Preliminary
Final Closing Statement and prepared by or for Purchaser or the Company, including historical financial information relating to the Company,
in each case, as the Shareholder Representative or its authorized Representatives may reasonably request for purposes of their review
of the Preliminary Final Closing Statement, to the extent such access does not unreasonably interfere with the operations of Purchaser
or any of its Affiliates (including the Company) and subject to prior execution of customary access letters; provided, that in
no event shall Purchaser or any of its Affiliates (including the Company) be required to provide any documents or other information covered
by the attorney-client privilege, the attorney work product doctrine or other similar protections or in violation of applicable Laws.
If the Shareholder Representative has accepted such Preliminary Final Closing Statement in writing or has not given written notice to
the Purchaser setting forth any objection of the Shareholder Representative to such Preliminary Final Closing Statement (a “Statement
of Objections”) prior to the expiration of the Review Period, then such Preliminary Final Closing Statement will be final and
binding upon the Parties and will be deemed the “Final Closing Statement” for all purposes under this Agreement. Any
Statement of Objections given by the Shareholder Representative pursuant to and in accordance with the terms hereof will specify in reasonable
detail each item that the Shareholder Representative disputes, the amount in dispute, an alternative amount for each such disputed item,
and calculations (including reasonable documentation and support) for each such disputed item, it being understood and agreed that all
items not included in the Statement of Objections shall be deemed final, conclusive and binding on the Parties.
7
(c)
If the Shareholder Representative delivers a Statement of Objections during the Review Period, Purchaser and the Shareholder Representative
will negotiate in good faith to resolve any such objection within thirty (30) days following the receipt by Purchaser of the Statement
of Objections (the “Consultation Period”), and upon any such resolution, the Final Closing Statement will be prepared
in accordance with the agreement of the Shareholder Representative and Purchaser. If the Shareholder Representative and Purchaser are
unable to reach an agreement as to any such objection(s) within the Consultation Period, then either of the Shareholder Representative
or Purchaser may submit such matter to a nationally recognized independent accounting firm as mutually approved by the Shareholder Representative
and Purchaser (which approval shall not be unreasonably withheld, conditioned or delayed) (the “Settlement Accountant”)
for resolution of the remaining disputed matters, which Settlement Accountant shall be engaged by the Shareholder Representative and
Purchaser within five (5) days after the later to occur of (i) the expiration of the Consultation Period and (ii) delivery of written
notice by either the Shareholder Representative or Purchaser to the other of its desire to engage the Settlement Accountant (and the
Shareholder Representative and Purchaser shall execute any agreement reasonably required by the Settlement Accountant in connection with
its engagement). Purchaser and the Shareholder Representative will instruct the Settlement Accountant that the Settlement Accountant
must act as an arbitrator and not an expert and must only consider those items that are properly identified on the Statement of Objections
as in dispute, unless otherwise agreed by mutual written agreement of the Shareholder Representative and Purchaser during the Consultation
Period. The Shareholder Representative and Purchaser will use their respective commercially reasonable efforts to cause the Settlement
Accountant to resolve all disagreements as soon as practicable and in any event within thirty (30) days after the submission of any dispute
to the Settlement Accountant. The Shareholder Representative and Purchaser will instruct the Settlement Accountant that (i) the Settlement
Accountant’s determination must (x) address only the remaining disputed items properly set forth on the Statement of Objections
and (y) be made solely (A) in accordance with the terms and procedures set forth in this Agreement, including the definitions herein
and the Accounting Principles, and (B) on a single written submission and one single written response and accompanying supporting materials
provided by Purchaser and the Shareholder Representative in accordance with the terms and procedures set forth in this Agreement (i.e.,
not on the basis of an independent review) (provided that a copy of such submission and supporting materials shall be provided
by Purchaser or the Shareholder Representative (as applicable) to the other Party concurrent with delivery of such materials to the Settlement
Accountant); and (ii) the Settlement Accountant may not assign a value to any item greater than the greatest value for such item claimed
by either the Shareholder Representative or Purchaser, or less than the smallest value for such item claimed by either the Shareholder
Representative or Purchaser. The costs and expenses of the Settlement Accountant will be borne equally by Purchaser and the Shareholder
Representative. The resolution of the dispute by the Settlement Accountant will be final, binding and non-appealable on the Parties absent
fraud or manifest error, and any Party may seek to enforce such decision in a court of competent jurisdiction. If any disputes are submitted
to the Settlement Accountant pursuant to this Section 2.3(c), the Final Closing Statement will be prepared in accordance
with the decision of the Settlement Accountant and, to the extent applicable, the mutual agreement of Purchaser and the Shareholder Representative.
(d)
Upon determination of the Final Closing Statement in accordance with Section 2.2(b) or Section 2.2(c), as
applicable, any resulting adjustment shall be effected by delivery or return of Purchaser Class A Ordinary Shares or, if agreed by
both Parties, payment of cash.
8
2.3
Allocation Statement. No later than two (2) Business Days prior to the Closing Date, the Company shall deliver to Purchaser a
statement (the “Allocation Statement”) setting forth each Selling Shareholder’s share of the Transaction Consideration,
calculated in accordance with Section 2.1 hereof (by 8:00 PM New York time) certified by the Company’s Director, to be attached
hereto as Exhibit A-2 at the Closing.
2.4
Fractional Shares. Notwithstanding anything to the contrary contained herein, no fraction of a Purchaser Class A Ordinary Share
will be issued by virtue of the transactions contemplated by this Agreement, and each Person who would otherwise be entitled to a fraction
of a Purchaser Class A Ordinary Share (after aggregating all fractional shares of Purchaser Class A Ordinary Shares that otherwise would
be received by such holder) shall instead have the number of shares of Purchaser Class A Ordinary Shares issued to such Person rounded
up in the aggregate to the nearest whole share of Purchaser Class A Ordinary Share.
2.5
Tax Withholding. Notwithstanding anything to the contrary contained in this Agreement, Purchaser and the Company (or any other
Person required to withhold with respect to any payment made under this Agreement) shall be entitled to deduct and withhold from any
Transaction Consideration payable or otherwise deliverable pursuant to this Agreement such amounts as are required to be deducted or
withheld therefrom under any provision of applicable Laws. To the extent that amounts are so deducted or withheld and paid over to the
appropriate Governmental Authority, such amounts shall be treated for all purposes of this Agreement as having been paid to the Person
to whom such amounts would otherwise have been paid.
Article
III
CLOSING
3.1
Closing. Subject to the satisfaction of the conditions set forth in Section 9.1, Section 9.2 and Section
9.3 hereof (or waiver in writing by the party entitled to waive such conditions), the closing of the sale and purchase of the Company
Shares provided for in Section 1.1 hereof (the “Closing”) shall take place via the electronic exchange of documents
on a date and at a time to be agreed upon by Purchaser and the Company, no later than the second Business Day after the satisfaction
or waiver of each condition to the Closing set forth in Article IX hereof (other than conditions that by their nature
are to be satisfied at the Closing, but subject to the satisfaction or waiver of such conditions), unless another time or date, or both,
are agreed to in writing by the Company and Purchaser. The date on which the Closing shall be held is referred to in this Agreement as
the “Closing Date”.
3.2
Surrender of Company Shares and Disbursement of Transaction Consideration.
(a)
At the Closing, each Selling Shareholder shall deliver to Purchaser the share certificate(s), if certificated, and if not certificated,
evidence of ownership representing such Selling Shareholder’s Company Shares (each, a “Company Certificate”
and collectively, the “Company Certificates”). Notwithstanding anything to the contrary contained herein, in the event
that any Company Certificate shall have been lost, stolen or destroyed, in lieu of delivery of a Company Certificate to Company, the
Selling Shareholder may instead deliver to Company an affidavit of lost certificate and indemnity of loss in form and substance reasonably
acceptable to Purchaser and Company (a “Lost Certificate Affidavit”). Any Lost Certificate Affidavit properly delivered
in accordance with this Section 3.2(a) shall be treated as a Company Certificate for all purposes of this Agreement.
(b)
Subject to the provisions of this Section 3.2, at the Closing, Purchaser shall issue, or cause its transfer agent,
Efficiency, Inc. to update the register of members of the Purchaser and provide a copy to the Purchaser’s registered agent FH
Corporate Services Ltd. If any portion of the Transaction Consideration is to be delivered or issued to a Person other than the
Person in whose name the surrendered Company Certificate is registered immediately.
9
(c)
prior to the Closing, it shall be a condition to such delivery that (i) the transfer of such Company Shares shall have been permitted
in accordance with the terms of the Company Governing Documents in effect immediately prior to the Closing, (ii) such Company Certificate
shall be properly endorsed or shall otherwise be in proper form for transfer and (iii) the Person requesting such delivery shall pay
to Purchaser or the Company, as applicable, any transfer or other Taxes required as a result of such delivery to a Person other than
the registered holder of such Company Certificate or establish to the satisfaction of Company and Purchaser that such Tax has been paid
or is not payable.
3.3
Closing Transactions. All transactions to be concluded at the Closing pursuant to this Agreement shall be deemed concluded simultaneously
at 12:01 a.m. New York time on the Closing Date. Unless waived, no transaction or delivery to be concluded at the Closing shall be deemed
finally concluded unless and until all such transactions or deliveries are concluded.
Article
IV
REPRESENTATIONS
AND WARRANTIES OF THE COMPANY
Except
as set forth in the disclosure schedules delivered by the Company to Purchaser on the date hereof and the Closing Date (the “Company
Disclosure Schedules”), the Section numbers of which are numbered to correspond to the Section numbers of this Agreement to
which they refer, the Company and the Selling Shareholders, hereby jointly and severally represent and warrant to Purchaser, as of the
Agreement Date and again as of the Closing Date, that:
4.1 Organization;
Standing and Power. The Company is a corporation duly incorporated, validly existing and in good standing under the Malaysian
Companies Act and has all requisite corporate power and authority to own, lease and operate its properties and to carry on its
business as now being conducted. The Company is duly qualified and in good standing in the jurisdiction in which it is incorporated
or registered and in each other jurisdiction where it does business or operates to the extent that the character of the property
owned, or leased or operated by it or the nature of the business conducted by it makes such qualification necessary, except where
the failure to be so qualified, individually or in the aggregate, would not reasonably be expected to be material to the Company.
The Company has the requisite power and authority and all necessary governmental licenses, authorizations, permits, consents and
approvals required to own, lease and operate its properties and to carry on its business as currently conducted, except for those
licenses, authorizations, permits, consents and approvals the absence of which, individually or in the aggregate, would not
reasonably be expected to be material to the Company. Schedule 4.1 lists all jurisdictions in which the Company is qualified
to conduct business and all names other than its legal name under which the Company does business. The Company has provided to
Purchaser accurate and complete copies of its Governing Documents, each as amended to date and as currently in full force and
effect. The Company is not in violation of any provision of its Governing Documents.
4.2
Authorization; Binding Agreement. The Company has all requisite corporate power and authority to execute and deliver this Agreement
and each Ancillary Document to which it is or is required to be a party, to perform the Company’s obligations hereunder and thereunder
and to consummate the transactions contemplated hereby and thereby. The execution and delivery of this Agreement and each Ancillary Document
to which the Company is or is required to be a party and the consummation of the transactions contemplated hereby and thereby, (a) have
been duly and validly authorized by the Company’s board of directors in accordance with the Company’s Governing Documents,
the Malaysian Companies Act and any other applicable Law or any Contract to which the Company or any of its shareholders is a party or
by which it or its securities are bound, and (b) no other corporate proceedings on the part of the Company are necessary to authorize
the execution and delivery of this Agreement and each Ancillary Document to which it is a party or to consummate the transactions contemplated
hereby and thereby. This Agreement has been, and each Ancillary Document to which the Company is or is required to be a party shall be
when delivered, duly and validly executed and delivered by the Company and assuming the due authorization, execution and delivery of
this Agreement and any such Ancillary Document by the other parties hereto and thereto, constitutes, or when delivered shall constitute,
the legal, valid and binding obligation of the Company, enforceable against the Company in accordance with its terms, subject to the
Enforceability Exceptions.
10
4.3
Capitalization.
(a)
The Company has a total of 3,636,400 Company Ordinary Shares issued and outstanding. Prior to giving effect to the transactions contemplated
by this Agreement, all of the issued and outstanding Company Securities are set forth on Schedule 4.3(a), along with the
beneficial and record owners thereof, all of which shares and other equity interests are owned free and clear of any Liens and Encumbrances,
other than those imposed under the Company’s Governing Documents. All of the outstanding Company Securities have been duly authorized,
validly issued, fully paid and non-assessable and are not in violation of any purchase option, right of first refusal, preemptive right,
subscription right or any similar right under any provision of the Malaysian Companies Act and any other applicable Law, the Company’s
Governing Documents or any Contract to which the Company is a party or by which it or its securities are bound. The Company holds no
shares or other equity interests of the Company in its treasury. None of the outstanding shares or other equity interests of the Company
were issued in violation of any applicable securities Laws. The rights, privileges and preferences of the Company Ordinary Shares are
as stated in the Company Governing Documents and as provided by the Malaysian Companies Act.
(b)
There are no outstanding options, warrants, calls, rights, commitments, conversion privileges, preemptive rights, rights of first refusal
or first offer, or other rights or Contracts outstanding to purchase or acquire any Company Securities, nor any commitments, arrangements,
promises, restrictions or obligations for the Company to grant, extend or enter into any such option, warrant, call, right, commitment,
conversion privilege, preemptive right, rights of first refusal or first offer, or other right or Contract or to redeem any Company Securities
to which the Company or any of its shareholders is a party or bound relating to any Company Securities, whether or not outstanding. There
are no outstanding or authorized share appreciation, equity appreciation, phantom equity or similar rights with respect to the Company.
Except as set forth on Schedule 4.3(b), there are no voting trusts, proxies, shareholder agreements or any other agreements
or understandings with respect to the voting of the Company’s equity interests. Except as set forth in the Company’s Governing
Documents, there are no outstanding contractual obligations of the Company to repurchase, redeem or otherwise acquire any equity interests
or securities of the Company, nor has the Company granted any registration rights to any Person with respect to the Company’s equity
securities. All of the Company’s securities have been granted, offered, sold and issued in compliance with all applicable securities
Laws. Except as set forth on Schedule 4.3(b), as a result of the consummation of the transactions contemplated by this Agreement,
there are no securities, options, warrants, calls, rights, contracts, commitments, agreements, instruments, arrangements, understandings,
obligations or undertakings of any kind to which the Company is a party or by which any of them is bound obligating (or purporting to
obligate) the Company to (including on a deferred basis) issue, deliver or sell, or cause to be issued, delivered or sold, additional
equity or other ownership interests of the Company, and no rights in connection with any interests, warrants, calls, rights, options
or other securities of the Company accelerate or otherwise become triggered (whether as to vesting, exercisability, convertibility or
otherwise).
(c)
Except as disclosed in the Company Financials or on Schedule 4.3(c), since the date of the Company’s formation, the
Company has not declared or paid any distribution or dividend in respect of its equity interests and has not repurchased, redeemed or
otherwise acquired any equity interests of the Company, and the board of directors of the Company has not authorized any of the foregoing.
(d)
No Changes. Since the close of business on June 30, 2026 and through the date hereof, there has been no change in the outstanding capital
stock of the Company or the number of options, warrants or other rights to purchase capital stock of the Company.
11
4.4
Subsidiaries. The Company has no Subsidiaries.
4.5 Governmental
Approvals. Except as otherwise described in Schedule 4.5, no Consent of or with any Governmental Authority on the part of
the Company is required to be obtained or made in connection with the execution, delivery or performance by the Company of this
Agreement or any Ancillary Documents or the consummation by the Company of the transactions contemplated hereby or thereby other
than (a) such filings as are expressly contemplated by this Agreement, (b) pursuant to Antitrust Laws, (c) the filing with the SEC
of (A) the Registration Statement/Proxy Statement and the declaration of the effectiveness thereof by the SEC and (B) such reports
under Section 13(a) or 15(d) of the Exchange Act as may be required in connection with this Agreement, the Ancillary Documents or
the transactions contemplated hereby or thereby, or (d) any other consents, approvals, authorizations, designations, declarations,
waivers or filings, the absence of which would not have a Material Adverse Effect.
4.6 Non-Contravention.
Except as otherwise described in Schedule 4.6, the execution and delivery by the Company of this Agreement and
each Ancillary Document to which the Company is or is required to be a party or otherwise bound, the consummation by the Company of
the transactions contemplated hereby and thereby, and compliance by the Company with any and all of the provisions hereof and
thereof, will not (a) conflict with or violate any provision of the Company’s Governing Documents, (b) subject to obtaining
the Consents from Governmental Authorities referred to in Section 4.5 hereof, the waiting periods referred to
therein having expired, and any condition precedent to such Consent or waiver having been satisfied, conflict with or violate any
Law, Order or Consent applicable to the Company or any of its material properties or assets, or (c) (i) violate, conflict with or
result in a breach of, (ii) constitute a default (or an event which, with notice or lapse of time or both, would constitute a
default) under, (iii) result in the termination, withdrawal, suspension, cancellation or modification of, (iv) accelerate the
performance required by the Company under, (v) result in a right of termination or acceleration under, (vi) give rise to any
obligation to make payments or provide compensation under, (vii) result in the creation of any Lien upon any of the properties or
assets of the Company under (other than Permitted Liens), (viii) give rise to any obligation to obtain any third party Consent or
provide any notice to any Person or (ix) give any Person the right to declare a default, exercise any remedy, claim a rebate,
chargeback, penalty or change in delivery schedule, accelerate the maturity or performance, cancel, terminate or modify any right,
benefit, obligation or other term under, any of the terms, conditions or provisions of any Company Material Contract, except in the
cases of clauses (b) and (c), as has not been and would not reasonably be expected to have a Material Adverse Effect on the Company
or its ability to consummate the transactions contemplated by this Agreement or the Ancillary Documents or to perform the
Company’s obligations hereunder or thereunder.
4.7
Financial Statements; Internal Controls.
(a)
As used herein, the term “Company Financials” means the (i) PCAOB-audited consolidated financial statements of the
Company (including, in each case, any related notes thereto), consisting of the consolidated balance sheets of the Company as of December
31, 2025 and December 31, 2024, and the related consolidated audited income statements, changes in shareholder equity and statements
of cash flows for the fiscal years then ended, audited by an independent registered public accounting firm in accordance with PCAOB standards
and prepared in accordance with U.S. GAAP and applicable SEC requirements (the “Audited Company Financials”), and
(ii) the Company-prepared financial statements, consisting of the consolidated unaudited balance sheet of the Company as of June 30,
2026 (the “Interim Balance Sheet Date”) and the related consolidated unaudited income statement, changes in shareholder
equity and statement of cash flows for the six (6) months then ended, prepared in accordance with U.S. GAAP and applicable SEC requirements.
True and correct copies of the Company Financials have been provided to Purchaser. The Company Financials (i) accurately reflect the
books and records of the Company as of the times and for the periods referred to therein, (ii) were prepared in accordance with Applicable
Accounting Standards, consistently applied throughout and among the periods involved (except that the unaudited statements exclude the
footnote disclosures and other presentation items required for Applicable Accounting Standards, and exclude year-end adjustments which
will not be material in amount), (iii) comply in all material respects with all applicable accounting requirements under the Securities
Act and the rules and regulations of the SEC thereunder, and (iv) fairly present in all material respects the consolidated financial
position of the Company as of the respective dates thereof and the consolidated results of the operations and cash flows of the Company
for the periods indicated. The Company has never been subject to the reporting requirements of Sections 13(a) and 15(d) of the Exchange
Act. The Company shall cause any other financial statements required for the Registration Statement or Proxy Statement to be prepared
in accordance with U.S. GAAP and applicable SEC requirements and, where required, audited in accordance with PCAOB standards.
12
(b)
The Company maintains accurate books and records reflecting its assets and Liabilities and maintains proper and adequate internal accounting
controls that provide reasonable assurance that (i) the Company does not maintain any off-the-book accounts and that the Company’s
assets are used only in accordance with the Company’s management directives, (ii) transactions are executed with management’s
authorization, (iii) transactions are recorded as necessary to permit preparation of the financial statements of the Company and to maintain
accountability for the Company’s assets, (iv) access to the Company’s assets is permitted only in accordance with management’s
authorization, (v) the reporting of the Company’s assets is compared with existing assets at regular intervals and verified for
actual amounts, and (vi) accounts, notes and other receivables and inventory are recorded accurately, and proper and adequate procedures
are implemented to effect the collection of accounts, notes and other receivables on a current and timely basis. All of the financial
books and records of the Company are complete and accurate in all material respects and have been maintained in the ordinary course consistent
with past practice and in accordance with applicable Laws. The Company has not been subject to or involved in any material fraud that
involves management or other employees who have a significant role in the internal controls over financial reporting of the Company.
In the past five (5) years, the Company or its Representatives has not received any written complaint, allegation, assertion or claim
regarding the accounting or auditing practices, procedures, methodologies or methods of the Company or its internal accounting controls,
including any material written complaint, allegation, assertion or claim that the Company has engaged in questionable accounting or auditing
practices.
(c)
The Company does not have any Indebtedness other than the Indebtedness set forth on Schedule 4.7(c), which schedule sets
forth the amounts (including principal and any accrued but unpaid interest or other obligations) with respect to such Indebtedness.
Except as disclosed on Schedule 4.7(c), no Indebtedness of the Company contains any restriction upon (i) the prepayment
of any of such Indebtedness, (ii) the incurrence of Indebtedness by the Company, or (iii) the ability of the Company to grant any
Lien on its property or assets.
(d)
Except as set forth on Schedule 4.7(d), the Company is not subject to any material Liabilities or obligations (whether or
not required to be reflected on a balance sheet prepared in accordance with Applicable Accounting Standards), except for those that are
either (i) adequately reflected or reserved on or provided for in the consolidated balance sheet of the Company as of the Interim Balance
Sheet Date contained in the Company Financials or (ii) not material and that were incurred after the Interim Balance Sheet Date in the
ordinary course of business consistent with past practice (other than Liabilities for breach of any Contract or violation of any Law).
(e)
All financial projections with respect to the Company that were delivered by or on behalf of the Company to Purchaser or its Representatives
were prepared in good faith using assumptions that the Company believes to be reasonable.
13
(f)
All accounts, notes and other receivables, whether or not accrued, and whether or not billed, of the Company (the “Accounts
Receivable”) arose from sales actually made or services actually performed in the ordinary course of business and represent
valid obligations to the Company arising from its business. None of the Accounts Receivable are subject to any right of recourse, defense,
deduction, return of goods, counterclaim, offset, or set off on the part of the obligor in excess of any amounts reserved therefore on
the Company Financials. All of the Accounts Receivable are, to the Knowledge of the Company, fully collectible according to their terms
in amounts not less than the aggregate amounts thereof carried on the books of the Company (net of reserves) within ninety (90) days.
In particular, all loan receivables included in Accounts Receivable arose from loans actually originated and funded by the Company in
the ordinary course of its moneylending business pursuant to written loan agreements and related loan documents, and, to the Knowledge
of the Company, constitute valid and binding obligations of the applicable borrowers, subject to the Enforceability Exceptions. Except
as set forth on Schedule 4.7(f), none of the Company’s material loan receivables is subject to any material defense, rescission
right, counterclaim, set-off or right of recoupment, other than as expressly provided in the applicable loan documents or required by
applicable Law, and the Company has not agreed to waive, defer or materially reduce any principal, interest, fee or other amount due
under any material loan except in the ordinary course of business consistent with its written credit and collection policies.
(g)
The Company has established and maintains a system of internal controls over financial reporting designed to provide reasonable assurances
regarding the reliability of financial reporting and the preparation of its consolidated financial statements in accordance with Applicable
Accounting Standards and including those policies and procedures that: (i) require the maintenance of records that, in reasonable detail,
accurately and fairly reflect the transactions and dispositions of the assets of the Company; (ii) provide reasonable assurance that
material information relating to the Company is promptly made known to the officers responsible for establishing and maintaining the
system of internal controls; (iii) provide reasonable assurance that transactions are recorded as necessary to permit preparation of
financial statements in accordance with Applicable Accounting Standards, and that receipts and expenditures of the Company are being
made only in accordance with authorizations of management and the board of directors of the Company; (iv) provide reasonable assurance
that the reporting of assets is compared with existing assets at regular intervals and appropriate action is taken with respect to any
differences; and (v) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition
of the assets of the Company and its Subsidiaries. There are no “material weaknesses” (as defined by the Public Company Accounting
Oversight Board) in the design or operation of the Company’s internal controls, and there is no series of multiple “significant
deficiencies” (as defined by the Public Company Accounting Oversight Board) that collectively represent a “material weakness”
in the design or operation of the Company’s internal controls. Since January 1, 2026, neither the Company (including any current
Company employee/service provider thereof) nor, to the Knowledge of the Company, the Company’s independent auditors have identified
or been made aware of (A) any significant deficiency or material weakness in the system of internal controls utilized by the Company,
(B) any fraud, whether or not material, that involves the Company’s management or other employees who have a role in the preparation
of financial statements or the internal controls utilized by the Company, or (C) any material claim or allegation regarding any of the
foregoing.
(h)
The Company has established and maintains a system of controls and procedures sufficient to (i) provide assurance that any significant
deficiencies or material weaknesses in the design or operation of internal controls which are reasonably likely to materially and adversely
affect the ability to record, process, summarize and report financial information, and any fraud that is detected by the Company, whether
or not material, that involves the Company’s management or other employees who have a role in the preparation of financial statements
or the internal controls utilized by the Company, are adequately and promptly disclosed to the Company’s independent auditors and
the Company’s board of directors and (ii) provide reasonable assurance that access to assets is permitted only in accordance with
management’s general or specific authorization.
4.8 Absence
of Certain Changes. Except as set forth on Schedule 4.8, since January 1, 2026, the Company has conducted its business
only in the ordinary course of business consistent with past practice, has not taken any action or committed or agreed to take any
action that would be prohibited by Section 7.2(b) (without giving effect to Schedule 7.2) if such action were taken on
or after the date hereof without the consent of Purchaser, and has not been, accrued or arisen:
(a)
any event, change or development that has had or would reasonably be expected to have, individually or in the aggregate, a Material Adverse
Effect on the Company;
14
(b)
any merger or consolidation involving the Company, or any acquisition by the Company of any business, whether by purchasing all or substantially
all of the assets of or equity securities of, or otherwise acquiring, any business or corporation, partnership, association or other
business organization or a division thereof;
(c)
any material Contract entered into by the Company, other than in the ordinary course of business and as provided to Purchaser, or any
material amendment or termination of, or default under, any material Contract to which the Company is a party or by which it or any of
them is bound;
(d)
any declaration, setting aside or payment of any dividend on, or other distribution (whether in cash, stock or property) in respect of,
any of the Company’s capital shares, or any purchase, redemption or other acquisition by the Company of any of the Company’s
capital shares or any other securities of the Company or any options, warrants, calls or rights to acquire any such shares or other securities;
(e)
any split, combination, recapitalization, exchange, readjustment or reclassification of any of the Company’s capital shares;
(f)
any granting by the Company, whether orally or in writing, of any (i) increase in compensation or fringe benefits payable or otherwise
due to officers of the Company or (ii) material increase in compensation or fringe benefits payable or otherwise due to any non-officer
employees of the Company whose annual base salary is in excess of $50,000 other than in the ordinary course of business consistent with
past practice;
(g)
(i) any change by the Company of severance, termination or bonus policies and practices (excluding sales commissions), (ii) any change
in the policy of the Company relating to the granting of stock options to its employees, directors and consultants; (iii) any entry by
the Company into, or amendment of, (A) any employment, severance, deferred compensation, termination, change of control or indemnification
agreement or (B) any agreement the benefits of which are contingent or the terms of which are materially altered upon the occurrence
of a transaction involving the Company of the nature contemplated hereby (either alone or upon the occurrence of additional or subsequent
events), or (iv) the establishment, adoption or amendment (except as required by law) of any collective bargaining, bonus, profit-sharing,
thrift, pension, retirement or other similar benefit plan or arrangement covering any director, officer or employee of the Company;
(h)
any material amendment or termination of any Company Material Contract except in accordance with its terms of expiration or in the ordinary
course of business;
(i)
any Contract entered into by the Company relating to its assets or business (including the acquisition or disposition of any assets or
property) or any relinquishment by the Company or any of its Subsidiaries of any Contract or other right, in each case having a stated
contract amount or involving obligations or entitlements with a value of more than $250,000 in each individual case (other than Contracts
with customers, suppliers, distributors and representatives entered into in the ordinary course of business, consistent with past practice);
(j)
any change in any method of accounting principles or practices by the Company, except for any such change required by reason of a concurrent
change in Applicable Accounting Standards;
(k)
any debt, capital lease or other debt or equity financing transaction by the Company or entry into any agreement by the Company in connection
with any such transaction, except for debt or capital leases entered into in the ordinary course of business consistent with past practice
which are not, individually or in the aggregate, material to the Company;
15
(l)
any grants of any material refunds, credits, rebates or other allowances by the Company to any customer, other than in the ordinary course
of business;
(m)
any material change in the level of bad debts or reserves relating to accounts receivable experienced by the Company;
(n)
any material restructuring activities by the Company, including any material reductions in force, or any lease terminations or restructuring
of contracts;
(o)
any license of or Lien on any properties or assets, except licenses and Liens which are not material, individually or in the aggregate,
to the business of the Company;
(p)
any loan, advance or capital contribution by the Company to, or investment in, any Person other than (i) loans or advances to Company
employees/service providers in connection with business related travel and expenses, in each case in the ordinary course of business
consistent with past practice; (ii) loans, advances or capital contributions or investments by the Company to or in any wholly owned
Subsidiary, by any wholly owned Subsidiary in the Company, or by a wholly owned Subsidiary of the Company in any other wholly owned Subsidiary
of the Company; or (iii) loans or advances to vendors consistent with past practice that are not, individually or in the aggregate, material
to the Company;
(q)
any material purchases of fixed assets or other long term assets other than in the ordinary course of business;
(r)
any amendment of any material Tax Returns, any adoption of or change in any material election in respect of Taxes, adoption or change
in any accounting method in respect of Taxes, agreement or settlement of any closing agreement relating to an audit, or consent to any
waiver of the statutory period of limitations in respect of any audit;
(s)
any material revaluation, or any indication that such a revaluation is required under Applicable Accounting Standards, by the Company
of any of its respective assets, including, without limitation, writing down the value of long-term or short-term investments, fixed
assets, goodwill, intangible assets, deferred tax assets, or writing off notes or accounts receivable other than in the ordinary course
of business consistent with past practice;
(t)
any significant deficiency or material weakness identified in the system of internal controls utilized by the Company;
(u)
any settlement of any lawsuit or other proceeding by the Company; or
(v)
any damage, destruction or loss, whether or not covered by insurance, materially and adversely affecting the properties, assets or business
of the Company.
4.9
Compliance with Laws. Since the date of the Company’s formation, the Company is not or has been in material conflict or
material non-compliance with, or in material default or violation of, nor has the Company received, since the date of the Company’s
formation, any written or, to the Knowledge of the Company, oral notice of any material conflict or non-compliance with, or material
default or violation of, any applicable Laws by which it or any of its properties, assets, employees, business, products or operations
are or were bound or affected. There is no agreement, judgment, injunction, order or decree binding upon the Company which has or would
reasonably be expected to have the effect of prohibiting or impairing any business practice of the Company in such a way as to be material
and adverse to the Company, nor, to the Knowledge of the Company, is there any pending investigation or inquiry relating thereto.
16
4.10
Company Permits. The Company (and its employees who are legally required to be licensed by a Governmental Authority in order to
perform his or her duties with respect to his or her employment with the Company), holds all Permits necessary to lawfully conduct in
all material respects its business as presently conducted; to own, lease and operate its assets and properties (collectively, the “Company
Permits”). Without limiting the foregoing, the Company holds and maintains all Company Permits required under applicable Money
Lending Laws to carry on its money lending business, including as a licensed moneylender or credit community business, and holds all
licenses, permits, approvals, advertisement permits, branch approvals, online or digital lending approvals, registrations and authorizations.
The Company has made available to Purchaser true, correct and complete copies of all Company Permits. Except as set forth on Schedule
4.10, all of the Company Permits are in full force and effect, and no suspension or cancellation of any of the Company Permits is
pending or, to the Company’s Knowledge, threatened. The Company is not in violation in any material respect of the terms of any
Company Permit, and the Company has not received any written or, to the Knowledge of the Company, oral notice of any Actions relating
to the revocation or modification of any Company Permit.
4.11 Litigation.
Except as described on Schedule 4.11, there is no (a) Action of any nature currently pending or, to the Knowledge
of the Company, threatened in writing, and no such Action has been brought in the past five (5) years; (b) Order now in effect,
pending or outstanding or that was rendered by a Governmental Authority in the past five (5) years, in either case of (a) or (b) by
or against the Company, its (i) current or, to the Knowledge of the Company, former directors or officers, or (ii) equity holders
(provided, that any litigation involving the directors, officers or equity holders of the Company must be directly related to the
Company’s business, securities or assets), or its business, securities, properties or assets (tangible or intangible); or (c)
internal investigations or inquiries now, or to the Knowledge of the Company, being conducted by the Company, the Company’s
board of directors (or any committee thereof) or any third party at the request of any of the foregoing concerning any financial,
accounting, Tax, conflict of interest, illegal activity, fraudulent or deceptive conduct or other misfeasance or malfeasance issues.
The items listed on Schedule 4.11, if finally determined adversely to the Company, will not have, either
individually or in the aggregate, a Material Adverse Effect upon the Company. In the past five (5) years, none of the current or
former, officers, senior management or directors of the Company has been charged with, indicted for, arrested for, or convicted of
any felony or any crime involving fraud.
4.12
Material Contracts.
(a)
Schedule 4.12(a) sets forth a true, correct and complete list of, and the Company has made available to Purchaser, true,
correct and complete copies of, each Contract to which the Company is a party or by which the Company or any of its properties or assets
is bound or affected (each Contract required to be set forth on Schedule 4.12(a), other than a Company Benefit Plan, a “Company
Material Contract”) that:
(i)
contains covenants that materially limit the ability of the Company (A) to compete in any line of business or with any Person or in any
geographic area or to sell, or provide any service or product or solicit any Person, including any non-competition covenants, employee
and customer non-solicit covenants, exclusivity restrictions, rights of first refusal or most-favored pricing clauses or (B) to purchase
or acquire an interest in any other Person;
(ii)
involves any joint venture, profit-sharing, partnership, limited liability company or other similar agreement or arrangement relating
to the formation, creation, operation, management or control of any partnership or joint venture;
(iii)
involves any exchange traded, over the counter or other swap, cap, floor, collar, futures contract, forward contract, option or other
derivative financial instrument or Contract, based on any commodity, security, instrument, asset, rate or index of any kind or nature
whatsoever, whether tangible or intangible, including currencies, interest rates, foreign currency and indices;
17
(iv)
evidences Indebtedness (whether incurred, assumed, guaranteed or secured by any asset) of the Company having an outstanding principal
amount in excess of $20,000;
(v)
involves the acquisition or disposition, directly or indirectly (by merger or otherwise), of assets with an aggregate value in excess
of $100,000 (other than in the ordinary course of business consistent with past practice) or shares or other equity interests of the
Company or another Person;
(vi)
relates to any merger, consolidation or other business combination with any other Person or the acquisition or disposition of any other
entity or its business or material assets or the sale of the Company, its business or material assets;
(vii)
by its terms, individually or with all related Contracts, calls for aggregate payments or receipts by the Company under such Contract
or Contracts of at least $20,000 per year or $100,000 in the aggregate;
(viii)
is with any Top Customer or Top Supplier;
(ix)
obligates the Company to provide continuing indemnification or a guarantee of obligations of a third party after the date hereof in excess
of $20,000;
(x)
is between the Company and any directors, officers or employees of the Company (other than at-will employment arrangements with employees
entered into in the ordinary course of business consistent with past practice), including all non-competition, severance and indemnification
agreements, or any Related Person;
(xi)
obligates the Company to make any capital commitment or expenditure in excess of $20,000 (including pursuant to any joint venture);
(xii)
relates to a material settlement entered into within two (2) years prior to the Agreement Date or under which the Company has outstanding
obligations (other than customary confidentiality obligations);
(xiii)
provides another Person (other than a manager, director or officer of the Company) with a power of attorney;
(xiv)
relates to the development, ownership, licensing or use of any Intellectual Property by, to or from the Company, other than (A) Off-the-Shelf
Software, (B) employee or consultant invention assignment agreements entered into on the Company’s standard form of such agreement,
(C) confidentiality agreements entered into in the ordinary course of business, (D) non-exclusive licenses from customers or distributors
to the Company entered into in the ordinary course of business or (E) feedback and ordinary course trade name or logo rights that are
not material to the Company;
(xv)
relates to the origination, servicing, administration, collection, sale, assignment, participation, securitization, warehouse financing
or other financing of the Company’s Loan Portfolio, or otherwise constitutes a material loan facility, credit facility, loan sale
agreement, servicing agreement, participation agreement, warehouse agreement or similar arrangement relating to the Company’s lending
business;
(xvi)
that will be required to be filed with the Registration Statement under applicable SEC requirements or would otherwise be required to
be filed by the Company as an exhibit for a Form S-1 (or similar successor form) pursuant to Items 601(b)(1), (2), (4), (9) or (10) of
Regulation S-K under the Securities Act as if the Company was the registrant; or
18
(xvii)
is otherwise material to the Company and not described in clauses (i) through (xvi) above.
(b)
Except as disclosed in Schedule 4.12(b), with respect to each Company Material Contract: (i) such Company Material Contract
is valid and binding and enforceable in all respects against the Company and, to the Knowledge of the Company, each other party thereto,
and is in full force and effect (except, in each case, as such enforcement may be limited by the Enforceability Exceptions); (ii) the
consummation of the transactions contemplated by this Agreement will not affect the validity or enforceability of any Company Material
Contract; (iii) the Company is not in breach or default in any material respect, and, to the Knowledge of the Company, no event has occurred
that with the passage of time or giving of notice or both would constitute a material breach or default by the Company, or permit termination
or acceleration by the other party thereto, under such Company Material Contract; (iv) to the Knowledge of the Company, no other party
to such Company Material Contract is in breach or default in any material respect, and no event has occurred that with the passage of
time or giving of notice or both would constitute such a material breach or default by such other party, or permit termination or acceleration
by the Company, under such Company Material Contract; (v) the Company has not received written notice or, to the Company’s Knowledge,
oral notice of an intention by any party to any such Company Material Contract that provides for a continuing obligation by any party
thereto to terminate such Company Material Contract or amend the terms thereof, other than modifications in the ordinary course of business
that do not adversely affect the Company in any material respect; and (vi) the Company has not waived any material rights under any such
Company Material Contract. The Company has no oral Material Contracts which have not been summarized in Schedule 4.12(b).
4.13
Intellectual Property.
(a) Schedule
4.13(a)(i) sets forth: (i) all U.S. and foreign registered Patents, Trademarks, Copyrights and Internet Assets and applications
owned or licensed by the Company or otherwise used or held for use by the Company in which the Company is the owner, applicant or
assignee (“Company Registered IP”), specifying as to each item, as applicable: (A) the nature of the item,
including the title, (B) the owner of the item, (C) the jurisdictions in which the item is issued or registered or in which an
application for issuance or registration has been filed and (D) the issuance, registration or application numbers and dates; and
(ii) all material unregistered Intellectual Property owned or purported to be owned by the Company. Schedule 4.13(a)(ii) sets
forth all Intellectual Property licenses, sublicenses and other agreements or permissions (“Company IP Licenses”)
(other than “shrink wrap,” “click wrap,” and “off the shelf” software agreements and other
agreements for Software commercially available on reasonable terms to the public generally with license, maintenance, support and
other fees of less than $20,000 per year (collectively, “Off-the-Shelf Software”), which are not required to be
listed, although such licenses are “Company IP Licenses” as that term is used herein), under which the Company is a
licensee or otherwise is authorized to use or practice any Intellectual Property, and describes (A) the applicable Intellectual
Property licensed, sublicensed or used and (B) any royalties, license fees or other compensation due from the Company, if any. The
Company owns, free and clear of all Liens and Encumbrances (other than Permitted Liens), has valid and enforceable rights in, and
has the unrestricted right to use, sell, license, transfer or assign, all Intellectual Property currently used, licensed or held for
use by the Company, and previously used or licensed by the Company, except for the Intellectual Property that is the subject of the
Company IP Licenses. No item of Company Registered IP that consists of a pending Patent application fails to identify all pertinent
inventors, and for each Patent and Patent application in the Company Registered IP, the Company has obtained valid assignments of
inventions from each inventor. Except as set forth on Schedule 4.13(a)(ii), all Company Registered IP is owned
exclusively by the Company without obligation to pay royalties, licensing fees or other fees, or otherwise account to any third
party with respect to such Company Registered IP, and the Company has recorded assignments of all Company Registered IP.
19
(b)
The Company has a valid and enforceable license to use all Intellectual Property that is the subject of the Company IP Licenses applicable
to the Company. The Company IP Licenses include all of the licenses, sublicenses and other agreements or permissions necessary to operate
the Company as presently conducted. The Company has performed all obligations imposed on it in the Company IP Licenses, has made all
payments required to date, and the Company is not, nor, to the Knowledge of the Company, is any other party thereto, in breach or default
thereunder, nor has any event occurred that with notice or lapse of time or both would constitute a default thereunder. The continued
use by the Company of the Intellectual Property that is the subject of the Company IP Licenses in the same manner that it is currently
being used is not restricted by any applicable license of the Company. All registrations for Copyrights, Patents, Trademarks and Internet
Assets that are owned by or exclusively licensed to the Company are valid, in force and in good standing with all required fees and maintenance
fees having been paid with no Actions pending, and all applications to register any Copyrights, Patents and Trademarks are pending and
in good standing, all without challenge of any kind. The Company is not party to any Contract that requires the Company to assign to
any Person all of its rights in any Intellectual Property developed by the Company under such Contract.
(c)
Schedule 4.13(c) sets forth all licenses, sublicenses and other agreements or permissions under which the Company is the
licensor (each, an “Outbound IP License”), and for each such Outbound IP License, describes (i) the applicable Intellectual
Property licensed, (ii) the licensee under such Outbound IP License, and (iii) any royalties, license fees or other compensation due
to the Company, if any. The Company has performed all obligations imposed on it in the Outbound IP Licenses, and the Company is not,
nor, to the Knowledge of the Company, is any other party thereto, in breach or default thereunder, nor has any event occurred that with
notice or lapse of time or both would constitute a default thereunder.
(d)
No Action is pending or, to the Company’s Knowledge, threatened against the Company that challenges the validity, enforceability,
ownership, or right to use, sell, license or sublicense, or that otherwise relates to, any Intellectual Property currently owned, licensed,
used or held for use by the Company, nor, to the Knowledge of the Company, is there any reasonable basis for any such Action. The Company
has not received any written or, to the Knowledge of the Company, oral notice or claim asserting or suggesting that any infringement,
misappropriation, violation, dilution or unauthorized use of the Intellectual Property of any other Person is or may be occurring or
has or may have occurred, as a consequence of the business activities of the Company, nor to the Knowledge of the Company is there a
reasonable basis therefor. There are no Orders to which the Company is a party or is otherwise bound that (i) restrict the rights of
the Company to use, transfer, license or enforce any Intellectual Property owned by the Company, (ii) restrict the conduct of the business
of the Company in order to accommodate a third Person’s Intellectual Property, or (iii) other than the Outbound IP Licenses, grant
any third Person any right with respect to any Intellectual Property owned by the Company. The Company is not currently infringing, or
has, in the past, infringed, misappropriated or violated any Intellectual Property of any other Person in any material respect in connection
with the ownership, use or license of any Intellectual Property owned or purported to be owned by the Company or, to the Knowledge of
the Company, otherwise in connection with the conduct of the respective businesses of the Company. To the Company’s Knowledge,
no third party is currently, or in the past five (5) years has been, infringing upon, misappropriating or otherwise violating any Intellectual
Property owned, licensed by, licensed to, or otherwise used or held for use by the Company (“Company IP”) in any material
respect.
(e)
All officers, directors, employees and independent contractors (to the extent any such independent contractor had access to Intellectual
Property of the Company) of the Company (and each of their respective Affiliates) have assigned to the Company all Intellectual Property
arising from the services performed for the Company by such Persons and all such assignments of Company Registered IP have been recorded.
No current or former officers, employees or independent contractors of the Company have claimed any ownership interest in any Intellectual
Property owned by the Company. To the Knowledge of the Company, there has been no violation of the Company’s policies or practices
related to protection of Company IP or any confidentiality or nondisclosure Contract relating to the Intellectual Property owned by the
Company. The Company has made available to Purchaser true and complete copies of all written Contracts referenced in subsections under
which employees and independent contractors assigned their Intellectual Property to the Company. To the Company’s Knowledge, none
of the employees of the Company is obligated under any Contract, or subject to any Order, that would materially interfere with the use
of such employee’s best efforts to promote the interests of the Company, or that would materially conflict with the business of
the Company as presently conducted or contemplated to be conducted. The Company has taken reasonable security measures in order to protect
the secrecy, confidentiality and value of the material Company IP.
20
(f)
To the Knowledge of the Company, no Person has obtained unauthorized access to third party information and data (including personally
identifiable information or information that can be used to identify a natural person (“personal information”)) in the possession
of the Company, nor has there been any other material compromise of the security, confidentiality or integrity of such information or
data, and no written or, to the Knowledge of the Company, oral complaint relating to an improper use or disclosure of, or a breach in
the security of, any such information or data has been received by the Company. The Company has complied in all material respects with
all applicable Laws and Contract requirements relating to privacy, personal information protection, and the collection, processing and
use of personal information and its own privacy policies and guidelines, if any, each with respect to the Company’s collection,
processing and use of personal information. To the Knowledge of the Company, the operation of the business of the Company has not and
does not violate any right to privacy or publicity of any third person, or constitute unfair competition or trade practices under applicable
Law.
(g)
The consummation of any of the transactions contemplated by this Agreement will not result in the material breach, material modification,
cancellation, termination, suspension of, or acceleration of any payments with respect to, or release of source code because of (i) any
Contract providing for the license or other use of Intellectual Property owned by the Company, or (ii) any Company IP License. Following
the Closing, the Company shall be permitted to exercise, directly or indirectly through its Subsidiaries, all of the Company’s
rights under such Contracts or Company IP Licenses to the same extent that the Company would have been able to exercise had the transactions
contemplated by this Agreement not occurred, without the payment of any additional amounts or consideration other than ongoing fees,
royalties or payments which the Company would otherwise be required to pay in the absence of such transactions.
4.14
Tax Returns and Audits.
(a)
The Company has or will have timely filed, or caused to be timely filed, all federal, state, local and foreign Tax Returns required to
be filed by it (taking into account all available extensions), which Tax Returns are true, accurate, correct and complete in all material
respects, and has paid, collected or withheld, or caused to be paid, collected or withheld, all Taxes required to be paid, collected
or withheld, other than such Taxes for which adequate reserves in the Company Financials have been established. The Company has complied
in all material respects with all applicable Laws relating to Tax.
(b)
There is no Action currently pending or, to the Knowledge of the Company, threatened in writing against the Company by a Governmental
Authority in a jurisdiction where the Company does not file Tax Returns that it is or may be subject to taxation by that jurisdiction.
(c)
The Company is not being audited by any Governmental Authority or has been notified in writing or, to the Knowledge of the Company, orally
by any Governmental Authority that any such audit is contemplated or pending. There are no claims, assessments, audits, examinations,
investigations or other Actions pending against the Company in respect of any Tax, and the Company has not been notified in writing of
any proposed Tax claims or assessments against it (other than, in each case, claims or assessments for which adequate reserves in the
Company Financials have been established). No material adjustment relating to any Tax Return of the Company has been proposed in writing
formally or informally by appropriate Governmental Authorities.
21
(d)
There are no Liens or other Encumbrances with respect to any Taxes upon the Company’s assets, other than Permitted Liens.
(e)
The Company has collected or withheld all Taxes currently required to be collected or withheld by it, and all such Taxes have been paid
to the appropriate Governmental Authorities or set aside in appropriate accounts for future payment when due. The Company has no liability
for unpaid Taxes which have not been accrued for or reserved on the Company balance sheet, whether asserted or unasserted, contingent
or otherwise, which is material to the Company, other than any liability for unpaid Taxes that may have accrued since the date of the
Company balance sheet in connection with the operation of the business of the Company in the ordinary course, including, without limitation,
as a result of acquisitions.
(f)
The Company does not have any outstanding waivers or extensions of any applicable statute of limitations to assess any amount of Taxes.
There are no outstanding requests by the Company for any extension of time within which to file any Tax Return or within which to pay
any Taxes shown to be due on any Tax Return.
(g)
The Company has not made any change in accounting method (except as required by a change in Law) or received a ruling from, or signed
an agreement with, any Governmental Authority that would reasonably be expected to have a material impact on its Taxes following the
Closing.
(h)
The Company does not have any Liability for the Taxes of another Person that are not adequately reflected in the Company Financials (i)
under any applicable Tax Law, (ii) as a transferee or successor, or (iii) by contract or indemnity (excluding commercial agreements entered
into in the ordinary course of business the primary purpose of which is not the sharing of Taxes). The Company is not a party to or bound
by any Tax indemnity agreement, Tax sharing agreement or Tax allocation agreement or similar agreement, arrangement or practice (excluding
commercial agreements, arrangements or practices entered into in the ordinary course of business the primary purpose of which is not
the sharing of Taxes) with respect to Taxes (including advance pricing agreement, closing agreement or other agreement relating to Taxes
with any Governmental Authority) that will be binding on the Company with respect to any period following the Closing Date.
(i)
The Company has not requested, nor is it the subject of or bound by any private letter ruling, technical advice memorandum, closing agreement
or similar ruling, memorandum or agreement with any Governmental Authority with respect to any Taxes, nor is any such request outstanding.
4.15 Real
Property. Schedule 4.15 contains a complete and accurate list of all premises currently leased, licensed or subleased or
otherwise used or occupied by the Company for the operation of the business of the Company, and of all current leases, lease
guarantees, agreements and documents related thereto, including all amendments, terminations and modifications thereof or waivers
thereto (collectively, the “Company Real Property Leases”), as well as the current annual rent and term under
each Company Real Property Lease. The Company has provided to Purchaser a true and complete copy of each of the Company Real
Property Leases. The Company Real Property Leases are valid, binding and enforceable in accordance with their terms and are in full
force and effect, subject to Enforceability Exceptions. To the Knowledge of the Company, no event has occurred which (whether with
or without notice, lapse of time or both or the happening or occurrence of any other event) would constitute a material breach,
default or event of default on the part of the Company or any other party under any of the Company Real Property Leases, and the
Company has not received notice of any such condition. The Company does not own nor has ever owned any real property or any interest
in real property (other than the leasehold interests in the Company Real Property Leases). The Company has no oral Company Real
Property Leases other than those summarized in Schedule 4.15. Except as set forth on Schedule 4.15,
(i) no party other than the Company has a right to occupy any material premises under the Company Real Property Leases, (ii) the
premises under the Company Real Property Leases are used only for the operation of the business of the Company, (iii) the premises
under the Company Real Property Leases and the physical assets of the Company are, in all material respects, in good condition and
repair and regularly maintained in accordance with standard industry practice, (iv) to the Company’s Knowledge, the premises
under the Company Real Property Leases are in compliance, in all material respects, with applicable legal requirements and (v) the
Company will not be required to incur any material cost or expense for any restoration or surrender obligations, or any other
material costs otherwise qualifying as asset retirement obligations under Financial Accounting Standards Board Statement of
Financial Accounting Standard No. 143 “Accounting for Asset Retirement Obligations,” upon the expiration or earlier
termination of the Company Real Property Leases.
22
4.16 Personal
Property. Each item of Personal Property which is currently owned, used or leased by the Company with a book value or fair
market value of greater than Twenty Thousand Dollars ($20,000) is set forth on Schedule 4.16, along with, to the extent
applicable, a list of lease agreements, lease guarantees, security agreements and other agreements related thereto, including all
amendments, terminations and modifications thereof or waivers thereto (“Company Personal Property Leases”).
Except as set forth in Schedule 4.16, all such items of Personal Property are in good operating condition and
repair (reasonable wear and tear excepted consistent with the age of such items) and are suitable for their intended use in the
business of the Company. The operation of the Company’s business as it is now conducted or presently proposed to be conducted
is not in any material respect dependent upon the right to use the Personal Property of Persons other than the Company, except for
such Personal Property that is owned, leased or licensed by or otherwise contracted to the Company. The Company has provided to
Purchaser a true and complete copy of each of the Company Personal Property Leases. The Company Personal Property Leases are valid,
binding and enforceable in accordance with their terms and are in full force and effect. To the Knowledge of the Company, no event
has occurred which (whether with or without notice, lapse of time or both or the happening or occurrence of any other event) would
constitute a default on the part of the Company or any other party under any of the Company Personal Property Leases, and the
Company has not received notice of any such condition. The Company has no oral Company Personal Property Leases other than those
summarized in Schedule 4.16.
4.17 Title
to and Sufficiency of Assets. The Company has good and marketable title to, or a valid leasehold interest in or right to use,
all of its assets, free and clear of all Liens and Encumbrances other than (a) Permitted Liens, (b) the rights of lessors under
leasehold interests, (c) Liens specifically identified on the consolidated balance sheet of the Company as of the Interim Balance
Sheet Date and (d) Liens set forth on Schedule 4.17. The assets (including Intellectual Property rights and contractual
rights) of the Company constitute all of the assets, rights and properties that are used in the operation of the businesses of the
Company as it is now conducted or that are used or held by the Company for use in the operation of the businesses of the Company,
and taken together, are adequate and sufficient for the operation of the businesses of the Company as currently
conducted.
4.18
Employee Matters.
(a)
Except as set forth in Schedule 4.18(a), the Company is not a party to any collective bargaining agreement or other Contract
covering any group of employees, labor organization or other representative of any of the employees of the Company, and the Company has
no Knowledge of any activities or proceedings of any labor union or other party to organize or represent such employees. There has not
occurred or, to the Knowledge of the Company, been threatened any strike, slow-down, picketing, work-stoppage, or other similar labor
activity with respect to any such employees. Schedule 4.18(a) sets forth all unresolved labor controversies (including unresolved
grievances and age or other discrimination claims other than any workers’ compensation or unemployment claims), if any, that are
pending or, to the Knowledge of the Company, threatened between the Company and Persons employed by or providing services as independent
contractors to the Company. No current officer or employee of the Company has provided the Company with written or oral notice of his
or her plan to terminate his or her employment with the Company.
23
(b)
Except as set forth in Schedule 4.18(b), the Company (i) is and has been in compliance in all material respects with all
applicable Laws respecting employment and employment practices, terms and conditions of employment, tax withholding, occupational health
and safety, wages (including overtime wages), worker classification, and other Laws relating to discrimination, disability, labor relations,
hours of work, pay equity, immigration, workers’ compensation, working conditions, employee scheduling, family and medical leave,
and employee terminations, and has not received written notice that there is any pending Action involving unfair labor practices against
the Company, (ii) is not liable for any material past due arrears of wages or any material penalty for failure to comply with any of
the foregoing, and (iii) is not liable for any material payment to any Governmental Authority with respect to unemployment compensation
benefits, social security or other benefits or obligations for employees, independent contractors or consultants (other than routine
payments to be made in the ordinary course of business and consistent with past practice). Except as set forth in Schedule 4.18(b),
there are no Actions pending or, to the Knowledge of the Company, threatened against the Company brought by or on behalf of any applicant
for employment, any current or former employee, any Person alleging to be a current or former employee, or any Governmental Authority,
relating to any such Law or regulation, or alleging breach of any express or implied contract of employment, wrongful termination of
employment, or alleging any other discriminatory, wrongful or tortious conduct in connection with the employment relationship.
(c) Schedule
4.18(c) hereto sets forth a complete and accurate list as of the date hereof of all employees of the Company showing for
each as of such date (i) the employee’s name, job title or description, employer, location, salary or hourly rate; and (ii)
wages, bonus, commission or other compensation paid during the fiscal year ending December 31, 2025. Except as set forth on Schedule
4.18(c), (A) no employee is a party to an employment Contract or agreement with the Company that is not terminable “at
will,” and (B) the Company has paid in full to all its employees all wages, salaries, commission, bonuses and other
compensation due to its employees, including overtime compensation, and the Company does not have any obligation or Liability
(whether or not contingent) with respect to severance payments to any such employees under the terms of any agreements or
commitments or any applicable Law, custom, trade or practice. Except as set forth in Schedule 4.18(c), each Company
employee has entered into the Company’s standard form of employee non-disclosure, inventions assignment and restrictive
covenants agreement with the Company (whether pursuant to a separate agreement or incorporated as part of such employee’s
overall employment agreement), copies of all of which agreements have been made available to Purchaser by the Company.
(d)
Schedule 4.18(d) contains a list of all independent contractors (including consultants) currently engaged by the Company,
along with a description of the general nature of the work performed, date of retention and rate of remuneration, most recent increase
(or decrease) in remuneration and amount thereof, for each such Person. Except as set forth on Schedule 4.18(d), all of such
independent contractors are a party to a written Contract with the Company. Except as set forth on Schedule 4.18(d), each
such independent contractor has entered into customary covenants regarding confidentiality and assignment of inventions and copyrights
in such Person’s agreement with the Company, a copy of which has been provided to Purchaser by the Company. No material Company
Liability exists under applicable Law related to the classification of any individual as an independent contractor who is currently,
or within the last six (6) years has been, engaged by the Company. Except as set forth in Schedule 4.18(d), each independent
contractor is terminable on fewer than thirty (30) days’ notice, without any obligation of the Company to pay severance or a termination
fee.
4.19
Benefit Plans.
(a)
Set forth on Schedule 4.19(a) is a true and complete list of each Benefit Plan of the Company (each, a “Company
Benefit Plan”). With respect to each Company Benefit Plan, there are no funded benefit obligations for which contributions
have not been made or properly accrued and there are no unfunded benefit obligations that have not been accounted for by reserves, or
otherwise properly footnoted in accordance with Applicable Accounting Standards on the Company Financials.
(b)
Each Company Benefit Plan is and has been operated at all times in compliance with all applicable Laws in all material respects. No fact
exists which could adversely affect the qualified status of such Company Benefit Plans or the exempt status of such trusts.
24
(c)
With respect to each Company Benefit Plan which covers any current or former officer, director, consultant or employee (or beneficiary
thereof) of the Company, the Company has provided to Purchaser accurate and complete copies, if applicable, of: (i) all Company Benefit
Plan documents and agreements and related trust agreements or annuity Contracts (including any amendments, modifications or supplements
thereto); (ii) all summary plan descriptions and summary of material modifications thereto; (iii) the most recent annual and periodic
accounting of plan assets; (iv) the three (3) most recent nondiscrimination testing reports, if applicable under the Malaysian Companies
Act; (v) the most recent determination letter received from the Malaysian authorities, if any; (vi) the most recent actuarial valuation,
if any; and (vii) all material communications with any Governmental Authority within the last three (3) years.
(d)
With respect to each Company Benefit Plan: (i) such Company Benefit Plan has been administered and enforced in all material respects
in accordance with its terms and the Malaysian Companies Act; (ii) no breach of fiduciary duty has occurred; (iii) no Action is pending
or, to the Knowledge of the Company, threatened in writing (other than routine claims for benefits arising in the ordinary course of
administration); (iv) no prohibited transaction, as defined in the Malaysian Companies Act, has occurred, excluding transactions effected
pursuant to a statutory or administration exemption; and (v) all contributions and premiums due through the Closing Date have been made
in all material respects as required under the respective Company Benefit Plan and the Malaysian Companies Act or have been fully accrued
in all material respects on the Company Financials.
(e)
No arrangement exists pursuant to which the Company will be required to “gross up” or otherwise compensate any person because
of the imposition of any excise tax on a payment to such person.
(f)
With respect to each Company Benefit Plan: (i) no such plan provides medical or death benefits with respect to current or former employees
of the Company beyond their termination of employment (other than coverage mandated by Law, which is paid solely by such employees);
and (ii) there are no reserves, assets, surplus or prepaid premiums under any such plan. The Company has complied in all material respects
with the provisions of the Company Benefit Plan and the Malaysian Companies Act, as applicable.
(g)
Except as set forth on Schedule 4.19(g), the consummation of the transactions contemplated by this Agreement and the
Ancillary Documents will not: (i) entitle any individual to severance pay, unemployment compensation or other benefits or
compensation (except as set forth on Schedule 4.19(g)); (ii) accelerate the time of payment or vesting, or increase the
amount of any compensation due, or in respect of, any individual; or (iii) result in or satisfy a condition to the payment of
compensation that would, in combination with any other payment, result in an “excess parachute payment”. The Company has
not incurred any Liability for any Tax imposed under any Malaysian Governmental Authority or any civil liability.
4.20
Environmental Matters. Except as set forth in Schedule 4.20:
(a)
The Company is and has been in compliance in all material respects with all applicable Environmental Laws, including obtaining, maintaining
in good standing, and complying in all material respects with all Permits and other governmental authorizations required for its business
and operations by Environmental Laws (“Environmental Permits”), no Action is pending or, to the Company’s Knowledge,
threatened to revoke, modify, or terminate any such Environmental Permit, no legitimate written communication, whether from a Governmental
Authority, citizens group, employee or otherwise, that alleges that the Company is not in such compliance, and, to the Company’s
Knowledge, no facts, circumstances, or conditions currently exist that could adversely affect such continued compliance with Environmental
Laws and Environmental Permits or require capital expenditures to achieve or maintain such continued compliance with Environmental Laws
and Environmental Permits.
(b)
The Company is not the subject of any outstanding Order or Contract with any Governmental Authority or other Person in respect of any
(i) Environmental Laws, (ii) Remedial Action, or (iii) Release or threatened Release of a Hazardous Material. The Company has not retained
or assumed, contractually or by operation of Law, any Liabilities or obligations under any Environmental Laws.
25
(c)
No Action has been commenced or is pending, or to the Company’s Knowledge, threatened against the Company or any assets of the
Company alleging either or both that the Company may be in material violation of any Environmental Law or Environmental Permit or may
have any material Liability under any Environmental Law.
(d)
The Company has not manufactured, treated, stored, disposed of, arranged for or permitted the disposal of, generated, handled or released
any Hazardous Material, or owned or operated any property or facility, in a manner that has given or would reasonably be expected to
give rise to any material Liability or obligation under applicable Environmental Laws. No fact, circumstance, or condition exists in
respect of the Company or any property currently or formerly owned, operated, or leased by the Company or any property to which the Company
arranged for the disposal or treatment of Hazardous Materials that could reasonably be expected to result in the Company incurring any
material Environmental Liabilities.
(e)
There is no investigation of the business, operations, or currently owned, operated, or leased property of the Company or, to the Company’s
Knowledge, previously owned, operated, or leased property of the Company pending or, to the Company’s Knowledge, threatened that
could lead to the imposition of any Liens or Encumbrances under any Environmental Law or material Environmental Liabilities.
(f)
To the Knowledge of the Company, there is not located at any of the properties of the Company any (i) underground storage tanks, (ii)
asbestos-containing material, (iii) equipment containing polychlorinated biphenyls, or (iv) any other hazardous materials.
(g)
The Company has provided to Purchaser all nonprivileged and material assessments, audits, studies, reports, data, analysis and results
of investigations that are in the possession or control of the Company regarding environmental matters pertaining to the environmental
condition of the business of the Company, including the currently or previously owned, leased, or operated properties of the Company.
4.21
Transactions with Related Persons. Except as set forth on Schedule 4.21, no officer, director, manager, employee,
trustee or beneficiary of the Company or any of its Affiliates, nor any immediate family member of any of the foregoing (whether directly
or indirectly through an Affiliate of such Person) (each of the foregoing, a “Related Person”) is presently, or in
the past two (2) years, has been, a party to any transaction with the Company, including any Contract or other arrangement (a) providing
for the furnishing of services by, (b) providing for the rental of real property or Personal Property from or (c) otherwise requiring
payments to (other than for services or expenses as directors, officers or employees of the Company in the ordinary course of business
consistent with past practice) any Related Person or any Person in which any Related Person has an interest as an owner, officer, manager,
director, trustee or partner or in which any Related Person has any direct or indirect interest (other than the ownership of securities
representing no more than two percent (2%) of the outstanding voting power or economic interest of a publicly traded company). Except
as set forth on Schedule 4.21, the Company has not outstanding any Contract or other arrangement or commitment with
any Related Person, and no Related Person owns any real property or Personal Property, or right, tangible or intangible (including Intellectual
Property) which is used in the business of the Company. The assets of the Company do not include any material receivable or other obligation
from a Related Person, and the liabilities of the Company do not include any material payable or other obligation or commitment to any
Related Person. No Related Person of any Affiliate that is not the Company owns any asset or intellectual property used by the Company
in operating its business.
4.22
Insurance.
(a) Schedule
4.22(a) lists all insurance policies and fidelity bonds (by policy number, insurer, coverage period, coverage amount, annual
premium and type of policy) held by the Company relating to the Company or its business, properties, assets, directors, officers and
employees, copies of which have been provided to Purchaser. Such policies and bonds are written by insurers of recognized financial
responsibility against such risks and losses and in such amounts as is reasonably sufficient for the conduct of the business of the
Company, including to cover the replacement cost of the fixed assets used in the Company’s businesses. All premiums due and
payable under all such insurance policies have been timely paid and the Company is otherwise in material compliance with the terms
of such insurance policies. Each such insurance policy (i) is legal, valid, binding, enforceable and in full force and effect and
(ii) will continue to be legal, valid, binding, enforceable, and in full force and effect on identical terms following the Closing.
The Company does not have any self-insurance or co-insurance programs. In the past five (5) years, the Company has not received any
notice from, or on behalf of, any insurance carrier relating to or involving any adverse change or any change other than in the
ordinary course of business, in the conditions of insurance, any refusal to issue an insurance policy or non-renewal of a
policy.
26
(b)
Schedule 4.22(b) identifies each individual insurance claim in excess of $20,000 made by the Company in the past five (5)
years. The Company has reported to its insurers all claims and pending circumstances that would reasonably be expected to result in a
claim, except where such failure to report such a claim would not be reasonably likely to be material to the Company. To the Knowledge
of the Company, no event has occurred, and no condition or circumstance exists, that would reasonably be expected to (with or without
notice or lapse of time) give rise to or serve as a basis for the denial of any such insurance claim. In the three (3) years preceding
the date hereof, the Company has not made any claim against an insurance policy as to which the insurer is denying or disputing coverage.
4.23
Books and Records. All of the financial books and records of the Company are complete and accurate in all material respects and
have been maintained in the ordinary course of business consistent with past practice and in accordance with applicable Laws and accounting
requirements and the Company Financials are consistent with such books and records. The Company is not a party to, or has any commitment
to become a party to, any “off-balance sheet arrangements” (as defined in Item 303(a) of Regulation S-K of the SEC).
4.24
Top Customers and Suppliers. Schedule 4.24 lists, by dollar volume received or paid, as applicable, for each
of (a) the twelve (12) months ended on December 31, 2025 and (b) the period from January 1, 2026 through the Interim Balance Sheet Date,
the five (5) largest customers of the Company (the “Top Customers”) and the five (5) largest suppliers of goods or
services to the Company (the “Top Suppliers”), along with the amounts of such dollar volumes. The relationships of
the Company with such suppliers and customers are good commercial working relationships and (i) no Top Supplier or Top Customer within
the last twelve (12) months has cancelled or otherwise terminated or modified the orders or requirements by more than ten (10) percent
for periods from or after the Agreement Date relative to the amounts prior to December 31, 2025 of such Top Customer or Top Suppliers,
or, to the Company’s Knowledge, intends to cancel or otherwise terminate, any material relationships of such Person with the Company,
(ii) no Top Supplier or Top Customer has during the last twelve (12) months decreased materially or, to the Company’s Knowledge,
threatened to stop, decrease or limit materially, or intends to modify materially its material relationships with the Company or stop,
decrease or limit materially its products or services to the Company or its usage or purchase of the products or services of the Company,
(iii) to the Company’s Knowledge, no Top Supplier or Top Customer intends to refuse to pay any amount due to the Company or seek
to exercise any remedy against the Company, and (iv) the Company has not within the past two (2) years been engaged in any material dispute
concerning its services with any Top Supplier or Top Customer.
27
4.25
Certain Business Practices.
(a)
Neither the Company nor any of its Representatives acting on its behalf has (i) used any funds for unlawful contributions, gifts, entertainment
or other unlawful expenses relating to political activity, (ii) made any unlawful payment to foreign or domestic government officials
or employees, to foreign or domestic political parties or campaigns or violated any provision of the U.S. Foreign Corrupt Practices Act
of 1977, as amended, or any other local or foreign anti-corruption or bribery Law applicable to the Company or (iii) made any other unlawful
payment. Neither the Company nor, to the Knowledge of the Company, any of its Representatives acting on its behalf has directly or indirectly,
used any corporate funds for unlawful contributions, gifts, entertainment or other unlawful expenses relating to political activity,
made, offered or authorized any unlawful payment, whether directly or indirectly, or made, offered or authorized any unlawful bribe,
rebate, payoff, influence payment, kickback or other similar unlawful payment, whether directly or indirectly, to any customer, supplier,
foreign or domestic governmental officials or employees or other Person who is or may be in a position to help or hinder the Company
or assist the Company in connection with any actual or proposed transaction. The Company has established reasonable internal controls
and procedures intended to ensure compliance with such anti-corruption or bribery Law.
(b)
The Company has adopted, implemented and maintained policies, procedures, controls, systems and training reasonably designed to ensure
compliance with applicable anti-money laundering, counter-terrorism financing, counter-proliferation financing, sanctions, targeted financial
sanctions, suspicious transaction reporting, customer due diligence, enhanced due diligence, recordkeeping and risk assessment requirements
applicable to moneylenders in Malaysia. The Company has conducted customer due diligence and, where required, enhanced due diligence
on borrowers, beneficial owners and relevant counterparties; has maintained all required records; has screened customers and counterparties
against applicable sanctions and watchlists; and has timely made all reports required by applicable Law. The Company has not received
any written notice alleging any material deficiency in its AML/CFT or sanctions compliance program.
(c)
Neither the Company nor any of its respective directors or officers, or, to the Knowledge of the Company, any other Representative acting
on behalf of the Company is currently identified on the specially designated nationals or other blocked person list or otherwise currently
subject to any U.S. sanctions administered by the Office of Foreign Assets Control of the U.S. Treasury Department (“OFAC”)
or on the sanctions lists adopted by the United Nations, European Union or United Kingdom (“UK”), as such lists may
be extended from time to time (“Sanctions List”) and the Company has not in the last five (5) fiscal years, directly
or indirectly, used any funds, or loaned, contributed or otherwise made available such funds to any Subsidiary, joint venture partner
or other Person, in connection with any sales or operations in Cuba, Iran, Syria, Sudan, Myanmar or any other country sanctioned by OFAC
or on the Sanctions List or for the purpose of financing the activities of any Person currently subject to, or otherwise in violation
of, any U.S. sanctions administered by OFAC or the Sanctions List.
(d)
The Company’s origination, documentation, disbursement, servicing and collection of loans, including its advertising and marketing
of money lending services, have been conducted in all material respects in accordance with applicable Money Lending Laws. The Company
maintains complete and accurate borrower files, credit assessment records, security documents, repayment records, receipts, notices,
collection records and statutory registers required by applicable Money Lending Laws. All collection, recovery, enforcement and repossession
activities conducted by or on behalf of the Company have been conducted in material compliance with applicable Law and the Company’s
policies, and neither the Company nor any agent, collector, outsourced service provider or Representative has used harassment, intimidation,
unlawful threats, misleading statements, unfair practices or any other unlawful collection practice in connection with the Company’s
money lending business. Except as set forth on Schedule 4.25(d), the Company has not charged interest, fees, costs or other amounts
in excess of amounts permitted by applicable Law and has not used any collection practice prohibited by applicable Law.
(e)
All advertisements, marketing materials, websites, mobile applications, social media, call scripts, borrower communications and other
promotional materials used by or on behalf of the Company in connection with its money lending business have been approved, licensed
or permitted to the extent required by applicable Law and have not been false, misleading, deceptive or in violation of any Money Lending
Law. The Company’s collection, use, processing, storage, disclosure and transfer of borrower and applicant data in connection with
its money lending business complies in all material respects with applicable privacy, data protection, cybersecurity and confidentiality
Laws and with the Company’s published policies and contractual obligations.
28
4.26
Compliance with Privacy Laws, Privacy Policies and Certain Contracts. Except as set forth on Schedule 4.26:
(a)
The Company, and, to the Knowledge of the Company, its officers, directors, managers, employees, agents, subcontractors and vendors to
whom the Company has given access to Personal Data and/or Loan Portfolio information, are and have been at all times, in compliance in
all material respects with all applicable Privacy Laws, and the Company has maintained appropriate safeguards reasonably designed to
protect such information against any loss, damage or unauthorized access, use, disclosure or modification, or breach of security;
(b)
Except as would not, individually or in the aggregate, have a Material Adverse Effect, to the Knowledge of the Company, the Company has
not experienced any loss, damage or unauthorized access, use, disclosure or modification, or breach of security of Personal Data and/or
Loan Portfolio information maintained by or on behalf of the Company (including, to the Knowledge of the Company, by any agent, subcontractor
or vendor of the Company);
(c)
Except as would not, individually or in the aggregate, have a Material Adverse Effect, to the Knowledge of the Company, (i) no Person,
including any Governmental Authority, has made any written claim or commenced any Proceeding with respect to any violation of any Privacy
Law by the Company; (ii) the Company has not been given written notice of any criminal, civil or administrative violation of any Privacy
Law, in any case including any claim or action with respect to any loss, damage or unauthorized access, use, disclosure, modification,
or breach of security, of Personal Data maintained by or on behalf of the Company (including by any agent, subcontractor or vendor of
the Company); and
(d)
To the Knowledge of the Company, all activities conducted by the Company with respect to any Personal Data are permitted under the Contracts
relating to Personal Data.
(e)
To the Knowledge of the Company, each Contract between the Company and a customer of the Company contains all the terms and conditions
that the Company is required to include therein under the Company’s Contracts with its vendors and suppliers.
4.27
Investment Company Act. The Company is not an “investment company” or a Person directly or indirectly “controlled”
by or acting on behalf of an “investment company,” or required to register as an “investment company,” in each
case within the meaning of the Investment Company Act of 1940, as amended.
4.28
Finders and Brokers. Except as set forth in Schedule 4.28, the Company has not incurred or will incur, directly
or indirectly, any Liability for any brokerage, finder’s or other fee or commission related to investment banking or similar advisory
services or any similar charges in connection with this Agreement or any transactions contemplated hereby, nor has the Company entered
into any indemnification agreement or arrangement with any Person specifically in connection with this Agreement and the transactions
contemplated hereby.
4.29
Restrictions on Business Activities. Except as set forth in Schedule 4.29, the Company is not party to or bound
by any Contract containing any covenant (a) limiting in any material respect the right of the Company to engage or compete in any line
of business, to make use of any material Company Registered IP or to compete with any Person, (b) granting any exclusive distribution
rights, (c) providing “most favored nations” terms for products and services developed or under development by or on behalf
of the Company, or (d) which otherwise adversely affects or would reasonably be expected to adversely affect the right of the Company
to sell or distribute any products and services developed or under development by or on behalf of the Company or material Company Registered
IP or to purchase or otherwise obtain any material software.
29
4.30
Fairness Opinion. The Company has received the written opinion of Strategic Capital Advisory Sdn. Bhd. (“Strategic Capital
Advisory”) dated as of August 21, 2026, to the effect that, as of such date and subject to the assumptions, qualifications
and limitations set forth therein, the Conversion Ratio was fair to the Selling Shareholders from a financial point of view and will
deliver to Purchaser solely for informational purposes a copy of such opinion as soon as practicable after a written copy thereof is
executed. The Company has been authorized by Strategic Capital Advisory to permit the inclusion of such opinion, but only in its entirety
in the Registration Statement and Proxy Statement to the extent permitted by the issuing firm and applicable Law.
4.31
Independent Investigation. The Company has conducted its own independent investigation, review and analysis of the business, results
of operations, prospects, condition (financial or otherwise) or assets of Purchaser, and acknowledges that it has been provided adequate
access to the personnel, properties, assets, premises, books and records, and other documents and data of Purchaser for such purpose.
The Company acknowledges and agrees that: (a) in making its decision to enter into this Agreement and to consummate the transactions
contemplated hereby, it has relied solely upon its own investigation and the express representations and warranties of Purchaser set
forth in this Agreement (including the related portions of Purchaser Disclosure Schedules) and in any certificate delivered to the Company
pursuant hereto; and (b) neither Purchaser nor any of its Representatives have made any representation or warranty as to Purchaser or
this Agreement, except as expressly set forth in this Agreement (including the related portions of Purchaser Disclosure Schedules) or
in any certificate delivered to the Company pursuant hereto.
4.32
Information Supplied. None of the information supplied or to be supplied by the Company expressly for inclusion or incorporation
by reference: (a) in any current report on Form 8-K (or similar successor form), and any exhibits thereto or any other report, form,
registration or other filing made with any Governmental Authority or stock exchange with respect to the transactions contemplated by
this Agreement or any Ancillary Documents; (b) in the Registration Statement; or (c) in the mailings or other distributions to Purchaser’s
shareholders and/or prospective investors with respect to the consummation of the transactions contemplated by this Agreement or in any
amendment to any of the documents identified in (a) through (c), will, when filed, made available, mailed or distributed, as the case
may be, contain any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary
in order to make the statements therein, in light of the circumstances under which they are made, not misleading. None of the information
supplied or to be supplied by the Company expressly for inclusion or incorporation by reference in any of the Signing Press Release,
the Signing Filing, the Closing Press Release and the Closing Filing will, when filed or distributed, as applicable, contain any untrue
statement of a material fact or omit to state any material fact required to be stated therein or necessary in order to make the statements
therein, in light of the circumstances under which they are made, not misleading. Notwithstanding the foregoing, the Company makes no
representation, warranty or covenant with respect to any information supplied by or on behalf of Purchaser or its Affiliates, or any
information provided by the Company and modified in any material respect by Purchaser or any of its Affiliates without the Company’s
prior written approval.
4.33
Disclosure. No representations or warranties by the Company in this Agreement (as modified by the Company Disclosure Schedules)
or the Ancillary Documents, (a) contains or will contain any untrue statement of a material fact, or (b) omits or will omit to state,
when read in conjunction with all of the information contained in this Agreement, the Company Disclosure Schedules and the Ancillary
Documents, any fact necessary to make the statements or facts contained therein not materially misleading. Except for the representations
and warranties expressly made by the Company in this Article IV (as modified by the Company Disclosure Schedules)
or as expressly set forth in an Ancillary Document, neither the Company nor any other Person on its behalf makes any express or implied
representation or warranty with respect to any of the Company, the Company Security Holders, the Company Shares, the business of the
Company, or the transactions contemplated by this Agreement or any of the other Ancillary Documents, and the Company hereby expressly
disclaims any other representations or warranties, whether implied or made by the Company or any of its Representatives. Except for the
representations and warranties expressly made by the Company in this Article IV (as modified by the Company Disclosure
Schedules) or in an Ancillary Document, the Company hereby expressly disclaims all liability and responsibility for any representation,
warranty, projection, forecast, statement or information made, communicated or furnished (orally or in writing) to Purchaser, Purchaser
Representative or any of their respective Representatives (including any opinion, information, projection or advice that may have been
or may be provided to Purchaser, Purchaser Representative or any of their respective Representatives by any Representative of the Company),
including any representations or warranties regarding the probable success or profitability of the businesses of the Company.
30
Article
V
REPRESENTATIONS
AND WARRANTIES OF THE SELLING SHAREHOLDERS
Each
Selling Shareholder, severally, hereby represents to Purchaser, as of the Agreement Date and again as of the Closing, that:
5.1
Authorization of Agreement; Enforceability. Such Selling Shareholder has all requisite power, authority and legal capacity to
execute and deliver this Agreement and each other agreement, document, instrument or certificate contemplated by any Ancillary Document,
or to be executed and delivered by such Selling Shareholder in connection with the consummation of the transactions contemplated by this
Agreement (this Agreement, any Ancillary Document, and all other documents executed and delivered by each Selling Shareholder in connection
with the transactions contemplated by this Agreement collectively referred to herein as the “Selling Shareholder Documents”),
and to consummate the transactions and perform its obligations contemplated hereby and thereby. This Agreement has been, and each other
Selling Shareholder Document will be at or prior to the Closing, duly and validly executed, stamped as necessary, and delivered by such
Selling Shareholder, and (assuming the due authorization, execution and delivery by Purchaser), this Agreement constitutes, and each
other Selling Shareholder Document, when so executed and delivered, will constitute, the legal, valid and binding obligation of such
Selling Shareholder, enforceable against such Selling Shareholder in accordance with their terms.
5.2
Conflicts; Consents of Third Parties.
(a)
None of the execution, delivery and performance by such Selling Shareholder of the Selling Shareholder Documents, the consummation of
the transactions contemplated thereby, or compliance by such Selling Shareholder with any of the provisions thereof will: (i) cause such
Selling Shareholder or the other Parties to this Agreement to breach any Law or Order of any Governmental Authority that is applicable
to such Selling Shareholder; or (ii) conflict with or result in a breach or termination of any of the terms, conditions or provisions
of, or constitute a default under, accelerate any obligations arising under, trigger any payment under, or result in the creation of
any Lien pursuant to, or otherwise adversely affect, in any material respect, any of the terms, conditions or provisions of any material
agreement or instrument to which such Selling Shareholder is a party or by which such Selling Shareholder (or its assets) may be bound,
or constitute a default thereunder.
(b)
No consent, waiver, approval or authorization of, or declaration or filing with, or notification to, any Person (including any spousal
consent or consent of the beneficiary of any trust) or Governmental Authority is required on the part of such Selling Shareholder or
the other Parties to this Agreement in connection with the execution and delivery of the Selling Shareholder Documents, or the compliance
by such Selling Shareholder with any of the provisions thereof, or the consummation of the transactions contemplated thereby.
5.3
Ownership and Transfer of Company Shares. Such Selling Shareholder is the record and beneficial owner of the Company Shares set
forth next to such Selling Shareholder’s name on Exhibit A-1 hereto, free and clear of any and all Liens and Encumbrances.
Such Selling Shareholder has the power and authority to sell, transfer, assign and deliver the Company Shares as provided in this Agreement,
and such delivery will vest in Purchaser good and valid title to the Company Shares, free and clear of any and all Liens and Encumbrances.
31
5.4
Litigation. There are no Legal Proceedings pending, or to the Knowledge of such Selling Shareholder threatened, that are reasonably
likely to prohibit or restrain the ability of such Selling Shareholder to enter into this Agreement or timely to consummate the transactions
contemplated hereby.
5.5
Financial Advisors. No Person has acted, directly or indirectly, as a broker, finder, agent, representative or similar intermediary
for such Selling Shareholder in connection with this Agreement and the transactions contemplated by this Agreement and no other Person
is entitled to any fee or commission or like payment in respect thereof.
Article
VI
REPRESENTATIONS
AND WARRANTIES OF PURCHASER
Except
as set forth in (i) the disclosure schedules delivered by Purchaser to the Company on the date hereof (the “Purchaser Disclosure
Schedules”), the Section numbers of which are numbered to correspond to the Section numbers of this Agreement to which they
refer, or (ii) the SEC Reports that are available on the SEC’s website through EDGAR, Purchaser represents and warrants to the
Company as of the Agreement Date and as of the Closing, as follows:
6.1
Organization and Standing. Purchaser is a British Virgin Islands business company duly incorporated, validly existing and in good
standing under the Laws of the British Virgin Islands. Purchaser has all requisite corporate power and authority to own, lease and operate
its properties and to carry on its business as now being conducted. Purchaser is duly qualified or licensed and in good standing to do
business in each jurisdiction in which the character of the property owned, leased or operated by it or the nature of the business conducted
by it makes such qualification or licensing necessary, except where the failure to be so qualified or licensed or in good standing can
be cured without material cost or expense. Purchaser has heretofore made available to the Company accurate and complete copies of its
Governing Documents, as currently in effect. Purchaser is not in violation of any provision of its Governing Documents in any material
respect.
6.2
Authorization; Binding Agreement. Purchaser has all requisite corporate power and authority to execute and deliver this Agreement
and each Ancillary Document to which it is a party, to perform Purchaser’s obligations hereunder and thereunder and to consummate
the transactions contemplated hereby and thereby, subject to obtaining the Required Purchaser Shareholder Approval. The execution and
delivery of this Agreement and each Ancillary Document to which it is a party and the consummation of the transactions contemplated hereby
and thereby (a) have been duly and validly authorized by the board of directors of Purchaser, and (b) other than the Required Purchaser
Shareholder Approval, no other corporate proceedings, other than as set forth elsewhere in the Agreement, on the part of Purchaser are
necessary to authorize the execution and delivery of this Agreement and each Ancillary Document to which it is a party or to consummate
the transactions contemplated hereby and thereby. This Agreement has been, and each Ancillary Document to which Purchaser is a party
shall be when delivered, duly and validly executed and delivered by Purchaser and, assuming the due authorization, execution and delivery
of this Agreement and such Ancillary Documents by the other parties hereto and thereto, constitutes, or when delivered shall constitute,
the valid and binding obligation of Purchaser, enforceable against Purchaser in accordance with its terms, except to the extent that
enforceability thereof may be limited by applicable bankruptcy, insolvency, reorganization and moratorium laws and other laws of general
application affecting the enforcement of creditors’ rights generally or by any applicable statute of limitation or by any valid
defense of set-off or counterclaim, and the fact that equitable remedies or relief (including the remedy of specific performance) are
subject to the discretion of the court from which such relief may be sought (collectively, the “Enforceability Exceptions”).
Purchaser’s board of directors, by resolutions duly adopted at a meeting duly called and held (i) determined that this Agreement
and transactions contemplated hereby are advisable, fair to, and in the best interests of, Purchaser and its shareholders, (ii) approved
this Agreement and the transactions contemplated by this Agreement in accordance with the BVI Companies Act, (iii) directed that this
Agreement be submitted to Purchaser’s shareholders for approval and (iv) resolved to recommend that Purchaser’s shareholders
adopt this Agreement.
32
6.3 Governmental
Approvals. Except as otherwise described in Schedule 6.3, no Consent of or with any Governmental Authority, on the part
of Purchaser is required to be obtained or made in connection with the execution, delivery or performance by Purchaser of this
Agreement and each Ancillary Document to which it is a party or the consummation by Purchaser of the transactions contemplated
hereby and thereby, other than (a) pursuant to Antitrust Laws, (b) such filings as contemplated by this Agreement, (c) any filings
required with Nasdaq or the SEC with respect to the transactions contemplated by this Agreement, (d) applicable requirements, if
any, of the Securities Act, the Exchange Act, and/or any state “blue sky” securities Laws, and the rules and regulations
thereunder, and (e) where the failure to obtain or make such Consents or to make such filings or notifications, would not reasonably
be expected to have a Material Adverse Effect on Purchaser.
6.4 Non-Contravention.
Except as otherwise described in Schedule 6.4, the execution and delivery by Purchaser of this Agreement and each Ancillary
Document to which it is a party, the consummation by Purchaser of the transactions contemplated hereby and thereby, and compliance
by Purchaser with any of the provisions hereof and thereof, will not (a) subject to obtaining the approval of the Purchaser’s
shareholders, conflict with or violate any provision of Purchaser’s Governing Documents, (b) subject to obtaining the Consents
from Governmental Authorities referred to in Section 6.3 hereof, and the waiting periods referred to therein having expired,
and any condition precedent to such Consent or waiver having been satisfied, conflict with or violate any Law, Order or Consent
applicable to Purchaser or any of their properties or assets, or (c) (i) violate, conflict with or result in a breach of, (ii)
constitute a default (or an event which, with notice or lapse of time or both, would constitute a default) under, (iii) result in
the termination, withdrawal, suspension, cancellation or modification of, (iv) accelerate the performance required by Purchaser
under, (v) result in a right of termination or acceleration under, (vi) give rise to any obligation to make payments or provide
compensation under, (vii) result in the creation of any Lien upon any of the properties or assets of Purchaser under, (viii) give
rise to any obligation to obtain any third party Consent or provide any notice to any Person or (ix) give any Person the right to
declare a default, exercise any remedy, claim a rebate, chargeback, penalty or change in delivery schedule, accelerate the maturity
or performance, cancel, terminate or modify any right, benefit, obligation or other term under, any of the terms, conditions or
provisions of, any Purchaser Material Contract, except for any deviations from any of the foregoing clauses (a), (b) or (c) that
would not reasonably be expected to have a Material Adverse Effect on Purchaser.
6.5
Capitalization.
(a)
Purchaser is authorized to issue up to 500,000,000 Purchaser Class A Ordinary Shares par value $0.0001 per share, 50,000,000 Purchaser
Class B Ordinary Shares, par value $0.0001 per share, and 5,000,000 Purchaser Preference Shares, par value $0.0001 per share. The issued
and outstanding Purchaser Securities as of the Agreement Date are set forth on Schedule 6.5(a). There are no issued or outstanding
Purchaser Preference Shares. All issued and outstanding Purchaser Ordinary Shares are duly authorized, validly issued, fully paid and
non-assessable and are not subject to or issued in violation of any purchase option, right of first refusal, preemptive right, subscription
right or any similar right under any provision of the BVI Companies Act, Purchaser’s Governing Documents or any Contract to which
Purchaser is a party. None of the outstanding Purchaser Securities has been issued in violation of any applicable securities Laws.
(b)
Except as set forth in Schedule 6.5(a) or Schedule 6.5(b), there are no (i) outstanding options, warrants, puts,
calls, convertible securities, preemptive or similar rights, (ii) bonds, debentures, notes or other Indebtedness having general
voting rights or that are convertible or exchangeable into securities having such rights or (iii) subscriptions or other rights,
agreements, arrangements, Contracts or commitments of any character (other than this Agreement and the Ancillary Documents), (A)
relating to the issued or unissued shares of Purchaser or (B) obligating Purchaser to issue, transfer, deliver or sell or cause to
be issued, transferred, delivered, sold or repurchased any options or shares or securities convertible into or exchangeable for such
shares, or (C) obligating Purchaser to grant, extend or enter into any such option, warrant, call, subscription or other right,
agreement, arrangement or commitment for such capital shares. Other than the Redemption or as expressly set forth in this Agreement,
there are no outstanding obligations of Purchaser to repurchase, redeem or otherwise acquire any Purchaser Securities or to provide
funds to make any investment (in the form of a loan, capital contribution or otherwise) in any Person. Except as set forth in Schedule
6.5(b), there are no shareholders agreements, voting trusts or other agreements or understandings to which Purchaser is a party
with respect to the voting of any shares of Purchaser.
33
(c)
All Indebtedness of Purchaser as of the Agreement Date is disclosed on Schedule 6.5(c). No Indebtedness of Purchaser contains
any restriction upon (i) the prepayment of any of such Indebtedness, (ii) the incurrence of Indebtedness by Purchaser or (iii) the
ability of Purchaser to grant any Lien on its properties or assets.
(d)
Since the date of formation of Purchaser, and except as contemplated by this Agreement, Purchaser has not declared or paid any distribution
or dividend in respect of its shares and has not repurchased, redeemed or otherwise acquired any of its shares, and Purchaser’s
board of directors has not authorized any of the foregoing.
6.6
SEC Filings and Purchaser Financials.
(a)
Purchaser, since the IPO, has filed all forms, reports, schedules, statements, registration statements, prospectuses and other
documents required to be filed or furnished by Purchaser with the SEC under the Securities Act and/or the Exchange Act, together
with any amendments, restatements or supplements thereto, and will file all such forms, reports, schedules, statements and other
documents required to be filed subsequent to the Agreement Date. Except to the extent available on the SEC’s web site through
EDGAR, Purchaser has delivered to the Company copies in the form filed with the SEC of all of the following: (i) Purchaser’s
annual reports on Form 10-K for each fiscal year of Purchaser beginning with the first year Purchaser was required to file such a
form, (ii) Purchaser’s quarterly reports on Form 10-Q for each fiscal quarter that Purchaser filed such reports to disclose
its quarterly financial results in each of the fiscal years of Purchaser referred to in clause (i) above, (iii) all other forms,
reports, registration statements, prospectuses and other documents (other than preliminary materials) filed by Purchaser with the
SEC since the beginning of the first fiscal year referred to in clause (i) above (the forms, reports, registration statements,
prospectuses and other documents referred to in clauses (i), (ii) and (iii) above, whether or not available through EDGAR, are,
collectively, the “SEC Reports”) and (iv) all certifications and statements required by (A) Rules 13a-14 or
15d-14 under the Exchange Act, and (B) 18 U.S.C. §1350 (Section 906 of SOX) with respect to any report referred to in clause
(i) above (collectively, the “Public Certifications”). The SEC Reports (x) were prepared in all material respects
in accordance with the requirements of the Securities Act and the Exchange Act, as the case may be, and the rules and regulations
thereunder and (y) did not, as of their respective effective dates (in the case of SEC Reports that are registration statements
filed pursuant to the requirements of the Securities Act) and at the time they were filed with the SEC (in the case of all other SEC
Reports) contain any untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary
in order to make the statements made therein, in the light of the circumstances under which they were made, not misleading. As of
the Agreement Date, there are no outstanding or unresolved comments in comment letters received from the SEC with respect to any SEC
Reports. None of the SEC Reports filed on or prior to the Agreement Date is subject to ongoing SEC review or investigation as of the
Agreement Date. The Public Certifications are each true as of their respective dates of filing. As used in this Section
6.6, the term “file” shall be broadly construed to include any manner permitted by SEC rules and regulations in
which a document or information is furnished, supplied or otherwise made available to the SEC. As of the Agreement Date, (A)
Purchaser Public Units, Purchaser Ordinary Shares, Purchaser Public Rights and Purchaser Public Warrants are listed on Nasdaq, (B)
Purchaser has not received any written deficiency notice from Nasdaq relating to the continued listing requirements of such
Purchaser Securities, (C) there are no Actions pending or, to the Knowledge of Purchaser, threatened against Purchaser by the
Financial Industry Regulatory Authority with respect to any intention by such entity to suspend, prohibit or terminate the quoting
of such Purchaser Securities on Nasdaq and (D) such Purchaser Securities are in compliance with all of the applicable corporate
governance rules of Nasdaq.
34
(b)
The financial statements and notes of Purchaser contained or incorporated by reference in the SEC Reports (the “Purchaser Financials”),
fairly present in all material respects the financial position and the results of operations, changes in shareholders’ equity,
and cash flows of Purchaser at the respective dates of and for the periods referred to in such financial statements, all in accordance
with (i) methodologies of Applicable Accounting Standards applied on a consistent basis throughout the periods involved and (ii) Regulation
S-X or Regulation S-K, as applicable (except as may be indicated in the notes thereto and for the omission of notes and audit adjustments
in the case of unaudited quarterly financial statements to the extent permitted by Regulation S-X or Regulation S-K, as applicable).
(c)
Except as and to the extent reflected or reserved against in Purchaser Financials, Purchaser has not incurred any Liabilities or obligations
of the type required to be reflected on a balance sheet in accordance with Applicable Accounting Standards that are not adequately reflected
or reserved on or provided for in Purchaser Financials, other than Liabilities of the type required to be reflected on a balance sheet
in accordance with Applicable Accounting Standards that have been incurred since Purchaser’s formation in the ordinary course of
business. All debts and Liabilities, whether fixed or contingent, which should be included under Applicable Accounting Standards on a
balance sheet are included in all material respects in Purchaser Financials as of the date of such Purchaser Financial.
6.7
Absence of Certain Changes. As of the Agreement Date, except as set forth in Schedule 6.7, Purchaser has (a)
since its formation, conducted no business other than its formation, the public offering of its securities (and the related private offerings),
public reporting and its search for an initial business combination (as such term is used in the IPO Prospectus) (“Business
Combination”) (including the investigation of the Company and the negotiation and execution of this Agreement) and related
activities and (b) since January 1, 2026, not been subject to a Material Adverse Effect on Purchaser.
6.8
Compliance with Laws. Purchaser is, and has since its formation been, in compliance with all Laws applicable to it and the conduct
of its business except for such noncompliance which would not reasonably be expected to have a Material Adverse Effect on Purchaser,
and Purchaser has not received written notice alleging any violation of applicable Law in any material respect by Purchaser. Purchaser
is not under investigation with respect to any violation or alleged violation of, any Law, or judgment, order or decree entered by any
court, arbitrator or Governmental Authority, domestic or foreign, and Purchaser has not previously received any subpoenas from any Governmental
Authority.
6.9
Actions; Orders; Permits. There is no pending or, to the Knowledge of Purchaser, threatened material Action to which Purchaser
is subject which would reasonably be expected to have a Material Adverse Effect on Purchaser. There is no material Action that Purchaser
has pending against any other Person. Purchaser is not subject to any material Orders of any Governmental Authority, nor are any such
Orders pending. Purchaser holds all material Permits necessary to lawfully conduct its business as presently conducted, and to own, lease
and operate its assets and properties, all of which are in full force and effect, except where the failure to hold such Permit or for
such Permit to be in full force and effect would not reasonably be expected to have a Material Adverse Effect on Purchaser.
6.10
Taxes and Returns.
(a)
Purchaser has timely filed, or caused to be timely filed, all material Tax Returns required to be filed by it, which such Tax
Returns are accurate and complete in all material respects, and has paid, collected or withheld, or caused to be paid, collected or
withheld, all material Taxes required to be paid, collected or withheld, other than such Taxes for which adequate reserves in
Purchaser Financials have been established in accordance with Applicable Accounting Standards. Purchaser has complied with all
applicable Laws relating to Taxes. Schedule 6.10(a) sets forth each jurisdiction where Purchaser files or is required to
file a Tax Return. There are no audits, examinations, investigations or other proceedings pending against Purchaser in respect of
any Tax, and Purchaser has not been notified in writing of any proposed Tax claims or assessments against Purchaser (other than, in
each case, claims or assessments for which adequate reserves in Purchaser Financials have been established in accordance with
Applicable Accounting Standards or are immaterial in amount). There are no Liens with respect to any Taxes upon any of
Purchaser’s assets, other than Permitted Liens. Purchaser has no outstanding waivers or extensions of any applicable statute
of limitations to assess any material amount of Taxes. There are no outstanding requests by Purchaser for any extension of time
within which to file any Tax Return or within which to pay any Taxes shown to be due on any Tax Return.
35
(b)
Since the date of its formation, Purchaser has not (i) changed any Tax accounting methods, policies or procedures except as required
by a change in Law, (ii) made, revoked, or amended any material Tax election, (iii) filed any amended Tax Returns or claim for refund
or (iv) entered into any closing agreement affecting or otherwise settled or compromised any material Tax liability or refund.
6.11
Employees and Employee Benefit Plans. Purchaser does not (a) have any paid employees or (b) maintain, sponsor, contribute to or
otherwise have any Liability under, any Benefit Plans.
6.12
Properties. Purchaser does not own, license or otherwise have any right, title or interest in or to any material Intellectual
Property. Purchaser does not own or lease any material real property or material Personal Property.
6.13
Material Contracts.
(a)
Except as set forth on Schedule 6.13(a), other than this Agreement and the Ancillary Documents, there are no Contracts to
which Purchaser is a party or by which any of its properties or assets may be bound, subject or affected, which (i) creates or imposes
a Liability greater than $500,000, (ii) may not be cancelled by Purchaser on less than sixty (60) days’ prior notice without payment
of a material penalty or termination fee or (iii) prohibits, prevents, restricts or impairs in any material respect any business practice
of Purchaser as its business is currently conducted, any acquisition of material property by Purchaser, or restricts in any material
respect the ability of Purchaser to engage in business as currently conducted by it or compete with any other Person (each, a “Purchaser
Material Contract”). All Purchaser Material Contracts have been made available to the Company other than those that are exhibits
to the SEC Reports.
(b)
With respect to each Purchaser Material Contract: (i) Purchaser Material Contract was entered into at arms’-length and in the ordinary
course of business; (ii) Purchaser Material Contract is legal, valid, binding and enforceable in all material respects against Purchaser
and, to the Knowledge of Purchaser, the other parties thereto, and is in full force and effect (except, in each case, as such enforcement
may be limited by the Enforceability Exceptions); (iii) Purchaser is not in breach or default in any material respect, and no event has
occurred that with the passage of time or giving of notice or both would constitute such a breach or default in any material respect
by Purchaser, or permit termination or acceleration by the other party, under such Purchaser Material Contract; and (iv) to the Knowledge
of Purchaser, no other party to any Purchaser Material Contract is in breach or default in any material respect, and no event has occurred
that with the passage of time or giving of notice or both would constitute such a breach or default by such other party, or permit termination
or acceleration by Purchaser under any Purchaser Material Contract.
6.14
Transactions with Affiliates. Schedule 6.14 sets forth a true, correct and complete list of the Contracts and
arrangements that are in existence as of the Agreement Date under which there are any existing or future Liabilities or obligations between
Purchaser and any (a) present or former director, officer or employee or Affiliate of Purchaser, or any immediate family member of any
of the foregoing, or (b) record or beneficial owner of more than five percent (5%) of Purchaser’s outstanding capital shares as
of the date hereof.
36
6.15
Investment Company Act. Purchaser is not an “investment company” or a Person directly or indirectly “controlled”
by or acting on behalf of an “investment company,” or required to register as an “investment company,” in each
case within the meaning of the Investment Company Act of 1940, as amended.
6.16
Finders and Brokers. Except as set forth on Schedule 6.16, no broker, finder or investment banker is entitled
to any brokerage, finder’s or other fee or commission from Purchaser, the Company or any of their respective Affiliates in connection
with the transactions contemplated hereby based upon arrangements made by or on behalf of Purchaser.
6.17
Ownership of Transaction Consideration. All Purchaser Ordinary Shares to be issued and delivered to the Selling Shareholders as
Transaction Consideration in accordance with Article II shall be, upon issuance and delivery of such Purchaser Ordinary
Shares, fully paid and non-assessable, free and clear of all Liens and Encumbrances, other than restrictions arising from applicable
securities Laws, the Lock-Up Agreement provisions, and any Liens and Encumbrances incurred by any Selling Shareholder, and the issuance
and sale of such Purchaser Ordinary Shares pursuant hereto will not be subject to or give rise to any preemptive rights or rights of
first refusal.
6.18
Certain Business Practices.
(a)
Neither Purchaser, nor any of its Representatives acting on its behalf, has (i) used any funds for unlawful contributions, gifts, entertainment
or other unlawful expenses relating to political activity, (ii) made any unlawful payment to foreign or domestic government officials
or employees, to foreign or domestic political parties or campaigns or violated any provision of the U.S. Foreign Corrupt Practices Act
of 1977 or any other local or foreign anti-corruption or bribery Law, (iii) made any other unlawful payment or (iv) since the formation
of Purchaser, directly or indirectly, given or agreed to give any unlawful gift or similar benefit in any material amount to any customer,
supplier, governmental employee or other Person who is or may be in a position to help or hinder Purchaser or assist it in connection
with any actual or proposed transaction.
(b)
The operations of Purchaser are and have been conducted at all times in material compliance with money laundering statutes in all applicable
jurisdictions, the rules and regulations thereunder and any related or similar rules, regulations or guidelines, issued, administered
or enforced by any Governmental Authority, and no Action involving Purchaser with respect to any of the foregoing is pending or, to the
Knowledge of Purchaser, threatened.
(c)
None of Purchaser or any of its directors or officers, or, to the Knowledge of Purchaser, any other Representative acting on behalf of
Purchaser is currently identified on the specially designated nationals or other blocked person list or otherwise currently subject to
any U.S. sanctions administered by the OFAC or is a designated persons of the purposes of the UK consolidated list (https://www.gov.uk/government/publications/financial-sanctions-consolidated-list-of-targets)
and Purchaser has not, in the last five (5) fiscal years, directly or indirectly, used any funds, or loaned, contributed or otherwise
made available such funds to any Subsidiary, joint venture partner or other Person, in connection with any sales or operations in any
other country sanctioned by OFAC or for the purpose of financing the activities of any Person currently subject to, or otherwise in violation
of, any U.S. sanctions administered by OFAC or any UK sanctions regulations which have been made and modified under the Sanctions and
Anti-Money Laundering Act 2018 (“Sanctions Act”) and extended to the BVI by an Overseas Territories Sanctions Order.
6.19
Insurance. Schedule 6.19 lists all insurance policies (by policy number, insurer, coverage period, coverage
amount, annual premium and type of policy) held by Purchaser relating to Purchaser or its business, properties, assets, directors, officers
and employees, copies of which have been provided to the Company. All premiums due and payable under all such insurance policies have
been timely paid and Purchaser is otherwise in material compliance with the terms of such insurance policies. All such insurance policies
are in full force and effect, and to the Knowledge of Purchaser, there is no threatened termination of, or material premium increase
with respect to, any of such insurance policies. There have been no insurance claims made by Purchaser. Purchaser has reported to its
insurers all claims and pending circumstances that would reasonably be expected to result in a claim, except where such failure to report
such a claim would not be reasonably likely to have a Material Adverse Effect on Purchaser.
37
6.20
Purchaser Trust Account. As of June 30, 2026, the Trust Account has a balance of no less than $121,464,805. Such monies are invested
solely in United States “government securities” within the meaning of Section 2(a)(16) of the Investment Company Act or money
market funds meeting certain conditions under Rule 2a-7 promulgated under the Investment Company Act, and held in trust by Efficiency,
Inc. pursuant to the Trust Agreement. The Trust Agreement is valid and in full force and effect and enforceable in accordance with its
terms (subject to the Enforceability Exceptions) and has not been amended or modified. Purchaser has performed all material obligations
required to be performed by it to date under, and is not in material default or delinquent in performance or any other respect (claimed
or actual) in connection with the Trust Agreement, and, to the Knowledge of Purchaser, no event has occurred which, with due notice or
lapse of time or both, would constitute such a material default thereunder. As of the Agreement Date, there are no claims or proceedings
pending with respect to the Trust Account. There are no separate agreements, side letters or other agreements that would cause the description
of the Trust Agreement in the SEC Reports to be inaccurate in any material respect and/or that would entitle any Person (other than the
underwriters of the IPO, Public Shareholders who shall have elected to redeem their Purchaser Ordinary Shares pursuant to Purchaser’s
Governing Documents (or in connection with an extension of Purchaser’s deadline to consummate a Business Combination) or Governmental
Authorities for Taxes, to any portion of the proceeds in the Trust Account. Prior to the Closing, none of the funds held in the Trust
Account may be released except as described in the Trust Agreement. Upon the consummation of the transactions contemplated hereby, including
the distribution of assets from the Trust Account, the Trust Agreement shall terminate in accordance with its terms.
6.21
Independent Investigation. Purchaser has conducted its own independent investigation, review and analysis of the business, results
of operations, prospects, condition (financial or otherwise) or assets of the Company, and acknowledges that it has been provided adequate
access to the personnel, properties, assets, premises, books and records, and other documents and data of the Company for such purpose.
Purchaser acknowledges and agrees that: (a) in making its decision to enter into this Agreement and to consummate the transactions contemplated
hereby, it has relied solely upon its own investigation and the express representations and warranties of the Company set forth in this
Agreement (including the related portions of the Company Disclosure Schedules) and in any certificate delivered to Purchaser pursuant
hereto, and the information provided by or on behalf of the Company for the Registration Statement; and (b) neither the Company nor its
respective Representatives have made any representation or warranty as to the Company, or this Agreement, except as expressly set forth
in this Agreement (including the related portions of the Company Disclosure Schedules) or in any certificate delivered to Purchaser pursuant
hereto, or with respect to the information provided by or on behalf of the Company for the Registration Statement.
Article
VII
COVENANTS
7.1
Access and Information.
(a)
During the period from the Agreement Date and continuing until the earlier of the termination of this Agreement in accordance with Section
10.1 or the Closing (the “Interim Period”), subject to Section 7.13, the Company shall give, and shall
cause its Representatives to give, Purchaser and its Representatives, at reasonable times during normal business hours and upon reasonable
intervals and notice, reasonable access to all offices and other facilities and to all employees, properties, Contracts, agreements,
commitments, books and records, financial and operating data and other information (including Tax Returns, internal working papers, client
files, client Contracts and director service agreements), of or pertaining to the Company, as Purchaser or its Representatives may reasonably
request regarding the Company and their respective businesses, assets, Liabilities, financial condition, prospects, operations, management,
employees and other aspects (including unaudited quarterly financial statements, including a consolidated quarterly balance sheet and
income statement, a copy of each material report, schedule and other document filed with or received by a Governmental Authority pursuant
to the requirements of applicable securities Laws, and independent public accountants’ work papers (subject to the consent or any
other conditions required by such accountants, if any)) and cause each of the Company’s Representatives to reasonably cooperate
with Purchaser and its Representatives in their investigation; provided, however, that Purchaser and its Representatives shall conduct
any such activities in such a manner as not to unreasonably interfere with the business or operations of the Company; and provided further,
the Company shall not be required to provide, or cause to be provided to, Purchaser or any of its Representatives any information (i)
if and to the extent doing so would (A) violate any Law to which the Company is subject, (B) result in the disclosure of any trade secrets
of third parties in breach of any Contract with such third party, (C) violate any legally-binding obligation of the Company with respect
to confidentiality, non-disclosure or privacy or (D) jeopardize protections afforded to the Company under the attorney-client privilege
or the attorney work product doctrine; provided that in each case the Company shall cooperate with Purchaser to effect disclosure of
such information in a manner which does not result in such a breach, violation or jeopardization.
38
(b)
During the Interim Period, subject to Section 7.13, Purchaser shall give, and shall cause its Representatives to give, the
Company and its Representatives, at reasonable times during normal business hours and upon reasonable intervals and notice, reasonable
access to all offices and other facilities and to all employees, properties, Contracts, agreements, commitments, books and records, financial
and operating data and other information (including Tax Returns, internal working papers, client files, client Contracts and director
service agreements), of or pertaining to Purchaser or its Subsidiaries, as the Company or its Representatives may reasonably request
regarding Purchaser, its Subsidiaries and their respective businesses, assets, Liabilities, financial condition, prospects, operations,
management, employees and other aspects (including unaudited quarterly financial statements, including a consolidated quarterly balance
sheet and income statement, a copy of each material report, schedule and other document filed with or received by a Governmental Authority
pursuant to the requirements of applicable securities Laws, and independent public accountants’ work papers (subject to the consent
or any other conditions required by such accountants, if any)) and cause each of Purchaser’s Representatives to reasonably cooperate
with the Company and its Representatives in their investigation; provided, however, that the Company and its Representatives shall conduct
any such activities in such a manner as not to unreasonably interfere with the business or operations of Purchaser or any of its Subsidiaries.
7.2
Conduct of Business of the Company.
(a)
Unless Purchaser shall otherwise consent in writing (such consent not to be unreasonably withheld, conditioned or delayed), during the
Interim Period, except as expressly contemplated by this Agreement or the Ancillary Documents or as set forth on Schedule 7.2,
the Company shall (i) conduct its business, in all material respects, in the ordinary course of business consistent with past practice,
(ii) comply with all Laws applicable to the Company and its business, assets and employees, including applicable Money Lending Laws concerning
loan origination, documentation, servicing, collections, interest, fees, advertising, borrower information and recordkeeping, and (iii)
take all commercially reasonable measures necessary or appropriate to preserve intact, in all material respects, its business organization,
to keep available the services of its managers, directors, officers, employees and consultants, and to preserve the possession, control
and condition of its material assets, all as consistent with past practice.
(b)
Without limiting the generality of Section 7.2(a) and except as contemplated by the terms of this Agreement or the Ancillary
Documents as set forth on Schedule 7.2, during the Interim Period, without the prior written consent of Purchaser (such
consent not to be unreasonably withheld, conditioned or delayed), the Company shall not:
(i)
amend, waive or otherwise change, in any respect, its Governing Documents, except as required by applicable Law and to effect the transactions
contemplated by this Agreement and the Ancillary Documents;
(ii)
authorize for issuance, issue, grant, sell, pledge, dispose of or propose to issue, grant, sell, pledge or dispose of any of its equity
securities or any options, warrants, commitments, subscriptions or rights of any kind to acquire or sell any of its equity securities,
or other securities, including any securities convertible into or exchangeable for any of its shares or other equity securities or securities
of any class and any other equity-based awards or engage in any hedging transaction with a third Person with respect to such securities;
39
(iii)
split, combine, recapitalize or reclassify any of its shares or other equity interests or issue any other securities in respect thereof
or pay or set aside any dividend or other distribution (whether in cash, equity or property or any combination thereof) in respect of
its equity interests, or directly or indirectly redeem, purchase or otherwise acquire or offer to acquire any of its securities (except
for the repurchase of Company Ordinary Shares from former employees, non-employee directors and consultants in accordance with agreements
as in effect on the date hereof providing for the repurchase of shares in connection with any termination of service;
(iv)
incur, create, assume, prepay or otherwise become liable for any Indebtedness (directly, contingently or otherwise) in excess of $20,000
individually or $100,000 in the aggregate, make a loan or advance to or investment in any third party (other than advancement or reimbursement
of expenses to employees in the ordinary course of business or loans in the ordinary course of business), or guarantee or endorse any
Indebtedness, Liability or obligation of any Person in excess of $20,000 individually or $100,000 in the aggregate or as required to
consummate the transactions contemplated by this Agreement or the Ancillary Documents;
(v)
increase the wages, salaries or compensation of its employees other than in the ordinary course of business, consistent with past practice,
and in any event not in the aggregate by more than five percent (5%), or make or commit to make any bonus payment (whether in cash, property
or securities) other than in the ordinary course of business consistent with past practice, to any employee, or materially increase other
benefits of employees generally other than in the ordinary course of business consistent with past practice, or enter into, establish,
materially amend or terminate any Company Benefit Plan with, for or in respect of any current consultant, officer, manager director or
employee, in each case other than as required by applicable Law, pursuant to the terms of any Company Benefit Plans, pursuant to the
terms of this Agreement or the Ancillary Documents, in the ordinary course of business consistent with past practice;
(vi)
make or rescind any material election relating to Taxes, settle any claim, action, suit, litigation, proceeding, arbitration, investigation,
audit or controversy relating to Taxes, file any amended Tax Return or claim for refund, or make any material change in its accounting
or Tax policies or procedures, in each case except as required by applicable Law or in compliance with Applicable Accounting Standards;
(vii)
transfer or license to any Person or otherwise extend, materially amend or modify, permit to lapse or fail to preserve any material Company
Registered IP, Company IP Licenses or other Company IP (excluding non-exclusive licenses of Company IP to Company customers in the ordinary
course of business consistent with past practice), or disclose to any Person who has not entered into a confidentiality agreement any
Trade Secrets;
(viii)
terminate, or waive or assign any material right under, any Company Material Contract or enter into any Contract that would be a Company
Material Contract, in any case outside of the ordinary course of business consistent with past practice, other than any termination at
the end of the term of such Company Material Contract pursuant to the terms thereof, or as required to consummate the transactions contemplated
by this Agreement or the Ancillary Documents;
(ix)
fail to maintain its books, accounts and records in all material respects in the ordinary course of business consistent with past practice;
40
(x)
establish any Subsidiary or enter into any new line of business;
(xi)
fail to use commercially reasonable efforts to keep in force material insurance policies or replacement or revised policies providing
insurance coverage with respect to its assets, operations and activities in such amount and scope of coverage substantially similar to
that which is currently in effect;
(xii)
revalue any of its material assets or make any material change in accounting methods, principles or practices, except to the extent required
to comply with Applicable Accounting Standards and after consulting with the Company’s outside auditors;
(xiii)
waive, release, assign, settle or compromise any claim, action or proceeding (including any suit, action, claim, proceeding or investigation
relating to this Agreement or the transactions contemplated hereby), other than waivers, releases, assignments, settlements or compromises
that involve only the payment of monetary damages (and not the imposition of equitable relief on, or the admission of wrongdoing by,
the Company or its Affiliates) not in excess of $20,000 (individually or $100,000 in the aggregate), or otherwise pay, discharge or satisfy
any Actions, Liabilities or obligations, unless such amount has been reserved in the Company Financials;
(xiv)
close or materially reduce its activities, or effect any layoff or other personnel reduction or change, at any of its facilities;
(xv)
acquire, including by merger, consolidation, acquisition of equity interests or assets, or any other form of business combination, any
corporation, partnership, limited liability company, other business organization or any division thereof, or any material amount of assets
outside the ordinary course of business consistent with past practice;
(xvi)
make capital expenditures in excess of $20,000 individually for any project or set of related projects or $100,000 in the aggregate,
other than pursuant to the terms of a Company Material Contract in effect on the Agreement Date;
(xvii)
adopt a plan of complete or partial liquidation, dissolution, merger, consolidation, restructuring, recapitalization or other reorganization;
(xviii)
voluntarily incur any Liability or obligation (whether absolute, accrued, contingent or otherwise) in excess of $20,000 individually
or $100,000 in the aggregate other than pursuant to the terms of a Company Material Contract or Company Benefit Plan;
(xix)
sell, lease, license, transfer, exchange or swap, mortgage or otherwise pledge or encumber (including securitizations), or otherwise
dispose of any material portion of its properties, assets or rights;
(xx)
enter into any agreement, understanding or arrangement with respect to the voting of equity securities of the Company;
(xxi)
take any action that would reasonably be expected to significantly delay or impair the obtaining of any Consents of any Governmental
Authority to be obtained in connection with this Agreement;
(xxii)
accelerate the collection of any trade receivables or delay the payment of trade payables or any other liabilities other than in the
ordinary course of business consistent with past practice;
41
(xxiii)
materially amend any underwriting, pricing, credit approval, collection or loan servicing policies, except as required by applicable
Law or a Governmental Authority;
(xxiv)
enter into, amend, waive or terminate (other than terminations in accordance with their terms) any transaction with any Related Person
(other than compensation and benefits and advancement of expenses, in each case, provided in the ordinary course of business consistent
with past practice); or
(xxv)
authorize or agree to do any of the foregoing actions.
7.3
Conduct of Business of Purchaser.
(a)
Unless the Company shall otherwise consent in writing (such consent not to be unreasonably withheld, conditioned or delayed), during
the Interim Period, except as expressly contemplated by this Agreement or the Ancillary Documents or as set forth on Schedule
7.3, Purchaser shall, and shall cause its Subsidiaries to, (i) conduct their respective businesses, in all material respects, in
the ordinary course of business consistent with past practice, (ii) comply with all Laws applicable to Purchaser and its
Subsidiaries and their respective businesses, assets and employees, and (iii) take all commercially reasonable measures necessary or
appropriate to preserve intact, in all material respects, their respective business organizations, to keep available the services of
their respective managers, directors, officers, employees and consultants, and to preserve the possession, control and condition of
their respective material assets, all as consistent with past practice. Notwithstanding anything to the contrary in this Section
7.3, nothing in this Agreement shall prohibit or restrict Purchaser from extending, in accordance with Purchaser’s
Governing Documents and the IPO Prospectus, the deadline by which it must complete its Business Combination (an
“Extension”), and no consent of any other Party shall be required in connection therewith.
(b)
Without limiting the generality of Section 7.3(a) and except as contemplated by the terms of this Agreement or the Ancillary
Documents (including as contemplated by any PIPE Investment consented to by the Company in accordance with Section 7.18) or as set
forth on Schedule 7.3, during the Interim Period, without the prior written consent of the Company (such consent not to be
unreasonably withheld, conditioned or delayed), Purchaser shall not, and shall cause its Subsidiaries not to:
(i)
amend, waive or otherwise change, in any respect, its Governing Documents except as required by applicable Law;
(ii)
authorize for issuance, issue, grant, sell, pledge, dispose of or propose to issue, grant, sell, pledge or dispose of any of its equity
securities or any options, warrants, commitments, subscriptions or rights of any kind to acquire or sell any of its equity securities,
or other securities, including any securities convertible into or exchangeable for any of its equity securities or other securities of
any class and any other equity-based awards, other than the issuance of Purchaser Securities issuable upon conversion or exchange of
outstanding Purchaser Securities in accordance with their terms, or engage in any hedging transaction with a third Person with respect
to such securities;
(iii)
split, combine, recapitalize or reclassify any of its shares or other equity interests or issue any other securities in respect thereof
or pay or set aside any dividend or other distribution (whether in cash, equity or property or any combination thereof) in respect of
its shares or other equity interests, or directly or indirectly redeem, purchase or otherwise acquire or offer to acquire any of its
securities;
42
(iv)
incur, create, assume, prepay or otherwise become liable for any Indebtedness (directly, contingently or otherwise) in excess of $500,000
individually or $1,000,000 in the aggregate, make a loan or advance to or investment in any third party, or guarantee or endorse any
Indebtedness, Liability or obligation of any Person (provided, that this Section 7.3(b)(iv) shall not prevent Purchaser from borrowing
funds necessary to finance its ordinary course administrative costs and expenses and Expenses incurred in connection with the consummation
of the transactions contemplated by this Agreement (including any PIPE Investment and the reasonable costs and expenses necessary for
any Extensions (such expenses, “Extension Expenses”)), up to aggregate additional Indebtedness during the Interim
Period of $3,000,000;
(v)
make or rescind any material election relating to Taxes, settle any claim, action, suit, litigation, proceeding, arbitration, investigation,
audit or controversy relating to Taxes, file any amended Tax Return or claim for refund, or make any material change in its accounting
or Tax policies or procedures, in each case except as required by applicable Law or in compliance with Applicable Accounting Standards;
(vi)
amend, waive or otherwise change the Trust Agreement in any manner adverse to Purchaser;
(vii)
terminate, waive or assign any material right under any Purchaser Material Contract or enter into any Contract that would be a Purchaser
Material Contract;
(viii)
fail to maintain its books, accounts and records in all material respects in the ordinary course of business consistent with past practice;
(ix)
establish any Subsidiary or enter into any new line of business;
(x)
fail to use commercially reasonable efforts to keep in force insurance policies or replacement or revised policies providing insurance
coverage with respect to its assets, operations and activities in such amount and scope of coverage substantially similar to that which
is currently in effect;
(xi)
revalue any of its material assets or make any material change in accounting methods, principles or practices, except to the extent required
to comply with Applicable Accounting Standards and after consulting Purchaser’s outside auditors;
(xii)
waive, release, assign, settle or compromise any claim, action or proceeding (including any suit, action, claim, proceeding or investigation
relating to this Agreement or the transactions contemplated hereby), other than waivers, releases, assignments, settlements or compromises
that involve only the payment of monetary damages (and not the imposition of equitable relief on, or the admission of wrongdoing by,
Purchaser or its Subsidiary) not in excess of $100,000 individually or $500,000 in the aggregate, or otherwise pay, discharge or satisfy
any Actions, Liabilities or obligations, unless such amount has been reserved in Purchaser Financials;
(xiii)
acquire, including by merger, consolidation, acquisition of equity interests or assets, or any other form of business combination, any
corporation, partnership, limited liability company, other business organization or any division thereof, or any material amount of assets
outside the ordinary course of business;
(xiv)
make capital expenditures in excess of $100,000 individually for any project (or set of related projects) or $500,000 in the aggregate
(excluding for the avoidance of doubt, incurring any Expenses);
(xv)
adopt a plan of complete or partial liquidation, dissolution, merger, consolidation, restructuring, recapitalization or other reorganization
(other than with respect to the transactions contemplated by this Agreement);
43
(xvi)
voluntarily incur any Liability or obligation (whether absolute, accrued, contingent or otherwise) in excess of $100,000 individually
or $500,000 in the aggregate (excluding the incurrence of any Expenses) other than pursuant to the terms of a Contract in existence as
of the Agreement Date or entered into in the ordinary course of business or in accordance with the terms of this Section 7.3
during the Interim Period;
(xvii)
sell, lease, license, transfer, exchange or swap, mortgage or otherwise pledge or encumber (including securitizations), or otherwise
dispose of any material portion of its properties, assets or rights;
(xviii)
enter into any agreement, understanding or arrangement with respect to the voting of Purchaser Securities;
(xix)
take any action that would reasonably be expected to significantly delay or impair the obtaining of any Consents of any Governmental
Authority to be obtained in connection with this Agreement; or
(xx)
authorize or agree to do any of the foregoing actions.
7.4
Annual and Interim Financial Statements. During the Interim Period, within thirty (30) calendar days following the end of each
three-month quarterly period and each fiscal year, the Company shall deliver to Purchaser an unaudited consolidated income statement
and an unaudited consolidated balance sheet of the Company for the period from the Interim Balance Sheet Date through the end of such
calendar month, quarterly period or fiscal year and the applicable comparative period in the preceding fiscal year, in each case accompanied
by a certificate of the Director and Chief Financial Officer of the Company to the effect that all such financial statements fairly present
the financial position and results of operations of the Company as of the date or for the periods indicated, in accordance with Applicable
Accounting Standards, subject to year-end audit adjustments and excluding footnotes (collectively, the “Interim Financial Statements”).
From the date hereof through the Closing Date, the Company will also promptly deliver to Purchaser copies of any audited consolidated
financial statements of the Company that the Company’s independent registered public accounting firm may issue.
7.5
Purchaser Public Filings. During the Interim Period, Purchaser will keep current all of its public filings with the SEC and will
otherwise comply in all material respects with applicable securities Laws and shall use its reasonable best efforts prior to the Closing
to maintain the listing of Purchaser Public Units, Purchaser Ordinary Shares, Purchaser Public Rights and Purchaser Public Warrants on
Nasdaq; provided, that the Parties acknowledge and agree that from and after the Closing, the Parties intend to list on Nasdaq
only Purchaser Ordinary Shares and Purchaser Public Warrants. Purchaser shall cause the ticker under which Purchaser Ordinary Shares
and Purchaser Public Warrants are listed for trading on Nasdaq to be changed to “BCIN” and “BCINW”, respectively,
and have Purchaser Ordinary Shares and Purchaser Public Warrants listed for trading with such trading ticker.
7.6
No Solicitation.
(a)
For purposes of this Agreement, (i) an “Acquisition Proposal” means any inquiry, proposal or offer, or any indication
of interest in making an offer or proposal, from any Person or group at any time relating to an Alternative Transaction, and (ii) an
“Alternative Transaction” means (A) with respect to the Company and its Affiliates, a transaction (other than the
transactions contemplated by this Agreement or a proposed PIPE Investment) concerning the sale of (x) all or any material part of the
business or assets of the Company (other than in the ordinary course of business consistent with past practice) or (y) any of the shares
or other equity interests or profits of the Company, in any case, whether such transaction takes the form of a sale of shares or other
equity interests, assets, merger, consolidation, issuance of debt securities, management Contract, joint venture or partnership, or otherwise
and (B) with respect to Purchaser and its Affiliates, a transaction (other than the transactions contemplated by this Agreement) concerning
a Business Combination involving Purchaser.
44
(b)
During the Interim Period, in order to induce the other Parties to continue to commit to expend management time and financial resources
in furtherance of the transactions contemplated hereby, each Party shall not, and shall cause its Representatives not to, without the
prior written consent of the Company and Purchaser, directly or indirectly, (i) solicit, assist, initiate or facilitate the making, submission
or announcement of, or intentionally encourage, any Acquisition Proposal, (ii) furnish any non-public information regarding such Party
or its Affiliates or their respective businesses, operations, assets, Liabilities, financial condition, prospects or employees to any
Person or group (other than a Party to this Agreement or their respective Representatives) in connection with or in response to an Acquisition
Proposal, (iii) engage or participate in discussions or negotiations with any Person or group with respect to, or that could reasonably
be expected to lead to, an Acquisition Proposal, (iv) approve, endorse or recommend, or publicly propose to approve, endorse or recommend,
any Acquisition Proposal, (v) negotiate or enter into any letter of intent, agreement in principle, acquisition agreement or other similar
agreement related to any Acquisition Proposal, or (vi) release any third Person from, or waive any provision of, any confidentiality
agreement to which such Party is a party; provided, however, that nothing in this Section 7.6 shall prohibit any Party or its
Representatives from pursuing, negotiating or consummating the PIPE Investment or otherwise taking actions expressly permitted by this
Agreement in connection with the PIPE Investment.
(c)
Each Party shall notify the others as promptly as practicable (and in any event within 48 hours) in writing of the receipt by such Party
or any of its Representatives of (i) any bona fide inquiries, proposals or offers, requests for information or requests for discussions
or negotiations regarding or constituting any Acquisition Proposal or any bona fide inquiries, proposals or offers, requests for information
or requests for discussions or negotiations that could reasonably be expected to result in an Acquisition Proposal, and (ii) any request
for non-public information relating to such Party or its Affiliates in connection with any Acquisition Proposal, specifying in each case
the material terms and conditions thereof (including a copy thereof if in writing or a written summary thereof if oral) and the identity
of the party making such inquiry, proposal, offer or request for information. Each Party shall keep the others promptly informed of the
status of any such inquiries, proposals, offers or requests for information. During the Interim Period, each Party shall, and shall cause
its Representatives to, immediately cease and cause to be terminated any solicitations, discussions or negotiations with any Person with
respect to any Acquisition Proposal and shall, and shall direct its Representatives to, cease and terminate any such solicitations or
discussions. The Company represents and warrants that neither it nor any of its Affiliates or equity holders is a party to or bound by
any binding or non-binding agreement or understanding with respect to any transaction that would constitute an Alternative Transaction.
7.7
No Trading. The Company and each Selling Shareholder acknowledge and agree that they are aware, and that their respective Affiliates
are aware (and each of their respective Representatives is aware or, upon receipt of any material nonpublic information of Purchaser,
will be advised) of the restrictions imposed by U.S. federal securities laws and the rules and regulations of the SEC and Nasdaq promulgated
thereunder or otherwise (the “Federal Securities Laws”) and other applicable foreign and domestic Laws on a Person
possessing material nonpublic information about a publicly traded company. The Company and each Selling Shareholder hereby agree that,
while it is in possession of such material nonpublic information, they shall not purchase or sell any securities of Purchaser, communicate
such information to any third party, take any other action with respect to Purchaser in violation of such Laws, or cause or encourage
any third party to do any of the foregoing.
45
7.8
Notification of Certain Matters. During the Interim Period, each Party shall give prompt notice to the other Parties if such Party
or its Affiliates: (a) fails to comply with or satisfy any covenant, condition or agreement to be complied with or satisfied by it or
its Affiliates hereunder in any material respect; (b) receives any notice or other communication in writing from any third party (including
any Governmental Authority) alleging (i) that the Consent of such third party is or may be required in connection with the transactions
contemplated by this Agreement or (ii) any non-compliance with any Law by such Party or its Affiliates; (c) receives any notice or other
communication from any Governmental Authority in connection with the transactions contemplated by this Agreement; (d) discovers any fact
or circumstance that, or becomes aware of the occurrence or non-occurrence of any event the occurrence or non-occurrence of which, would
reasonably be expected to cause or result in any of the conditions to the Closing set forth in Article IX not being
satisfied or the satisfaction of those conditions being materially delayed; or (e) becomes aware of the commencement or threat, in writing,
of any Action against such Party or any of its Affiliates, or any of their respective properties or assets, or, to the Knowledge of such
Party, any officer, director, partner, member or manager, in his, her or its capacity as such, of such Party or of its Affiliates with
respect to the consummation of the transactions contemplated by this Agreement. No such notice shall constitute an acknowledgement or
admission by the Party providing the notice regarding whether or not any of the conditions to the Closing have been satisfied or in determining
whether or not any of the representations, warranties or covenants contained in this Agreement have been breached.
7.9
Efforts.
(a)
Subject to the terms and conditions of this Agreement, each Party shall use its reasonable best efforts, and shall cooperate fully with
the other Parties, to take, or cause to be taken, all actions and to do, or cause to be done, all things reasonably necessary, proper
or advisable under applicable Laws and regulations to consummate the transactions contemplated by this Agreement (including the receipt
of all applicable Consents of Governmental Authorities) and to comply as promptly as practicable with all requirements of Governmental
Authorities applicable to the transactions contemplated by this Agreement.
(b)
In furtherance and not in limitation of Section 7.9(a), to the extent required under any Laws that are designed to prohibit, restrict
or regulate actions having the purpose or effect of monopolization or restraint of trade (“Antitrust Laws”), each
Party hereto agrees to make any required filing or application under Antitrust Laws, as applicable, at such Party’s sole cost and
expense, with respect to the transactions contemplated hereby as promptly as practicable, to supply as promptly as reasonably practicable
any additional information and documentary material that may be reasonably requested pursuant to Antitrust Laws and to take all other
actions reasonably necessary, proper or advisable to cause the expiration or termination of the applicable waiting periods under Antitrust
Laws as soon as practicable, including by requesting early termination of the waiting period provided for under the Antitrust Laws. Each
Party shall, in connection with its efforts to obtain all requisite approvals and authorizations for the transactions contemplated by
this Agreement under any Antitrust Law, use its commercially reasonable efforts to: (i) cooperate in all respects with each other Party
or its Affiliates in connection with any filing or submission and in connection with any investigation or other inquiry, including any
proceeding initiated by a private Person; (ii) keep the other Parties reasonably informed of any communication received by such Party
or its Representatives from, or given by such Party or its Representatives to, any Governmental Authority and of any communication received
or given in connection with any proceeding by a private Person, in each case regarding any of the transactions contemplated by this Agreement;
(iii) permit a Representative of the other Parties and their respective outside counsel to review any communication given by it to, and
consult with each other in advance of any meeting or conference with, any Governmental Authority or, in connection with any proceeding
by a private Person, with any other Person, and to the extent permitted by such Governmental Authority or other Person, give a Representative
or Representatives of the other Parties the opportunity to attend and participate in such meetings and conferences; (iv) in the event
a Party’s Representative is prohibited from participating in or attending any meetings or conferences, the other Parties shall
keep such Party promptly and reasonably apprised with respect thereto; and (v) use commercially reasonable efforts to cooperate in the
filing of any memoranda, white papers, filings, correspondence or other written communications explaining or defending the transactions
contemplated hereby, articulating any regulatory or competitive argument, and/or responding to requests or objections made by any Governmental
Authority.
46
(c)
As soon as reasonably practicable following the Agreement Date, the Parties shall reasonably cooperate with each other and use (and shall
cause their respective Affiliates to use) their respective commercially reasonable efforts to prepare and file with Governmental Authorities
requests for approval of the transactions contemplated by this Agreement and shall use all commercially reasonable efforts to have such
Governmental Authorities approve the transactions contemplated by this Agreement. Each Party shall give prompt written notice to the
other Parties if such Party or any of its Representatives receives any notice from such Governmental Authorities in connection with the
transactions contemplated by this Agreement, and shall promptly furnish the other Parties with a copy of such Governmental Authority
notice. If any Governmental Authority requires that a hearing or meeting be held in connection with its approval of the transactions
contemplated hereby, whether prior to the Closing or after the Closing, each Party shall arrange for Representatives of such Party to
be present for such hearing or meeting. If any objections are asserted with respect to the transactions contemplated by this Agreement
under any applicable Law or if any Action is instituted (or threatened to be instituted) by any applicable Governmental Authority or
any private Person challenging any of the transactions contemplated by this Agreement or any Ancillary Document as violative of any applicable
Law or which would otherwise prevent, materially impede or materially delay the consummation of the transactions contemplated hereby
or thereby, the Parties shall use their commercially reasonable efforts to resolve any such objections or Actions so as to timely permit
consummation of the transactions contemplated by this Agreement and the Ancillary Documents, including in order to resolve such objections
or Actions which, in any case if not resolved, could reasonably be expected to prevent, materially impede or materially delay the consummation
of the transactions contemplated hereby or thereby. In the event any Action is instituted (or threatened to be instituted) by a Governmental
Authority or private Person challenging the transactions contemplated by this Agreement, or any Ancillary Document, the Parties shall,
and shall cause their respective Representatives to, reasonably cooperate with each other and use their respective commercially reasonable
efforts to contest and resist any such Action and to have vacated, lifted, reversed or overturned any Order, whether temporary, preliminary
or permanent, that is in effect and that prohibits, prevents or restricts consummation of the transactions contemplated by this Agreement
or the Ancillary Documents.
(d)
Prior to the Closing, each Party shall use its commercially reasonable efforts to obtain any Consents of Governmental Authorities or
other third Persons as may be necessary for the consummation by such Party or its Affiliates of the transactions contemplated by this
Agreement or required as a result of the execution or performance of, or consummation of the transactions contemplated by, this Agreement
by such Party or its Affiliates, and the other Parties shall provide reasonable cooperation in connection with such efforts.
7.10
Further Assurances. The Parties hereto shall further cooperate with each other and use their respective commercially reasonable
best efforts to take or cause to be taken all actions, and do or cause to be done all things, necessary, proper or advisable on their
part under this Agreement and applicable Laws to consummate the transactions contemplated by this Agreement as soon as reasonably practicable,
including preparing and filing as soon as practicable all documentation to effect all necessary notices, reports and other filings.
47
7.11
The Registration Statement.
(a)
As promptly as practicable after the Agreement Date, Purchaser shall prepare with the cooperation and assistance of the Company, and
file with the SEC a registration statement on Form S-4 (as amended or supplemented from time to time, and including the Proxy
Statement contained therein, the “Registration Statement”) in connection with the registration under the
Securities Act of Purchaser Ordinary Shares to be issued under this Agreement as the Transaction Consideration, which Registration
Statement will also contain a proxy statement (as amended, the “Proxy Statement”) for the purpose of soliciting
proxies from Purchaser Shareholders for the matters to be acted upon at the Extraordinary General Meeting and providing the Public
Shareholders an opportunity in accordance with Purchaser’s Governing Documents and the IPO Prospectus to have their Purchaser
Ordinary Shares redeemed (the “Redemption”) in conjunction with the shareholder vote on Purchaser Shareholder
Approval Matters. The Proxy Statement shall include proxy materials for the purpose of soliciting proxies from Purchaser
shareholders to vote, at an extraordinary general meeting of Purchaser shareholders to be called and held for such purpose (the
“Extraordinary General Meeting”), in favor of resolutions approving (i) as an ordinary resolution, the adoption
and approval of this Agreement and the transactions contemplated hereby or referred to herein, including, to the extent required,
the issuance of any shares in connection with the PIPE Investment, by the holders of Purchaser Ordinary Shares in accordance with
Purchaser’s Governing Documents and IPO Prospectus, the Securities Act, the BVI Companies Act, the Malaysian Companies Act,
and the rules and regulations of the SEC and Nasdaq, (ii) as a special resolution, the adoption and approval of an Amended and
Restated Memorandum and Articles of Association of Purchaser, including a change of the name of Purchaser to “BlueCrest
Investment, Inc.,” (iii) as an ordinary resolution, adoption and approval of a new equity incentive plan in substantially the
form attached as Exhibit D hereto (the “New Equity Incentive Plan”), which will provide for awards for up
to a number of Purchaser Ordinary Shares mutually acceptable to Purchaser and the Company, (iv) as an ordinary resolution, the
appointment of the members of the Post-Closing Board in accordance with Section 7.15 hereof, and (v) as an ordinary
resolution (or, if required by applicable Law or the Purchaser’s Governing Documents, as a special resolution), such other
matters as the Company and Purchaser shall hereafter mutually determine to be necessary or appropriate in order to effect the
transactions contemplated by this Agreement and in connection with the Business Combination and each other proposal that either the
SEC or Nasdaq (or the respective staff members thereof) indicates is necessary in its comments to the Registration Statement/Proxy
Statement or in correspondence related thereto (the approvals described in foregoing clauses (i) through (v), collectively, the
“Purchaser Shareholder Approval Matters”), and (vi) as an ordinary resolution, the adjournment of the
Extraordinary General Meeting, if necessary to permit further solicitation of proxies because there are not sufficient votes to
approve and adopt any of the foregoing. If on the date for which the Extraordinary General Meeting is scheduled, Purchaser has not
received proxies representing a sufficient number of shares to obtain the Required Purchaser Shareholder Approval, whether or not a
quorum is present, Purchaser may make one or more successive postponements or adjournments (as permitted by the Purchaser’s
Governing Documents) of the Extraordinary General Meeting. In connection with the Registration Statement, Purchaser will file with
the SEC financial and other information about the transactions contemplated by this Agreement in accordance with applicable Law and
applicable proxy solicitation and registration statement rules set forth in Purchaser’s Governing Documents, the Securities
Act, the BVI Companies Act and the rules and regulations of the SEC and Nasdaq. Purchaser shall cooperate and provide the Company
(and its counsel) with a reasonable opportunity to review and comment on the Registration Statement and any amendment or supplement
thereto prior to filing the same with the SEC, and Purchaser shall consider any such comments timely made in good faith. In
connection with Purchaser’s preparation of the Registration Statement, Proxy Statement and any other filings required to be
made by Purchaser with the SEC under the Securities Act, or any responses to any comments from the SEC related thereto, the Company
and Selling Shareholders shall provide, and shall use its best efforts to cause its Representatives including legal and accounting
representatives to provide, all cooperation reasonably requested by Purchaser that is customary in connection with the preparation
of any such filings or responses, including but not limited to, obtaining the consents of any auditor to the inclusion of the
financial statements of the Company or any of its Subsidiaries in the Registration Statement, Proxy Statement and other filings with
the SEC. The Company shall provide Purchaser with such information concerning the Company and its shareholders, officers, directors,
employees, assets, Liabilities, condition (financial or otherwise), business and operations that may be required or appropriate for
inclusion in the Registration Statement, Proxy Statement or in any amendments or supplements thereto, or any other filings with the
SEC. The Company shall ensure that all information provided by the Company, the Selling Shareholders and their respective
representatives to Purchaser for inclusion or incorporation by reference in the Registration Statement, Proxy Statement, or any
other filings with the SEC, shall be true and correct and not contain any untrue statement of a material fact or omit to state a
material fact required to be stated therein or necessary in order to make the statements made, in light of the circumstances under
which they were made, not misleading. Any filing fees related to the filing of the Registration Statement with the SEC as
contemplated by this Section 7.11(a) shall be borne by Purchaser.
48
(b)
Purchaser shall take any and all reasonable and necessary actions required to satisfy the requirements of the Securities Act, the Exchange
Act and other applicable Laws in connection with the Registration Statement, the Extraordinary General Meeting and the Redemption. Each
of Purchaser and the Company shall, and shall cause each of its Subsidiaries to, make their respective directors, officers and employees,
upon reasonable advance notice, available to the Company, Purchaser and, after the Closing, Purchaser Representative, and their respective
Representatives in connection with the drafting of the public filings with respect to the transactions contemplated by this Agreement,
including the Registration Statement, and responding in a timely manner to comments from the SEC. Each Party shall promptly correct any
information provided by it for use in the Registration Statement (and other related materials) if and to the extent that such information
is determined to have become false or misleading in any material respect or as otherwise required by applicable Laws. If at any time
prior to the Closing, any information relating to the Company or Purchaser, or any of their respective directors, officers or Affiliates,
is discovered by the Company or Purchaser that is required to be set forth in an amendment or supplement to the Proxy Statement so that
such document would not include any misstatement of a material fact or omit to state any material fact required to be stated therein
or necessary to make the statements therein, in light of the circumstances under which they were made, not misleading, the Party that
discovers such information shall promptly notify the other Party. Purchaser shall amend or supplement the Registration Statement and
cause the Registration Statement, as so amended or supplemented, to be filed with the SEC and to be disseminated to Purchaser shareholders,
in each case as and to the extent required by applicable Laws and subject to the terms and conditions of this Agreement and Purchaser’s
Governing Documents; provided, however, that Purchaser shall not amend or supplement the Registration Statement without prior consultation
with the Company as is reasonable under the circumstances.
(c)
Purchaser, with the assistance of the other Parties, shall promptly respond to any SEC comments on the Registration Statement and shall
otherwise use its commercially reasonable efforts to cause the Registration Statement to “clear” comments from the SEC and
become effective. Purchaser shall provide the Company with copies of any written comments, and shall inform the Company of any material
oral comments, that Purchaser or its Representatives receive from the SEC or its staff with respect to the Registration Statement, the
Extraordinary General Meeting and the Redemption promptly after the receipt of such comments and shall give the Company and its counsel
a reasonable opportunity under the circumstances to review and comment on any proposed written or material oral responses to such comments,
including, to the extent permitted by the SEC, participation by the Company or its counsel in any discussions or meetings with the SEC,
and Purchaser shall consider any such comments timely made in good faith under the circumstances.
(d)
As soon as practicable following the Registration Statement “clearing” comments from the SEC and becoming effective, Purchaser
shall distribute the Registration Statement to Purchaser’s shareholders and the Selling Shareholders, and, pursuant thereto, shall
call the Extraordinary General Meeting in accordance with the Securities Act for a date no later than sixty (60) days following the effectiveness
of the Registration Statement.
(e)
Purchaser shall comply with all applicable Laws, any applicable rules and regulations of Nasdaq, Purchaser’s Governing Documents
and this Agreement in the preparation, filing and distribution of the Registration Statement, any solicitation of proxies thereunder,
the calling and holding of the Extraordinary General Meeting and the Redemption. Purchaser shall apply for, and shall take commercially
reasonable actions to cause, Purchaser Ordinary Shares to be issued in connection with the transactions to be approved for listing on
Nasdaq as of the Closing.
49
7.12
Public Announcements.
(a)
The Parties agree that during the Interim Period no public release, filing or announcement concerning this Agreement or the Ancillary
Documents or the transactions contemplated hereby or thereby shall be issued by any Party or any of their Affiliates without the prior
written consent of Purchaser and the Company (which consent shall not be unreasonably withheld, conditioned or delayed). The Parties
acknowledge and affirm the confidentiality agreement dated June 22, 2026 between Purchaser and the Company (the “NDA”),
which remains in effect. Notwithstanding the foregoing, Purchaser and its Representatives may, on a confidential basis, share this Agreement
and Company information approved by the Company (such approval not to be unreasonably withheld, conditioned or delayed) with selected
existing public shareholders and potential co-investors who have been informed of the confidential nature of the information and agreed
to keep it confidential, in order to gauge support for the transactions contemplated hereby and the PIPE Investment, and the Company
shall reasonably cooperate with those efforts, including by making its Director and other senior management reasonably available for
discussions, presentations and meetings. The foregoing restrictions shall not apply to any release, filing or announcement required by
applicable Law or the rules or regulations of any securities exchange, in which case the applicable Party shall use commercially reasonable
efforts to allow the other Parties reasonable time to comment on, and arrange for any required filing with respect to, such release or
announcement in advance of its issuance.
(b)
The Parties shall mutually agree upon and, as promptly as practicable after the execution of this Agreement (but in any event within
four (4) Business Days thereafter), issue a press release announcing the execution of this Agreement (the “Signing Press Release”).
Promptly after the issuance of the Signing Press Release, Purchaser shall file a current report on Form 8-K (the “Signing Filing”)
with the Signing Press Release and a description of this Agreement as required by Federal Securities Laws, which the Company shall review,
comment upon and approve (which approval shall not be unreasonably withheld, conditioned or delayed) prior to filing (with the Company
reviewing, commenting upon and approving such Signing Filing in any event no later than the third (3rd) Business Day after
the execution of this Agreement); provided that Purchaser provides the Company with a reasonable amount of time to complete such review,
comment and approval prior to the third (3rd) Business Day after the date thereof. The Parties shall mutually agree upon and,
as promptly as practicable after the Closing (but in any event within four (4) Business Days thereafter), issue a press release announcing
the consummation of the transactions contemplated by this Agreement (the “Closing Press Release”). Promptly after
the issuance of the Closing Press Release, Purchaser shall file a current report on Form 8-K (the “Closing Filing”)
with the Closing Press Release and a description of the Closing as required by Federal Securities Laws which the Shareholder Representative
and Purchaser Representative shall review, comment upon and approve (which approval shall not be unreasonably withheld, conditioned or
delayed) prior to filing. In connection with the preparation of the Signing Press Release, the Signing Filing, the Closing Filing, the
Closing Press Release, or any other report, statement, filing notice or application made by or on behalf of a Party to any Governmental
Authority or other third party in connection with the transactions contemplated hereby, each Party shall, upon request by any other Party,
furnish the Parties with all information concerning themselves, their respective directors, officers and equity holders, and such other
matters as may be reasonably necessary or advisable in connection with the transactions contemplated hereby, or any other report, statement,
filing, notice or application made by or on behalf of a Party to any third party and/or any Governmental Authority in connection with
the transactions contemplated hereby.
7.13
Confidential Information.
(a)
The Company, the Selling Shareholders and the Shareholder Representative hereby agree that during the Interim Period and, in the event
that this Agreement is terminated in accordance with Article X, for a period of two (2) years after such termination, they
shall, and shall cause their respective Representatives to: (i) treat and hold in strict confidence any Purchaser Confidential Information,
and will not use for any purpose (except in connection with the consummation of the transactions contemplated by this Agreement or the
Ancillary Documents, performing their obligations hereunder or thereunder, enforcing their rights hereunder or thereunder, or in furtherance
of their authorized duties on behalf of Purchaser or its Subsidiaries), nor directly or indirectly disclose, distribute, publish, disseminate
or otherwise make available to any third party any Purchaser Confidential Information without Purchaser’s prior written consent;
and (ii) in the event that the Company, any Selling Shareholder or the Shareholder Representative or any of their respective Representatives,
during the Interim Period or, in the event that this Agreement is terminated in accordance with Article X, for a period of
two (2) years after such termination, becomes legally compelled to disclose any Purchaser Confidential Information, (A) provide Purchaser
to the extent legally permitted with prompt written notice of such requirement so that Purchaser or an Affiliate thereof may seek, at
Purchaser’s cost, a protective Order or other remedy or waive compliance with this Section 7.13(a), and (B) in the
event that such protective Order or other remedy is not obtained, or Purchaser waives compliance with this Section 7.13(a), furnish
only that portion of such Purchaser Confidential Information which is legally required to be provided as advised in writing by outside
counsel and to exercise its commercially reasonable efforts to obtain assurances that confidential treatment will be accorded such Purchaser
Confidential Information. In the event that this Agreement is terminated and the transactions contemplated hereby are not consummated,
the Company, each Selling Shareholder and the Shareholder Representative shall, and shall cause their respective Representatives to,
promptly deliver to Purchaser or destroy (at Purchaser’s election) any and all copies (in whatever form or medium) of Purchaser
Confidential Information and destroy all notes, memoranda, summaries, analyses, compilations and other writings related thereto or based
thereon; provided, however, that the Company and the Shareholder Representative and their respective Representatives shall be entitled
to keep any records required by applicable Law or bona fide record retention policies; and provided, further, that any Purchaser Confidential
Information that is not returned or destroyed shall remain subject to the confidentiality obligations set forth in this Agreement.
50
(b)
Purchaser hereby agrees that during the Interim Period and, in the event that this Agreement is terminated in accordance with Article
X, for a period of two (2) years after such termination, it shall, and shall cause its Representatives to: (i) treat and hold in
strict confidence any Company Confidential Information, and will not use for any purpose (except in connection with the consummation
of the transactions contemplated by this Agreement or the Ancillary Documents, performing its obligations hereunder or thereunder or
enforcing its rights hereunder or thereunder), nor directly or indirectly disclose, distribute, publish, disseminate or otherwise make
available to any third party any of the Company Confidential Information without the Company’s prior written consent; and (ii)
in the event that Purchaser or any of its Representatives, during the Interim Period or, in the event that this Agreement is terminated
in accordance with Article X for a period of two (2) years after such termination, becomes legally compelled to disclose
any Company Confidential Information, (A) provide the Company to the extent legally permitted with prompt written notice of such requirement
so that the Company may seek, at the Company’s sole expense, a protective Order or other remedy or waive compliance with this Section
7.13(b) and (B) in the event that such protective Order or other remedy is not obtained, or the Company waives compliance with
this Section 7.13(b), furnish only that portion of such Company Confidential Information which is legally required to be
provided as advised in writing by outside counsel and to exercise its commercially reasonable efforts to obtain assurances that confidential
treatment will be accorded such Company Confidential Information. In the event that this Agreement is terminated and the transactions
contemplated hereby are not consummated, Purchaser shall, and shall cause its Representatives to, promptly deliver to the Company or
destroy (at Purchaser’s election) any and all copies (in whatever form or medium) of Company Confidential Information and destroy
all notes, memoranda, summaries, analyses, compilations and other writings related thereto or based thereon; provided, however, that
Purchaser and its Representatives shall be entitled to keep any records required by applicable Law or bona fide record retention policies;
and provided, further, that any Company Confidential Information that is not returned or destroyed shall remain subject to the confidentiality
obligations set forth in this Agreement. Notwithstanding the foregoing, Purchaser and its Representatives shall be permitted to disclose
any and all Company Confidential Information to the extent required by all applicable Laws.
7.14
Documents and Information. After the Closing Date, Purchaser and the Company shall, and shall cause their respective Subsidiaries
to, until the seventh (7th) anniversary of the Closing Date, retain all books, records and other documents pertaining to the
business of the Company in existence on the Closing Date and make the same available for inspection and copying by Purchaser Representative
during normal business hours of the Company and its Subsidiaries, as applicable, upon reasonable request and upon reasonable notice.
No such books, records or documents shall be destroyed after the seventh (7th) anniversary of the Closing Date by Purchaser
or its Subsidiaries (including the Company) without first advising Purchaser Representative in writing and giving Purchaser Representative
a reasonable opportunity to obtain possession thereof.
51
7.15
Post-Closing Board of Directors and Executive Officers.
(a)
The Parties shall take all necessary action, including causing certain directors of Purchaser to resign, so that effective as of the
Closing, the Board of Directors of Purchaser, as the surviving public company, will consist of five (5) individuals (the “Post-Closing
Board”). Effective as of immediately prior to the Closing, the Parties shall take all necessary action to designate and appoint
to the Post-Closing Board: four (4) persons designated by Purchaser prior to the Closing, at least three (3) of whom shall be required
to qualify as independent directors under SEC and Nasdaq rules (the “Purchaser Designees”), and one (1) person designated
by the Company prior to the Closing (together with the Purchaser Designees, the “Post-Closing Directors”). At or prior
to the Closing, each Post-Closing Director shall sign an Indemnification Agreement, in form and substance reasonably acceptable to Purchaser,
the Company and each Post-Closing Director in substantially the form attached hereto as Exhibit E.
(b)
The Parties shall take all action necessary, including causing executive officers to resign as necessary, so that the individuals serving
as the executive officers of Purchaser immediately after the Closing will be the current management team of the Company immediately prior
to the Closing, unless the Company, in consultation with Purchaser, reasonably determines that another qualified person should serve
in a particular role; any such replacement shall be subject to Purchaser’s prior written approval, not to be unreasonably withheld,
conditioned or delayed.
7.16
Indemnification of Directors and Officers; Tail Insurance.
(a)
The Parties agree that all rights to exculpation, indemnification and advancement of expenses existing in favor of the current or
former directors and officers of Purchaser and each Person who served as a director, officer, member, trustee or fiduciary of
another corporation, partnership, joint venture, trust, pension or other employee benefit plan or enterprise at the request of
Purchaser (the “D&O Indemnified Persons”) as provided in their respective Governing Documents or under any
indemnification, employment or other similar agreements between any D&O Indemnified Person and Purchaser, in each case as in
effect on the Agreement Date, shall survive the Closing and continue in full force and effect in accordance with their respective
terms to the extent permitted by applicable Law. The provisions of this Section 7.16 shall survive the consummation of
the transactions contemplated by this Agreement and are intended to be for the benefit of, and shall be enforceable by, each of the
D&O Indemnified Persons and their respective heirs and representatives.
(b)
For the benefit of Purchaser’s and the Company’s directors and officers, Purchaser shall be permitted prior to the Closing
to obtain, and the Company shall fully pay the premium for, a “tail” insurance policy that provides coverage for up to a
six-year period from and after the Closing for events occurring prior to the Closing (the “D&O Tail Insurance”)
that is substantially equivalent to and in any event not less favorable in the aggregate than Purchaser’s existing policy or, if
substantially equivalent insurance coverage is unavailable, the best available coverage. If obtained, Purchaser shall maintain the D&O
Tail Insurance in full force and effect, and continue to honor the obligations thereunder, and the Company shall timely pay or caused
to be paid all premiums with respect to the D&O Tail Insurance.
7.17
Trust Account Proceeds. Immediately upon the Closing, the cash of Purchaser, as the post-Closing combined company, including the
funds remaining in the Trust Account after payments for the Redemption and any proceeds received from the PIPE Investment, shall first
be used to pay (i) Purchaser’s accrued but unpaid Expenses, including transaction expenses, deferred IPO fees, deferred advisor
fees and obligations owed to the Sponsor, and (ii) any other accrued and unpaid expenses and Liabilities of Purchaser properly payable
at the Closing. Any remaining cash shall be used for working capital and general corporate purposes of the post-Closing combined company.
For the avoidance of doubt, Transaction Expenses incurred by the Company (and not any Transaction Expenses incurred solely by a Selling
Shareholder) shall be funded by the post-Closing combined company without reducing the Transaction Consideration, except for unpaid transaction
bonuses and other transaction-related compensation expressly deducted under Section 2.1.
52
7.18
PIPE Investment. During the Interim Period, Purchaser and the Company shall reasonably cooperate to seek a PIPE Investment pursuant
to customary and binding Subscription Agreements with PIPE Investors agreed by Purchaser and the Company, and shall use their respective
commercially reasonable efforts to cause the PIPE Investment to close concurrently with the Closing. The terms of the PIPE Investment
shall be negotiated and agreed by Purchaser and the Company consistent with market terms, and Purchaser and the Company shall negotiate
and agree on the choice of placement agent, fees, approach and target investor universe. In no event shall any new promote or any additional
shares of Purchaser be issued to the Sponsor, upon conversion of existing founder shares or otherwise, attributable to the PIPE Investment.
Purchaser and the Company shall, and shall cause their respective Representatives to, cooperate with each other and their respective
Representatives in connection with the PIPE Investment, including having the Company’s senior management participate in investor
meetings and roadshows as reasonably requested by Purchaser, and use their respective commercially reasonable efforts to cause the PIPE
Investment to occur. Purchaser shall use its commercially reasonable best efforts to satisfy the conditions of the PIPE Investors’
closing obligations contained in the Subscription Agreements and consummate the transactions contemplated thereby. Each of Purchaser
and, as applicable, the Company, shall, and shall cause its Affiliates to, use commercially reasonable best efforts to avoid being in
breach or default under the Subscription Agreements. Purchaser may, but shall not be required to, enter into additional Subscription
Agreements with additional PIPE Investors, including in the event of an actual or threatened material breach or default by a PIPE Investor
or if Purchaser reasonably believes in good faith that such PIPE Investor is unwilling or unable to consummate its investment, and any
such additional Subscription Agreements shall become part of the PIPE Investment. If Purchaser elects to seek such additional Subscription
Agreements containing terms substantially different from the Subscription Agreements then in effect, the Company’s prior written
consent shall be required, not to be unreasonably withheld, delayed or conditioned. Purchaser and the Company shall deliver to each other
true, correct and complete copies of each Subscription Agreement and any other Contract with a PIPE Investor that could affect the obligation
of such PIPE Investor to contribute its applicable portion of the aggregate gross proceeds of the PIPE Investment. The Company shall
not enter into any Contract with a PIPE Investor during the Interim Period without the prior written consent of Purchaser, not to be
unreasonably withheld, delayed or conditioned.
7.19
Incentive Equity Plan. Prior to the Closing Date, Purchaser and the Company shall agree upon and Purchaser shall approve and adopt
the Incentive Equity Plan in substantially the form attached hereto as Exhibit D (with such changes as may be agreed by Purchaser
and the Company). The Company’s existing long-term employee equity compensation plan shall not be cashed out as part of the Acquisition,
and the Incentive Equity Plan shall absorb and reconstitute that plan. Within thirty (30) days after the Closing, Purchaser shall file
a registration statement on Form S-8 (or other applicable form) with respect to the Purchaser Class A Ordinary Shares issuable under
the Incentive Equity Plan, and Purchaser shall use reasonable efforts to maintain the effectiveness of such registration statement (and
maintain the current status of the prospectus contained therein) for so long as awards granted pursuant to the Incentive Equity Plan
remain outstanding.
7.20
Tax Matters.
(a)
The Selling Shareholders shall prepare or cause to be prepared at their own expense and the Company shall file or cause to be filed all
Tax Returns of the Company for all taxable periods ending on or prior to the Closing Date (“Pre-Closing Periods”)
that are filed after the Closing Date, other than any Tax Return due for the short tax period ending on the Closing Date (the “Final
Pre-Closing Period”). The Shareholder Representative shall provide Purchaser with a copy of the Tax Returns prepared under
this Section 7.20(a) at least twenty (20) days prior to the filing of such Tax Returns, and the Selling Shareholders will
incorporate any reasonable comments made by Purchaser within such 20-day period; provided, that nothing herein shall require the
Company to file any Tax Return that, in the opinion of Purchaser’s tax advisors, is not complete and accurate; provided, further,
that the Selling Shareholders shall not take any position or apply any methodology in preparing any such Tax Return that is not consistent
with the Tax practices and methodologies consistently applied in the ordinary course of business by the Company and its Subsidiaries
in the preparation of its Tax Returns relating to prior taxable periods (such as, for example and without limitation, practices with
respect to the calculation of depreciation expense deductions), provided that such practices and methodologies comply with applicable
Law. Except as required by Law, without the prior written consent of the Shareholder Representative (which consent shall not be unreasonably
withheld, conditioned or delayed), neither the Company, any of its Subsidiaries, Purchaser nor any Affiliate of the Company, the Subsidiaries
or Purchaser shall file any amended Tax Return with respect to any such period. To the extent permitted by applicable Law, neither the
Company nor its Subsidiaries shall carry back any Tax attribute to any such period. Purchaser shall have the right to handle, defend,
conduct and control any Tax Claim relating to any Tax refund arising by operation of the preceding sentence; provided, that Purchaser
shall consult periodically with the Shareholder Representative as to strategic and tactical issues for pursuing any Tax Claim and shall
consider in good faith any suggestions made by the Shareholder Representative about the conduct of such Tax Claim. Purchaser shall not
have the right to compromise or settle any such Tax Claim relating to a refund without the prior consent of the Shareholder Representative,
which consent shall not be unreasonably withheld, conditioned or delayed.
53
(b)
Purchaser shall prepare (or cause to be prepared) and file (or cause to be filed) when due (taking into account all extensions properly
obtained) all Tax Returns required to be filed by or with respect to the Company and its Subsidiaries relating to: (i) the Final Pre-Closing
Period; and (ii) taxable periods that begin before and end after the Closing Date (“Straddle Periods”). Purchaser
shall deliver to the Shareholder Representative copies of each such Tax Return relating to the Final Pre-Closing Period and Straddle
Periods, along with a statement (a “Tax Statement”) showing the pre-Closing portion of any Liability in respect of
any Taxes required to be paid with such Tax Return (computed in accordance with Section 7.20(d)), at least twenty (20) days
prior to the due date for filing such Tax Return, and shall permit the Shareholder Representative to review and comment on such Tax Return
and Tax Statement prior to filing. Purchaser shall not file any such Tax Return relating to the Final Pre-Closing Period and Straddle
Periods without the prior written consent of the Shareholder Representative (which shall not be unreasonably withheld, conditioned or
delayed); provided that the failure of the Shareholder Representative to deliver written consent to Purchaser prior to the due
date for filing such Tax Return shall be deemed to constitute consent. If the parties have not resolved any dispute relating to any such
Tax Return prior to the due date for filing such Tax Return, then Purchaser shall file such Tax Return as prepared, but such filing shall
not prejudice the rights of any party to pursue such dispute.
(c)
Not later than two (2) days prior to the due date for the payment of Taxes on any Tax Returns relating to Pre-Closing Periods or Straddle
Periods, the Shareholder Representative for and on behalf of the Selling Shareholders shall pay to Purchaser the amount of cash Taxes
payable shown on the Tax Return (in the case of a Pre-Closing Period other than the Final Pre-Closing Period) or the Tax Statement (in
the case of the Final Pre-Closing Period and a Straddle Period).
(d)
The Company and each Subsidiary will, unless prohibited by applicable Law, close the taxable year of the Company and each Subsidiary
as of the close of business on the Closing Date. If applicable Law does not permit the Company or any Subsidiary to close its taxable
year on the Closing Date, the Taxes, if any, attributable to such Straddle Period shall be allocated: (i) to the Selling Shareholders
for the period up to and including the close of business on the Closing Date; and (ii) to Purchaser for the period subsequent to the
Closing Date, pursuant to the following methodology: (x) Taxes, other than those referred to in clause (y) below, shall be allocated
by means of a closing of the books and records of the Company and its Subsidiaries as of the close of the Closing Date, provided
that exemptions, allowances or deductions that are calculated on an annual basis (including, but not limited to, depreciation and amortization
deductions) shall be allocated between the period ending on the Closing Date and the period after the Closing Date in proportion to the
number of days in each such period, and (y) property Taxes and ad valorem Taxes shall be allocated between the period ending on the Closing
Date and the period after the Closing Date in proportion to the number of days in each such period. For the avoidance of doubt, all management
bonuses, severance payments, interest payments and deductible financing costs and expenses accrued or paid by the Company or its Subsidiaries
on or prior to the Closing Date, including, without limitation, the Transaction Expenses, shall be treated as incurred in a Pre-Closing
Period or the pre-Closing portion of the Straddle Period, as appropriate.
54
(e)
Notwithstanding any other provisions hereof, if an audit or other proceeding is commenced, an adjustment is proposed or any other claim
is made by any taxing authority with respect to a Tax liability of the Company or any Subsidiary relating to a Pre-Closing Period, the
Final Pre-Closing Period or the pre-Closing portion of any Straddle Period (a “Tax Claim”), Purchaser shall promptly
notify the Shareholder Representative of such audit or other proceeding, proposed adjustment or claim. Purchaser shall have the right
to handle, defend, conduct and control any such Tax Claim; provided, that Purchaser shall consult periodically with the Shareholder
Representative as to strategic and tactical issues for pursuing any Tax Claim and shall consider in good faith any suggestions made by
the Shareholder Representative about the conduct of such audit or contest. Purchaser shall not have the right to compromise or settle
any such Tax Claim which would result in an increased Tax liability or a decreased refund to the Shareholder Representative without the
prior consent of the Shareholder Representative, which consent shall not be unreasonably withheld, conditioned or delayed.
(f)
Any refunds (and any interest received thereon) of any Tax imposed on the Company or any Subsidiary for any Pre-Closing Period, the Final
Pre-Closing Period or the pre-Closing portion of any Straddle Period (determined in accordance with Section 7.20(d)) shall
be payable to the Selling Shareholders.
(g)
Following the Closing, Purchaser and the Shareholder Representative shall provide each other with such assistance as may reasonably be
requested by any of them in connection with the preparation of any Tax Return, any audit or other examination by any taxing authority,
or any judicial or administrative proceedings relating to Liability for Taxes of the Company and its Subsidiaries. The party requesting
assistance hereunder shall reimburse the other for reasonable out-of-pocket expenses incurred in providing such assistance. Purchaser
and the Shareholder Representative shall preserve and cause to be preserved all information, returns, books, records and documents relating
to any Liabilities for Taxes of the Company and its Subsidiaries with respect to a taxable period until the later of sixty (60) days
after the expiration of all applicable statutes of limitations and extensions thereof; or the conclusion of all litigation with respect
to Taxes for such period.
7.21
Related Party Matters. At or prior to the Closing, any and all assets, Intellectual Property, Contracts and benefits accruing
to the Company that are either held or licensed by any Affiliates of the Company and are used or to be used in the business of the Company
shall be transferred to the Company to the satisfaction of Purchaser. The Company shall not have, and shall not enter into, any related-party
transaction that is not bona fide, on arm’s-length terms, necessary for the Company’s business and approved in writing by
Purchaser before it is entered into. The Company shall provide Purchaser with complete copies of all agreements and other documentation
relating to such transactions.
Article
VIII
NO
SURVIVAL
8.1
No Survival. Representations and warranties of the Company, Purchaser and the Selling Shareholders contained in this Agreement
or in any certificate or instrument delivered by or on behalf of the Company, Purchaser or the Selling Shareholders pursuant to this
Agreement shall not survive the Closing, and from and after the Closing, the Company, Purchaser, and the Selling Shareholders and their
respective Representatives shall not have any further obligations, nor shall any claim be asserted or action be brought against the Company,
Purchaser or the Selling Shareholders or their respective Representatives with respect thereto. The covenants and agreements made by
the Company and Purchaser in this Agreement or in any certificate or instrument delivered pursuant to this Agreement, including any rights
arising out of any breach of such covenants or agreements, shall not survive the Closing, except for those covenants and agreements contained
herein and therein that by their terms apply or are to be performed in whole or in part after the Closing (which such covenants shall
survive the Closing and continue until fully performed in accordance with their terms).
55
Article
IX
CONDITIONS
TO CLOSING
9.1
Conditions to Each Party’s Obligations. The obligations of each Party to consummate the transactions contemplated by this
Agreement shall be subject to the satisfaction or written waiver (where permissible) by the Company, Selling Shareholders and Purchaser,
as applicable, of the following conditions:
(a)
Required Purchaser Shareholder Approval. Purchaser Shareholder Approval Matters that are submitted to the vote of the shareholders
of Purchaser at the Extraordinary General Meeting in accordance with the Proxy Statement shall have been approved by the requisite vote
of the shareholders of Purchaser at the Extraordinary General Meeting in accordance with Purchaser’s Governing Documents, applicable
Law and the Proxy Statement (the “Required Purchaser Shareholder Approval”).
(b)
Antitrust Laws. Any waiting period (and any extension thereof) applicable to the consummation of this Agreement under any Antitrust
Laws shall have expired or been terminated.
(c)
Requisite Regulatory Approvals. All Consents required to be obtained from or made with any Governmental Authority in order to
consummate the transactions contemplated by this Agreement shall have been obtained or made.
(d)
Requisite Consents. The Consents required to be obtained from or made with any third Person (other than a Governmental Authority)
in order to consummate the transactions contemplated by this Agreement that are set forth in Schedule 9.1(d) shall have each
been obtained or made.
(e)
No Adverse Law or Order. No Governmental Authority shall have enacted, issued, promulgated, enforced or entered any Law (whether
temporary, preliminary or permanent) or Order that is then in effect and which has the effect of making the transactions or agreements
contemplated by this Agreement illegal or which otherwise prevents or prohibits consummation of the transactions contemplated by this
Agreement.
(f)
Net Tangible Assets Test. Upon the Closing, after giving effect to the Redemption and any PIPE Investment, Purchaser shall
have net tangible assets of at least $5,000,001.
(g)
Appointment of Directors and Officers. The post-Closing directors and officers of Purchaser, as the surviving public company,
identified on Schedule 9.1(g) shall have been duly elected or appointed effective as of the Closing, consistent with the
requirements of Purchaser’s Governing Documents, each to hold office in accordance until their respective successors are duly elected
or appointed and qualified or their earlier death, resignation or removal, and each such director and officer shall have entered into
an Indemnification Agreement.
(h)
Registration Statement. The Registration Statement shall have been declared effective by the SEC and shall remain effective
as of the Closing, and no stop order or similar order shall be in effect with respect to the Registration Statement.
(i)
Nasdaq Listing. The Purchaser Class A Ordinary Shares issued as Consideration Shares shall have been approved for listing on Nasdaq,
subject to official notice of issuance.
9.2 Conditions
to Obligations of Purchaser. In addition to the conditions specified in Section 9.1, the obligations of
Purchaser to consummate the other transactions contemplated by this Agreement are subject to the satisfaction or written waiver (by
Purchaser) of the following conditions:
(a)
Representations and Warranties. All of the representations and warranties of the Company and the Selling Shareholders set forth
in this Agreement and in any certificate delivered by or on behalf of the Company or the Selling Shareholders pursuant hereto shall be
true and correct on and as of the Agreement Date and on and as of the Closing Date as if made on the Closing Date, except for (i) those
representations and warranties that address matters only as of a particular date (which representations and warranties shall have been
accurate as of such date), and (ii) any failures to be true and correct that (without giving effect to any qualifications or limitations
as to materiality or Material Adverse Effect), individually or in the aggregate, have not had and would not reasonably be expected to
have a Material Adverse Effect on, or with respect to, the Company or the Selling Shareholders, as the case may be.
56
(b)
Agreements and Covenants. The Company and the Selling Shareholders shall have performed in all material respects all of their
respective obligations and complied in all material respects with all of their respective agreements and covenants under this Agreement
to be performed or complied with thereby on or prior to the Closing Date.
(c)
No Material Adverse Effect. No Material Adverse Effect shall have occurred with respect to the Company or any Selling Shareholder
since the Agreement Date which is continuing and uncured.
(d)
Certain Ancillary Documents. Each Executive Employment Agreement, Restrictive Covenant Agreement, Lock-Up Agreement, Indemnification
Agreement and Registration Rights Agreement required to be executed at or before the Closing shall be in full force and effect in accordance
with its terms, effective as of the Closing.
(e)
Closing Deliveries.
(i)
Officer Certificate. Purchaser shall have received a certificate from the Company, dated as the Closing Date, signed by the chief
executive officer of the Company in such capacity, certifying as to the satisfaction of the conditions specified in Sections 9.2(a),
9.2(b) and 9.2(c).
(ii) Secretary
Certificate. The Company shall have delivered to Purchaser a certificate executed by the Company’s Secretary certifying as
to the validity and effectiveness of, and attaching (A) copies of the Company’s Governing Documents as in effect as of the
Closing, (B) the requisite resolutions of the Company’s board of directors and shareholders authorizing and approving the
execution, delivery and performance of this Agreement and each Ancillary Document to which the Company is or is required to be a
party or bound and the consummation of the transactions contemplated hereby and thereby, the adoption by the Company of the Company
Amended Charter in a form acceptable to Purchaser, and the election of Company officers and directors listed on Schedule
9.1(e) and (C) the incumbency of officers of the Company authorized to execute this Agreement or any Ancillary Document to which
the Company is or is required to be a party or otherwise bound.
(iii)
Good Standing. The Company shall have delivered to Purchaser good standing certificates (or similar documents applicable for such
jurisdictions) for the Company certified as of a date no earlier than twenty (20) days prior to the Closing Date from the proper Governmental
Authority of the Company’s jurisdiction of organization and from each other jurisdiction in which the Company is qualified to do
business as a foreign corporation or other entity as of the Closing, in each case to the extent that good standing certificates or similar
documents are generally available in such jurisdictions.
(iv)
Certified Company Amended Charter. The Company shall have filed the Company Amended Charter, and shall have delivered to Purchaser
a copy thereof, in effect as of immediately prior to the Closing, certified by the proper Governmental Authority.
(v)
Registration Rights Agreement. The Registration Rights Agreement, providing customary demand and piggyback registration rights
subject to customary exceptions and limitations, shall have been duly executed and delivered by the Parties thereto in form and substance
reasonably satisfactory to Purchaser.
57
(vi)
Executive Employment Agreements. Purchaser shall have received Executive Employment Agreements duly executed by each applicable
Key Executive, in each case effective as of the Closing, in form and substance reasonably satisfactory to Purchaser, including customary
confidentiality, non-competition, non-solicitation and assignment of inventions provisions.
(vii)
Indemnification Agreements. The Company shall have delivered to Purchaser copies of Indemnification Agreements duly executed by
each officer and director of the Company.
(viii)
Share Certificates and Transmittal Documents. Each Selling Shareholder shall have delivered to Purchaser Company Certificate(s)
representing all Company Shares held by such Selling Shareholder, duly endorsed in blank or accompanied by share transfer powers, if
certificated, and/or such other transmittal documents required for transfer on the books of the Company and acceptable to Purchaser.
(ix)
Convertible Securities. Purchaser shall have received evidence reasonably acceptable to Purchaser that the Company shall have
terminated, extinguished and cancelled in full any outstanding Company Convertible Securities.
(x)
PCAOB and U.S. GAAP Financial Statements. Purchaser shall have received the PCAOB-audited annual Company Financials and any other
financial statements, auditor consents and related deliverables required for the Registration Statement and Proxy Statement, each prepared
in accordance with U.S. GAAP and applicable SEC requirements, in form and substance reasonably satisfactory to Purchaser and its counsel.
(xi)
Resignations. Purchaser shall have received written resignations, effective as of the Closing, of each of the directors
and officers of the Company listed on Schedule 9.2(e)(xi) prior to the Closing.
(xii)
Restrictive Covenant Agreement. Purchaser shall have received Restrictive Covenant Agreements duly executed by the significant
shareholders of the Company listed on Schedule 9.2(e)(xii), in each case effective as of the Closing.
(xiii)
Lock-Up Agreement. The Company shall have delivered to Purchaser copies of Lock-Up Agreements duly executed by each officer and
director of the Company and each holder of five percent (5%) or more of the Company’s voting stock listed on Schedule 9.2(e)(xiii),
in each case effective as of the Closing.
9.3
Conditions to Obligations of the Company. In addition to the conditions specified in Section 9.1, the obligations of the
Company to consummate the transactions contemplated by this Agreement are subject to the satisfaction or written waiver (by the Company)
of the following conditions:
(a)
Representations and Warranties. All of the representations and warranties of Purchaser set forth in this Agreement and in any
certificate delivered by or on behalf of Purchaser pursuant hereto shall be true and correct on and as of the date of this Agreement
and on and as of the Closing Date as if made on the Closing Date, except for (i) those representations and warranties that address matters
only as of a particular date (which representations and warranties shall have been accurate as of such date), and (ii) any failures to
be true and correct that (without giving effect to any qualifications or limitations as to materiality or Material Adverse Effect), individually
or in the aggregate, have not had and would not reasonably be expected to have a Material Adverse Effect on, or with respect to, Purchaser.
58
(b)
Agreements and Covenants. The Purchaser shall have performed in all material respects all of Purchaser’s obligations and
complied in all material respects with all of Purchaser’s agreements and covenants under this Agreement to be performed or complied
with by it on or prior to the Closing Date.
(c)
No Purchaser Material Adverse Effect. No Material Adverse Effect shall have occurred with respect to Purchaser since the date
of this Agreement which is continuing and uncured.
(d)
Closing Deliveries.
(i)
Officer Certificate. The Purchaser shall have delivered to the Company a certificate, dated as of the Closing Date, signed by
an executive officer of Purchaser in such capacity, certifying as to the satisfaction of the conditions specified in Sections 9.3(a),
9.3(b) and 9.3(c).
(ii)
Secretary Certificate. The Purchaser shall have delivered to the Company a certificate from its secretary or other executive officer
certifying as to, and attaching, (A) copies of Purchaser’s Governing Documents as in effect as of the Closing Date (after giving
effect to the transactions contemplated hereby), (B) the resolutions of Purchaser’s board of directors authorizing and approving
the execution, delivery and performance of this Agreement and each of the Ancillary Documents to which it is a party or by which it is
bound, and the consummation of the transactions contemplated hereby and thereby, (C) evidence that the Required Purchaser Shareholder
Approval has been obtained and (D) the incumbency of officers authorized to execute this Agreement or any Ancillary Document to which
Purchaser is or is required to be a party or otherwise bound.
(iii)
Good Standing. The Purchaser shall have delivered to the Company a good standing certificate (or similar documents applicable
for such jurisdictions) for Purchaser certified as of a date no earlier than thirty (30) days prior to the Closing Date from the proper
Governmental Authority of Purchaser’s jurisdiction of organization and from each other jurisdiction in which Purchaser is qualified
to do business as a foreign entity as of the Closing, in each case to the extent that good standing certificates or similar documents
are generally available in such jurisdictions.
(iv)
Registration Rights Agreement. The Registration Rights Agreement, providing customary demand and piggyback registration rights
subject to customary exceptions and limitations, shall have been duly executed and delivered by the Parties thereto in form and substance
reasonably satisfactory to the Company and Purchaser.
9.4
Frustration of Closing Conditions. A Party may not rely on the failure of any condition set forth in Sections 9.1
to 9.3, as the case may be, if such failure was caused by such Party’s failure to comply in any material way
with any material provision of this Agreement.
Article
X
TERMINATION
AND EXPENSES
10.1
Termination of Agreement. This Agreement may be terminated prior to the Closing as follows:
(a)
by mutual written consent of the Company and Purchaser;
(b)
by written notice by the Company or Purchaser if any of the conditions to the Closing set forth in Article IX have not been
satisfied or waived by January 31, 2027 (the “Expiration Date”) (provided, that if Purchaser seeks and obtains one
or more Extensions, Purchaser shall have the right with respect to each extension, by providing written notice thereof to the Company
and the Shareholder Representative, to extend the Expiration Date for an additional period equal to the shortest of (i) three (3) additional
months, (ii) the period ending on the last date for Purchaser to consummate its Business Combination as described in the IPO Prospectus
pursuant to such Extension and (iii) such period as determined by Purchaser); provided, however, the right to terminate this Agreement
under this Section 10.1(b) shall not be available to a Party if the breach or violation by such Party or its Affiliates of
any representation, warranty, covenant or obligation under this Agreement was the cause of, or resulted in, the failure of the Closing
to occur on or before the Expiration Date;
59
(c)
the Company may terminate this Agreement by giving written notice to Purchaser at any time prior to the Closing if: (i) Purchaser
has materially breached any covenant, representation or warranty in any material respect contained in this Agreement, or if any
representation or warranty of Purchaser shall have become untrue or inaccurate, in any case, which would result in the failure of a
condition set forth in Section 9.3(a) or Section 9.3(b) to be satisfied (treating the Closing Date for such
purposes as the Agreement Date or, if later, the date of such breach), and (ii) such breach is not curable or, if curable, has not
been cured within the earlier of (A) thirty (30) days after written notice of such breach or inaccuracy is provided to Purchaser or
(B) the Expiration Date; provided that the Company shall not have the right to terminate this Agreement pursuant to this Section
10.1(c) if either the Company or any Selling Shareholder is in material breach of any covenant, representation or warranty
contained in this Agreement on the date of such written notice;
(d)
Purchaser may terminate this Agreement by giving written notice to the Company at any time prior to the Closing if: (i) the Company or
any Selling Shareholder has materially breached any covenant, representation or warranty in any material respect contained in this Agreement,
or if any representation or warranty of such Parties shall have become untrue or inaccurate, in any case, which would result in the failure
of a condition set forth in Sections 9.2(a) or 9.2(b) to be satisfied (treating the Closing Date for such purposes
as the Agreement Date or, if later, the date of such breach), and (ii) such breach is not curable or, if curable, such breach has not
been cured within the earlier of (A) thirty (30) days after written notice of such breach or inaccuracy is provided to the Company or
(B) the Expiration Date (so long as Purchaser is not then in material breach of any covenant, representation or warranty contained in
this Agreement); or
(e)
by the Company or Purchaser if there shall be in effect a final non-appealable Order of a Governmental Authority of competent jurisdiction
permanently restraining, enjoining or otherwise prohibiting the consummation of the transactions contemplated hereby; it being agreed
that the parties hereto shall use commercially reasonable efforts to appeal any adverse determination which is not non-appealable (and
pursue such appeal with reasonable diligence); provided, however, that the right to terminate this Agreement under this
Section 10.1(e) will not be available to any Party whose failure to fulfill any material covenant or agreement under this Agreement
has been the cause of or resulted in the action or event described in this Section 10.1(e) occurring;
(f)
by written notice by Purchaser to the Company and the Shareholder Representative if there shall have been a Material Adverse Effect on
the Company following the Agreement Date which is uncured for at least twenty (20) days after written notice of such Material Adverse
Effect is provided by Purchaser to the Company; or
(g)
by written notice by Purchaser to the Company and the Shareholder Representative, if the Extraordinary General Meeting is held (including
any adjournment or postponement thereof) and has concluded, Purchaser’s shareholders have duly voted, and the Required Purchaser
Shareholder Approval was not obtained.
10.2
Effect of Termination. This Agreement may only be terminated in the circumstances described in Section 10.1 and pursuant
to a written notice delivered by the applicable Party to the other applicable Parties, which sets forth the basis for such termination,
including the provision of Section 10.1 under which such termination is made. In the event of the valid termination of this Agreement
pursuant to Section 10.1, this Agreement shall forthwith become void, and there shall be no Liability on the part of any Party
or any of their respective Representatives, and all rights and obligations of each Party shall cease, except: (i) Sections 7.12,
7.13, 10.3, 11.1, Article XIV and this Section
10.2 shall survive the termination of this Agreement, and (ii) nothing herein shall relieve any Party from Liability for any willful
breach of any representation, warranty, covenant or obligation under this Agreement or any Fraud Claim against such Party, in either
case, prior to termination of this Agreement (in each case of clauses (i) and (ii) above, subject to Section 11.1).
Without limiting the foregoing, and except as provided in Section 10.3 and this Section 10.2 (but subject to Section
11.1) and subject to the right to seek injunctions, specific performance or other equitable relief in accordance with Section
12.7, the Parties’ sole right prior to the Closing with respect to any breach of any representation, warranty, covenant or
other agreement contained in this Agreement by another Party or with respect to the transactions contemplated by this Agreement shall
be the right, if applicable, to terminate this Agreement pursuant to Section 10.1.
60
10.3
Fees and Expenses. Subject to Sections 7.3, 11.1, Article VII
and Article XIV, all Expenses incurred in connection with this Agreement and the transactions contemplated
hereby shall be paid by the Party incurring such Expenses; provided, however, that if the Closing occurs, all Transaction Expenses incurred
by the Company (and not any Transaction Expenses incurred solely by a Selling Shareholder) shall be funded by the post-Closing combined
company without reducing the Transaction Consideration, except for unpaid transaction bonuses and other transaction-related compensation
expressly deducted under Section 2.1, and any filing fees or similar fees relating to regulatory or governmental approvals shall
be borne by Purchaser. As used in this Agreement, “Expenses” shall include all out-of-pocket expenses (including all
fees and expenses of counsel, accountants, investment bankers, financial advisors, financing sources, experts and consultants to a Party
hereto or any of its Affiliates) incurred by a Party or on its behalf in connection with or related to the authorization, preparation,
negotiation, execution or performance of this Agreement or any Ancillary Document related hereto and all other matters related to the
consummation of this Agreement. With respect to Purchaser, Expenses shall include any and all expenses, filing fees, costs and deferred
expenses (including fees or commissions payable to the underwriters and any legal fees) of the IPO, upon consummation of a Business Combination
and any Extension Expenses.
Article
XI
WAIVERS
AND RELEASES
11.1
Waiver of Claims Against Trust. Reference is made to the IPO Prospectus. The Company, each Selling Shareholder and the Shareholder
Representative each represents and warrants that it has read the IPO Prospectus and understands that Purchaser has established the Trust
Account containing the proceeds of the IPO and the overallotment shares acquired by Purchaser’s underwriters and from certain private
placements occurring simultaneously with the IPO (including interest accrued from time to time thereon) for the benefit of Purchaser’s
public shareholders (including overallotment shares acquired by Purchaser’s underwriters) (the “Public Shareholders”)
and that, except as otherwise described in the IPO Prospectus, Purchaser may disburse monies from the Trust Account only: (a) to the
Public Shareholders in the event they elect to redeem their Purchaser Ordinary Shares in connection with the consummation of its Business
Combination or in connection with an amendment to Purchaser’s Governing Documents to extend Purchaser’s deadline to consummate
a Business Combination, (b) to the Public Shareholders if Purchaser fails to consummate a Business Combination within twelve (12) months
after the closing of the IPO, subject to extension, (c) with respect to any interest earned on the amounts held in the Trust Account,
amounts necessary to pay for any taxes, and (d) to Purchaser after or concurrently with the consummation of a Business Combination. For
and in consideration of Purchaser entering into this Agreement and for other good and valuable consideration, the receipt and sufficiency
of which is hereby acknowledged, the Company, each Selling Shareholder and the Shareholder Representative, on behalf of itself and its
Affiliates, hereby agree that, notwithstanding anything to the contrary in this Agreement, none of the Company, any Selling Shareholder
or the Shareholder Representative, nor any of their respective Affiliates, has or shall at any time hereafter have any right, title,
interest or claim of any kind in or to any monies in the Trust Account or distributions therefrom, or make any claim against the Trust
Account (including any distributions therefrom), regardless of whether such claim arises as a result of, in connection with or relating
in any way to, this Agreement or any proposed or actual business relationship between Purchaser or any of its Representatives, on the
one hand, and the Company, any Selling Shareholder, the Shareholder Representative or any of their respective Representatives, on the
other hand, or any other matter, and regardless of whether such claim arises based on contract, tort, equity or any other theory of legal
liability (collectively, the “Released Claims”). The Company, each Selling Shareholder and the Shareholder Representative,
on behalf of itself and its Affiliates, hereby irrevocably waive any Released Claims that any such Party or any of its Affiliates may
have against the Trust Account (including any distributions therefrom) now or in the future as a result of, or arising out of, any negotiations,
contracts or agreements with Purchaser or its Representatives and will not seek recourse against the Trust Account (including any distributions
therefrom) for any reason whatsoever (including for an alleged breach of this Agreement or any other agreement with Purchaser or its
Affiliates). The Company, each Selling Shareholder and the Shareholder Representative each agrees and acknowledges that such irrevocable
waiver is material to this Agreement and specifically relied upon by Purchaser and its Affiliates to induce Purchaser to enter into this
Agreement, and each such Party further intends and understands such waiver to be valid, binding and enforceable against such Party and
each of its Affiliates under applicable Law. To the extent that the Company, any Selling Shareholder or the Shareholder Representative
or any of their respective Affiliates commences any Action based upon, in connection with, relating to or arising out of any matter relating
to Purchaser or its Representatives, which proceeding seeks, in whole or in part, monetary relief against Purchaser or its Representatives,
each such Party hereby acknowledges and agrees that its and its Affiliates’ sole remedy shall be against funds held outside of
the Trust Account and that such claim shall not permit such Party or any of its Affiliates (or any Person claiming on its behalf or in
lieu of it) to have any claim against the Trust Account (including any distributions therefrom) or any amounts contained therein. If
the Company, any Selling Shareholder or the Shareholder Representative or any of their respective Affiliates commences any Action based
upon, in connection with, relating to or arising out of any matter relating to Purchaser or its Representatives that seeks, in whole
or in part, relief against the Trust Account (including any distributions therefrom) or the Public Shareholders, whether in the form
of money damages or injunctive relief, Purchaser and its Representatives, as applicable, shall be entitled to recover from the Company,
each Selling Shareholder, the Shareholder Representative and their respective Affiliates, as applicable, the associated legal fees and
costs in connection with any such Action, in the event Purchaser or its Representatives, as applicable, prevails in such Action. This
Section 11.1 shall survive termination of this Agreement for any reason and continue indefinitely.
61
Article
XII
MISCELLANEOUS
12.1
Notices. All notices, consents, waivers and other communications hereunder shall be in writing and shall be deemed to have been
duly given when delivered (i) in person, (ii) by facsimile or other electronic means (including e-mail), with affirmative confirmation
of receipt, (iii) one Business Day after being sent, if sent by reputable, nationally recognized overnight courier service or (iv) three
(3) Business Days after being mailed, if sent by registered or certified mail, pre-paid and return receipt requested, in each case to
the applicable Party at the following addresses (or at such other address for a Party as shall be specified by like notice):
If
to Purchaser, to:
ARC
Group Acquisition I Corp.
398
S Mill Avenue,
Suite
306,
Tempe,
AZ 85284
Attn:
Datuk Dr. Doris Wong
Telephone
No.:
E-mail:
with
a copy (which will not constitute notice) to:
Rimon,
P.C.
1050
Connecticut Avenue, NW, Suite 500
Washington,
DC 20036
Attn:
Debbie A. Klis Esq.
Mark
C Lee, Esq.
Telephone
No.: (202) 935-3390
Email:
deborrah.klis@rimonlaw.com
mark.c.lee@rimonlaw.com
If
to Purchaser Representative, to:
Datuk
Dr. Doris Wong c/o ARC Group Acquisition I Corp.
398
S Mill Avenue,
Suite
306,
Tempe,
AZ 85284
Telephone
No.:
E-mail:
with
a copy (which will not constitute notice) to:
Rimon,
P.C.
1050
Connecticut Avenue, NW, Suite 500
Washington,
DC 20036
Attn:
Debbie A. Klis Esq.
Mark
C Lee, Esq.
Telephone
No.: (202) 935-3390
Email:
deborrah.klis@rimonlaw.com
mark.c.lee@rimonlaw.com
If
to the Company, to:
Firstborn
Top Capital Sdn. Bhd.
13A-3A,
Q Sentral, 2A
Jalan
Stesen Sentral 2
KL
Sentral, Kuala Lumpur
Wilayah
Persekutuan 50470
Malaysia
Attn:
Ow Ruey Shen
Telephone
No.:
E-mail:
with
a copy (which will not constitute notice) to:
Rohamat
& Ling
Unit
1009, 10th Floor, Menara PJ,
Amcorp
Trade Centre,
No.
18 Jalan Persiaran Barat,
46050
Petaling Jaya, Selangor.
Attn:
Mark Wong Kah Kit
Telephone
No.: 03-7932 5115
E-mail:
mark@r-ling.com
If
to the Selling Shareholders or the Shareholder Representative, at the respective address specified in Exhibit A-1.
With
a copy (which will not constitute notice) to:
Rohamat
& Ling
Unit
1009, 10th Floor, Menara PJ,
Amcorp
Trade Centre,
No.
18 Jalan Persiaran Barat,
46050
Petaling Jaya, Selangor.
Attn:
Mark Wong Kah Kit
Telephone
No.: 03-7932 5115
E-mail:
mark@r-ling.com
62
12.2
Binding Effect; Assignment. This Agreement and all of the provisions hereof shall be binding upon and inure to the benefit of
the Parties hereto and their respective successors and permitted assigns. This Agreement shall not be assigned by operation of Law or
otherwise without the prior written consent of Purchaser and the Company (and after the Closing, Purchaser Representative and the Shareholder
Representative), and any assignment without such consent shall be null and void; provided that no such assignment shall relieve
the assigning Party of its obligations hereunder.
12.3
Third Parties. Except for the rights of the D&O Indemnified Persons set forth in Section 7.16, which the
Parties acknowledge and agree are express third party beneficiaries of this Agreement, nothing contained in this Agreement or in any
instrument or document executed by any party in connection with the transactions contemplated hereby shall create any rights in, or be
deemed to have been executed for the benefit of, any Person that is not a Party hereto or thereto or a successor or permitted assign
of such a Party.
12.4
Reserved..
12.5
Governing Law; Jurisdiction. This Agreement shall be governed by, construed and enforced in accordance with the Laws of the State
of Delaware without regard to the conflict of laws principles thereof. All Actions arising out of or relating to this Agreement shall
be heard and determined exclusively in the Chancery Court of the State of Delaware (or in any other court in the State of Delaware or
any appellate court thereof) (the “Specified Courts”). Each Party hereto hereby (a) submits to the exclusive jurisdiction
of any Specified Court for the purpose of any Action arising out of or relating to this Agreement brought by any Party hereto and (b)
irrevocably waives, and agrees not to assert by way of motion, defense or otherwise, in any such Action, any claim that it is not subject
personally to the jurisdiction of the above-named courts, that its property is exempt or immune from attachment or execution, that the
Action is brought in an inconvenient forum, that the venue of the Action is improper, or that this Agreement or the transactions contemplated
hereby may not be enforced in or by any Specified Court. Each Party agrees that a final judgment in any Action shall be conclusive and
may be enforced in other jurisdictions by suit on the judgment or in any other manner provided by Law. Each Party irrevocably consents
to the service of the summons and complaint and any other process in any other Action relating to the transactions contemplated by this
Agreement, on behalf of itself, or its property, by personal delivery of copies of such process to such Party at the applicable address
set forth in Section 12.1. Nothing in this Section 12.5 shall affect the right of any Party to
serve legal process in any other manner permitted by Law.
12.6
WAIVER OF JURY TRIAL. EACH PARTY HERETO HEREBY WAIVES TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW ANY RIGHT IT MAY HAVE
TO A TRIAL BY JURY WITH RESPECT TO ANY ACTION DIRECTLY OR INDIRECTLY ARISING OUT OF, UNDER OR IN CONNECTION WITH THIS AGREEMENT OR THE
TRANSACTIONS CONTEMPLATED HEREBY. EACH PARTY HERETO (A) CERTIFIES THAT NO REPRESENTATIVE OF ANY OTHER PARTY HAS REPRESENTED, EXPRESSLY
OR OTHERWISE, THAT SUCH OTHER PARTY WOULD NOT, IN THE EVENT OF ANY ACTION, SEEK TO ENFORCE THAT FOREGOING WAIVER AND (B) ACKNOWLEDGES
THAT IT AND THE OTHER PARTIES HERETO HAVE BEEN INDUCED TO ENTER INTO THIS AGREEMENT BY, AMONG OTHER THINGS, THE MUTUAL WAIVERS AND CERTIFICATIONS
IN THIS SECTION 12.6.
12.7
Specific Performance. Each Party acknowledges that the rights of each Party to consummate the transactions contemplated hereby
are unique, recognizes and affirms that in the event of a breach of this Agreement by any Party, money damages may be inadequate and
the non-breaching Parties may not have an adequate remedy at law, and agrees that irreparable damage would occur in the event that any
of the provisions of this Agreement were not performed by an applicable Party in accordance with their specific terms or were otherwise
breached. Accordingly, each Party shall be entitled to seek an injunction or restraining order to prevent breaches of this Agreement
and to seek to enforce specifically the terms and provisions hereof, including the obligations to execute and deliver the Ancillary Documents
and consummate the transactions contemplated hereby, without the requirement to post any bond or other security or to prove that money
damages would be inadequate, this being in addition to any other right or remedy to which such Party may be entitled under this Agreement,
at law or in equity.
12.8
Severability. In case any provision in this Agreement shall be held invalid, illegal or unenforceable in a jurisdiction, such
provision shall be modified or deleted, as to the jurisdiction involved, only to the extent necessary to render the same valid, legal
and enforceable, and the validity, legality and enforceability of the remaining provisions hereof shall not in any way be affected or
impaired thereby nor shall the validity, legality or enforceability of such provision be affected thereby in any other jurisdiction.
Upon such determination that any term or other provision is invalid, illegal or incapable of being enforced, the Parties will substitute
for any invalid, illegal or unenforceable provision a suitable and equitable provision that carries out, so far as may be valid, legal
and enforceable, the intent and purpose of such invalid, illegal or unenforceable provision.
63
12.9
Amendment. This Agreement may be amended, supplemented or modified only by execution of a written instrument signed by Purchaser,
the Company, Purchaser Representative and the Shareholder Representative.
12.10
Waiver. Purchaser on behalf of itself and its Affiliates, the Company on behalf of itself and its Affiliates, and the Shareholder
Representative on behalf of itself and the Selling Shareholders, may in its sole discretion (i) extend the time for the performance of
any obligation or other act of any other non-Affiliated Party hereto, (ii) waive any inaccuracy in the representations and warranties
by such other non-Affiliated Party contained herein or in any document delivered pursuant hereto and (iii) waive compliance by such other
non-Affiliated Party with any covenant or condition contained herein. Any such extension or waiver shall be valid only if set forth in
an instrument in writing signed by the Party or Parties to be bound thereby (including by Purchaser Representative or Shareholder Representative
in lieu of such Party to the extent provided in this Agreement). Notwithstanding the foregoing, no failure or delay by a Party in exercising
any right hereunder shall operate as a waiver thereof nor shall any single or partial exercise thereof preclude any other or further
exercise of any other right hereunder. Notwithstanding the foregoing, any waiver of any provision of this Agreement after the Closing
shall also require the prior written consent of Purchaser Representative.
12.11
Entire Agreement. This Agreement and the documents or instruments referred to herein, including any exhibits and schedules attached
hereto, which exhibits and schedules are incorporated herein by reference, together with the Ancillary Documents, embody the entire agreement
and understanding of the Parties hereto in respect of the subject matter contained herein. There are no restrictions, promises, representations,
warranties, covenants or undertakings, other than those expressly set forth or referred to herein or the documents or instruments referred
to herein, which collectively supersede all prior agreements and the understandings among the Parties with respect to the subject matter
contained herein. The Parties expressly disclaim, renounce, and waive any and all rights pursuant to, all prior verbal negotiations and
agreements related to the subject matter hereof.
12.12
Interpretation. The table of contents and the Article and Section headings contained in this Agreement are solely for the purpose
of reference, are not part of the agreement of the Parties and shall not in any way affect the meaning or interpretation of this Agreement.
In this Agreement, unless the context otherwise requires: (a) any pronoun used shall include the corresponding masculine, feminine or
neuter forms, and words in the singular, including any defined terms, include the plural and vice versa; (b) reference to any Person
includes such Person’s successors and assigns but, if applicable, only if such successors and assigns are permitted by this Agreement,
and reference to a Person in a particular capacity excludes such Person in any other capacity; (c) any accounting term used and not otherwise
defined in this Agreement or any Ancillary Document has the meaning assigned to such term in accordance with Applicable Accounting Standards;
(d) “including” (and with correlative meaning “include”) means including without limiting the generality of any
description preceding or succeeding such term and shall be deemed in each case to be followed by the words “without limitation”;
(e) the words “herein,” “hereto,” and “hereby” and other words of similar import shall be deemed
in each case to refer to this Agreement as a whole and not to any particular Section or other subdivision of this Agreement; (f) the
word “if” and other words of similar import when used herein shall be deemed in each case to be followed by the phrase “and
only if”; (g) the term “or” means “and/or”; (h) any reference to the term “ordinary course”
or “ordinary course of business” shall be deemed in each case to be followed by the words “consistent with past practice;”
(i) any agreement, instrument, insurance policy, Law or Order defined or referred to herein or in any agreement or instrument that is
referred to herein means such agreement, instrument, insurance policy, Law or Order as from time to time amended, modified or supplemented,
including (in the case of agreements or instruments) by waiver or consent and (in the case of statutes, regulations, rules or orders)
by succession of comparable successor statutes, regulations, rules or orders and references to all attachments thereto and instruments
incorporated therein; (j) except as otherwise indicated, all references in this Agreement to the words “Section,” “Article,”
“Schedule” and “Exhibit” are intended to refer to Sections, Articles, Schedules and Exhibits to this Agreement;
and (k) the term “Dollars” or “$” means United States dollars. Any reference in this Agreement to a Person’s
directors shall include any member of such Person’s governing body and any reference in this Agreement to a Person’s officers
shall include any Person filling a substantially similar position for such Person. Any reference in this Agreement or any Ancillary Document
to a Person’s shareholders or shareholders shall include any applicable owners of the equity interests of such Person, in whatever
form, including with respect to Purchaser its shareholders under the BVI Companies Act, as then applicable, or its Governing Documents.
The Parties have participated jointly in the negotiation and drafting of this Agreement. Consequently, in the event an ambiguity or question
of intent or interpretation arises, this Agreement shall be construed as if drafted jointly by the Parties hereto, and no presumption
or burden of proof shall arise favoring or disfavoring any Party by virtue of the authorship of any provision of this Agreement. To the
extent that any Contract, document, certificate or instrument is represented and warranted to by the Company to be given, delivered,
provided or made available by the Company, in order for such Contract, document, certificate or instrument to have been deemed to have
been given, delivered, provided and made available to Purchaser or its Representatives, such Contract, document, certificate or instrument
shall have been posted to the electronic data site maintained on behalf of the Company for the benefit of Purchaser and its Representatives
and Purchaser and its Representatives have been given access to the electronic folders containing such information.
64
12.13
Counterparts. This Agreement and each Ancillary Document may be executed and delivered (including by facsimile or other electronic
transmission) in one or more counterparts, and by the different Parties hereto in separate counterparts, each of which when executed
shall be deemed to be an original but all of which taken together shall constitute one and the same agreement.
12.14
Purchaser Representative.
(a)
Purchaser, on behalf of itself and its Subsidiaries, successors and assigns, by execution and delivery of this Agreement, hereby irrevocably
appoints Datuk Dr. Doris Wong, in the capacity as Purchaser Representative, as each such Person’s agent, attorney-in-fact and representative,
with full power of substitution to act in the name, place and stead of such Person, to act on behalf of such Person from and after the
Closing in connection with: (i) terminating, amending or waiving on behalf of such Person any provision of this Agreement or any Ancillary
Documents to which Purchaser Representative is a party or otherwise has rights in such capacity (together with this Agreement, the “Purchaser
Representative Documents”); (ii) signing on behalf of such Person any releases or other documents with respect to any dispute
or remedy arising under any Purchaser Representative Documents; (iii) employing and obtaining the advice of legal counsel, accountants
and other professional advisors as Purchaser Representative, in its reasonable discretion, deems necessary or advisable in the performance
of its duties as Purchaser Representative and to rely on their advice and counsel; (iv) incurring and paying reasonable out-of-pocket
costs and expenses, including fees of brokers, attorneys and accountants incurred pursuant to the transactions contemplated hereby, and
any other reasonable out-of-pocket fees and expenses allocable or in any way relating to such transaction or any indemnification claim;
and (v) otherwise enforcing the rights and obligations of any such Persons under any Purchaser Representative Documents, including giving
and receiving all notices and communications hereunder or thereunder on behalf of such Person; provided, that the Parties acknowledge
that Purchaser Representative is specifically authorized and directed to act on behalf of, and for the benefit of, the holders of Purchaser
Securities (other than the Company Security Holders immediately prior to the Closing and their respective successors and assigns). All
decisions and actions by Purchaser Representative shall be binding upon Purchaser and its Subsidiaries, successors and assigns, and neither
they nor any other Party shall have the right to object, dissent, protest or otherwise contest the same. The provisions of this Section
12.14 are irrevocable and coupled with an interest. Purchaser Representative hereby accepts its appointment and authorization
as Purchaser Representative under this Agreement.
65
(b)
Purchaser Representative shall not be liable for any act done or omitted under any Purchaser Representative Document as Purchaser Representative
while acting in good faith and without willful misconduct or gross negligence, and any act done or omitted pursuant to the advice of
counsel shall be conclusive evidence of such good faith. Purchaser shall indemnify, defend and hold harmless Purchaser Representative
from and against any and all losses incurred without gross negligence, bad faith or willful misconduct on the part of Purchaser Representative
(in his capacity as such) and arising out of or in connection with the acceptance or administration of Purchaser Representative’s
duties under any Purchaser Representative Document, including the reasonable fees and expenses of any legal counsel retained by Purchaser
Representative. In no event shall Purchaser Representative in such capacity be liable hereunder or in connection herewith for any indirect,
punitive, special or consequential damages. Purchaser Representative shall be fully protected in relying upon any written notice, demand,
certificate or document that it in good faith believes to be genuine, including facsimiles or copies thereof, and no Person shall have
any Liability for relying on Purchaser Representative in the foregoing manner. In connection with the performance of its rights and obligations
hereunder, Purchaser Representative shall have the right at any time and from time to time to select and engage, at the cost and expense
of Purchaser, attorneys, accountants, investment bankers, advisors, consultants and clerical personnel and obtain such other professional
and expert assistance, maintain such records and incur other out-of-pocket expenses, as Purchaser Representative may deem necessary or
appropriate from time to time. All of the indemnities, immunities, releases and powers granted to Purchaser Representative under this
Section 12.14 shall survive the Closing and continue indefinitely.
(c)
The Person serving as Purchaser Representative may resign upon ten (10) days’ prior written notice to Purchaser and the Shareholder
Representative, provided, that Purchaser Representative appoints in writing a replacement Purchaser Representative. Each successor Purchaser
Representative shall have all of the power, authority, rights and privileges conferred by this Agreement upon the original Purchaser
Representative, and the term “Purchaser Representative” as used herein shall be deemed to include any such successor Purchaser
Representatives.
12.15
Shareholder Representative.
(a)
The Selling Shareholders, on behalf of themselves and their successors and assigns, by execution and delivery of this Agreement, hereby
irrevocably appoint Ow Ruey Shen, in the capacity as the Shareholder Representative, as each such Person’s agent, attorney-in-fact
and representative, with full power of substitution to act in the name, place and stead of such Person, to act on behalf of such Person
from and after the Closing in connection with: (i) terminating, amending or waiving on behalf of such Person any provision of this Agreement
or any Ancillary Documents to which the Shareholder Representative is a party or otherwise has rights in such capacity (together with
this Agreement, the “Shareholder Representative Documents”); (ii) signing on behalf of such Person any releases or
other documents with respect to any dispute or remedy arising under any Shareholder Representative Documents; (iii) employing and obtaining
the advice of legal counsel, accountants and other professional advisors as the Shareholder Representative, in its reasonable discretion,
deems necessary or advisable in the performance of its duties as the Shareholder Representative and to rely on their advice and counsel;
(iv) incurring and paying reasonable out-of-pocket costs and expenses, including fees of brokers, attorneys and accountants incurred
pursuant to the transactions contemplated hereby, and any other reasonable out-of-pocket fees and expenses allocable or in any way relating
to such transaction or any indemnification claim; and (v) otherwise enforcing the rights and obligations of any such Persons under any
Shareholder Representative Documents, including giving and receiving all notices and communications hereunder or thereunder on behalf
of such Person; provided, that the Parties acknowledge that the Shareholder Representative is specifically authorized and directed
to act on behalf of, and for the benefit of, all Selling Shareholders and their respective successors and assigns. All decisions and
actions by the Shareholder Representative shall be binding upon each Selling Shareholder and its successors and assigns, and neither
they nor any other Party shall have the right to object, dissent, protest or otherwise contest the same. The provisions of this Section
12.15 are irrevocable and coupled with an interest. The Shareholder Representative hereby accepts its appointment and authorization
as the Shareholder Representative under this Agreement.
(b)
Any other Person, including the Purchaser Representative, Purchaser and the Company, may conclusively and absolutely rely, without inquiry,
upon any actions of the Shareholder Representative as the acts of the Selling Shareholders under any Shareholder Representative Documents.
The Purchaser Representative, Purchaser and the Company shall be entitled to rely conclusively on the instructions and decisions of the
Shareholder Representative as to (i) any payment instructions provided by the Shareholder Representative or (ii) any other actions required
or permitted to be taken by the Shareholder Representative hereunder, and no Selling Shareholder shall have any cause of action against
the Purchaser Representative, Purchaser or the Company for any action taken by any of them in reliance upon the instructions or decisions
of the Shareholder Representative. The Purchaser Representative, Purchaser and the Company shall not have any Liability to any Selling
Shareholder for any allocation or distribution among the Selling Shareholders by the Shareholder Representative of payments made to or
at the direction of the Shareholder Representative. All notices or other communications required to be made or delivered to a Selling
Shareholder under any Shareholder Representative Document shall be made to the Shareholder Representative for the benefit of such Selling
Shareholder, and any notices so made shall discharge in full all notice requirements of the other parties hereto or thereto to such Selling
Shareholder with respect thereto. All notices or other communications required to be made or delivered by a Selling Shareholder shall
be made by the Shareholder Representative (except for a notice under Section 12.15(d) of the replacement of the Shareholder
Representative).
66
(c)
The Shareholder Representative shall not be liable for any act done or omitted under any Shareholder Representative Document as the Shareholder
Representative while acting in good faith and without willful misconduct or gross negligence, and any act done or omitted pursuant to
the advice of counsel shall be conclusive evidence of such good faith. The Selling Shareholders shall indemnify, defend and hold harmless
the Shareholder Representative from and against any and all losses incurred without gross negligence, bad faith or willful misconduct
on the part of the Shareholder Representative (in his capacity as such) and arising out of or in connection with the acceptance or administration
of the Shareholder Representative’s duties under any Shareholder Representative Document, including the reasonable fees and expenses
of any legal counsel retained by the Shareholder Representative. In no event shall the Shareholder Representative in such capacity be
liable hereunder or in connection herewith for any indirect, punitive, special or consequential damages. The Shareholder Representative
shall be fully protected in relying upon any written notice, demand, certificate or document that it in good faith believes to be genuine,
including facsimiles or copies thereof, and no Person shall have any Liability for relying on the Shareholder Representative in the foregoing
manner. In connection with the performance of its rights and obligations hereunder, the Shareholder Representative shall have the right
at any time and from time to time to select and engage, at the cost and expense of the Selling Shareholders, attorneys, accountants,
investment bankers, advisors, consultants and clerical personnel and obtain such other professional and expert assistance, maintain such
records and incur other out-of-pocket expenses, as the Shareholder Representative may deem necessary or appropriate from time to time.
All of the indemnities, immunities, releases and powers granted to the Shareholder Representative under this Section 12.15
shall survive the Closing and continue indefinitely.
(d)
The Person serving as the Shareholder Representative may resign upon ten (10) days’ prior written notice to the other Parties to
this Agreement, provided that the Shareholder Representative appoints in writing a replacement Shareholder Representative and provides
written notice of the identity of such successor to the other Parties hereto. Each successor Shareholder Representative shall have all
of the power, authority, rights and privileges conferred by this Agreement upon the original Shareholder Representative, and the term
“Shareholder Representative” as used herein shall be deemed to include any such successor Shareholder Representatives.
12.16
Legal Representation. The Parties agree that, notwithstanding the fact that Rimon, P.C. and Rohamat & Ling may have, prior
to Closing, jointly represented Purchaser, Purchaser Representative and/or Sponsor in connection with this Agreement, the Ancillary Documents
and the transactions contemplated hereby and thereby, and have also represented Purchaser and/or its Affiliates in connection with matters
other than the transaction that is the subject of this Agreement, Rimon, P.C. and Rohamat & Ling will be permitted in the future,
after Closing, to represent Sponsor, Purchaser Representative or their respective Affiliates in connection with matters in which such
Persons are adverse to Purchaser or any of its Affiliates, including any disputes arising out of, or related to, this Agreement. Additionally,
the Parties agree that Rimon, P.C. and Rohamat & Ling will be permitted in the future, after Closing, to represent Purchaser in connection
with matters in which Purchaser is adverse to the Company, Shareholder Representative or any of its Affiliates, including any disputes
arising out of, or related to, this Agreement. The Company and the Shareholder Representative, who are or have the right to be represented
by independent counsel in connection with the transactions contemplated by this Agreement, hereby agree, in advance, to waive (and to
cause their Affiliates to waive) any actual or potential conflict of interest that may hereafter arise in connection with Rimon, P.C.’s
future representation of one or more of Purchaser, Sponsor, Purchaser Representative or their respective Affiliates in which the interests
of such Person are adverse to the interests of the Company and/or the Shareholder Representative or any of their respective Affiliates,
including any matters that arise out of this Agreement or that are substantially related to this Agreement or to any prior representation
by Rimon, P.C. or Rohamat & Ling of Purchaser, Sponsor, Purchaser Representative or any of their respective Affiliates. The Parties
acknowledge and agree that, for the purposes of the attorney-client privilege, Sponsor and Purchaser Representative shall each be deemed
a client of Rimon, P.C. and Rohamat & Ling with respect to the negotiation, execution and performance of this Agreement and the Ancillary
Documents. All such communications shall remain privileged after the Closing and the privilege and the expectation of client confidence
relating thereto shall belong solely to Sponsor and Purchaser Representative, shall be controlled by Sponsor and Purchaser Representative
and shall not pass to or be claimed by Purchaser or the Company; provided, further, that nothing contained herein shall be deemed
to be a waiver by Purchaser or any of its Affiliates (including, after the Closing Date, the Company and its Affiliates) of any applicable
privileges or protections that can or may be asserted to prevent disclosure of any such communications to any third party.
67
Article
XIII
RESERVED
Article
XIV
DEFINITIONS
14.1
Certain Definitions.
(a)
For purposes of this Agreement, the following terms shall have the meanings specified in this Section 14.1:
“Accounting
Principles” means U.S. GAAP as in effect at the date of the financial statement to which it refers and to which such standards
are applicable, or if there is no such financial statement, then as of the Closing Date, using and applying the same accounting principles,
practices, procedures, policies and methods (with consistent classifications, judgments, elections, inclusions, exclusions and valuation
and estimation methodologies) used and applied by the Company in the preparation of the latest Audited Company Financials.
“Applicable
Accounting Standards” means U.S. GAAP as in effect from time to time and applicable to the financial statement or calculation
to which it refers.
“Action”
means any notice of noncompliance or violation, or any claim, demand, charge, action, suit, litigation, audit, settlement, complaint,
stipulation, assessment or arbitration, or any request (including any request for information), inquiry, hearing, proceeding or investigation,
by or before any Governmental Authority.
“Affiliate”
means, with respect to any Person, any other Person directly or indirectly Controlling, Controlled by, or under common Control with such
Person. For the avoidance of doubt, the Sponsor shall be deemed to be Affiliates of Purchaser prior to the Closing.
“Agreement”
has the meaning set forth in the Recitals.
“Amended
and Restated Memorandum and Articles of Association” means Purchaser’s amended and restated memorandum and articles of
association, governed by the BVI Companies Act, as amended from time-to-time.
68
“Ancillary
Documents” means each agreement, instrument or document attached hereto as an Exhibit, and the other agreements, certificates
and instruments to be executed or delivered by any of the Parties hereto in connection with or pursuant to this Agreement.
“Antitrust
Laws” means the Sherman Act, as amended, the Clayton Act, as amended, the HSR Act, the Federal Trade Commission Act, as amended,
all applicable non-U.S. anti-trust laws and all other applicable Laws and Orders issued by a Governmental Authority that are designed
or intended to prohibit, restrict or regulate actions having the purpose or effect of monopolization or restraint of trade or lessening
of competition through merger or acquisition.
“Audited
Company Financials” has the meaning set forth in Section 4.7(a).
“Benefit
Plans” of any Person means any and all deferred compensation, executive compensation, incentive compensation, equity purchase
or other equity-based compensation plan, severance or termination pay, holiday, vacation or other bonus plan or practice, hospitalization
or other medical, life or other insurance, supplemental unemployment benefits, profit sharing, pension, or retirement plan, program,
agreement, commitment or arrangement, and each other employee benefit plan, program, agreement or arrangement, including each employee
benefit plan maintained or contributed to or required to be contributed to by a Person for the benefit of any employee or terminated
employee of such Person, or with respect to which such Person has any Liability, whether direct or indirect, actual or contingent, whether
formal or informal, and whether legally binding or not.
“Business
Day” means any day other than a Saturday, Sunday or a legal holiday on which commercial banking institutions in New York, New
York and the British Virgin Islands are authorized to close for business, excluding as a result of “stay at home,” “shelter-in-place,”
“non-essential employee” or any other similar orders or restrictions or the closure of any physical branch locations at the
direction of any governmental authority so long as the electronic funds transfer systems, including for wire transfers, of commercially
banking institutions in New York, New York and the British Virgin Islands are generally open for use by customers on such day.
“BVI
Companies Act” means the BVI Business Companies Act, (Revised Edition 2020) as amended from time to time.
“Calculation
Date” has the meaning set forth in Section 2.2(a).
“Cash”
means the aggregate amount of cash, bank deposits and marketable securities, in each case as defined in accordance with Applicable Accounting
Standards. For the avoidance of doubt, Cash shall (a) include checks, wires and drafts deposited for the account of the Company but not
yet reflected as available proceeds in the Company’s account and (b) be reduced by the sum of (i) any outstanding checks issued
by the Company and (ii) any cash overdrafts and negative balances in the Company’s account.
“Chairman”
means Datuk Dr. Doris Wong in her capacity as Chairman of the Company.
“Closing”
has the meaning set forth in Section 3.1.
“Closing
Date” has the meaning set forth in Section 3.1.
“Closing
Net Indebtedness” means, as of immediately before the effective time of the Closing, (i) the aggregate amount of all Indebtedness
of the Company, less (ii) the Closing Company Cash, in each case of clauses (i) and (ii), on a consolidated basis and as determined in
accordance with the Accounting Principles.
“Closing
Statement” has the meaning set forth in Section 2.2(a).
69
“Code”
means Malaysian Code on Take-Overs and Mergers 2016.
“Company”
has the meaning set forth in the Recitals.
“Company
Governing Documents” means the Company’s Governing Documents, as amended from time to time.
“Company
Benefit Plan” has the meaning set forth in Section 4.19.
“Company
Closing Cash” means the amount of the Company’s Cash as of 12:01 a.m. on the Closing Date.
“Company
Confidential Information” means all confidential or proprietary documents and information concerning the Company, furnished
in connection with this Agreement or the transactions contemplated hereby; provided, however, that Company Confidential Information
shall not include any information which, (i) at the time of disclosure by the Company or any of its Representatives, is generally available
publicly and was not disclosed in breach of this Agreement or (ii) at the time of disclosure by the Company or any of its Representatives
to Purchaser or any of its Representatives, was previously known by such receiving party without violation of Law or any confidentiality
obligation by the Person receiving such Company Confidential Information.
“Company
Convertible Securities” means, collectively, any warrants or rights to subscribe for or purchase any capital shares of the
Company or securities convertible into or exchangeable for, or that otherwise confer on the holder any right to acquire any capital shares
of the Company.
“Company
Financials” has the meaning set forth in Section 4.7(a).
“Company
Ordinary Shares” means the ordinary shares of the Company.
“Company
Securities” means, collectively, the Company Ordinary Shares, the Company Convertible Securities and any other securities of
the Company.
“Company
Security Holders” means, collectively, the holders of Company Securities.
“Company
Shares” has the meaning set forth in the Recitals.
“Company
Support Agreement” means the Company Support Agreement in the form of Exhibit G hereto.
“Confidential
Information” has the meaning set forth in Section 7.13.
“Consent”
means any consent, approval, waiver, authorization or Permit of, or notice to or declaration or filing with any Governmental Authority
or any other Person.
“Consultation
Period” has the meaning set forth in Section 2.2(c).
“Contract”
means all contracts, agreements, binding arrangements, bonds, notes, indentures, mortgages, debt instruments, purchase order, licenses
(and all other contracts, agreements or binding arrangements concerning Intellectual Property), franchises, leases and other instruments
or obligations of any kind, written or oral (including any amendments and other modifications thereto).
70
“Control”
of a Person means the possession, directly or indirectly, of the power to direct or cause the direction of the management and policies
of such Person, whether through the ownership of voting securities, by contract, or otherwise. “Controlled,” “Controlling”
and “under common Control with” have correlative meanings. Without limiting the foregoing a Person (the “Controlled
Person”) shall be deemed Controlled by (a) any other Person (i) owning beneficially, as meant in Rule 13d-3 under the Exchange
Act, securities entitling such Person to ten percent (10%) or more of the votes for election of directors or equivalent governing authority
of the Controlled Person or (ii) entitled to be allocated or receive ten percent (10%) or more of the profits, losses, or distributions
of the Controlled Person; (b) an officer, director, general partner, partner (other than a limited partner), manager, or member (other
than a member having no management authority that is not a Person described in clause (a) above) of the Controlled Person; or (c) a spouse,
parent, lineal descendant, sibling, aunt, uncle, niece, nephew, mother-in-law, father-in-law, sister-in-law, or brother-in-law of an
Affiliate of the Controlled Person or a trust for the benefit of an Affiliate of the Controlled Person or of which an Affiliate of the
Controlled Person is a trustee.
“Copyrights”
means any works of authorship, mask works and all copyrights therein, including all renewals and extensions, copyright registrations
and applications for registration and renewal, and non-registered copyrights.
“Encumbrances”
means, with respect to any asset, any mortgage, deed of trust, lien, pledge, charge, security interest, title retention device, collateral
assignment, adverse claim, restriction or other encumbrance of any kind in respect of such asset (including any restriction on the voting
of any security, any restriction on the transfer of any security or other asset, any restriction on the receipt of any income derived
from any asset, any restriction on the use of any asset and any restriction on the possession, exercise or transfer of any other attribute
of ownership of any asset). For purposes of clarification only, an inability to sell a security without registering such security for
sale under the Securities Act or other securities laws of any jurisdiction or other restrictions arising from applicable securities laws
of any jurisdiction shall not represent an Encumbrance.
“Environmental
Law” means any and all applicable Laws relating to pollution, human health and safety (to the extent related to Hazardous Materials),
or protection of the environment (including natural resources), or the use, storage, emission, distribution, transport, handling, disposal
or release of, or exposure of any Person to, Hazardous Materials.
“Environmental
Liabilities” means, in respect of any Person, all Liabilities, obligations, responsibilities, Remedial Actions, losses, damages,
costs, and expenses (including all reasonable fees, disbursements, and expenses of counsel, experts, and consultants and costs of investigation
and feasibility studies), fines, penalties, sanctions, and interest incurred as a result of any claim or demand by any other Person or
in response to any violation of Environmental Law, whether known or unknown, accrued or contingent, whether based in contract, tort,
implied or express warranty, strict liability, criminal or civil statute, to the extent based upon, related to, or arising under or pursuant
to any Environmental Law, Environmental Permit, Order, or Contract with any Governmental Authority or other Person, that relates to any
environmental, health or safety condition, violation of Environmental Law, or a Release or threatened Release of Hazardous Materials.
“Environmental
Permits” has the meaning set forth in Section 4.20.
“Exchange
Act” means the U.S. Securities Exchange Act of 1934, as amended.
“Expiration
Date” has the meaning set forth in Section 10.1(b).
“Extension”
has the meaning set forth in Section 7.3(a).
“Extension
Expenses” has the meaning set forth in Section 7.3(b)(iv).
“Final
Closing Statement” has the meaning set forth in Section 2.2(b).
“Final
Pre-Closing Period” has the meaning set forth in Section 7.20(a).
71
“Fraud
Claim” means any claim based in whole or in part upon fraud, willful misconduct or intentional misrepresentation.
“GAAP”
means generally accepted accounting principles in the United States in effect as of the date hereof.
“Governing
Documents” means, with respect to any Person that is an entity, its certificate of incorporation or formation, bylaws, operating
agreement, memorandum and articles of association or similar organizational documents, in each case, as amended.
“Governmental
Authority” means any federal, state, local, foreign or other governmental, quasi-governmental or administrative body, instrumentality,
department or agency or any court, tribunal, administrative hearing body, arbitration panel, commission, or other similar dispute-resolving
panel or body.
“Hazardous
Material” means any waste, gas, liquid or other substance or material that is defined, listed or designated as a “hazardous
substance,” “pollutant,” “contaminant,” “hazardous waste,” “regulated substance,”
“hazardous chemical,” or “toxic chemical” (or by any similar term) under any Environmental Law, or any other
material regulated, or that could result in the imposition of Liability or responsibility, under any Environmental Law, including petroleum
and its by-products, asbestos, polychlorinated biphenyls, radon, mold, and urea formaldehyde insulation.
“IFRS”
means the International Financial Reporting Standards in effect as of the date hereof.
“Indebtedness”
of any Person means, without duplication, (a) all indebtedness of such Person for borrowed money (including the outstanding principal
and accrued but unpaid interest), (b) all obligations for the deferred purchase price of property or services (other than trade payables
incurred in the ordinary course of business), (c) any other indebtedness of such Person that is evidenced by a note, bond, debenture,
credit agreement or similar instrument, (d) all obligations of such Person under leases that should be classified as capital leases in
accordance with Applicable Accounting Standards, (e) all obligations of such Person for the reimbursement of any obligor on any line
or letter of credit, banker’s acceptance, guarantee or similar credit transaction, in each case, that has been drawn or claimed
against, (f) all obligations of such Person in respect of acceptances issued or created, (g) all interest rate and currency swaps, caps,
collars and similar agreements or hedging devices under which payments are obligated to be made by such Person, whether periodically
or upon the happening of a contingency, (h) all obligations secured by an Lien on any property of such Person, (i) any premiums, prepayment
fees or other penalties, fees, costs or expenses associated with payment of any Indebtedness of such Person and (j) all obligations described
in clauses (a) through (i) above of any other Person which is directly or indirectly guaranteed by such Person or which such Person has
agreed (contingently or otherwise) to purchase or otherwise acquire or in respect of which it has otherwise assured a creditor against
loss.
“Intellectual
Property” means all of the following as they exist in any jurisdiction throughout the world: Patents, Trademarks, Copyrights,
Trade Secrets, Internet Assets, Software and other intellectual property, and all licenses, sublicenses and other agreements or permissions
related to the preceding property.
“Interim
Balance Sheet Date” has the meaning set forth in Section 4.7(a).
“Interim
Period” has the meaning set forth in Section 7.1(a).
“Interim
Financial Statements” has the meaning set forth in Section 7.4.
“Internet
Assets” means any and all domain name registrations, web sites and web addresses and related rights, items and documentation
related thereto, and applications for registration therefor.
72
“IPO”
means the initial public offering of Purchaser Public Units pursuant to the IPO Prospectus.
“IPO
Prospectus” means the final prospectus of Purchaser dated as of April 30, 2026, and filed with the SEC on April 30, 2026 (File
No. 333-288410).
“IPO
Underwriter” means IB Capital, LLC.
“IRS”
means the Internal Revenue Service.
“Key
Executives” means Mr. Ow Ruey Shen.
“Knowledge”
means, (i) with respect to the Company, the actual knowledge of the Key Executives and directors of the Company, after reasonable inquiry,
or (ii) with respect to any other Party, (A) if an entity, the actual knowledge of its directors and executive officers, after reasonable
inquiry, or (B) if a natural person, the actual knowledge of such Party after reasonable inquiry.
“Law”
means any federal, state, local, municipal, foreign or other law, statute, legislation, principle of common law, ordinance, code, edict,
decree, proclamation, treaty, convention, rule, regulation, directive, requirement, writ, injunction, settlement, Order or Consent that
is or has been issued, enacted, adopted, passed, approved, promulgated, made, implemented or otherwise put into effect by or under the
authority of any Governmental Authority.
“Liabilities”
means any and all liabilities, Indebtedness, Actions or obligations of any nature (whether absolute, accrued, contingent or otherwise,
whether known or unknown, whether direct or indirect, whether matured or unmatured, whether due or to become due and whether or not required
to be recorded or reflected on a balance sheet under Applicable Accounting Standards), including Tax liabilities due or to become due.
“Lien”
means any mortgage, pledge, security interest, attachment, right of first refusal, option, proxy, voting trust, encumbrance, lien or
charge of any kind (including any conditional sale or other title retention agreement or lease in the nature thereof), restriction (whether
on voting, sale, transfer, disposition or otherwise), any subordination arrangement in favor of another Person, or any filing or agreement
to file a financing statement as debtor under the Uniform Commercial Code or any similar Law.
“Loan
Portfolio” means all loans, advances and other credit accommodations originated, acquired, funded or held by the Company, together
with all related accrued interest, fees, charges, collateral, guarantees and other rights and receivables.
“Lock-Up
Agreement” means the Lock-Up Agreement in the form of Exhibit H hereto.
“Losses”
means losses, liabilities, obligations, damages, notices, actions, suits, proceedings, claims, demands, assessments, judgments, costs,
penalties and expenses, including defense costs, amounts paid in settlement and reasonable attorneys’ and other professionals’
fees and disbursements, but excluding special, incidental, consequential and punitive damages except to the extent awarded to a third
party in connection with a third-party claim.
“Malaysian
Companies Act” means the Laws of Malaysia, Act 125, Companies Act 2016.
73
“Material
Adverse Effect” means, with respect to any specified Person, any fact, event, occurrence, change or effect that has had, or
would reasonably be expected to have, individually or in the aggregate, a material adverse effect upon (a) the business, assets, Liabilities,
results of operations, prospects or condition (financial or otherwise) of such Person and its Subsidiaries, taken as a whole, or (b)
the ability of such Person or any of its Subsidiaries on a timely basis to consummate the transactions contemplated by this Agreement
or the Ancillary Documents to which it is a party or bound or to perform its obligations hereunder or thereunder; provided, however,
that for purposes of clause (a) above, any changes or effects directly or indirectly attributable to, resulting from, relating to or
arising out of the following (by themselves or when aggregated with any other, changes or effects) shall not be deemed to be, constitute,
or be taken into account when determining whether there has or may, would or could have occurred a Material Adverse Effect: (i) general
changes in the financial or securities markets or general economic or political conditions in the country or region in which such Person
or any of its Subsidiaries do business; (ii) changes, conditions or effects that generally affect the industries in which such Person
or any of its Subsidiaries principally operate; (iii) changes in Applicable Accounting Standards or mandatory changes in the regulatory
accounting requirements applicable to any industry in which such Person and its Subsidiaries principally operate; (iv) conditions caused
by acts of God, terrorism, war (whether or not declared) or natural disaster; (v) any failure in and of itself by such Person and its
Subsidiaries to meet any internal or published budgets, projections, forecasts or predictions of financial performance for any period
(provided that the underlying cause of any such failure may be considered in determining whether a Material Adverse Effect has occurred
or would reasonably be expected to occur to the extent not excluded by another exception herein) and (vi) with respect to Purchaser,
the consummation and effects of the Redemption (or any redemption in connection with the Extension); provided further, however,
that any event, occurrence, fact, condition, or change referred to in clauses (i) - (iv) immediately above shall be taken into account
in determining whether a Material Adverse Effect has occurred or could reasonably be expected to occur to the extent that such event,
occurrence, fact, condition, or change has a disproportionate effect on such Person or any of its Subsidiaries compared to other participants
in the industries in which such Person or any of its Subsidiaries primarily conducts its businesses. Notwithstanding the foregoing, with
respect to Purchaser, the amount of the Redemption (or any redemption in connection with the Extension, if any) or the failure to obtain
the Required Purchaser Shareholder Approval shall not be deemed to be a Material Adverse Effect on or with respect to Purchaser.
“Material
Contracts” has the meaning set forth in Section 4.12.
“Money
Lending Laws” means, collectively, the Moneylenders Act 1951 of Malaysia (Act 400), the Moneylenders (Control and Licensing)
Regulations 2003 of Malaysia, the Moneylenders (Compounding of Offences) Regulations 2003 of Malaysia, the Consumer Credit Act 2025 of
Malaysia (Act 873), the Anti-Money Laundering, Anti-Terrorism Financing and Proceeds of Unlawful Activities Act 2001, and all other applicable
Laws, guidelines, circulars, directions and requirements of the Ministry of Housing and Local Government, the Registrar of Moneylenders,
Bank Negara Malaysia and any other Governmental Authority having jurisdiction over the Company or its business.
“Nasdaq”
means The Nasdaq Global Market, LLC.
“Net
Working Capital Amount” means, as of the Closing, (i) all current assets of the Company (excluding, without duplication, Closing
Company Cash), on a consolidated basis, minus (ii) all current liabilities of the Company (excluding, without duplication, Indebtedness
and unpaid Transaction Expenses), as determined in accordance with the Accounting Principles.
“Order”
means any order, decree, ruling, judgment, injunction, writ, determination, binding decision, verdict, judicial award or other action
that is or has been made, entered, rendered, or otherwise put into effect by or under the authority of any Governmental Authority.
“Patents”
means any patents, patent applications and the inventions, designs and improvements described and claimed therein, patentable inventions,
and other patent rights (including any divisionals, provisionals, continuations, continuations-in-part, substitutions, or reissues thereof,
whether or not patents are issued on any such applications and whether or not any such applications are amended, modified, withdrawn,
or refiled).
74
“Permits”
means all federal, state, local or foreign or other third-party permits, grants, easements, consents, approvals, authorizations, exemptions,
licenses, franchises, concessions, ratifications, permissions, permits, clearances, confirmations, endorsements, waivers, certifications,
designations, ratings, registrations, qualifications or orders of any Governmental Authority or any other Person.
“Permitted
Liens” means (a) Liens for Taxes or assessments and similar governmental charges or levies, which either are (i) not delinquent
or (ii) being contested in good faith and by appropriate proceedings, and adequate reserves have been established with respect thereto,
(b) other Liens imposed by operation of Law arising in the ordinary course of business for amounts which are not due and payable and
as would not in the aggregate materially adversely affect the value of, or materially adversely interfere with the use of, the property
subject thereto, (c) Liens incurred or deposits made in the ordinary course of business in connection with social security, (d) Liens
on goods in transit incurred pursuant to documentary letters of credit, in each case arising in the ordinary course of business, or (e)
Liens arising under this Agreement or any Ancillary Document.
“Person”
means an individual, corporation, partnership (including a general partnership, limited partnership or limited liability partnership),
limited liability company, association, trust or other entity or organization, including a government, domestic or foreign, or political
subdivision thereof, or an agency or instrumentality thereof.
“Personal
Data” means, with respect to any natural Person, such Person’s name, street address, telephone number, e-mail address,
photograph, social security number, tax identification number, driver’s license number, passport number, credit card number, bank
account number and other financial information, customer or account numbers, account access codes and passwords, any other information
that allows the identification of such Person or enables access to such Person’s financial information or that is defined as “personal
data,” “personally identifiable information,” “personal information,” “protected health information”
or similar term under any applicable Privacy Laws.
“Personal
Property” means any machinery, equipment, tools, vehicles, furniture, leasehold improvements, office equipment, plant, parts
and other tangible personal property.
“PIPE
Investors” has the meaning set forth in the Recitals.
“Privacy
Laws” means all applicable Laws, and the laws of applicable jurisdictions, relating to privacy and protection of Personal Data,
and any and all similar applicable Laws relating to privacy, security, data protection, data availability and destruction and data breach,
including security incident notification.
“Pre-Closing
Periods” has the meaning set forth in Section 7.20(a).
“Preliminary
Final Closing Statement” has the meaning set forth in Section 2.2(b).
“Proceeding”
means any action, suit, proceeding, complaint, claim, charge, hearing, labor dispute, inquiry or investigation before or by a Governmental
Authority or an arbitrator.
“Purchaser”
has the meaning set forth in the Recitals.
“Purchaser
Documents” means collectively this Agreement and each other agreement, document, instrument or certificate contemplated by
this Agreement or to be executed by Purchaser in connection with the consummation of the transactions contemplated hereby.
“Purchaser
Class A Ordinary Shares” means the Class A ordinary shares, par value $0.0001 per share, of Purchaser.
75
“Purchaser
Class B Ordinary Shares” means the Class B ordinary shares, par value $0.0001 per share, of Purchaser.
“Purchaser
Confidential Information” means all confidential or proprietary documents and information concerning Purchaser or any of its
Representatives; provided, however, that Purchaser Confidential Information shall not include any information which, (i) at the time
of disclosure by any other Party or any of their respective Representatives, is generally available publicly and was not disclosed in
breach of this Agreement or (ii) at the time of the disclosure by Purchaser or its Representatives to any other Party or any of their
respective Representatives, was previously known by such receiving party without violation of Law or any confidentiality obligation by
the Person receiving such Purchaser Confidential Information. For the avoidance of doubt, from and after the Closing, Purchaser Confidential
Information will include the confidential or proprietary information of the Company.
“Purchaser
Ordinary Shares” means Purchaser Class A Ordinary Shares and Purchaser Class B Ordinary Shares, collectively.
“Purchaser
Preference Shares” means the preference shares, par value $0.0001 per share, of Purchaser.
“Purchaser
Private Units” means the units issued by Purchaser in a private placement to Sponsor at the time of the consummation of the
IPO consisting of one (1) Purchaser Class A Ordinary Share, one (1) Purchaser Public Right and one (1) Purchaser Private Warrant.
“Purchaser
Private Warrants” means one redeemable warrant that was included as part of each Purchaser Private Unit, entitling the holder
of one whole warrant thereof to purchase one (1) Purchaser Class A Ordinary Share at a purchase price of $11.50 per share, subject to
adjustment in accordance with the Warrant Agreement.
“Purchaser
Public Rights” means one right that was included as part of each Purchaser Public Unit, entitling the holder thereof of one
right to receive one-fourth (1/4th) of one (1) Purchaser Class A Ordinary Share at the closing of the Business Combination.
“Purchaser
Public Units” means the units issued in the IPO (including overallotment units acquired by Purchaser’s underwriter) consisting
of one (1) Purchaser Class A Ordinary Share, one (1) Purchaser Public Right and one (1) Purchaser Public Warrant.
“Purchaser
Public Warrants” means one redeemable warrant that was included as part of each Purchaser Public Unit, entitling the holder
thereof of one (1) whole warrant to purchase one (1) Purchaser Class A Ordinary Share at a purchase price of $11.50 per share, subject
to adjustment in accordance with the Warrant Agreement.
“Purchaser
Securities” means Purchaser Units, Purchaser Ordinary Shares, Purchaser Preference Shares, Purchaser Public Rights and Purchaser
Warrants, collectively.
“Purchaser
Units” means Purchaser Private Units and Purchaser Public Units, collectively.
“Purchaser
Warrants” means Purchaser Private Warrants and Purchaser Public Warrants, collectively.
“Purchaser’s
Governing Documents” means the Amended and Restated Memorandum and Articles of Association of Purchaser adopted under the BVI
Companies Act by special resolution passed on April 29, 2026, as amended from time to time.
76
“Redemption”
has the meaning set forth in Section 7.11(a).
“Redemption
Price” means an amount equal to the price at which each share of Purchaser Ordinary Shares is redeemed or converted pursuant
to the Redemption (as equitably adjusted for share splits, share dividends, combinations, recapitalizations and the like after the Closing).
“Registration
Rights Agreement” means the Registration Rights Agreement in the form of Exhibit B hereto, pursuant to which certain
shareholders of the Company and Purchaser shall be granted customary demand and piggyback registration rights with respect to registrations
of shares of common stock of Purchaser, subject to customary exceptions and limitations.
“Release”
means any release, spill, emission, leaking, pumping, injection, deposit, disposal, discharge, dispersal, or leaching into the indoor
or outdoor environment, or into or out of any property.
“Remedial
Action” means all actions to (i) clean up, remove, treat, or in any other way address any Hazardous Material, (ii) prevent
the Release of any Hazardous Material so it does not endanger or threaten to endanger public health or welfare or the indoor or outdoor
environment, (iii) perform pre-remedial studies and investigations or post-remedial monitoring and care, or (iv) correct a condition
of noncompliance with Environmental Laws.
“Representatives”
means, as to any Person, such Person’s Affiliates and the respective managers, directors, officers, employees, independent contractors,
consultants, advisors (including financial advisors, counsel and accountants), agents and other legal representatives of such Person
or its Affiliates.
“Restrictive
Covenant Agreement” means the Restrictive Covenant Agreement in the form of Exhibit I hereto.
“Review
Period” has the meaning set forth in Section 2.2(b).
“SEC”
means the U.S. Securities and Exchange Commission (or any successor Governmental Authority).
“Securities
Act” means the Securities Act of 1933, as amended.
“Selling
Shareholder(s)” has the meaning set forth in the Recitals.
“Selling
Shareholder Documents” has the meaning set forth in Section 5.1.
“Settlement
Accountant” has the meaning set forth in Section 2.2(c).
“Software”
means any computer software programs, including all source code, object code, and documentation related thereto and all software modules,
tools and databases.
“SOX”
means the U.S. Sarbanes-Oxley Act of 2002, as amended.
“Sponsor”
means MFH 2, LLC, a Delaware limited liability company.
“Sponsor
Support Agreement” means the Sponsor Support Agreement in the form of Exhibit F hereto.
77
“Statement
of Objections” has the meaning set forth in Section 2.2(b).
“Straddle
Periods” has the meaning set forth in Section 7.20(b).
“Subscription
Agreements” has the meaning set forth in the Recitals.
“Subsidiary”
means, with respect to any Person, any corporation, partnership, association or other business entity of which (i) if a corporation,
a majority of the total voting power of shares entitled (without regard to the occurrence of any contingency) to vote in the election
of directors, managers or trustees thereof is at the time owned or controlled, directly or indirectly, by that Person or one or more
of the other Subsidiaries of that Person or a combination thereof, or (ii) if a partnership, association or other business entity, a
majority of the partnership or other similar ownership interests thereof is at the time owned or controlled, directly or indirectly,
by any Person or one or more Subsidiaries of that Person or a combination thereof. For purposes hereof, a Person or Persons will be deemed
to have a majority ownership interest in a partnership, association or other business entity if such Person or Persons will be allocated
a majority of partnership, association or other business entity gains or losses or will be or control the managing director, managing
member, general partner or other managing Person of such partnership, association or other business entity. A Subsidiary of a Person
will also include any variable interest entity which is consolidated with such Person under applicable accounting rules.
“Tangible
Assets” means all machinery, office equipment, furniture, fixtures, trade fixtures, vehicles, rolling stock, molds, tools and
other tangible assets (other than inventory or real estate).
“Target
Net Working Capital Amount” means an amount equal to US$618,000.00.
“Tax
Claim” has the meaning set forth in Section 7.20(e).
“Tax
Return” means any return, declaration, report, claim for refund, information return or other documents (including any related
or supporting schedules, statements or information) filed or required to be filed in connection with the determination, assessment or
collection of any Taxes or the administration of any Laws or administrative requirements relating to any Taxes.
“Tax
Statement” has the meaning set forth in Section 7.20(b).
“Taxes”
means (a) all direct or indirect applicable federal, state, local, foreign and other net income, gross income, gross receipts, sales,
use, value-added, ad valorem, transfer, franchise, profits, license, lease, service, service use, withholding, payroll, employment, social
security and related contributions due in relation to the payment of compensation to employees, excise, severance, stamp, occupation,
premium, property, windfall profits, alternative minimum, estimated, customs, duties or other taxes, fees, assessments or charges of
any kind whatsoever, together with any interest and any penalties, additions to tax or additional amounts with respect thereto, (b) any
Liability for payment of amounts described in clause (a) whether as a result of being a member of an affiliated, consolidated, combined
or unitary group for any period or otherwise through operation of law and (c) any Liability for the payment of amounts described in clauses
(a) or (b) as a result of any tax sharing, tax group, tax indemnity or tax allocation agreement (excluding commercial agreements entered
into in the ordinary course of business the primary purpose of which is not the sharing of Taxes) with, or any other express or implied
agreement to indemnify, any other Person.
“Top
Customers” has the meaning set forth in Section 4.24.
“Top
Suppliers” has the meaning set forth in Section 4.24.
“Trade
Secrets” means any trade secrets, confidential business information, concepts, ideas, designs, research or development information,
processes, procedures, techniques, technical information, specifications, operating and maintenance manuals, engineering drawings, methods,
know-how, data, mask works, discoveries, inventions, modifications, extensions, improvements, and other proprietary rights (whether or
not patentable or subject to copyright, trademark, or trade secret protection).
78
“Trademarks”
means any trademarks, service marks, trade dress, trade names, brand names, internet domain names, designs, logos, or corporate names
(including, in each case, the goodwill associated therewith), whether registered or unregistered, and all registrations and applications
for registration and renewal thereof.
“Transaction
Expenses” means all fees and expenses of any of the Company or any Selling Shareholder incurred or payable as of the Closing
and not paid prior to the Closing (i) in connection with the consummation of the transactions contemplated hereby, including any amounts
payable to professionals (including investment bankers, brokers, finders, attorneys, accountants and other consultants and advisors)
retained by or on behalf of the Company, (ii) any change in control bonus, transaction bonus, retention bonus, termination or severance
payment or payment relating to terminated options, warrants or other equity appreciation, phantom equity, profit participation or similar
rights, in any case, to be made to any current or former employee, independent contractor, director or officer of the Company at or after
the Closing pursuant to any agreement to which the Company is a party prior to the Closing which become payable (including if subject
to continued employment) as a result of the execution of this Agreement or the consummation of the transactions contemplated hereby and
(iii) any sales, use, real property transfer, stamp, share transfer or other similar transfer Taxes imposed on Purchaser or the Company
in connection with transactions contemplated by this Agreement.
“Trust
Account” means the trust account established by Purchaser with the proceeds from the IPO pursuant to the Trust Agreement in
accordance with the IPO Prospectus.
“Trust
Agreement” means that certain Investment Management Trust Agreement, dated as of April 29, 2026, as it may be amended, by and
between Purchaser and the Trustee, as well as any other agreements entered into related to or governing the Trust Account.
“Trustee”
means Efficiency Inc., in its capacity as trustee under the Trust Agreement.
“Warrant
Agreement” means the Warrant Agreement, dated April 29, 2026, by and between Purchaser and the Trustee.
**
REMAINDER OF PAGE INTENTIONALLY LEFT BLANK **
79
IN
WITNESS WHEREOF, each Party has duly executed and delivered this Agreement or caused this Agreement to be duly executed and delivered
as a deed as of the day and year first above written.
THE
COMPANY:
FIRSTBORN
TOP CAPITAL SDN. BHD.
By:
Name:
Ow
Ruey Shen
Title:
Director
[Signature
Page to Share Purchase Agreement]
SELLING
SHAREHOLDERS:
Name:
WONG CHEE SIN
Ordinary
Shares: 254,548
Name:
OW RUEY SHEN (Corporate Representative of Mastika Heritage Sdn. Bhd.)
Ordinary
Shares: 2,000,020
Name:
LIM YEN CHENG
Ordinary
Shares: 72,728
Name:
LIM ENG KIAN
Ordinary
Shares: 72,728
Name:
YAP ONN LEONG
Ordinary
Shares Held: 145,456
Name:
PHUN YOON YEE
Ordinary
Shares: 72,728
Name:
NG SIN YEE
Ordinary
Shares: 72,728
[Signature
Page to Share Purchase Agreement]
Name:
SOONG SOON WENG
Ordinary
Shares: 72,728
Name:
WANG POH CHEE
Ordinary
Shares: 72,728
Name:
STACY SOH SIOK CHENG
Ordinary
Shares: 72,728
Name:
WANG MOOI CHOO
Ordinary
Shares: 72,728
Name:
PHUAH EE JIE
Ordinary
Shares: 327,276
Name:
NG LEI TENG (Corporate Representative of P88 Capital Sdn. Bhd.)
Ordinary
Shares: 327,276
SHAREHOLDER
REPRESENTATIVE:
Ow
Ruey Shen, solely in his capacity as Shareholder Representative
By:
[Signature
Page to Share Purchase Agreement]
PURCHASER:
ARC
GROUP ACQUISITION I CORP.
By:
Name:
Datuk
Dr. Doris Wong
Title:
Chief
Executive Officer
PURCHASER
REPRESENTATIVE:
Datuk
Dr. Doris Wong, solely in her capacity as Purchaser Representative
By:
[Signature
Page to Share Purchase Agreement]
EXHIBIT
A-1
EXHIBIT
A-2
ALLOCATION
SCHEDULE
Name
and Address of Selling Shareholder
Number
of Company Shares Immediately Prior to Closing
Percentage
of Outstanding Company Shares Prior to Closing
Number
of Purchaser Shares Issuable at Closing
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
EX-10.1
EX-10.1
Filename: ex10-1.htm · Sequence: 3
Exhibit 10.1
SPONSOR
SUPPORT AGREEMENT
This
SPONSOR SUPPORT AGREEMENT (this “Agreement”) is made and entered into as of September 10, 2026, by and among MFH 2,
LLC, a Delaware limited liability company (“Sponsor”), ARC Group Acquisition I Corp., a British Virgin Islands business
company (“Purchaser”), and Firstborn Top Capital Sdn. Bhd., a Malaysian private limited company (the “Company”)
and the officers, directors and shareholders of Purchaser listed on Schedule A hereto (“Purchaser Insiders”).
Any capitalized term used but not defined in this Agreement will have the meaning ascribed to such term in the Share Purchase Agreement
(as defined below).
RECITALS
WHEREAS,
contemporaneously herewith, Purchaser, the Company, the shareholders of the Company (the “Selling Shareholders”) and
a representative of each of the Purchaser and the Company, entered into a share purchase agreement, dated September 10, 2026 (the “Share
Purchase Agreement”), pursuant to which the Selling Shareholders agreed to sell and transfer to Purchaser, and Purchaser
agreed to purchase, acquire and accept from the Selling Shareholders, all of the issued and outstanding capital shares of the Company,
upon the terms and conditions set forth therein (the “Business Combination”);
WHEREAS,
as of the date of this Agreement, the Sponsor and each Purchaser Insider is the holder of record and the “beneficial owner”
(within the meaning of Rule 13d-3 under the Exchange Act) of the issued and outstanding Purchaser Securities set forth opposite such
Person’s name on Schedule A hereto ((all such securities or other equity securities, together with any classes of Purchaser’s
shares, or other equity securities of which ownership of record or the power to vote (including, without limitation, by proxy or power
of attorney) whether by purchase, as a result of a share dividend, share split, recapitalization, combination, reclassification, exchange
or change of such shares, or upon the exercise or conversion of any securities, acquired by such Person after the date hereof and during
the term of this Agreement being collectively referred to herein as the “Subject Securities”);
WHEREAS,
in connection with Purchaser’s initial public offering, Purchaser, Sponsor and certain other parties thereto entered into a letter
agreement, dated April 29, 2026 (the “Letter Agreement”), pursuant to which Sponsor and certain other parties thereto
agreed to certain voting requirements, transfer restrictions and waiver of redemption rights with respect to the securities of Purchaser
owned by them; and
WHEREAS,
in order to induce the Company to enter into the Share Purchase Agreement and consummate the Business Combination, Sponsor and Purchaser
Insiders are each executing and delivering this Agreement.
NOW,
THEREFORE, in consideration of the foregoing, which are incorporated into this Agreement as if fully set forth below, and of the mutual
covenants and agreements contained herein, and intending to be legally bound hereby, the parties hereby agree as follows:
1.
Agreement to Vote. Each of Sponsor and Purchaser Insiders, with respect to the Subject Securities, hereby agrees (and agrees to
execute such documents or certificates evidencing such agreement as the Company may request in connection therewith), irrevocably and
unconditionally, to:
(a)
when any meetings of the shareholders of Purchaser are held, appear at such meeting or otherwise cause the Subject Securities to be counted
as present thereat for the purpose of establishing a quorum;
(b)
vote at any meetings of the shareholders of Purchaser, and in any action by written consent of the shareholders of Purchaser, all of
the Subject Securities (i) in favor of the approval and adoption of the Share Purchase Agreement, the Ancillary Documents and the Business
Combination, (ii) in favor of Purchaser Shareholder Approval Matters and any other matter reasonably necessary to the consummation of
the Business Combination and considered and voted upon by the shareholders of Purchaser, and (iii) against (A) any Acquisition Proposal
relating to an Alternative Transaction with respect to Purchaser and any and all other proposals (x) for a Business Combination involving
Purchaser with other Person(s) (y) that could reasonably be expected to in any material respect delay or impair the ability of Purchaser
to consummate any of the Business Combination, or (z) which are in competition with or materially inconsistent with the Share Purchase
Agreement or the Ancillary Documents or (B) any action or proposal involving Purchaser or Sponsor that is intended, or would reasonably
be expected to prevent, impede, interfere with, delay, postpone or adversely affect in any material respect the Business Combination
or would reasonably be expected to result in any of the conditions to the Closing under the Share Purchase Agreement not being fulfilled;
(c)
execute and deliver all related documentation and take such other action in support of the Share Purchase Agreement, the Ancillary Documents
and the Business Combination, as shall reasonably be requested by the Company, in order to carry out the terms and provisions of this
Section 1, including, without limitation, the execution and delivery of any applicable Ancillary Documents, customary instruments
of conveyance and transfer, and any consent, waiver, governmental filing, and any similar or related documents; and
(d)
except as contemplated by the Share Purchase Agreement or the Ancillary Documents, make, or in any manner participate in, directly or
indirectly, a “solicitation” of “proxies” or consents (as such terms are used in the rules of the SEC) or powers
of attorney or similar rights to vote (other than a proxy granted to a representative of Sponsor to attend the vote of a meeting which
is voted in accordance with this Agreement).
2.
No Transfer. Each of Sponsor and Purchaser Insiders agrees that it shall not, and shall cause its Affiliates not to, except as
otherwise contemplated pursuant to the Share Purchase Agreement, directly or indirectly, (a) sell, assign, transfer (including by operation
of law), redeem, pledge, distribute, dispose of or otherwise encumber any of the Subject Securities (collectively, a “Transfer”)
or otherwise agree to do any of the foregoing (unless the transferee agrees to be bound by this Agreement), (b) deposit any Subject Securities
into a voting trust, enter into a voting agreement or arrangement or grant any proxy or power of attorney with respect thereto (other
than a proxy granted to a representative of Sponsor to attend and vote at a meeting which is voted in accordance with this Agreement),
(c) enter into any contract, option, derivative, hedging or other agreement or arrangement or understanding (including any profit-sharing
arrangement) with respect to, or consent to, a Transfer of any Subject Securities, or (d) take any action that would have the effect
of preventing, impeding, interfering with or adversely affecting its ability to perform its obligations hereunder.
3.
No Redemption. Each of Sponsor and Purchaser Insiders irrevocably and unconditionally agrees that, from the date hereof and until
the termination of this Agreement, it shall not elect to cause or demand that Purchaser redeem any Purchaser Ordinary Shares now or at
any time legally or beneficially owned by Sponsor or Purchaser Insiders, respectively, or submit, tender, or surrender any of its Subject
Securities for redemption.
4.
Waiver of Anti-Dilution Protection. Each of Sponsor and Purchaser Insiders hereby waives (and agrees to execute such documents
or certificates evidencing such waiver as Purchaser and/or the Company may reasonably request), forfeits, surrenders and agrees not to
exercise, assert or claim, to the fullest extent permitted by applicable Law, any anti-dilution protection (if any) pursuant to Purchaser’s
Governing Documents in connection with the transactions contemplated by this Agreement, the Share Purchase Agreement and any other Ancillary
Document. Each of Sponsor and Purchaser Insiders acknowledges and agrees that (i) this Section 4 shall constitute written consent
waiving, forfeiting and surrendering the adjustment anti-dilution protection pursuant to Purchaser’s Governing Documents in connection
with the transactions contemplated by this Agreement, the Share Purchase Agreement and any other Ancillary Document; and (ii) such waiver,
forfeiture and surrender granted hereunder shall only terminate upon the termination of this Agreement.
5.
Letter Agreement. Sponsor and to the extent applicable, Purchaser Insiders, and Purchaser shall comply with, and fully perform
all of their obligations, covenants, and agreements set forth in the Letter Agreement. Without the prior written consent of the Company,
Sponsor and Purchaser hereby agree that from the date hereof until the termination of this Agreement, neither of them shall, or shall
agree to, amend, modify or vary the Letter Agreement, except as otherwise provided for under this Agreement, the Share Purchase Agreement
or any Ancillary Documents. In the event of a conflict between the Letter Agreement and this Agreement, the terms and conditions of this
Agreement shall control.
6.
Representations and Warranties. Each of Sponsor and Purchaser Insiders represents and warrants to the Company as follows:
(a)
It has received and reviewed a copy of the Share Purchase Agreement and this Agreement and has had the opportunity to consult with its
tax and legal advisors.
(b)
The execution, delivery and performance by such Person of this Agreement and the consummation by such Person of the transactions contemplated
hereby do not and will not (i) conflict with or violate any Law or Order applicable to such Person or any agreement to which such Person
is bound, (ii) require any consent, approval or authorization of, declaration, filing or registration with, or notice to, any person
or entity, (iii) result in the creation of any Lien on any Subject Securities (other than pursuant to this Agreement or transfer restrictions
under applicable securities Laws, the Governing Documents of the Purchaser and Sponsor, the Letter Agreement, or the SEC Reports available
on the SEC’s website through EDGAR), or (iv) conflict with or result in a breach of or constitute a default under any provision
of the Governing Documents of such Person, if and as applicable.
(c)
It owns of record and has good, valid and marketable title to all of the Subject Securities free and clear of any Lien (other than pursuant
to this Agreement or transfer restrictions under applicable securities Laws, the Governing Documents of the Purchaser and Sponsor, the
Letter Agreement, or the SEC Reports available on the SEC’s website through EDGAR) and has the sole power (as currently in effect)
to vote the Subject Securities and has the full right, power and authority to sell, transfer and deliver the Subject Securities. It does
not own, directly or indirectly, (i) any other Purchaser Ordinary Shares other than the Subject Securities or (ii) any options, warrants
or other rights to acquire any additional Purchaser Ordinary Shares or any security exercisable for or convertible into the Purchaser
Ordinary Shares other than the Subject Securities.
(d)
It is duly organized, validly existing and in good standing under the Laws of the jurisdiction in which it is organized, and has the
power, authority and capacity to execute, deliver and perform this Agreement, and this Agreement has been duly authorized, executed and
delivered by such Person.
(e)
This Agreement has been duly executed and delivered by such Person and, assuming due authorization, execution and delivery by the other
parties to this Agreement, this Agreement constitutes a legally valid and binding obligation of such Person, enforceable against such
Person in accordance with the terms hereof (except as enforceability may be limited by bankruptcy Laws, other similar Laws affecting
creditors’ rights and general principles of equity affecting the availability of specific performance and other equitable remedies).
(f)
There is no Action pending, or, to the Knowledge of such Person, threatened, against such Person in writing that would reasonably be
expected to materially impair the ability of such Person to perform its obligations hereunder or to consummate the transactions contemplated
by this Agreement or the Business Combination.
(g)
it has never been suspended or expelled from membership in any securities or commodities exchange or association or had a securities
or commodities license or registration denied, suspended or revoked.
(h)
Except as set forth in Purchaser Disclosure Schedule, no broker, finder, investment banker or other Person is entitled to any brokerage
fee, finders’ fee or other commission in connection with this Agreement or any of the respective transactions contemplated hereby,
based upon arrangements made by or on behalf of such Person.
7.
Other Covenants and Agreements.
(a)
Each of Sponsor and Purchaser Insiders agrees to and shall be bound by and subject to Section 7.6 (No Solicitation),
Section 7.12 (Public Announcements), Section 7.13 (Confidential Information), and Section 11.1 (Waiver
of Claims Against Trust) of the Share Purchase Agreement to the same extent as such provisions apply to Purchaser, as if it was directly
party thereto.
(b)
Each of Sponsor and Purchaser Insiders hereby waives, and agrees not to assert or perfect, any rights of appraisal or rights to dissent
from the Business Combination that Sponsor may have by virtue of ownership of the Subject Securities and agrees not to commence or participate
in any claim, derivative or otherwise, against Purchaser relating to the negotiation, execution or delivery of this Agreement or the
Share Purchase Agreement or the consummation of the Business Combination.
(c)
Each of Sponsor and Purchaser Insiders agrees not to take or agree or commit to take any action that would make any representation or
warranty of such Person contained in this Agreement inaccurate in any material respect. Such Person further agrees that it shall use
its reasonable best efforts to cooperate with the Company and Purchaser to effect the Business Combination, the Share Purchase Agreement,
the Ancillary Documents, and the provisions of this Agreement.
(d)
Each of Sponsor and Purchaser Insiders hereby consents to the publication and disclosure in the Form S-4, and the Proxy Statement (and,
as and to the extent otherwise required by applicable securities Laws or the SEC or any other securities authorities, any other documents
or communications provided by Purchaser to any Authority or to securityholders of Purchaser) of such Person’s identity and beneficial
ownership of the Subject Securities and the nature of such Person’s commitments, arrangements and understandings under and relating
to this Agreement and, if deemed appropriate by the Company or the Purchaser, a copy of this Agreement. Each of Sponsor and Purchaser
Insiders will promptly provide any information reasonably requested by the Company or the Purchaser for any regulatory application or
filing made, or approval sought in connection with the Business Combination (including filings with the SEC). Each of Sponsor and Purchaser
Insiders shall not issue any press release or otherwise make any public statements with respect to the Business Combination or the transactions
contemplated herein without the prior written approval of the Purchaser and the Company.
8.
Termination. Other than Section 5, which shall terminate in accordance with the terms of the Letter Agreement and Section
2 as set forth below, this Agreement, and the obligations of each of Sponsor and Purchaser Insiders under this Agreement shall automatically
terminate upon the earliest of: (a) the Closing Date; (b) the termination of the Share Purchase Agreement in accordance with its terms;
or (c) the mutual written agreement of the Company and Purchaser. Other than pursuant to Section 5, which shall terminate in accordance
with the terms of the Letter Agreement, upon termination or expiration of this Agreement, no party shall have any further obligations
or liabilities under this Agreement; provided, however, such termination or expiration shall not relieve any party from
liability for any willful breach of this Agreement occurring prior to its termination. The Transfer restrictions under Section 2
shall terminate upon the earlier of (A) one (1) year following the Business Combination, and (B) subsequent to the completion of the
Business Combination, (x) the date on which the last sale price of the Class A Shares equals or exceeds $12.00 per share (as adjusted
for share sub-divisions, share capitalizations, reorganizations, recapitalizations and the like) for any twenty (20) trading days within
any 30-trading day period commencing at least one hundred eighty (180) days after the completion of the Business Combination, or (y)
the date on which Purchaser completes a liquidation, merger, amalgamation, capital stock exchange, reorganization or other similar transaction
that results in all of Purchaser’s Public Shareholders having the right to exchange their Class A Shares for cash, securities or
other property.
9.
Miscellaneous.
(a)
Except as otherwise provided herein or in the Share Purchase Agreement or any Ancillary Document, all costs and expenses incurred in
connection with this Agreement and the transactions contemplated hereby shall be paid by the party incurring such costs and expenses,
whether or not the transactions contemplated hereby are consummated.
(b)
All notices, requests, claims, demands and other communications hereunder shall be in writing and shall be given (and shall be deemed
to have been duly given upon receipt) by delivery in person, by telecopy, e-mail, facsimile or other electronic means, with affirmative
confirmation of receipt, one (1) Business Day after being sent, if sent by reputable, nationally recognized overnight courier service,
or three (3) Business Days after being mailed, if sent by registered or certified mail (postage prepaid, return receipt requested) to
the respective parties at the following addresses (or at such other address for a party as shall be specified in a notice given in accordance
with this Section 9(b)):
To
the Purchaser, to:
ARC
Group Acquisition I Corp.
398
S Mill Avenue,
Suite
306,
Tempe,
AZ 85284
Attn:
Datuk Dr. Doris Wong
Telephone
No.:
E-mail:
To
the Sponsor, to:
MFH
2, LLC
398
S Mill Avenue,
Suite
306,
Tempe,
AZ 85284
Attn:
Datuk Dr. Doris Wong
Telephone
No.:
E-mail:
with
a copy to:
Rimon,
P.C.
1050
Connecticut Avenue, NW, Suite 500
Washington,
DC 20006
Attn:
Debbie A. Klis Esq.; Mark C Lee, Esq.
Telephone
No.: (202) 935-3390
Email:
deborrah.klis@rimonlaw.com; mark.c.lee@rimonlaw.com
To
the Company, to:
Firstborn
Top Capital Sdn. Bhd.
13A-3A,
Q Sentral, 2A
Jalan
Stesen Sentral 2
KL
Sentral, Kuala Lumpur
Wilayah
Persekutuan 50470
Malaysia
Attn:
Wilson Ow
Telephone
No.:
E-mail:
with
a copy to:
Rohamat
& Ling
Unit
1009, 10th Floor, Menara PJ,
Amcorp
Trade Centre,
No.
18 Jalan Persiaran Barat,
46050
Petaling Jaya, Selangor.
Attn:
Mark Wong Kah Kit
Telephone
No.: 03-7932 5115
E-mail:
mark@r-ling.com
(c)
If any term or other provision of this Agreement is invalid, illegal or incapable of being enforced by any rule of law, or public policy,
all other conditions and provisions of this Agreement shall nevertheless remain in full force and effect so long as the economic or legal
substance of the transactions contemplated hereby is not affected in any manner materially adverse to any party. Upon such determination
that any term or other provision is invalid, illegal or incapable of being enforced, the parties hereto shall negotiate in good faith
to modify this Agreement so as to effect the original intent of the parties as closely as possible in a mutually acceptable manner in
order that the transactions contemplated hereby be consummated as originally contemplated to the fullest extent possible.
(d)
This Agreement, the Share Purchase Agreement and the Ancillary Documents constitute the entire agreement among the parties with respect
to the subject matter hereof and supersede all prior agreements and undertakings, both written and oral, among the parties, or any of
them, with respect to the subject matter hereof. This Agreement shall not be assigned (whether pursuant to a merger, by operation of
law or otherwise).
(e)
This Agreement shall be binding upon and inure solely to the benefit of each party hereto, and nothing in this Agreement, express or
implied, is intended to or shall confer upon any other person any right, benefit or remedy of any nature whatsoever under or by reason
of this Agreement.
(f)
The parties hereto agree that irreparable damage may occur in the event any provision of this Agreement is not performed in accordance
with the terms hereof and that the parties shall be entitled to specific performance of the terms hereof, in addition to any other remedy
at law or in equity. Each of the parties agrees that it shall not oppose the granting of an injunction, specific performance, and other
equitable relief when expressly available pursuant to the terms of this Agreement on the basis that the other parties have an adequate
remedy at law or an award of specific performance is not an appropriate remedy for any reason at law or equity. Any party seeking an
injunction or injunctions to prevent breaches or threatened breaches of, or to enforce compliance with this Agreement when expressly
available pursuant to the terms of this Agreement shall not be required to provide any bond or other security in connection with any
such Order.
(g)
This Agreement shall be governed by, and construed in accordance with, the Laws of the State of Delaware applicable to contracts executed
in and to be performed in that State without giving effect to principles or rules of conflict of laws to the extent such principles or
rules would require or permit the application of Laws of another jurisdiction. All actions, suits or proceedings (collectively, “Action”)
arising out of or relating to this Agreement shall be heard and determined exclusively in any federal or state court having jurisdiction
located in Delaware (or in any appellate courts thereof) (the “Specified Courts”). The parties hereto hereby (i) submit
to the exclusive jurisdiction of federal or state courts within the State of Delaware for the purpose of any Action arising out of or
relating to this Agreement brought by any party hereto, and (ii) irrevocably waive, and agree not to assert by way of motion, defense,
or otherwise, in any such Action, any claim that it is not subject personally to the jurisdiction of the above-named courts, that its
property is exempt or immune from attachment or execution, that the Action is brought in an inconvenient forum, that the venue of the
Action is improper, or that this Agreement or the transactions contemplated hereunder may not be enforced in or by any Specified Court.
Each party agrees that a final judgment in any Action shall be conclusive and may be enforced in other jurisdictions by suit on the judgment
or in any other manner provided by Law. Each party irrevocably consents to the service of the summons and complaint and any other process
in any other action or proceeding relating to the transactions contemplated by this Agreement, on behalf of itself, or its property,
by personal delivery of copies of such process to such party at the applicable address set forth in Section 9(b). Nothing in this
Section shall affect the right of any party to serve legal process in any other manner permitted by applicable law.
(h)
WAIVER OF JURY TRIAL. EACH OF THE PARTIES HERETO HEREBY WAIVES TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW ANY RIGHT IT
MAY HAVE TO A TRIAL BY JURY WITH RESPECT TO ANY ACTION DIRECTLY OR INDIRECTLY ARISING OUT OF, UNDER OR IN CONNECTION WITH THIS AGREEMENT
OR THE TRANSACTIONS CONTEMPLATED HEREBY. EACH PARTY HERETO (i) CERTIFIES THAT NO REPRESENTATIVE OF ANY OTHER PARTY HAS REPRESENTED,
EXPRESSLY OR OTHERWISE, THAT SUCH OTHER PARTY WOULD NOT, IN THE EVENT OF ANY ACTION, SEEK TO ENFORCE THAT FOREGOING WAIVER AND (ii) ACKNOWLEDGES
THAT IT AND THE OTHER PARTIES HERETO HAVE BEEN INDUCED TO ENTER INTO THIS AGREEMENT BY, AMONG OTHER THINGS, THE MUTUAL WAIVERS AND CERTIFICATIONS
IN THIS SECTION.
(i)
This Agreement may be executed and delivered (including by facsimile or electronic portable document format (.pdf) transmission) in one
or more counterparts, and by the different parties hereto in separate counterparts, each of which when executed shall be deemed to be
an original but all of which taken together shall constitute one and the same agreement.
(j)
Without further consideration, each party shall use commercially reasonable efforts to execute and deliver or cause to be executed and
delivered such additional documents and instruments and take all such further action as may be reasonably necessary or desirable to consummate
the transactions contemplated by this Agreement.
(k)
This Agreement shall not be effective or binding upon Sponsor until such time as the Share Purchase Agreement is executed by each of
the parties thereto.
(l)
If, and as often as, there are any changes in Purchaser or Purchaser Ordinary Shares by way of stock split, stock dividend, combination
or reclassification, or through merger, consolidation, reorganization, recapitalization or business combination, or by any other means,
equitable adjustment shall be made to the provisions of this Agreement as may be required so that the rights, privileges, duties and
obligations hereunder shall continue with respect to Purchaser, Purchaser Insiders, Sponsor and the Subject Securities as so changed,
and the term “Subject Securities” shall be deemed to refer to and include the Subject Securities as well as all such stock
dividends and distributions and any securities into which or for which any or all of the Subject Securities may be changed or exchanged
or which are received in such transaction.
(m)
The titles and subtitles used in this Agreement are for convenience only and are not to be considered in construing or interpreting this
Agreement. In this Agreement, unless the context otherwise requires: (i) any pronoun used in this Agreement shall include the corresponding
masculine, feminine, or neuter forms, and the singular form of nouns, pronouns, and verbs shall include the plural and vice versa; (ii)
“including” (and with correlative meaning “include”) means including without limiting the generality of any description
preceding or succeeding such term and shall be deemed in each case to be followed by the words “without limitation”; (iii)
the words “herein,” “hereto,” and “hereby” and other words of similar import in this Agreement shall
be deemed in each case to refer to this Agreement as a whole and not to any particular section or other subdivision of this Agreement;
and (iv) the term “or” means “and/or”. The Parties have participated jointly in the negotiation and drafting
of this Agreement. Consequently, in the event an ambiguity or question of intent or interpretation arises, this Agreement shall be construed
as if drafted jointly by the Parties hereto, and no presumption or burden of proof shall arise favoring or disfavoring any party by virtue
of the authorship of any provision of this Agreement.
(n)
Any term of this Agreement may be amended, and the observance of any term of this Agreement may be waived (either generally or in a particular
instance, and either retroactively or prospectively) only with the written consent of Purchaser, Purchaser Insiders, the Company and
Sponsor. No failure or delay by a party in exercising any right hereunder shall operate as a waiver thereof. No waivers of or exceptions
to any term, condition, or provision of this Agreement, in any one or more instances, shall be deemed to be or construed as a further
or continuing waiver of any such term, condition, or provision.
(o)
This Agreement is intended to create a contractual relationship among Sponsor, Purchaser Insiders, the Company and Purchaser, and is
not intended to create, and does not create, any agency, partnership, joint venture, or any like relationship among the parties hereto
or among any other shareholders of Purchaser entering into voting agreements with the Company or Purchaser. Each of Sponsor and Purchaser
Insiders has acted independently regarding its decision to enter into this Agreement. Nothing contained in this Agreement shall be deemed
to vest in the Company or Purchaser any direct or indirect ownership or incidence of ownership of or with respect to any Subject Securities.
[Signature
pages follow]
IN
WITNESS WHEREOF, the parties have executed this Agreement as of the date first written above.
PURCHASER:
ARC
GROUP ACQUISITION I CORP.
By:
Name:
Datuk
Dr. Doris Wong
Title:
Chief
Executive Officer
SPONSOR:
MFH
2, LLC
By:
Name:
Datuk
Dr. Doris Wong
Title:
Chief
Executive Officer
COMPANY:
FIRSTBORN
TOP CAPITAL SDN. BHD.
By:
Name:
Wilson
Ow Ruey Shen
Title:
Chief
Executive Officer
PURCHASER
INSIDERS:
By:
Name:
Datuk
Dr. Doris Wong
Title:
Chief
Executive Officer
[Signature
Page to Sponsor Support Agreement]
Schedule
A
EX-10.2
EX-10.2
Filename: ex10-2.htm · Sequence: 4
Exhibit 10.2
COMPANY
SUPPORT AGREEMENT
This
COMPANY SUPPORT AGREEMENT (this “Agreement”) is made and entered into as of September 10, 2026, by and among ARC Group
Acquisition I Corp., a British Virgin Islands business company (“Purchaser”), Firstborn Top Capital Sdn. Bhd., a Malaysian
private limited company (the “Company”), and the officers, directors and shareholders of the Company listed on Schedule
A hereto (the “Company Shareholders”). Any capitalized term used but not defined in this Agreement will have the
meaning ascribed to such term in the Share Purchase Agreement (as defined below).
RECITALS
WHEREAS,
contemporaneously herewith, Purchaser, the Company, the shareholders of the Company (the “Selling Shareholders”) and
a representative each of Purchaser and the Company, entered into a share purchase agreement, dated September 10, 2026 (the “Share
Purchase Agreement”), pursuant to which the Selling Shareholders agreed to sell and transfer to Purchaser, and Purchaser
agreed to purchase, acquire and accept from the Selling Shareholders, all of the issued and outstanding capital shares of the Company,
upon the terms and conditions set forth therein (the “Business Combination”).
WHEREAS,
as of the date of this Agreement, each Company Shareholder is the holder of record and the “beneficial owner” (within the
meaning of Rule 13d-3 under the Exchange Act) of the issued and outstanding Company Ordinary Shares set forth opposite such Company Shareholder’s
name on Schedule A hereto (all such securities or other equity securities, together with any classes of the Company’s shares,
or other equity securities of which ownership of record or the power to vote (including, without limitation, by proxy or power of attorney)
is hereafter acquired by such Company Shareholder during the period from the date hereof through the termination of this Agreement are
referred to herein as the “Subject Shares”); and
WHEREAS,
in order to induce Purchaser to enter into the Share Purchase Agreement and to consummate the Business Combination, the parties hereto
are executing and delivering this Agreement.
NOW,
THEREFORE, in consideration of the foregoing, which are incorporated into this Agreement as if fully set forth below, and of the mutual
covenants and agreements contained herein, and intending to be legally bound hereby, the parties hereby agree as follows:
1.
Agreement to Vote. Each Company Shareholder, severally and not jointly, with respect to the Subject Shares, hereby agrees (and
agrees to execute such documents or certificates evidencing such agreement as Purchaser may request in connection therewith), irrevocably
and unconditionally, to:
(a)
when any meetings of the shareholders of the Company are held, appear at such meeting or otherwise cause the Subject Shares to be counted
as present thereat for the purpose of establishing a quorum;
(b)
vote at any meetings of the shareholders of the Company, and in any action by written consent of the shareholders of the Company, all
of the Subject Shares (i) in favor of the approval and adoption of the Share Purchase Agreement, the Ancillary Documents and the Business
Combination, (ii) in favor of the approval of any other matter reasonably necessary to the consummation of the Business Combination and
considered and voted upon by the Company Shareholders, and (iii) against (A) any Acquisition Proposal relating to an Alternative Transaction
with respect to the Company and any and all other proposals (x) for a Business Combination involving the Company with other Person(s),
(y) that could reasonably be expected to in any material respect delay or impair the ability of the Company to consummate any of the
Business Combination, or (z) which are in competition with or materially inconsistent with the Share Purchase Agreement or the Ancillary
Documents or (B) any action or proposal involving the Company that is intended, or would reasonably be expected to prevent, impede, interfere
with, delay, postpone or adversely affect in any material respect the Business Combination or would reasonably be expected to result
in any of the conditions to the Closing under the Share Purchase Agreement not being fulfilled;
(c)
execute and deliver all related documentation and take such other action in support of the Share Purchase Agreement, the Ancillary Documents
and the Business Combination, as shall reasonably be requested by Purchaser, in order to carry out the terms and provisions of this Section
1, including, without limitation, the execution and delivery of any applicable Ancillary Documents, customary instruments of conveyance
and transfer, and any consent, waiver, governmental filing, and any similar or related documents; and
(d)
except as contemplated by the Share Purchase Agreement or the Ancillary Documents, not make, or in any manner participate in, directly
or indirectly, a “solicitation” of “proxies” or consents (as such terms are used in the rules of the SEC) or
powers of attorney or similar rights to vote.
2.
Representations and Warranties. Each Company Shareholder, severally and not jointly, represents and warrants to Purchaser and
the Company as follows:
(a)
Such Company Shareholder has received and reviewed a copy of the Share Purchase Agreement and this Agreement and has had the opportunity
to consult with their tax and legal advisors.
(b)
The execution, delivery and performance by such Company Shareholder of this Agreement and the consummation by such Company Shareholder
of the transactions contemplated hereby do not and will not (i) conflict with or violate any Law or Order applicable to such Company
Shareholder or any agreement to which such Company Shareholder is bound, (ii) require any consent, approval or authorization of, declaration,
filing or registration with, or notice to, any person or entity, (iii) result in the creation of any Lien on any Subject Shares of such
Company Shareholder (other than pursuant to this Agreement to the extent applicable), or (iv) conflict with or result in a breach of
or constitute a default under any provision of the Governing Documents of such Company Shareholder, if and as applicable.
(c)
Such Company Shareholder owns of record and has good, valid and marketable title to all of the Subject Shares free and clear of any Lien
(other than pursuant to this Agreement to the extent applicable) and has the sole or shared power (as currently in effect) to vote the
Subject Shares and subject to the Lock-Up Agreement, has the full right, power and authority to sell, transfer and deliver the Subject
Shares. Such Company Shareholder does not own, directly or indirectly, (i) any other Company Securities other than the Subject Shares
or (ii) any options, warrants or other rights to acquire any additional shares of the Company or any security exercisable for or convertible
into Company Securities other than the Subject Shares.
(d)
If such Company Shareholder (i) is not an individual, such Company Shareholder is duly organized, validly existing and in good standing
under the Laws of the jurisdiction in which it is organized, and has the power, authority and capacity to execute, deliver and perform
this Agreement, and this Agreement has been duly authorized, executed and delivered by such Company Shareholder; and (ii) is an individual,
the signature on this Agreement is genuine, such Company Shareholder has legal competence and capacity to execute the same.
(e)
This Agreement has been duly executed and delivered by such Company Shareholder and, assuming due authorization, execution and delivery
by the other parties to this Agreement, this Agreement constitutes a legally valid and binding obligation of such Company Shareholder,
enforceable against such Company Shareholder in accordance with the terms hereof (except as enforceability may be limited by bankruptcy
Laws, other similar Laws affecting creditors’ rights and general principles of equity affecting the availability of specific performance
and other equitable remedies).
(f)
There is no Action pending, or, to the knowledge of such Company Shareholder, threatened, against such Company Shareholder in writing
that would reasonably be expected to materially impair the ability of such Company Shareholder to perform its obligations hereunder or
to consummate the transactions contemplated by this Agreement or the Business Combination.
(g)
Such Company Shareholder has never been suspended or expelled from membership in any securities or commodities exchange or association
or had a securities or commodities license or registration denied, suspended or revoked.
(h)
Except as set forth in the Company Disclosure Schedule, no broker, finder, investment banker or other Person is entitled to any brokerage
fee, finders’ fee or other commission in connection with this Agreement or any of the respective transactions contemplated hereby,
based upon arrangements made by or on behalf of such Company Shareholder.
3.
Other Covenants and Agreements.
(a)
Each Company Shareholder agrees to and shall be bound by and subject to Section 7.6 (No Solicitation), Section 7.12
(Public Announcements), Section 7.13 (Confidential Information), and Section 11.1 (Waiver of Claims Against
Trust) of the Share Purchase Agreement to the same extent as such provisions apply to the Company, as if such Company Shareholder
was directly party thereto.
(b)
Each Company Shareholder hereby waives, and agrees not to assert or perfect, any rights of appraisal or rights to dissent from the Business
Combination that such Company Shareholder may have by virtue of ownership of the Subject Shares and agrees not to commence or participate
in any claim, derivative or otherwise, against Purchaser relating to the negotiation, execution or delivery of this Agreement or the
Share Purchase Agreement or the consummation of the Business Combination.
(c)
Each Company Shareholder agrees not to take or agree or commit to take any action that would make any representation or warranty of such
Company Shareholder contained in this Agreement inaccurate in any material respect. Each Company Shareholder further agrees that it shall
use its reasonable best efforts to cooperate with the Company and Purchaser to effect the Business Combination, the Share Purchase Agreement,
the Ancillary Documents, and the provisions of this Agreement.
(d)
Each Company Shareholder hereby consents to the publication and disclosure in the Form S-4, and the Proxy Statement (and, as and to the
extent otherwise required by applicable securities Laws or the SEC or any other securities authorities, any other documents or communications
provided by the Company to any Authority or to securityholders of the Company) of such Company Shareholder’s identity and beneficial
ownership of the Subject Shares and the nature of such Company Shareholder’s commitments, arrangements and understandings under
and relating to this Agreement and, if deemed appropriate by the Company or the Purchaser, a copy of this Agreement. Each Company Shareholder
will promptly provide any information reasonably requested by the Company or the Purchaser for any regulatory application or filing made
or approval sought in connection with the Business Combination (including filings with the SEC). No Company Shareholder shall issue any
press release or otherwise make any public statements with respect to the Business Combination or the transactions contemplated herein
without the prior written approval of the Purchaser and the Company.
4.
Termination. This Agreement, and the obligations of the Company Shareholders under this Agreement shall automatically terminate
upon the earliest of: (a) the Closing Date; (b) the termination of the Share Purchase Agreement in accordance with its terms; or (c)
the mutual written agreement of the Company Shareholders, the Company and Purchaser. Upon termination or expiration of this Agreement,
no party shall have any further obligations or liabilities under this Agreement; provided, however, such termination or
expiration shall not relieve any party from liability for any willful breach of this Agreement occurring prior to its termination.
5.
Miscellaneous.
(a)
Except as otherwise provided herein or in the Share Purchase Agreement or any Ancillary Document, all costs and expenses incurred in
connection with this Agreement and the transactions contemplated hereby shall be paid by the party incurring such costs and expenses,
whether or not the transactions contemplated hereby are consummated.
(b)
All notices, consents, waivers and other communications hereunder shall be governed by the provisions under the Share Purchase Agreement.
(c)
If any term or other provision of this Agreement is invalid, illegal or incapable of being enforced by any rule of law, or public policy,
all other conditions and provisions of this Agreement shall nevertheless remain in full force and effect so long as the economic or legal
substance of the transactions contemplated hereby is not affected in any manner materially adverse to any party. Upon such determination
that any term or other provision is invalid, illegal or incapable of being enforced, the parties hereto shall negotiate in good faith
to modify this Agreement so as to effect the original intent of the parties as closely as possible in a mutually acceptable manner in
order that the transactions contemplated hereby be consummated as originally contemplated to the fullest extent possible.
(d)
This Agreement, the Share Purchase Agreement and the Ancillary Documents constitute the entire agreement among the parties with respect
to the subject matter hereof and supersede all prior agreements and undertakings, both written and oral, among the parties, or any of
them, with respect to the subject matter hereof. This Agreement shall not be assigned (whether pursuant to a merger, by operation of
law or otherwise).
(e)
This Agreement shall be binding upon and inure solely to the benefit of each party hereto, and nothing in this Agreement, express or
implied, is intended to or shall confer upon any other person any right, benefit or remedy of any nature whatsoever under or by reason
of this Agreement.
(f)
The parties hereto agree that irreparable damage may occur in the event any provision of this Agreement was not performed in accordance
with the terms hereof and that the parties shall be entitled to specific performance of the terms hereof, in addition to any other remedy
at law or in equity. Each of the parties agrees that it shall not oppose the granting of an injunction, specific performance, and other
equitable relief when expressly available pursuant to the terms of this Agreement on the basis that the other parties have an adequate
remedy at law or an award of specific performance is not an appropriate remedy for any reason at law or equity. Any party seeking an
injunction or injunctions to prevent breaches or threatened breaches of, or to enforce compliance with this Agreement when expressly
available pursuant to the terms of this Agreement shall not be required to provide any bond or other security in connection with any
such Order.
(g)
This Agreement shall be governed by, and construed in accordance with, the Laws of the State of Delaware applicable to contracts executed
in and to be performed in that State without giving effect to principles or rules of conflict of laws to the extent such principles or
rules would require or permit the application of Laws of another jurisdiction. All actions, suits or proceedings (collectively, “Action”)
arising out of or relating to this Agreement shall be heard and determined exclusively in any federal or state court having jurisdiction
located in Delaware (or in any appellate courts thereof) (the “Specified Courts”). The parties hereto hereby (i) submit
to the exclusive jurisdiction of federal or state courts within the State of Delaware for the purpose of any Action arising out of or
relating to this Agreement brought by any party hereto, and (ii) irrevocably waive, and agree not to assert by way of motion, defense,
or otherwise, in any such Action, any claim that it is not subject personally to the jurisdiction of the above-named courts, that its
property is exempt or immune from attachment or execution, that the Action is brought in an inconvenient forum, that the venue of the
Action is improper, or that this Agreement or the transactions contemplated hereunder may not be enforced in or by any Specified Court.
Each party agrees that a final judgment in any Action shall be conclusive and may be enforced in other jurisdictions by suit on the judgment
or in any other manner provided by Law. Each party irrevocably consents to the service of the summons and complaint and any other process
in any other action or proceeding relating to the transactions contemplated by this Agreement, on behalf of itself, or its property,
by personal delivery of copies of such process to such party at the applicable address set forth in Section 5(b). Nothing in this
Section shall affect the right of any party to serve legal process in any other manner permitted by applicable law.
(h)
WAIVER OF JURY TRIAL. EACH OF THE PARTIES HERETO HEREBY WAIVES TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW ANY RIGHT IT
MAY HAVE TO A TRIAL BY JURY WITH RESPECT TO ANY ACTION DIRECTLY OR INDIRECTLY ARISING OUT OF, UNDER OR IN CONNECTION WITH THIS AGREEMENT
OR THE TRANSACTIONS CONTEMPLATED HEREBY. EACH PARTY HERETO (i) CERTIFIES THAT NO REPRESENTATIVE OF ANY OTHER PARTY HAS REPRESENTED, EXPRESSLY
OR OTHERWISE, THAT SUCH OTHER PARTY WOULD NOT, IN THE EVENT OF ANY ACTION, SEEK TO ENFORCE THAT FOREGOING WAIVER AND (ii) ACKNOWLEDGES
THAT IT AND THE OTHER PARTIES HERETO HAVE BEEN INDUCED TO ENTER INTO THIS AGREEMENT BY, AMONG OTHER THINGS, THE MUTUAL WAIVERS AND CERTIFICATIONS
IN THIS SECTION.
(i)
This Agreement may be executed and delivered (including by facsimile or electronic portable document format (.pdf) transmission) in one
or more counterparts, and by the different parties hereto in separate counterparts, each of which when executed shall be deemed to be
an original but all of which taken together shall constitute one and the same agreement.
(j)
Without further consideration, each party shall use commercially reasonable efforts to execute and deliver or cause to be executed and
delivered such additional documents and instruments and take all such further action as may be reasonably necessary or desirable to consummate
the transactions contemplated by this Agreement.
(k)
This Agreement shall not be effective or binding upon any Company Shareholder until such time as the Share Purchase Agreement is executed
by each of the parties thereto.
(l)
If, and as often as, there are any changes in Company or Company Ordinary Shares by way of stock split, stock dividend, combination or
reclassification, or through merger, consolidation, reorganization, recapitalization or business combination, or by any other means,
equitable adjustment shall be made to the provisions of this Agreement as may be required so that the rights, privileges, duties and
obligations hereunder shall continue with respect to the Company and the Company Shareholders and the Subject Shares as so changed, and
the term “Subject Shares” shall be deemed to refer to and include the Subject Shares as well as all such stock dividends
and distributions and any securities into which or for which any or all of the Subject Shares may be changed or exchanged or which are
received in such transaction.
(m)
The titles and subtitles used in this Agreement are for convenience only and are not to be considered in construing or interpreting this
Agreement. In this Agreement, unless the context otherwise requires: (i) any pronoun used in this Agreement shall include the corresponding
masculine, feminine, or neuter forms, and the singular form of nouns, pronouns, and verbs shall include the plural and vice versa; (ii)
“including” (and with correlative meaning “include”) means including without limiting the generality of any description
preceding or succeeding such term and shall be deemed in each case to be followed by the words “without limitation”; (iii)
the words “herein,” “hereto,” and “hereby” and other words of similar import in this Agreement shall
be deemed in each case to refer to this Agreement as a whole and not to any particular section or other subdivision of this Agreement;
and (iv) the term “or” means “and/or”. The parties have participated jointly in the negotiation and drafting
of this Agreement. Consequently, in the event an ambiguity or question of intent or interpretation arises, this Agreement shall be construed
as if drafted jointly by the parties hereto, and no presumption or burden of proof shall arise favoring or disfavoring any party by virtue
of the authorship of any provision of this Agreement.
(n)
Any term of this Agreement may be amended and the observance of any term of this Agreement may be waived (either generally or in a particular
instance, and either retroactively or prospectively) only with the written consent of Purchaser, the Company Shareholder (acting by majority
in interest of the Subject Shares), and the Company. No failure or delay by a party in exercising any right hereunder shall operate as
a waiver thereof. No waivers of or exceptions to any term, condition, or provision of this Agreement, in any one or more instances, shall
be deemed to be or construed as a further or continuing waiver of any such term, condition, or provision.
(o)
This Agreement is intended to create a contractual relationship among the Company Shareholders, the Company and Purchaser, and is not
intended to create, and does not create, any agency, partnership, joint venture, or any like relationship among the parties hereto or
among any other shareholders of the Company entering into voting agreements with the Company or Purchaser. Each Company Shareholder has
acted independently regarding its decision to enter into this Agreement. Nothing contained in this Agreement shall be deemed to vest
in Company Shareholder, the Company or Purchaser any direct or indirect ownership or incidence of ownership of or with respect to any
Subject Shares.
[Signature
pages follow]
IN
WITNESS WHEREOF, the parties have executed this Agreement as of the date first written above.
PURCHASER:
ARC
GROUP ACQUISITION I CORP.
By:
Name:
Datuk
Dr. Doris Wong
Title:
Chief
Executive Officer
COMPANY:
FIRSTBORN
TOP CAPITAL SDN. BHD.
By:
Name:
Ow
Ruey Shen
Title:
Director
COMPANY
SHAREHOLDERS:
By:
Name:
Wong
Chee Sin
By:
Name:
Ow
Ruey Shen (Corporate Representative of Mastika Heritage Sdn Bhd)
By:
Name:
Phuah
Ee Jie
By:
Name:
Ng
Lei Teng (Corporate Representative of P88 Capital Sdn. Bhd.)
Schedule
A
EX-10.3
EX-10.3
Filename: ex10-3.htm · Sequence: 5
Exhibit
10.3
Exhibit
B
REGISTRATION
RIGHTS AGREEMENT
This
REGISTRATION RIGHTS AGREEMENT (this “Agreement”), is made and entered into effective as of [●], 2026, by and
among ARC Group Acquisition I Corp., a British Virgin Islands business company (“Purchaser”), MFH 2, LLC, a Delaware
limited liability company (the “Sponsor”), and each of the undersigned parties listed on the signature page hereto
under “Holders” (each such party, together with the Sponsor and any person or entity who hereafter becomes a party to this
Agreement pursuant to Section 5.2 of this Agreement, a “Holder” and collectively the “Holders”).
RECITALS
WHEREAS,
Purchaser, Firstborn Top Capital Sdn. Bhd., a Malaysian private limited company (the “Company”), the shareholders
of the Company (the “Selling Shareholders”) and a representative each of the Company and Purchaser entered into a
share purchase agreement, dated ________, 2026 (the “Share Purchase Agreement”), pursuant to which the Selling Shareholders
agreed to sell and transfer to Purchaser, and Purchaser agreed to purchase, acquire and accept from the Selling Shareholders, all of
the issued and outstanding capital shares of the Company, upon the terms and conditions set forth therein (the “Business Combination”);
WHEREAS,
at the completion of the Business Combination, Purchaser shall issue as consideration to the Selling Shareholders Class A Shares (as
defined below) of Purchaser (the “Consideration Shares”), in exchange for the ordinary shares of the Company held
thereby;
WHEREAS,
Purchaser, the Sponsor and certain Holders named therein are parties to a certain Registration Rights Agreement dated April 29, 2026
(the “Prior Agreement”), pursuant to which Purchaser granted to the Sponsor certain registration rights related to
securities of Purchaser held thereby; and
WHEREAS,
the parties to the Prior Agreement desire to terminate such agreement and enter into this Agreement, effective as of the completion of
the Business Combination, to provide the Sponsor and the Holders with certain registration rights pursuant to the terms and conditions
of this Agreement.
NOW,
THEREFORE, in consideration of the representations, covenants and agreements contained herein, and certain other good and valuable
consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto, intending to be legally bound, hereby
agree as follows:
ARTICLE
I
DEFINITIONS
1.1
Definitions. The terms defined in this Article I shall, for all purposes of this Agreement, have the respective
meanings set forth below. Capitalized terms used but not otherwise defined herein shall have the meanings ascribed to such terms in the
Business Combination Agreement.
“Adverse
Disclosure” shall mean any public disclosure of material non-public information, which disclosure, in the good faith judgment
of the Chief Executive Officer or principal financial officer of Purchaser, after consultation with counsel to Purchaser, (i) would be
required to be made in any Registration Statement or Prospectus in order for the applicable Registration Statement or Prospectus not
to contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements contained therein
(in the case of any prospectus and any preliminary prospectus, in the light of the circumstances under which they were made) not misleading,
(ii) would not be required to be made at such time if the Registration Statement were not being filed, and (iii) Purchaser has a bona
fide business purpose for not making such information public.
“Agreement”
shall have the meaning given in the Preamble.
“Board”
shall mean the Board of Directors of Purchaser.
“Business
Combination” shall have the meaning given in the Recitals.
“Class
A Shares” shall mean Class A ordinary shares of Purchaser, par value $0.0001 per share.
“Commission”
shall mean the United States Securities and Exchange Commission.
“Company”
shall have the meaning given in the Preamble.
“Consideration
Shares Lock-up Period” means with respect to the Holders of Consideration Shares, the period ending on the earlier of (A) one
(1) year following the Business Combination and (B) subsequent to the completion of the Business Combination, (x) the date on which the
last sale price of the Class A Shares equals or exceeds $12.00 per share (as adjusted for share sub-divisions, share capitalizations,
reorganizations, recapitalizations and the like) for any twenty (20) trading days within any 30-trading day period commencing at least
one hundred eighty (180) days after the completion of the Business Combination, or (y) the date on which Purchaser completes a liquidation,
merger, amalgamation, capital stock exchange, reorganization or other similar transaction that results in all of Purchaser’s Public
Shareholders having the right to exchange their Class A Shares for cash, securities or other property.
“Demand
Registration” shall have the meaning given in subsection 2.2.1.
“Demanding
Holder” shall have the meaning given in subsection 2.2.1.
“Exchange
Act” shall mean the Securities Exchange Act of 1934, as it may be amended from time to time.
“Filing
Date” means, with respect to the Initial Registration Statement required to be filed on or before the 30th calendar day following
the date hereof and, with respect to any additional Registration Statements which may be required pursuant to Sections 2.2 and
2.3, the earliest practical date on which Purchaser is permitted by Commission guidance to file such additional Registration Statement
related to the Registrable Securities; provided, however, that, if the Filing Date falls on a Saturday, Sunday or any other day which
shall be a legal holiday or a day on which the Commission is authorized or required by law or other government actions to close, the
Filing Date shall be the following Business Day.
“Form
S-1” shall have the meaning given in subsection 2.2.1.
“Form
S-3” shall have the meaning given in subsection 2.4.
“Founder
Shares” shall mean 5,175,000 shares of Class B ordinary shares, par value $0.00001 per share, and shall be deemed to include
the Class A Shares issuable upon conversion thereof.
“Holders”
shall have the meaning given in the Preamble.
“Initial
Registration Statement” means the Registration Statement required to be filed pursuant to Section 2.1.
“Insider
Letter” shall mean that certain letter agreement, dated as of April 29, 2026, by and among Purchaser, the Sponsor and each
of Purchaser’s officers and directors.
“Lock-up
Agreement” shall mean that certain Lock-up Agreement, dated [*], 2026.
“Maximum
Number of Securities” shall have the meaning given in subsection 2.2.4.
“Misstatement”
shall mean an untrue statement of a material fact or an omission to state a material fact required to be stated in a Registration Statement
or Prospectus, or necessary to make the statements in a Registration Statement or Prospectus (in the light of the circumstances under
which they were made) not misleading.
“Permitted
Transferees” shall mean any person or entity to whom a Holder of Registrable Securities is permitted to transfer such Registrable
Securities prior to the expiration of the applicable Sponsor Lock-up Period or Consideration Shares Lock-up Period, and to any transferee
thereafter.
“Person”
shall mean an individual, a corporation, a partnership, a joint venture, a trust, an unincorporated organization, a limited liability
company or partnership, a government and any agency or political subdivision thereof.
“Piggyback
Registration” shall have the meaning given in subsection 2.3.1.
“Purchaser”
shall have the meaning given in the Preamble.
“Private
Placement Rights” means the rights included in the Private Placement Units.
“Private
Placement Shares” means the Class A Shares included in the Private Placement Units.
“Private
Placement Units” means an aggregate of 200,000 private placement units purchased by the Sponsor pursuant to the Private Units
Purchase Agreement.
“Private
Placement Warrants” means the warrants included in the Private Placement Units.
“Private
Units Purchase Agreement” means that certain Private Units Purchase Agreement, dated April 29, 2026, by and between Purchaser
and the Sponsor.
“Pro
Rata” shall have the meaning given in subsection 2.1.2.
“Prospectus”
shall mean the prospectus included in any Registration Statement, as supplemented by any and all prospectus supplements and as amended
by any and all post-effective amendments and including all material incorporated by reference in such prospectus.
“Registrable
Security” shall mean (a) the Founder Shares and the Class A Shares issued or issuable upon the conversion of the Founder Shares,
(b) the Private Placement Shares, the Private Placement Warrants, and any Class A Shares issued or issuable upon the exercise of the
Private Placement Warrants and the conversion of the Private Placement Rights, (c) any outstanding Class A Shares or any other equity
security (including the Class A Shares issued or issuable upon the exercise of any other equity security) of Purchaser held by a Holder
as of the date of this Agreement, (d) any equity securities (including the Class A Shares issued or issuable upon the exercise of any
such equity security) of Purchaser issuable upon conversion of any working capital loans in an amount up to $2,500,000 made to Purchaser
by a Holder, (e) the Consideration Shares, and (f) any other equity security of Purchaser issued or issuable by way of a share capitalization
or share split or in connection with a combination of shares, recapitalization, merger, consolidation or reorganization; provided,
however, that, as to any particular Registrable Security, such securities shall cease to be Registrable Securities when: (A) a
Registration Statement with respect to the sale of such securities shall have become effective under the Securities Act and such securities
shall have been sold, transferred, disposed of or exchanged in accordance with such Registration Statement; (B) such securities shall
have been otherwise transferred, new certificates for such securities not bearing a legend restricting further transfer shall have been
delivered by Purchaser and subsequent public distribution of such securities shall not require registration under the Securities Act;
(C) such securities shall have ceased to be outstanding; (D) such securities may be sold without registration pursuant to Rule 144 promulgated
under the Securities Act (or any successor rule promulgated thereafter by the Commission) (but with no volume or other restrictions or
limitations); or (E) such securities have been sold to, or through, a broker, dealer or underwriter in a public distribution or other
public securities transaction.
“Registration”
shall mean a registration effected by preparing and filing a registration statement or similar document in compliance with the requirements
of the Securities Act, and the applicable rules and regulations promulgated thereunder, and such registration statement becoming effective.
“Registration
Expenses” shall mean the out-of-pocket expenses of a Registration, including, without limitation, the following:
(A)
all registration and filing fees (including fees with respect to filings required to be made with the Financial Industry Regulatory Authority
Inc.) and any securities exchange on which the Class A Shares are then listed;
(B)
fees and expenses of compliance with securities or blue sky laws (including reasonable fees and disbursements of outside counsel for
the Underwriters in connection with blue sky qualifications of Registrable Securities);
(C)
printing, messenger, telephone and delivery expenses;
(D)
reasonable fees and disbursements of counsel for Purchaser;
(E)
reasonable fees and disbursements of all independent registered public accountants of Purchaser incurred specifically in connection with
such Registration; and
(F)
reasonable fees and expenses of one (1) legal counsel selected by the Demanding Holders holding the majority of shares to be included
in initiating a Demand Registration to be registered for offer and sale in the applicable Registration.
“Registration
Statement” shall mean any registration statement that covers the Registrable Securities pursuant to the provisions of this
Agreement, including the Prospectus included in such registration statement, amendments (including post-effective amendments) and supplements
to such registration statement, and all exhibits to and all material incorporated by reference in such registration statement.
“Requesting
Holder” shall have the meaning given in subsection 2.2.1.
“Securities
Act” shall mean the Securities Act of 1933, as amended from time to time.
“Sponsor”
shall have the meaning given in the Preamble.
“Sponsor
Lock-up Period” shall mean, with respect to the Founder Shares, Private Placement Shares, the Private Placement Warrants, any
Class A Shares issued or issuable upon the exercise of the Private Placement Warrants, and any Class A Shares issued or issuable upon
the conversion of the Private Placement Rights, the period ending on the earlier of (A) one year following the Business Combination and
(B) subsequent to the completion of the Business Combination, (x) the date on which the last sale price of the Class A Shares equals
or exceeds $12.00 per share (as adjusted for share sub-divisions, share capitalizations, reorganizations, recapitalizations and the like)
for any 20 trading days within any 30-trading day period commencing at least 180 days after the completion of the Business Combination,
or (y) the date on which Purchaser completes a liquidation, merger, amalgamation, capital stock exchange, reorganization or other similar
transaction that results in all of Purchaser’s Public Shareholders having the right to exchange their Class A Shares for cash,
securities or other property.
“Underwriter”
shall mean a securities dealer who purchases any Registrable Securities as principal in an Underwritten Offering and not as part of such
dealer’s market-making activities.
“Underwritten
Registration” or “Underwritten Offering” shall mean a Registration in which securities of Purchaser are
sold to an Underwriter in a firm commitment underwriting for distribution to the public.
ARTICLE
II
REGISTRATION
RIGHTS
2.1
Shelf Registration.
2.1.1
On or prior to each Filing Date, Purchaser shall prepare and file with the Commission a Registration Statement covering the resale
of all or such maximum portion of the Registrable Securities as permitted by Commission guidance (provided that, Purchaser shall use
diligent efforts to advocate with the Commission for the registration of all of the Registrable Securities in accordance with the
Commission guidance, including without limitation, the Manual of Publicly Available Telephone Interpretations D.29) that are not
then registered on an effective Registration Statement for an offering to be made on a continuous basis pursuant to Rule 415. Each
Registration Statement filed hereunder shall be on Form S-1 (except if Purchaser is then eligible to register for resale the
Registrable Securities on Form S-3, such registration shall be on Form S-3 in accordance herewith). Subject to the terms of this
Agreement, Purchaser shall use its commercially reasonable efforts to cause a Registration Statement to be declared effective under
the Securities Act as promptly as practicable after the filing thereof, but in any event prior to the applicable Effectiveness Date,
and shall use its commercially reasonable efforts to keep such Registration Statement continuously effective under the Securities
Act until all Registrable Securities covered by such Registration Statement have been sold, or may be sold without volume or
manner-of-sale restrictions pursuant to Rule 144, without the requirement for Purchaser to be in compliance with the current public
information requirement under Rule 144, as determined by the counsel to Purchaser pursuant to a written opinion letter to such
effect, addressed and acceptable to Purchaser’s Transfer Agent and the affected Holders (the “Effectiveness
Period”). Purchaser shall telephonically request effectiveness of a Registration Statement as of 5:00 p.m. New York City
time on a Business Day. Purchaser shall promptly notify the Holders by e-mail of the effectiveness of a Registration Statement on
the same Business Day that Purchaser telephonically confirms effectiveness with the Commission. Purchaser shall, no later than the
second Business Day after the effective date of such Registration Statement, file a final Prospectus with the Commission as required
by Rule 424.
2.1.2
Notwithstanding any other provision of this Agreement, if any Commission guidance sets forth a limitation on the number of Registrable
Securities permitted to be registered on a particular Registration Statement (and notwithstanding that Purchaser used diligent efforts
to advocate with the Commission for the registration of all or a greater portion of Registrable Securities), the number of Registrable
Securities to be registered shall be reduced on a pro rata basis based on the total number of Registrable Securities held by such Holders
(such proportion is referred to herein as “Pro Rata”). In the event of a reduction hereunder, Purchaser shall give
the Holder at least five (5) Business Days prior written notice along with the calculations as to such Holder’s allotment. Promptly
after such Commission guidance is no longer applicable with respect to some or all of the remaining unregistered Registrable Securities,
Purchaser shall file an additional Registration Statement in accordance with this Section 2.1.2 with respect to such Registrable
Securities.
2.1.3
Each Holder agrees to furnish to Purchaser a completed Selling Shareholder Questionnaire within five (5) Business Days following the
date of this Agreement. Each Holder further acknowledges and agrees that it shall not be entitled to be named as a selling security holder
in the Registration Statement or use the Prospectus for offers and resales of Registrable Securities at any time unless such Holder has
returned to Purchaser a completed and signed Selling Shareholder Questionnaire. If a Holder of Registrable Securities returns a Selling
Shareholder Questionnaire after the deadline specified in the previous sentence, Purchaser shall use its commercially reasonable efforts
to take such actions as are required to name such Holder as a selling security holder in the Registration Statement or any pre-effective
or post-effective amendment thereto and to include (to the extent not theretofore included) in the Registration Statement the Registrable
Securities identified in such late Selling Shareholder Questionnaire; provided that Purchaser shall not be required to file an additional
Registration Statement solely for such shares. Each Holder acknowledges and agrees that the information in the Selling Shareholder Questionnaire
will be used by Purchaser in the preparation of the Registration Statement and hereby consents to the inclusion of such information in
the Registration Statement.
2.2
Demand Registration.
2.2.1
Request for Registration. Subject to the provisions of subsection 2.2.4 and Section 2.5 hereof, at any time and
from time to time on or after the date Purchaser consummates the Business Combination, the Holders of at least twenty-five percent (25%)
of the then-outstanding number of Registrable Securities (the “Demanding Holders”) may make a written demand for Registration
of all or part of their Registrable Securities, which written demand shall describe the amount and type of securities to be included
in such Registration and the intended method(s) of distribution thereof (such written demand a “Demand Registration”).
Purchaser shall, within ten (10) days of Purchaser’s receipt of the Demand Registration, notify, in writing, all other Holders
of Registrable Securities of such demand, and each Holder of Registrable Securities who thereafter wishes to include all or a portion
of such Holder’s Registrable Securities in a Registration pursuant to a Demand Registration (each such Holder that includes all
or a portion of such Holder’s Registrable Securities in such Registration, a “Requesting Holder”) shall so notify
Purchaser, in writing, within five (5) days after the receipt by the Holder of the notice from Purchaser. Upon receipt by Purchaser of
any such written notification from a Requesting Holder(s) to Purchaser, such Requesting Holder(s) shall be entitled to have their Registrable
Securities included in a Registration pursuant to a Demand Registration and Purchaser shall use its commercially reasonable efforts to
effect, as soon thereafter as practicable, but not more than forty five (45) days immediately after Purchaser’s receipt of the
Demand Registration, the Registration of all Registrable Securities requested by the Demanding Holders and Requesting Holders pursuant
to such Demand Registration. Under no circumstances shall Purchaser be obligated to effect more than an aggregate of two (2) Registrations
pursuant to a Demand Registration under this subsection 2.2.1 with respect to any or all Registrable Securities; provided,
however, that a Registration shall not be counted for such purposes unless a Form S-1 or any similar long-form registration statement
that may be available at such time (“Form S-1”) has become effective and all of the Registrable Securities requested
by the Requesting Holders to be registered on behalf of the Requesting Holders in such Form S-1 Registration have been sold, in accordance
with Section 3.1 of this Agreement.
2.2.2
Effective Registration. Notwithstanding the provisions of subsection 2.2.1 above or any other part of this Agreement, a
Registration pursuant to a Demand Registration shall not count as a Registration unless and until (i) the Registration Statement filed
with the Commission with respect to a Registration pursuant to a Demand Registration has been declared effective by the Commission and
(ii) Purchaser has complied with all of its obligations under this Agreement with respect thereto; provided, further, that
if, after such Registration Statement has been declared effective, an offering of Registrable Securities in a Registration pursuant to
a Demand Registration is subsequently interfered with by any stop order or injunction of the Commission, federal or state court or any
other governmental agency the Registration Statement with respect to such Registration shall be deemed not to have been declared effective,
unless and until, (i) such stop order or injunction is removed, rescinded or otherwise terminated, and (ii) Demanding Holders holding
a majority in interest of the outstanding Registrable Securities initiating such Demand Registration thereafter affirmatively elect to
continue with such Registration and accordingly notify Purchaser in writing, but in no event later than five (5) days, of such election;
and provided, further, that Purchaser shall not be obligated or required to file another Registration Statement until the
Registration Statement that has been previously filed with respect to a Registration pursuant to a Demand Registration becomes effective
or is subsequently terminated.
2.2.3
Underwritten Offering. Subject to the provisions of subsection 2.2.4 and Section 2.4 hereof, if a majority-in-interest
of the Demanding Holders advise Purchaser as part of their Demand Registration that the offering of the Registrable Securities pursuant
to such Demand Registration shall be in the form of an Underwritten Offering, then the right of such Demanding Holder or Requesting Holder
(if any) to include its Registrable Securities in such Registration shall be conditioned upon such Holder’s participation in such
Underwritten Offering and the inclusion of such Holder’s Registrable Securities in such Underwritten Offering to the extent provided
herein. All such Holders proposing to distribute their Registrable Securities through an Underwritten Offering under this subsection
2.2.3 shall enter into an underwriting agreement in customary form with the Underwriter(s) selected for such Underwritten Offering
by the holders of a majority in interest of shares by Demanding Holders initiating the Demand Registration.
2.2.4
Reduction of Underwritten Offering. If the managing Underwriter or Underwriters in an Underwritten Registration pursuant to a
Demand Registration, in good faith, advises Purchaser, the Demanding Holders and the Requesting Holders (if any) in writing that the
dollar amount or number of Registrable Securities that the Demanding Holders and the Requesting Holders (if any) desire to sell, taken
together with all other Class A Shares or other equity securities that Purchaser desires to sell and the Class A Shares, if any, as to
which a Registration has been requested pursuant to separate written contractual piggy-back registration rights held by any other shareholders
who desire to sell, exceeds the maximum dollar amount or maximum number of equity securities that can be sold in the Underwritten Offering
without adversely affecting the proposed offering price, the timing, the distribution method, or the probability of success of such offering
(such maximum dollar amount or maximum number of such securities, as applicable, the “Maximum Number of Securities”),
then Purchaser shall include in such Underwritten Offering, as follows: (i) first, the Registrable Securities of the Demanding Holders
and the Requesting Holders (if any) (pro rata based on the respective number of Registrable Securities that each Demanding Holder and
Requesting Holder (if any) has requested be included in such Underwritten Registration and the aggregate number of Registrable Securities
that the Demanding Holders and Requesting Holders have requested be included in such Underwritten Registration (such proportion is referred
to herein as “Pro Rata”)) that can be sold without exceeding the Maximum Number of Securities; (ii) second, to the
extent that the Maximum Number of Securities has not been reached under the foregoing clause (i), the Registrable Securities of Holders
(Pro Rata, based on the respective number of Registrable Securities that each Holder has so requested) exercising their rights to register
their Registrable Securities pursuant to subsection 2.2.1 hereof, without exceeding the Maximum Number of Securities; and (iii)
third, to the extent that the Maximum Number of Securities has not been reached under the foregoing clauses (i) and (ii), the Class A
Shares or other equity securities that Purchaser desires to sell, which can be sold without exceeding the Maximum Number of Securities;
and (iv) fourth, to the extent that the Maximum Number of Securities has not been reached under the foregoing clauses (i), (ii) and (iii),
the Class A Shares or other equity securities of other persons or entities that Purchaser is obligated to register in a Registration
pursuant to separate written contractual arrangements with such persons and that can be sold without exceeding the Maximum Number of
Securities.
2.2.5
Demand Registration Withdrawal. A majority-in-interest of the Demanding Holders, or a majority-in-interest of the Requesting Holders
(if any), shall have the right to withdraw from a Registration pursuant to a Demand Registration for any or no reason whatsoever, upon
written notification to Purchaser and the Underwriter or Underwriters (if any) of their intention to withdraw from such Registration
prior to the effectiveness of the Registration Statement filed with the Commission with respect to the Registration of their Registrable
Securities pursuant to such Demand Registration. Notwithstanding anything to the contrary in this Agreement, Purchaser shall be responsible
for the Registration Expenses incurred in connection with a Registration pursuant to a Demand Registration prior to its withdrawal under
this subsection 2.2.5.
2.3
Piggyback Registration.
2.3.1
Piggyback Rights. If, at any time on or after the date Purchaser consummates a Business Combination, Purchaser proposes to file
a Registration Statement under the Securities Act with respect to an offering of equity securities, or securities or other obligations
exercisable or exchangeable for, or convertible into equity securities, for its own account or for the account of shareholders of Purchaser
(or by Purchaser and by the shareholders of Purchaser including, without limitation, pursuant to Section 2.2 hereof), other than
a Registration Statement (i) filed in connection with any employee share option or other benefit plan, (ii) for an exchange offer or
offering of securities solely to Purchaser’s existing shareholders, (iii) for an offering of debt that is convertible into equity
securities of Purchaser or (iv) for a dividend reinvestment plan, then Purchaser shall give written notice of such proposed filing to
all of the Holders of Registrable Securities as soon as practicable but not less than ten (10) days before the anticipated filing date
of such Registration Statement, which notice shall (A) describe the amount and type of securities to be included in such offering, the
intended method(s) of distribution, and the name of the proposed managing Underwriter or Underwriters, if any, in such offering, and
(B) offer to all of the Holders of Registrable Securities the opportunity to register the sale of such number of Registrable Securities
as such Holders may request in writing within five (5) days after receipt of such written notice (such Registration, a “Piggyback
Registration”). Purchaser shall, in good faith, cause such Registrable Securities to be included in such Piggyback Registration
and shall use its best efforts to cause the managing Underwriter or Underwriters of a proposed Underwritten Offering to permit the Registrable
Securities requested by the Holders pursuant to this subsection 2.3.1 to be included in a Piggyback Registration on the same terms
and conditions as any similar securities of Purchaser included in such Registration and to permit the sale or other disposition of such
Registrable Securities in accordance with the intended method(s) of distribution thereof. All such Holders proposing to distribute their
Registrable Securities through an Underwritten Offering under this subsection 2.3.1 shall enter into an underwriting agreement
in customary form with the Underwriter(s) selected for such Underwritten Offering by Purchaser.
2.3.2
Reduction of Piggyback Registration. If the managing Underwriter or Underwriters in an Underwritten Registration that is to be
a Piggyback Registration, in good faith, advises Purchaser and the Holders of Registrable Securities participating in the Piggyback Registration
in writing that the dollar amount or number of the Class A Shares that Purchaser desires to sell, taken together with (i) the Class A
Shares, if any, as to which Registration has been demanded pursuant to separate written contractual arrangements with persons or entities
other than the Holders of Registrable Securities hereunder, (ii) the Registrable Securities as to which registration has been requested
pursuant to Section 2.3 hereof, and (iii) the Class A Shares, if any, as to which Registration has been requested pursuant to
separate written contractual piggy-back registration rights of other shareholders of Purchaser, exceeds the Maximum Number of Securities,
then:
(a)
If the Registration is undertaken for Purchaser’s account, Purchaser shall include in any such Registration (A) first, the Class
A Shares or other equity securities that Purchaser desires to sell, which can be sold without exceeding the Maximum Number of Securities;
(B) second, to the extent that the Maximum Number of Securities has not been reached under the foregoing clause (A), the Registrable
Securities of Holders exercising their rights to register their Registrable Securities pursuant to subsection 2.3.1 hereof, Pro
Rata, which can be sold without exceeding the Maximum Number of Securities; and (C) third, to the extent that the Maximum Number of Securities
has not been reached under the foregoing clauses (A) and (B), the Class A Shares, if any, as to which Registration has been requested
pursuant to written contractual piggy-back registration rights of other shareholders of Purchaser, which can be sold without exceeding
the Maximum Number of Securities;
(b)
If the Registration is pursuant to a request by persons or entities other than the Holders of Registrable Securities, then Purchaser
shall include in any such Registration (A) first, the Class A Shares or other equity securities, if any, of such requesting persons or
entities, other than the Holders of Registrable Securities, which can be sold without exceeding the Maximum Number of Securities; (B)
second, to the extent that the Maximum Number of Securities has not been reached under the foregoing clause (A), the Registrable Securities
of Holders exercising their rights to register their Registrable Securities pursuant to subsection 2.3.1, pro rata based on the
number of Registrable Securities that each Holder has requested be included in such Underwritten Registration and the aggregate number
of Registrable Securities that the Holders have requested to be included in such Underwritten Registration, which can be sold without
exceeding the Maximum Number of Securities; (C) third, to the extent that the Maximum Number of Securities has not been reached under
the foregoing clauses (A) and (B), the Class A Shares or other equity securities that Purchaser desires to sell, which can be sold without
exceeding the Maximum Number of Securities; and (D) fourth, to the extent that the Maximum Number of Securities has not been reached
under the foregoing clauses (A), (B) and (C), the Class A Shares or other equity securities for the account of other persons or entities
that Purchaser is obligated to register pursuant to separate written contractual arrangements with such persons or entities, which can
be sold without exceeding the Maximum Number of Securities.
2.3.3
Piggyback Registration Withdrawal. Any Holder of Registrable Securities shall have the right to withdraw from a Piggyback Registration
for any or no reason whatsoever upon written notification to Purchaser and the Underwriter or Underwriters (if any) of his, her or its
intention to withdraw from such Piggyback Registration prior to the effectiveness of the Registration Statement filed with the Commission
with respect to such Piggyback Registration. Purchaser (whether on its own good faith determination or as the result of a request for
withdrawal by persons pursuant to separate written contractual obligations) may withdraw a Registration Statement filed with the Commission
in connection with a Piggyback Registration at any time prior to the effectiveness of such Registration Statement. Notwithstanding anything
to the contrary in this Agreement, Purchaser shall be responsible for the Registration Expenses incurred in connection with the Piggyback
Registration prior to its withdrawal under this subsection 2.3.3.
2.3.4
Unlimited Piggyback Registration Rights. For purposes of clarity, any Registration effected pursuant to Section 2.3 hereof
shall not be counted as a Registration pursuant to a Demand Registration effected under Section 2.2 hereof.
2.4
Registrations on Form S-3. Holders of Registrable Securities may at any time, and from time to time, request in writing that Purchaser,
pursuant to Rule 415 under the Securities Act (or any successor rule promulgated thereafter by the Commission), register the resale of
any or all of their Registrable Securities on Form S-3 or any similar short form registration statement that may be available at such
time (“Form S-3”); provided, however, that Purchaser shall not be obligated to effect such request through
an Underwritten Offering. Within five (5) days of Purchaser’s receipt of a written request from a Holder or Holders of Registrable
Securities for a Registration on Form S-3, Purchaser shall promptly give written notice of the proposed Registration on Form S-3 to all
other Holders of Registrable Securities, and each Holder of Registrable Securities who thereafter wishes to include all or a portion
of such Holder’s Registrable Securities in such Registration on Form S-3 shall so notify Purchaser, in writing, within ten (10)
days after the receipt by the Holder of the notice from Purchaser. As soon as practicable thereafter, but not more than twelve (12) days
after Purchaser’s initial receipt of such written request for a Registration on Form S-3, Purchaser shall register all or such
portion of such Holder’s Registrable Securities as are specified in such written request, together with all or such portion of
Registrable Securities of any other Holder or Holders joining in such request as are specified in the written notification given by such
Holder or Holders; provided, however, that Purchaser shall not be obligated to effect any such Registration pursuant to
this Section 2.4 if (i) a Form S-3 is not available for such offering; or (ii) the Holders of Registrable Securities, together
with the Holders of any other equity securities of Purchaser entitled to inclusion in such Registration, propose to sell the Registrable
Securities and such other equity securities (if any) at any aggregate price to the public of less than $10,000,000.
2.5
Restrictions on Registration Rights. If (A) during the period starting with the date sixty (60) days prior to Purchaser’s
good faith estimate of the date of the filing of, and ending on a date one hundred and twenty (120) days after the effective date of,
a Company initiated Registration and provided that Purchaser has delivered written notice to the Holders prior to receipt of a Demand
Registration pursuant to subsection 2.2.1 and it continues to actively employ, in good faith, all reasonable efforts to cause
the applicable Registration Statement to become effective; (B) the Holders have requested an Underwritten Registration and Purchaser
and the Holders are unable to obtain the commitment of underwriters to firmly underwrite the offer; or (C) in the good faith judgment
of the Board such Registration would be seriously detrimental to Purchaser and the Board concludes as a result that it is essential to
defer the filing of such Registration Statement at such time, then in each case Purchaser shall furnish to such Holders a certificate
signed by Purchaser’s Chairman of the Board (or President of Purchaser) stating that in the good faith judgment of the Board it
would be seriously detrimental to Purchaser for such Registration Statement to be filed in the near future and that it is therefore essential
to defer the filing of such Registration Statement. In such event, Purchaser shall have the right to defer such filing for a period of
not more than thirty (30) days; provided, however, that Purchaser shall not defer its obligation in this manner more than
once in any 12-month period.
2.6
Block Trades; Other Coordinated Offerings.
2.6.1
Notwithstanding any other provision of this Section 2.6.1, at any time and from time to time when an effective Shelf Registration
is on file with the Commission, if a Demanding Holder wishes to engage in (a) an underwritten registered offering (whether firm commitment
or otherwise) not involving a “road show” or other substantial marketing efforts prior to pricing (commonly referred to as
a “Block Trade”) or (b) an otherwise coordinated “at the market” or similar registered offering through
a broker, sales agent or distribution agent, whether as agent or principal (an “Other Coordinated Offering”), in each
case, with a total offering price reasonably expected to exceed, in the aggregate, either (x) $10,000,000 or (y) all remaining Registrable
Securities held by the Demanding Holder, then such Demanding Holder shall notify Purchaser of the Block Trade or Other Coordinated Offering
at least five (5) business days prior to the day such offering is expected to commence, and Purchaser shall as expeditiously as possible
use its commercially reasonable efforts to facilitate such Block Trade or Other Coordinated Offering; provided that the Demanding Holders
representing a majority of the Registrable Securities wishing to engage in the Block Trade or Other Coordinated Offering shall use commercially
reasonable efforts to work with Purchaser and any Underwriters, brokers, sales agents or placement agents prior to making such request
in order to facilitate preparation of the registration statement, prospectus and other offering documentation related to the Block Trade
or Other Coordinated Offering.
2.6.2
Purchaser may facilitate a Block Trade or Other Coordinated Offering if it determines that sufficient shares shall be traded by any Holder
or Holders that would be more efficiently traded as a block trade.
2.6.3
Prior to the filing of the applicable “red herring” prospectus or prospectus supplement used in connection with a Block Trade
or Other Coordinated Offering, a majority-in-interest of the Demanding Holders initiating such Block Trade or Other Coordinated Offering
shall have the right to submit a notice to Purchaser and the Underwriter(s) if any, of their intention to withdraw from such Block Trade
or Other Coordinated Offering. Notwithstanding anything to the contrary in this Agreement, Purchaser shall be responsible for the Registration
Expenses incurred in connection with a block trade prior to its withdrawal under this Section 2.6.3.
2.6.4
Notwithstanding anything to the contrary in this Agreement, Section 2.3 shall not apply to a Block Trade or Other Coordinated
Offering initiated by a Demanding Holder pursuant to this Section 2.6.4.
2.6.5
Purchaser shall have the right to select the Underwriters, and brokers, sale agents or placement agents (if any) for such Block Trade
or Other Coordinated Offering, in each case, which shall consist of one or more reputable nationally recognized investment banks.
2.6.6
A Holder in the aggregate may demand no more than two (2) Block Trades or Other Coordinated Offerings pursuant to this Section 2.6.6
in any twelve (12) month period.
ARTICLE
III
COMPANY
PROCEDURES
3.1
General Procedures. If at any time on or after the date Purchaser consummates a Business Combination, Purchaser is required to
effect the Registration of Registrable Securities, Purchaser shall use its commercially reasonable efforts to effect such Registration
to permit the sale of such Registrable Securities in accordance with the intended plan of distribution thereof, and pursuant thereto
Purchaser shall, as expeditiously as possible:
3.1.1
prepare and file with the Commission as soon as practicable a Registration Statement with respect to such Registrable Securities and
use its commercially reasonable efforts to cause such Registration Statement to become effective and remain effective until all Registrable
Securities covered by such Registration Statement have been sold;
3.1.2
prepare and file with the Commission such amendments and post-effective amendments to the Registration Statement, and such supplements
to the Prospectus, as may be requested by the Holders or any Underwriter of Registrable Securities or as may be required by the rules,
regulations or instructions applicable to the registration form used by Purchaser or by the Securities Act or rules and regulations thereunder
to keep the Registration Statement effective until all Registrable Securities covered by such Registration Statement are sold in accordance
with the intended plan of distribution set forth in such Registration Statement or supplement to the Prospectus;
3.1.3
prior to filing a Registration Statement or prospectus, or any amendment or supplement thereto, furnish without charge to the Underwriters,
if any, and the Holders of Registrable Securities included in such Registration, and such Holders’ legal counsel, copies of such
Registration Statement as proposed to be filed, each amendment and supplement to such Registration Statement (in each case including
all exhibits thereto and documents incorporated by reference therein), the Prospectus included in such Registration Statement (including
each preliminary Prospectus), and such other documents as the Underwriters and the Holders of Registrable Securities included in such
Registration or the legal counsel for any such Holders may request in order to facilitate the disposition of the Registrable Securities
owned by such Holders;
3.1.4
prior to any public offering of Registrable Securities, use its commercially reasonable efforts to (i) register or qualify the Registrable
Securities covered by the Registration Statement under such securities or “blue sky” laws of such jurisdictions in the United
States as the Holders of Registrable Securities included in such Registration Statement (in light of their intended plan of distribution)
may request and (ii) take such action necessary to cause such Registrable Securities covered by the Registration Statement to be registered
with or approved by such other governmental authorities as may be necessary by virtue of the business and operations of Purchaser and
do any and all other acts and things that may be necessary or advisable to enable the Holders of Registrable Securities included in such
Registration Statement to consummate the disposition of such Registrable Securities in such jurisdictions; provided, however,
that Purchaser shall not be required to qualify generally to do business in any jurisdiction where it would not otherwise be required
to qualify or take any action to which it would be subject to general service of process or taxation in any such jurisdiction where it
is not then otherwise so subject;
3.1.5
cause all such Registrable Securities to be listed on each securities exchange or automated quotation system on which similar securities
issued by Purchaser are then listed;
3.1.6
provide a transfer agent or warrant agent, as applicable, and registrar for all such Registrable Securities no later than the effective
date of such Registration Statement;
3.1.7
advise each seller of such Registrable Securities, promptly after it shall receive notice or obtain knowledge thereof, of the issuance
of any stop order by the Commission suspending the effectiveness of such Registration Statement or the initiation or threatening of any
proceeding for such purpose and promptly use its reasonable best efforts to prevent the issuance of any stop order or to obtain its withdrawal
if such stop order should be issued;
3.1.8
at least five (5) days prior to the filing of any Registration Statement or Prospectus or any amendment or supplement to such Registration
Statement or Prospectus or any document that is to be incorporated by reference into such Registration Statement, furnish a copy thereof
to each seller of such Registrable Securities and its counsel, including, without limitation, providing copies promptly upon receipt
of any comment letters received with respect to any such Registration Statement or Prospectus;
3.1.9
notify the Holders at any time when a Prospectus relating to such Registration Statement is required to be delivered under the Securities
Act, of the happening of any event as a result of which the Prospectus included in such Registration Statement, as then in effect, includes
a Misstatement, and then to correct such Misstatement as set forth in Section 3.4 hereof;
3.1.10
permit a representative of the Holders (such representative to be selected by a majority of the participating Holders), the Underwriters,
if any, and any attorney or accountant retained by such Holders or Underwriter to participate, at each such person’s own expense,
in the preparation of the Registration Statement, and cause Purchaser’s officers, directors and employees to supply all information
reasonably requested by any such representative, Underwriter, attorney or accountant in connection with the Registration; provided,
however, that such representatives or Underwriters enter into a confidentiality agreement, in form and substance reasonably satisfactory
to Purchaser, prior to the release or disclosure of any such information; and provided further, Purchaser may not include the
name of any Holder or Underwriter or any information regarding any Holder or Underwriter in any Registration Statement or Prospectus,
any amendment or supplement to such Registration Statement or Prospectus, any document that is to be incorporated by reference into such
Registration Statement or Prospectus, or any response to any comment letter, without the prior written consent of such Holder or Underwriter
and providing each such Holder or Underwriter a reasonable amount of time to review and comment on such applicable document, which comments
Purchaser shall include unless contrary to applicable law;
3.1.11
obtain a “cold comfort” letter from Purchaser’s independent registered public accountants in the event of an Underwritten
Registration which the participating Holders may rely on, in customary form and covering such matters of the type customarily covered
by “cold comfort” letters as the managing Underwriter may reasonably request, and reasonably satisfactory to a majority-in-interest
of the participating Holders;
3.1.12
on the date the Registrable Securities are delivered for sale pursuant to such Registration, obtain an opinion, dated such date, of counsel
representing Purchaser for the purposes of such Registration, addressed to the Holders, the placement agent or sales agent, if any, and
the Underwriters, if any, covering such legal matters with respect to the Registration in respect of which such opinion is being given
as the Holders, placement agent, sales agent, or Underwriter may reasonably request and as are customarily included in such opinions
and negative assurance letters, and reasonably satisfactory to a majority in interest of the participating Holders;
3.1.13
in the event of any Underwritten Offering, enter into and perform its obligations under an underwriting agreement, in usual and customary
form, with the managing Underwriter of such offering;
3.1.14
make available to its security holders, as soon as reasonably practicable, an earnings statement covering the period of at least twelve
(12) months beginning with the first day of Purchaser’s first full calendar quarter after the effective date of the Registration
Statement which satisfies the provisions of Section 11(a) of the Securities Act and Rule 158 thereunder (or any successor rule
promulgated thereafter by the Commission);
3.1.15
if the Registration involves the Registration of Registrable Securities involving gross proceeds in excess of $50,000,000, use its reasonable
efforts to make available senior executives of Purchaser to participate in customary “road show” presentations that may be
reasonably requested by the Underwriter in any Underwritten Offering; and
3.1.16
otherwise, in good faith, cooperate reasonably with, and take such customary actions as may reasonably be requested by the Holders, in
connection with such Registration.
3.2
Registration Expenses. The Registration Expenses of all Registrations shall be borne by Purchaser. It is acknowledged by the Holders
that the Holders shall bear all incremental selling expenses relating to the sale of Registrable Securities, such as Underwriters’
commissions and discounts, brokerage fees, Underwriter marketing costs and, other than as set forth in the definition of “Registration
Expenses,” all reasonable fees and expenses of any legal counsel representing the Holders.
3.3
Requirements for Participation in Underwritten Offerings. No Person may participate in any Underwritten Offering for equity securities
of Purchaser pursuant to a Registration initiated by Purchaser hereunder unless such person (i) agrees to sell such person’s securities
on the basis provided in any underwriting arrangements approved by Purchaser and (ii) completes and executes all customary questionnaires,
powers of attorney, indemnities, lock-up agreements, underwriting agreements and other customary documents as may be reasonably required
under the terms of such underwriting arrangements.
3.4
Suspension of Sales; Adverse Disclosure. Upon receipt of written notice from Purchaser that a Registration Statement or Prospectus
contains a Misstatement, each of the Holders shall forthwith discontinue disposition of Registrable Securities until he, she or it has
received copies of a supplemented or amended Prospectus correcting the Misstatement (it being understood that Purchaser hereby covenants
to prepare and file such supplement or amendment as soon as practicable after the time of such notice), or until he, she or it is advised
in writing by Purchaser that the use of the Prospectus may be resumed. If the filing, initial effectiveness or continued use of a Registration
Statement in respect of any Registration at any time would require Purchaser to make an Adverse Disclosure or would require the inclusion
in such Registration Statement of financial statements that are unavailable to Purchaser for reasons beyond Purchaser’s control,
Purchaser may, upon giving prompt written notice of such action to the Holders, delay the filing or initial effectiveness of, or suspend
use of, such Registration Statement for the shortest period of time, but in no event more than thirty (30) days, determined in good faith
by Purchaser to be necessary for such purpose. In the event Purchaser exercises its rights under the preceding sentence, the Holders
agree to suspend, immediately upon their receipt of the notice referred to above, their use of the Prospectus relating to any Registration
in connection with any sale or offer to sell Registrable Securities. Purchaser shall immediately notify the Holders of the expiration
of any period during which it exercised its rights under this Section 3.4.
3.5
Reporting Obligations. As long as any Holder shall own Registrable Securities, Purchaser, at all times while it shall be a reporting
company under the Exchange Act, covenants to file timely (or obtain extensions in respect thereof and file within the applicable grace
period) all reports required to be filed by Purchaser after the date hereof pursuant to Sections 13(a) or 15(d) of the Exchange Act and
to promptly furnish the Holders with true and complete copies of all such filings. Purchaser further covenants that it shall take such
further action as any Holder may reasonably request, all to the extent required from time to time to enable such Holder to sell Class
A Shares held by such Holder without registration under the Securities Act within the limitation of the exemptions provided by Rule 144
promulgated under the Securities Act (or any successor rule promulgated thereafter by the Commission), including providing any legal
opinions. Upon the request of any Holder, Purchaser shall deliver to such Holder a written certification of a duly authorized officer
as to whether it has complied with such requirements.
ARTICLE
IV
INDEMNIFICATION
AND CONTRIBUTION
4.1
Indemnification.
4.1.1
Purchaser agrees to indemnify, to the extent permitted by law, each Holder of Registrable Securities, its officers and directors and
each person who controls such Holder (within the meaning of the Securities Act) against all losses, claims, damages, liabilities and
expenses (including attorneys’ fees) caused by any untrue or alleged untrue statement of material fact contained in any Registration
Statement, Prospectus or preliminary Prospectus or any amendment thereof or supplement thereto or any omission or alleged omission of
a material fact required to be stated therein or necessary to make the statements therein not misleading, except insofar as the same
are caused by or contained in any information furnished in writing to Purchaser by such Holder expressly for use therein. Purchaser shall
indemnify the Underwriters, their officers and directors and each person who controls such Underwriters (within the meaning of the Securities
Act) to the same extent as provided in the foregoing with respect to the indemnification of the Holder.
4.1.2
In connection with any Registration Statement in which a Holder of Registrable Securities is participating, such Holder shall furnish
to Purchaser in writing such information and affidavits as Purchaser reasonably requests for use in connection with any such Registration
Statement or Prospectus and, to the extent permitted by law, shall indemnify Purchaser, its directors and officers and agents and each
person who controls Purchaser (within the meaning of the Securities Act) against any losses, claims, damages, liabilities and expenses
(including without limitation reasonable attorneys’ fees) resulting from any untrue statement of material fact contained in the
Registration Statement, Prospectus or preliminary Prospectus or any amendment thereof or supplement thereto or any omission of a material
fact required to be stated therein or necessary to make the statements therein not misleading, but only to the extent that such untrue
statement or omission is contained in any information or affidavit so furnished in writing by such Holder expressly for use therein;
provided, however, that the obligation to indemnify shall be several, not joint and several, among such Holders of Registrable
Securities, and the liability of each such Holder of Registrable Securities shall be in proportion to and limited to the net proceeds
received by such Holder from the sale of Registrable Securities pursuant to such Registration Statement. The Holders of Registrable Securities
shall indemnify the Underwriters, their officers, directors and each person who controls such Underwriters (within the meaning of the
Securities Act) to the same extent as provided in the foregoing with respect to indemnification of Purchaser.
4.1.3
Any person entitled to indemnification herein shall (i) give prompt written notice to the indemnifying party of any claim with respect
to which it seeks indemnification (provided that the failure to give prompt notice shall not impair any person’s right to indemnification
hereunder to the extent such failure has not materially prejudiced the indemnifying party) and (ii) unless in such indemnified party’s
reasonable judgment a conflict of interest between such indemnified and indemnifying parties may exist with respect to such claim, permit
such indemnifying party to assume the defense of such claim with counsel reasonably satisfactory to the indemnified party. If such defense
is assumed, the indemnifying party shall not be subject to any liability for any settlement made by the indemnified party without its
consent (but such consent shall not be unreasonably withheld). An indemnifying party who is not entitled to, or elects not to, assume
the defense of a claim shall not be obligated to pay the fees and expenses of more than one counsel (plus local counsel) for all parties
indemnified by such indemnifying party with respect to such claim, unless in the reasonable judgment of any indemnified party a conflict
of interest may exist between such indemnified party and any other of such indemnified parties with respect to such claim. No indemnifying
party shall, without the consent of the indemnified party, consent to the entry of any judgment or enter into any settlement which cannot
be settled in all respects by the payment of money (and such money is so paid by the indemnifying party pursuant to the terms of such
settlement) or which settlement does not include as an unconditional term thereof the giving by the claimant or plaintiff to such indemnified
party of a release from all liability in respect to such claim or litigation.
4.1.4
The indemnification provided for under this Agreement shall remain in full force and effect regardless of any investigation made by or
on behalf of the indemnified party or any officer, director or controlling person of such indemnified party and shall survive the transfer
of securities. Purchaser and each Holder of Registrable Securities participating in an offering also agrees to make such provisions as
are reasonably requested by any indemnified party for contribution to such party in the event Purchaser’s or such Holder’s
indemnification is unavailable for any reason.
4.1.5
If the indemnification provided under Section 4.1 hereof from the indemnifying party is unavailable or insufficient to hold harmless
an indemnified party in respect of any losses, claims, damages, liabilities and expenses referred to herein (except as provided herein),
then the indemnifying party, in lieu of indemnifying the indemnified party, shall contribute to the amount paid or payable by the indemnified
party as a result of such losses, claims, damages, liabilities and expenses in such proportion as is appropriate to reflect the relative
fault of the indemnifying party and the indemnified party, as well as any other relevant equitable considerations. The relative fault
of the indemnifying party and indemnified party shall be determined by reference to, among other things, whether any action in question,
including any untrue or alleged untrue statement of a material fact or omission or alleged omission to state a material fact, was made
by, or relates to information supplied by, such indemnifying party or indemnified party, and the indemnifying party’s and indemnified
party’s relative intent, knowledge, access to information and opportunity to correct or prevent such action; provided, however,
that the liability of any Holder under this subsection 4.1.5 shall be limited to the amount of the net proceeds received by such
Holder in such offering giving rise to such liability. The amount paid or payable by a party as a result of the losses or other liabilities
referred to above shall be deemed to include, subject to the limitations set forth in subsections 4.1.1, 4.1.2 and 4.1.3
above, any legal or other fees, charges or expenses reasonably incurred by such party in connection with any investigation or proceeding.
The parties hereto agree that it would not be just and equitable if contribution pursuant to this subsection 4.1.5 were determined
by pro rata allocation or by any other method of allocation, which does not take account of the equitable considerations referred to
in this subsection 4.1.5. No person guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the Securities
Act) shall be entitled to contribution pursuant to this subsection 4.1.5 from any person who was not guilty of such fraudulent
misrepresentation.
ARTICLE
V
MISCELLANEOUS
5.1
Notices. Any notice or communication under this Agreement must be in writing and given by (i) deposit in the United States mail,
addressed to the party to be notified, postage prepaid and registered or certified with return receipt requested, (ii) delivery in person
or by courier service providing evidence of delivery, or (iii) transmission by hand delivery, electronic mail, or facsimile. Each notice
or communication that is mailed, delivered, or transmitted in the manner described above shall be deemed sufficiently given, served,
sent, and received, in the case of mailed notices, on the third business day following the date on which it is mailed and, in the case
of notices delivered by courier service, hand delivery, electronic mail, or facsimile, at such time as it is delivered to the addressee
(with the delivery receipt or the affidavit of messenger) or at such time as delivery is refused by the addressee upon presentation.
Any notice or communication under this Agreement must be addressed:
To
Purchaser, to:
ARC
Group Acquisition I Corp.
398
S Mill Avenue,
Suite
306,
Tempe,
AZ 85284
Attn:
____________________
Telephone
No.: __________________________
E-mail:
___________________
with
a copy to:
Rimon,
P.C.
1050
Connecticut Avenue, NW, Suite 500
Washington,
DC 20006
Attn:
Debbie A. Klis Esq.; Mark C Lee, Esq.
Telephone
No.: (202) 935-3390
Email:
deborrah.klis@rimonlaw.com; mark.c.lee@rimonlaw.com
To
Purchaser, to:
Firstborn
Top Capital Sdn. Bhd.
13A-3A,
Q Sentral, 2A
Jalan
Stesen Sentral 2
KL
Sentral, Kuala Lumpur
Wilayah
Persekutuan 50470
Malaysia
Attn:
Wilson Ow
Telephone
No.:
E-mail:
with
a copy to:
Rohamat
& Ling
Unit
1009, 10th Floor, Menara PJ,
Amcorp
Trade Centre,
No.
18 Jalan Persiaran Barat,
46050
Petaling Jaya, Selangor.
Attn:
Mark Wong Kah Kit
Telephone
No.: 03-7932 5115
E-mail:
mark@r-ling.com
To
a Holder, to the address set forth below such Holder’s name on the signature page hereto.
Any
party may change its address for notice at any time and from time to time by written notice to the other parties hereto, and such change
of address shall become effective thirty (30) days after delivery of such notice as provided in this Section 5.1.
5.2
Assignment; No Third Party Beneficiaries.
5.2.1
This Agreement and the rights, duties and obligations of Purchaser hereunder may not be assigned or delegated by Purchaser in whole or
in part.
5.2.2
Prior to the expiration of the Sponsor Lock-up Period or Consideration Shares Lock-up Period, no Holder of Founder Shares, Private Placement
Shares, the Private Placement Warrants, any Class A Shares issued or issuable upon the exercise of the Private Placement Warrants and
the conversion of the Private Placement Rights, or Consideration Shares may assign or delegate such Holder’s rights, duties or
obligations under this Agreement, in whole or in part, except in connection with a transfer of Registrable Securities by such Holder
to a Permitted Transferee but only if such Permitted Transferee agrees to become bound by the transfer restrictions set forth in this
Agreement.
5.2.3
This Agreement and the provisions hereof shall be binding upon and shall inure to the benefit of each of the parties and its successors
and the permitted assigns of the Holders, which shall include Permitted Transferees.
5.2.4
This Agreement shall not confer any rights or benefits on any persons that are not parties hereto, other than as expressly set forth
in this Agreement and Section 5.2 hereof.
5.2.5
No assignment by any party hereto of such party’s rights, duties and obligations hereunder shall be binding upon or obligate Purchaser
unless and until Purchaser shall have received (i) written notice of such assignment as provided in Section 5.1 hereof and (ii)
the written agreement of the assignee, in a form reasonably satisfactory to Purchaser, to be bound by the terms and provisions of this
Agreement (which may be accomplished by an addendum or certificate of joinder to this Agreement). Any transfer or assignment made other
than as provided in this Section 5.2 shall be null and void.
5.3
Counterparts. This Agreement may be executed in multiple counterparts (including facsimile or PDF counterparts), each of which
shall be deemed an original, and all of which together shall constitute the same instrument, but only one of which need be produced.
5.4
Governing Law; Venue. NOTWITHSTANDING THE PLACE WHERE THIS AGREEMENT MAY BE EXECUTED BY ANY OF THE PARTIES HERETO, THE PARTIES
EXPRESSLY AGREE THAT THIS AGREEMENT SHALL BE GOVERNED BY AND CONSTRUED UNDER THE LAWS OF THE STATE OF DELAWARE AS APPLIED TO AGREEMENTS
AMONG DELAWARE RESIDENTS ENTERED INTO AND TO BE PERFORMED ENTIRELY WITHIN DELAWARE, WITHOUT REGARD TO THE CONFLICT OF LAW PROVISIONS
OF SUCH JURISDICTION. ANY LEGAL SUIT, ACTION OR PROCEEDING ARISING OUT OF OR BASED UPON THIS AGREEMENT OR THE TRANSACTIONS CONTEMPLATED
HEREBY MAY BE INSTITUTED IN THE FEDERAL COURTS OF THE UNITED STATES LOCATED IN DELAWARE, AND EACH PARTY IRREVOCABLY SUBMITS TO THE EXCLUSIVE
JURISDICTION OF SUCH COURTS IN ANY SUCH SUIT, ACTION OR PROCEEDING.
5.5
Amendments and Modifications. Upon the written consent of (i) Purchaser, (ii) the Sponsor (if the Sponsor holds Registrable Securities
at the time in question), ) (iii) a majority-in-interest of Registrable Securities held by the Founders at the time in question, and
(iv) a majority-in-interest of the Holders of Registrable Securities at the time in question, compliance with any of the provisions,
covenants and conditions set forth in this Agreement may be waived, or any of such provisions, covenants or conditions may be amended
or modified; provided, however, that notwithstanding the foregoing, any amendment hereto or waiver hereof that adversely
affects one Holder, solely in his, her or its capacity as a holder of the capital shares of Purchaser, in a manner that is materially
different from the other Holders (in such capacity) shall require the consent of the Holder so affected. No course of dealing between
any Holder or Purchaser and any other party hereto or any failure or delay on the part of a Holder or Purchaser in exercising any rights
or remedies under this Agreement shall operate as a waiver of any rights or remedies of any Holder or Purchaser. No single or partial
exercise of any rights or remedies under this Agreement by a party shall operate as a waiver or preclude the exercise of any other rights
or remedies hereunder or thereunder by such party.
5.6
Termination of Prior Agreement. The Prior Agreement is hereby terminated in its entirety effective as of the completion of the
Business Combination.
5.7
Term. This Agreement shall terminate upon the earlier of (i) the tenth (10th) anniversary of the date of this Agreement
or (ii) the date as of which (A) all of the Registrable Securities have been sold pursuant to a Registration Statement (but in no event
prior to the applicable period referred to in Section 4(a)(3) of the Securities Act and Rule 174 thereunder (or any successor rule promulgated
thereafter by the Commission)) or (B) the Holders of all Registrable Securities are permitted to sell the Registrable Securities without
registration pursuant to Rule 144 (or any similar provision) under the Securities Act with no volume or other restrictions or limitations.
The provisions of Section 3.5 and Article IV shall survive any termination.
[Signature
Pages Follow]
IN
WITNESS WHEREOF, the undersigned have caused this Agreement to be executed as of the date first written above.
COMPANY:
ARC
GROUP ACQUISITION I CORP.
By:
Name:
Title:
[Signature
Page to Registration Rights Agreement]
IN
WITNESS WHEREOF, the undersigned have caused this Agreement to be executed as of the date first written above.
SPONSOR:
MFH
2, LLC
By:
Name:
Title:
IN
WITNESS WHEREOF, the undersigned have caused this Agreement to be executed as of the date first written above.
HOLDERS:
By:
Name:
Title:
Email:
Address:
[Signature
Page to Registration Rights Agreement]
EX-10.4
EX-10.4
Filename: ex10-4.htm · Sequence: 6
Exhibit 10.4
LOCK-UP
AGREEMENT
THIS
LOCK-UP AGREEMENT (this “Agreement”) is made and entered into as of [●], between BlueCrest Investment, Inc.,
a British Virgin Islands business company (formerly known as ARC Group Acquisition I Corp., hereinafter referred to as “Purchaser”
prior to the Closing and “PubCo” following the Closing)) and (ii) the undersigned (each of such undersigned, a “Holder”
and collectively, the “Holders”). Purchaser or Pubco and the Holders are sometimes referred to herein individually
as a “Party” and, collectively, as the “Parties”. Any capitalized term used but not defined in
this Agreement will have the meaning ascribed to such term in the Share Purchase Agreement (as defined below).
WHEREAS,
Purchaser, Firstborn Top Capital Sdn. Bhd., a Malaysian private limited company (the “Company”), the shareholders
of the Company (the “Selling Shareholders”) and a representative each of Purchaser and the Company entered into a
share purchase agreement, dated ________, 2026 (the “Share Purchase Agreement”), pursuant to which the Selling Shareholders
agreed to sell and transfer to Purchaser, and Purchaser agreed to purchase, acquire and accept from the Selling Shareholders, all of
the issued and outstanding capital shares of the Company, upon the terms and conditions set forth therein (the “Business Combination”);
WHEREAS,
pursuant to the Share Purchase Agreement, and in view of the valuable consideration to be received by the Holders thereunder, the Parties
desire to enter into this Agreement, pursuant to which the Class A ordinary shares, par value $0.0001 per share, of Purchaser to be received
by the Holders pursuant to the Share Purchase Agreement and in accordance with the provisions of applicable Law (together with any securities
paid as bonus share issuance, dividends or distributions with respect to such securities or into which such securities are changed or
exchanged or which are received in any recapitalization, share exchange, share conversion or similar transactions, the “Restricted
Securities”), shall become subject to limitations on disposition as set forth herein; and
WHEREAS,
as of immediately after the Closing Date, each Holder will be the holder of record and beneficial owner (as such term is defined in Rule
13d-3 promulgated under the Exchange Act), with the sole or shared power to dispose of (or power to cause the disposition of) and the
sole or shared power to vote (or power to direct the voting of) such number of Restricted Securities set forth opposite such Holder’s
name on Exhibit A hereto.
NOW,
THEREFORE, in consideration of the premises set forth above, which are incorporated into this Agreement as if fully set forth below,
and intending to be legally bound hereby, the Parties hereby agree as follows:
1.
Lock-Up Provisions.
(a)
For the purposes of this Section 1, “Transfer” shall mean the (i) sale of, offer to sell, contract or agreement
to sell (including, for the avoidance of doubt, by operation of law and through a distribution in specie), hypothecate, pledge, grant
of any option to purchase or otherwise dispose of or agreement to dispose of, directly or indirectly, or establishment or increase of
a put equivalent position or liquidation with respect to or decrease of a call equivalent position within the meaning of Section 16 of
the Securities Exchange Act of 1934, as amended, and the rules and regulations of the U.S. Securities and Exchange Commission promulgated
thereunder with respect to, any security, (ii) entry into any swap or other arrangement that transfers to another, in whole or in part,
any of the economic consequences of ownership of any security, whether any such transaction is to be settled by delivery of such securities,
in cash or otherwise, (iii) deposit any Restricted Securities into a voting trust or enter into a voting agreement or arrangement or
grant any proxy or power of attorney with respect thereto that is inconsistent with this Agreement or (iv) public announcement of any
intention to effect any transaction specified in clause (i), (ii) or (iii).
(b)
Subject to Section 1(c) and the other terms of this Agreement, each Holder agrees that it shall not effectuate a Transfer of the Restricted
Securities during the period commencing on the Closing Date and ending at 11:59 p.m. Eastern time on the date that is the earlier of
(A) one (1) year following the Business Combination, and (B) subsequent to the completion of the Business Combination, (x) the date on
which the last sale price of the Class A Shares equals or exceeds $12.00 per share (as adjusted for share sub-divisions, share capitalizations,
reorganizations, recapitalizations and the like) for any twenty (20) trading days within any 30-trading day period commencing at least
one hundred eighty (180) days after the completion of the Business Combination, or (y) the date on which Purchaser completes a liquidation,
merger, amalgamation, capital stock exchange, reorganization or other similar transaction that results in all of Purchaser’s Public
Shareholders having the right to exchange their Class A Shares for cash, securities or other property (the “Lock-Up Period”).
(c)
Notwithstanding the provisions set forth in Section 1(b), the following Transfers of the Restricted Securities that are held by
any of the Holders (and that have complied with this Section 1(c)) are permitted during the Lock-Up Period in the case of any Holder
or its permitted transferees:
(i)
to
any Affiliates or immediate family members of any of the relevant Holder’s officers or directors, any Affiliates of the Holders,
or any employees of such Affiliates;
(ii)
in
the case of an individual, to any immediate family members of such individual;
(iii)
to
any investment funds or vehicles controlled or managed by the securityholder or any of its Affiliates;
(iv)
by
gift to a trust, the beneficiary of which is a Person to whom a Transfer would be permitted under Section 1(c)(i), or to a
charitable organization;
(v)
in
the case of an individual, by virtue of laws of descent and distribution upon death of such individual;
(vi)
in
the case of an individual, pursuant to a qualified domestic relations order;
(vii)
in
the case of an individual, to a partnership, limited liability company or other entity of which such individual and/or the family
members of such individual are the legal and beneficial owner of all of the outstanding equity securities or similar interests;
(viii)
to
a nominee or custodian of a Person to whom a Transfer would be permitted under Section 1(c)(i);
(ix)
pursuant
to any final, non-appealable order of a court or regulatory authority of competent jurisdiction to which such Holder is subject;
(x)
in
the case of an entity that is a trust, to a trustor or beneficiary of the trust or to the estate of a beneficiary of such trust;
(xi)
in
the case of an entity, as part of a distribution to members, partners, shareholders or equityholders of the entity;
(xii)
by
virtue of the laws of an entity’s jurisdiction of incorporation or organization, an entity’s organizational documents
or the rights attaching to the equity interests in the entity upon dissolution of such entity;
(xiii)
in
connection with the exercise of any options, warrants or other convertible securities to purchase Restricted Securities (which exercises
may be effected on a cashless basis to the extent the instruments representing such options or warrants permit exercises on a cashless
basis) to the extent that any Restricted Securities issued upon such exercise are Restricted Securities subject to the applicable restrictions
under Section 1(b) of this Agreement;
(xiv)
in
the case of an entity, to satisfy tax withholding obligations in connection with such entity’s equity incentive plans or arrangements;
(xv)
in
connection with any bona fide mortgage, pledge or encumbrance to a financial institution, as collateral or security in connection
with any bona fide loan or debt transaction or enforcement thereunder, including foreclosure thereof;
(xvi)
in
connection with a transfer pursuant to a bona fide third party tender offer, merger, consolidation, liquidation, share exchange
or other similar transaction made to all holders of Restricted Securities involving a change of control of Purchaser or which results
in all of the holders of Restricted Securities having the right to exchange their Restricted Securities for cash, securities or other
property subsequent to the consummation of such transaction;
(xvii)
the
entry, by the securityholder, at any time on or after the Closing Date, of any trading plan providing for the sale of Restricted
Securities, which trading plan meets the requirements of Rule 10b5-1(c) under the Exchange Act; provided, however, that such plan
does not provide for, or permit, the sale of any Restricted Securities during the applicable Lock-Up Period and no public announcement
or filing is voluntarily made or required regarding such plan during the applicable Lock-Up Period; and
(xviii)
to
satisfy any applicable U.S. or non-U.S. federal, state, or local income tax obligations of a securityholder (or its direct or indirect
owners) arising from a change in applicable tax law after the date on which the Share Purchase Agreement was executed by the parties,
and such change prevents the Business Combination from qualifying as a “reorganization” pursuant to Section 368 of the
Code (and the Business Combination does not qualify for similar tax-free treatment pursuant to any successor or other provision of
the Code or Regulations taking into account such changes), in each case solely and to the extent necessary to cover any tax liability
as a direct result of the transaction.
provided,
that in each of clauses (i) through (xiii), (xv) and (xvi), the transferee must enter into a written joinder agreement, in a form reasonably
acceptable to Purchaser, agreeing to be bound by the terms of the applicable restrictions under Section 1(a) and the Lock-Up Period in
Section 1(b) of this Agreement (unless the transferee is Purchaser). If dividends are declared and payable on any Restricted Securities,
such dividends will also be Restricted Securities subject to the applicable restrictions under Section 1(b) of this Agreement.
(d)
If any Transfer is made or attempted contrary to the provisions of this Agreement, such Transfer shall be null and void ab initio,
and Purchaser shall refuse to recognize any such transferee of the Restricted Securities as one of its equity holders for any purpose.
In order to enforce this Section 1, Purchaser may impose stop-transfer instructions with respect to the Restricted Securities
of the Holder (and any transferees and assigns thereof) until the end of the Lock-Up Period and may pursue any other remedy available
to it at law or in equity.
(e)
During the Lock-Up Period, each certificate and book entry position evidencing any Restricted Securities (if any are issued) shall be
stamped or otherwise imprinted with a legend in substantially the following form, in addition to any other applicable legends:
“THE
SECURITIES REPRESENTED BY THIS CERTIFICATE ARE SUBJECT TO RESTRICTIONS ON TRANSFER SET FORTH IN A LOCK-UP AGREEMENT, DATED AS OF [●],
BY AND AMONG THE ISSUER OF SUCH SECURITIES (THE “ISSUER”) AND THE ISSUER’S SECURITY HOLDER NAMED THEREIN. A
COPY OF SUCH LOCK-UP AGREEMENT, AS AMENDED, WILL BE FURNISHED WITHOUT CHARGE BY THE ISSUER TO THE HOLDER HEREOF UPON WRITTEN REQUEST.”
(f)
For the avoidance of any doubt, each Holder shall retain all of its, his or her rights as a shareholder of Purchaser with respect to
the Restricted Securities during the Lock-Up Period, including the right to receive dividends and the right to vote any Restricted Securities
(subject to the other provisions hereof).
2.
Miscellaneous.
(a)
Authorization. Each Holder, severally and not jointly, hereby represents and warrants that he, she or it has full power and authority
to enter into this Agreement and that this Agreement constitutes the legal, valid and binding obligation of such Holder, enforceable
in accordance with its terms. Upon request, each Holder will execute any additional documents as may be necessary in connection with
enforcement hereof.
(b)
Termination. This Agreement shall automatically terminate with respect to each of the Parties when the applicable restrictions
on the securities of such Party hereunder have ended.
(c)
Binding Effect; Assignment. This Agreement and all of the provisions hereof shall be binding upon and inure solely to the benefit
of the Parties hereto and their respective permitted successors and assigns. Except as otherwise provided in this Agreement, this Agreement
shall not be assigned by operation of Law or otherwise without the prior written consent of all Parties hereto, provided, further, that
no consent shall be required in connection with an assignment of rights arising solely from a Transfer permitted under Section 1(c)
of this Agreement. Any assignment without such consent shall be null and void; provided, that no such assignment shall relieve
the assigning Party of its obligations hereunder.
(d)
Third Parties. Nothing contained in this Agreement or in any instrument or document executed by any party in connection with the
transactions contemplated hereby shall create any rights in, or be deemed to have been executed for the benefit of, any person or entity
that is not a Party hereto or thereto or a successor or permitted assign of such a Party.
(e)
Governing Law; Jurisdiction. This Agreement shall be governed by, and construed in accordance with, the internal laws of the State
of Delaware. All legal actions and proceedings arising out of or relating to this Agreement shall be heard and determined exclusively
in any state or federal court located in Delaware (or in any appellate court thereof) (the “Specified Courts”). The
Parties hereby (a) submit to the exclusive jurisdiction of any Specified Court for the purpose of any Action arising out of or relating
to this Agreement brought by any Party hereto and (b) irrevocably waive, and agree not to assert by way of motion, defense or otherwise,
in any such Action, any claim that it is not subject personally to the jurisdiction of the above-named courts, that its property is exempt
or immune from attachment or execution, that the Action is brought in an inconvenient forum, that the venue of the Action is improper,
or that this Agreement or the Transactions may not be enforced in or by any Specified Court. Each Party agrees that a final judgment
in any Action shall be conclusive and may be enforced in other jurisdictions by suit on the judgment or in any other manner provided
by Law.
(f)
WAIVER OF JURY TRIAL. EACH PARTY HEREBY WAIVES TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW ANY RIGHT IT MAY HAVE TO A TRIAL
BY JURY WITH RESPECT TO ANY LITIGATION DIRECTLY OR INDIRECTLY ARISING OUT OF, UNDER OR IN CONNECTION WITH THIS AGREEMENT OR ANY TRANSACTION
CONTEMPLATED HEREIN. EACH PARTY (A) CERTIFIES THAT NO REPRESENTATIVE, AGENT OR ATTORNEY OF ANY OTHER PARTY HAS REPRESENTED, EXPRESSLY
OR OTHERWISE, THAT SUCH OTHER PARTY WOULD NOT, IN THE EVENT OF LITIGATION, SEEK TO ENFORCE THE FOREGOING WAIVER AND (B) ACKNOWLEDGES
THAT IT AND THE OTHER PARTIES HERETO HAVE BEEN INDUCED TO ENTER INTO THIS AGREEMENT AND THE TRANSACTIONS CONTEMPLATED HEREIN, AS APPLICABLE,
BY, AMONG OTHER THINGS, THE MUTUAL WAIVERS AND CERTIFICATIONS IN THIS SECTION 2(f).
(g)
Interpretation. The titles and subtitles used in this Agreement are for convenience only and are not to be considered in construing
or interpreting this Agreement. In this Agreement, unless the context otherwise requires: (i) any pronoun used in this Agreement shall
include the corresponding masculine, feminine or neuter forms, and the singular form of nouns, pronouns and verbs shall include the plural
and vice versa; (ii) “including” (and with correlative meaning “include”) means including without limiting the
generality of any description preceding or succeeding such term and shall be deemed in each case to be followed by the words “without
limitation”; (iii) the words “herein,” “hereto,” and “hereby” and other words of similar import
in this Agreement shall be deemed in each case to refer to this Agreement as a whole and not to any particular section or other subdivision
of this Agreement; and (iv) the term “or” means “and/or”. The Parties have participated jointly in the negotiation
and drafting of this Agreement. Consequently, in the event an ambiguity or question of intent or interpretation arises, this Agreement
shall be construed as if drafted jointly by the Parties hereto, and no presumption or burden of proof shall arise favoring or disfavoring
any party by virtue of the authorship of any provision of this Agreement.
(h)
Notices. All notices, consents, waivers and other communications hereunder shall be governed by the provisions under the Share
Purchase Agreement.
(i)
Amendments and Waivers. This Agreement may be amended, supplemented, modified or waived only by execution of a written instrument
signed by each of the Parties. No failure or delay by a Party in exercising any right hereunder shall operate as a waiver thereof. No
waivers of or exceptions to any term, condition, or provision of this Agreement, in any one or more instances, shall be deemed to be
or construed as a further or continuing waiver of any such term, condition, or provision.
(j)
Severability. In case any provision in this Agreement shall be held invalid, illegal or unenforceable in a jurisdiction, such
provision shall be modified or deleted, as to the jurisdiction involved, only to the extent necessary to render the same valid, legal
and enforceable, and the validity, legality and enforceability of the remaining provisions hereof shall not in any way be affected or
impaired thereby nor shall the validity, legality or enforceability of such provision be affected thereby in any other jurisdiction.
Upon such determination that any term or other provision is invalid, illegal or incapable of being enforced, the Parties will substitute
for any invalid, illegal or unenforceable provision a suitable and equitable provision that carries out, so far as may be valid, legal
and enforceable, the intent and purpose of such invalid, illegal or unenforceable provision.
(k)
Specific Performance. The Parties agree that irreparable damage would occur in the event that any of the provisions of this Agreement
were not performed in accordance with their specific terms or were otherwise breached. The Parties further agree that each party shall
be entitled to seek specific performance of the terms hereof and immediate injunctive relief and other equitable relief to prevent breaches,
or threatened breaches, of this Agreement, without the necessity of proving the inadequacy of money damages as a remedy and without bond
or other security being required, this being in addition to any other remedy to which they are entitled at law or in equity. The Parties
further agree (i) not to assert that a remedy of specific enforcement pursuant to this Section 2(k) is unenforceable, invalid,
contrary to applicable law or inequitable for any reason and (ii) to waive any defenses in any action for specific performance, including
the defense that a remedy at law would be adequate.
(l)
No Partnership, Agency or Joint Venture. This Agreement is intended to create a contractual relationship between the Parties,
and is not intended to create, and does not create, any agency, partnership, joint venture or any like relationship between or among
the Parties.
(m)
Entire Agreement. This Agreement and the Share Purchase Agreement constitute the full and entire understanding and agreement
among the Parties with respect to the subject matter hereof, and any other written or oral agreement relating to the subject matter hereof
existing between the Parties is expressly superseded; provided, that, for the avoidance of doubt, the foregoing shall not affect
the rights and obligations of the Parties under the Share Purchase Agreement or any Ancillary Document. Notwithstanding the foregoing,
nothing in this Agreement shall limit any of the rights, remedies or obligations of the Parties under any other agreement among the Parties
or any certificate or instrument executed by any Holder in favor of Purchaser, and nothing in any other agreement, certificate or instrument
shall limit any of the rights, remedies or obligations of the Parties under this Agreement.
(n)
Further Assurances. From time to time, at another Party’s request and without further consideration (but at the requesting
Party’s reasonable cost and expense), each Party shall execute and deliver such additional documents and take all such further
action as may be reasonably necessary to consummate the transactions contemplated by this Agreement.
(o)
Counterparts; Electronic Signatures. This Agreement may be executed and delivered (including by email, electronic signature (including
via DocuSign or similar platform) or other electronic transmission) in one or more counterparts, and by the different Parties in separate
counterparts, each of which when executed shall be deemed to be an original but all of which taken together shall constitute one and
the same agreement.
[Signature
Pages Follow]
IN
WITNESS WHEREOF, the undersigned have caused this Agreement to be executed as of the date first written above.
PURCHASER:
ARC GROUP ACQUISITION I CORP.
By:
Name:
Title:
IN
WITNESS WHEREOF, the undersigned have caused this Agreement to be executed as of the date first written above.
HOLDERS:
By:
Name:
Title:
Email:
Address:
[Signature
Page to Lock-up Agreement]
Exhibit
A
Restricted
Securities
Party
Restricted
Securities
EX-10.5
EX-10.5
Filename: ex10-5.htm · Sequence: 7
Exhibit 10.5
FORM
OF RESTRICTIVE COVENANT AGREEMENT
THIS
RESTRICTIVE COVENANT AGREEMENT (this “Agreement”) is made and entered into as of [●], between (i) BlueCrest
Investment, Inc., a British Virgin Islands business company (formerly known as ARC Group Acquisition I Corp., hereinafter referred to
as “Purchaser” prior to the Closing and “PubCo” following the Closing), and (ii) the undersigned
(each of such undersigned, a “Holder” and collectively, the “Holders”). Purchaser (or PubCo) and
the Holders are sometimes referred to herein individually as a “Party” and, collectively, as the “Parties”.
Any capitalized term used but not defined in this Agreement will have the meaning ascribed to such term in the Share Purchase Agreement
(as defined below).
WHEREAS,
Purchaser, Firstborn Top Capital Sdn. Bhd., a Malaysian private limited company (the “Company”), the shareholders
of the Company (the “Selling Shareholders”) and a representative each of the Purchaser and the Company, entered into
a share purchase agreement, dated ________, 2026 (the “Share Purchase Agreement”), pursuant to which the Selling Shareholders
agreed to sell and transfer to Purchaser, and Purchaser agreed to purchase, acquire and accept from the Selling Shareholders, all of
the issued and outstanding capital shares of the Company, upon the terms and conditions set forth therein; and
WHEREAS,
pursuant to the Share Purchase Agreement, and in view of the valuable consideration to be received by the Holders thereunder, the Parties
desire to enter into this Agreement, pursuant to which each Holder agrees to the restrictive covenants as set forth herein.
NOW,
THEREFORE, in consideration of the premises set forth above, which are incorporated into this Agreement as if fully set forth below,
and intending to be legally bound hereby, the Parties hereby agree as follows:
1.
Non-Competition and Non-Solicitation.
(a)
During the period commencing on the Closing Date and ending on the twenty four month (24) anniversary of the Closing Date, none of the
Holders or their respective Affiliates will, directly or indirectly, engage in any business in competition with the Business anywhere
in Southeast Asia as the Business is conducted in the twelve (12)-month period prior to the Closing (each, a “Competing Activity”);
provided that the foregoing shall not prohibit (i) any Holder or any of their respective Affiliates from acquiring, holding of
investments in, or direct or indirect ownership (as a passive investor) of, any ownership interest of any Person engaged in a Competing
Activity, so long as such ownership interest represents not more than five percent (5%) of the aggregate voting power or outstanding
equity interests of such Person, or (ii) any Holder from performing services for an on behalf of Pubco or the Company, or any of their
respective Affiliates, in any such case, subject to the terms of any written agreement between such Person, on the one hand, and Pubco,
the Company, or any such Affiliate, on the other hand. “Business” shall mean the moneylending business.
(b)
During the period commencing on the Closing Date and ending on the fourth (4th) anniversary of the Closing Date, none of the
Holders or their respective Affiliates or representatives acting on their behalf will, directly or indirectly, (i) solicit, cause to
be solicited, offer to employ, or recruit for employment or independent contracting or consulting arrangements, any employee of Pubco
or the Company (a “Continuing Employee”), (ii) interfere with, endeavor to entice away or induce any Continuing Employee
to terminate his or her employment with Pubco or its relevant Affiliate (including the Company) or otherwise seek to influence or alter
any Continuing Employee’s relationship with Pubco or its relevant Affiliate (including the Company), (iii) hire, employ, or engage,
in each case, whether on a full-time, part-time, independent contracting, consulting or any other basis, any Continuing Employee, (iv)
interfere with, endeavor to entice away or induce any existing or potential customer of the Business to withdraw, curtail or terminate
its existing business relationship or not enter into a business relationship with the Business or otherwise seek to influence or alter
any such customer’s relationship with the Business, or (v) solicit, cause to be solicited, service or accept any business from
any existing or potential customer of the Business.
(c)
If any provision set forth in this Section 1 is invalid, illegal or incapable of being enforced by any Law or public policy, such
invalidity, illegality or unenforceability shall not affect any other provisions of this Section, but this Section shall be construed
as if such invalid, illegal or unenforceable provision had never been set forth in this Section. It is the intention of the Parties that
if any of the restrictions or covenants contained in this Section 1 is held to cover a geographic area or to be for a length of
time that is not permitted by applicable Law, or in any way construed to be too broad or to any extent invalid, such provision shall
not be construed to be null, void and of no effect, but to the extent such provision would be valid or enforceable under applicable Law,
a court of competent jurisdiction shall construe and interpret or reform this Section to provide for a covenant having the maximum enforceable
geographic area, time period and other provisions, in each case not greater than those contained in this Section, as shall be valid and
enforceable under such applicable Law.
2.
Miscellaneous.
(a)
Authorization. Each Holder, severally and not jointly, hereby represents and warrants that he, she or it has full power and authority
to enter into this Agreement and that this Agreement constitutes the legal, valid and binding obligation of such Holder, enforceable
in accordance with its terms. Upon request, each Holder will execute any additional documents as may be necessary in connection with
enforcement hereof.
(b)
Termination. This Agreement shall automatically terminate with respect to each of the Parties when the applicable restrictive
period applicable to such Party hereunder, have ended.
(c)
Binding Effect; Assignment. This Agreement and all of the provisions hereof shall be binding upon and inure solely to the benefit
of the Parties hereto and their respective permitted successors and assigns. Except as otherwise provided in this Agreement, this Agreement
shall not be assigned by operation of Law or otherwise without the prior written consent of all Parties hereto. Any assignment without
such consent shall be null and void; provided, that no such assignment shall relieve the assigning Party of its obligations hereunder.
(d)
Governing Law; Jurisdiction. This Agreement shall be governed by, construed and enforced in accordance with the Laws of the State
of Delaware without regard to the conflict of laws principles thereof. All Actions arising out of or relating to this Agreement shall
be heard and determined exclusively in the Chancery Court of the State of Delaware (or in any other court in the State of Delaware or
any appellate court thereof) (the “Specified Courts”). Each Party hereto hereby (a) submits to the exclusive jurisdiction
of any Specified Court for the purpose of any Action arising out of or relating to this Agreement brought by any Party hereto and (b)
irrevocably waives, and agrees not to assert by way of motion, defense or otherwise, in any such Action, any claim that it is not subject
personally to the jurisdiction of the above-named courts, that its property is exempt or immune from attachment or execution, that the
Action is brought in an inconvenient forum, that the venue of the Action is improper, or that this Agreement or the transactions contemplated
hereby may not be enforced in or by any Specified Court. Each Party agrees that a final judgment in any Action shall be conclusive and
may be enforced in other jurisdictions by suit on the judgment or in any other manner provided by Law.
2
(e)
WAIVER OF JURY TRIAL. EACH PARTY HEREBY WAIVES TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW ANY RIGHT IT MAY HAVE TO A TRIAL
BY JURY WITH RESPECT TO ANY LITIGATION DIRECTLY OR INDIRECTLY ARISING OUT OF, UNDER OR IN CONNECTION WITH THIS AGREEMENT OR ANY TRANSACTION
CONTEMPLATED HEREIN. EACH PARTY (A) CERTIFIES THAT NO REPRESENTATIVE, AGENT OR ATTORNEY OF ANY OTHER PARTY HAS REPRESENTED, EXPRESSLY
OR OTHERWISE, THAT SUCH OTHER PARTY WOULD NOT, IN THE EVENT OF LITIGATION, SEEK TO ENFORCE THE FOREGOING WAIVER AND (B) ACKNOWLEDGES
THAT IT AND THE OTHER PARTIES HERETO HAVE BEEN INDUCED TO ENTER INTO THIS AGREEMENT AND THE TRANSACTIONS CONTEMPLATED HEREIN, AS APPLICABLE,
BY, AMONG OTHER THINGS, THE MUTUAL WAIVERS AND CERTIFICATIONS IN THIS SECTION 2(e).
(f)
Notices. All notices, consents, waivers and other communications hereunder shall be governed by the provisions under the Share
Purchase Agreement.
(g)
Amendments and Waivers. This Agreement may be amended, supplemented, modified or waived only by execution of a written instrument
signed by each of the Parties. No failure or delay by a Party in exercising any right hereunder shall operate as a waiver thereof. No
waivers of or exceptions to any term, condition, or provision of this Agreement, in any one or more instances, shall be deemed to be
or construed as a further or continuing waiver of any such term, condition, or provision.
(h)
Severability. In case any provision in this Agreement shall be held invalid, illegal or unenforceable in a jurisdiction, such
provision shall be modified or deleted, as to the jurisdiction involved, only to the extent necessary to render the same valid, legal
and enforceable, and the validity, legality and enforceability of the remaining provisions hereof shall not in any way be affected or
impaired thereby nor shall the validity, legality or enforceability of such provision be affected thereby in any other jurisdiction.
Upon such determination that any term or other provision is invalid, illegal or incapable of being enforced, the Parties will substitute
for any invalid, illegal or unenforceable provision a suitable and equitable provision that carries out, so far as may be valid, legal
and enforceable, the intent and purpose of such invalid, illegal or unenforceable provision.
(i)
Specific Performance. The Parties agree that irreparable damage would occur in the event that any of the provisions of this Agreement
were not performed in accordance with their specific terms or were otherwise breached. The Parties further agree that each party shall
be entitled to seek specific performance of the terms hereof and immediate injunctive relief and other equitable relief to prevent breaches,
or threatened breaches, of this Agreement, without the necessity of proving the inadequacy of money damages as a remedy and without bond
or other security being required, this being in addition to any other remedy to which they are entitled at law or in equity. The Parties
further agree (i) not to assert that a remedy of specific enforcement pursuant to this Section 2(i) is unenforceable, invalid,
contrary to applicable Law or inequitable for any reason and (ii) to waive any defenses in any action for specific performance, including
the defense that a remedy at law would be adequate.
(j)
Entire Agreement. This Agreement and the Share Purchase Agreement constitute the full and entire understanding and agreement
among the Parties with respect to the subject matter hereof, and any other written or oral agreement relating to the subject matter hereof
existing between the Parties is expressly superseded; provided, that, for the avoidance of doubt, the foregoing shall not affect
the rights and obligations of the Parties under the Share Purchase Agreement or any Ancillary Document. Notwithstanding the foregoing,
nothing in this Agreement shall limit any of the rights, remedies or obligations of the Parties under any other agreement among the Parties
or any certificate or instrument executed by any Holder in favor of PubCo, and nothing in any other agreement, certificate or instrument
shall limit any of the rights, remedies or obligations of the Parties under this Agreement.
(k)
Further Assurances. From time to time, at another Party’s request and without further consideration (but at the requesting
Party’s reasonable cost and expense), each Party shall execute and deliver such additional documents and take all such further
action as may be reasonably necessary to consummate the transactions contemplated by this Agreement.
(l)
Counterparts; Electronic Signatures. This Agreement may be executed and delivered (including by email, electronic signature (including
via DocuSign or similar platform) or other electronic transmission) in one or more counterparts, and by the different Parties in separate
counterparts, each of which when executed shall be deemed to be an original but all of which taken together shall constitute one and
the same agreement.
[Signature
Pages Follow]
3
IN
WITNESS WHEREOF, the Parties have executed this Agreement as of the date first written above.
PUBCO
[_________________]
By:
Name:
Title:
HOLDER
By:
Name:
Address:
EX-10.6
EX-10.6
Filename: ex10-6.htm · Sequence: 8
Exhibit 10.6
INDEMNIFICATION
AGREEMENT
THIS
INDEMNIFICATION AGREEMENT (the “Agreement”) is made and entered into as of ___________, between BlueCrest Investment,
Inc., a British Virgin Islands business company (formerly known as ARC Group Acquisition I Corp., hereinafter referred to as the “Company”),
and ______________ (“Indemnitee”).
WITNESSETH
THAT:
WHEREAS,
highly competent persons have become more reluctant to serve corporations as directors or in other capacities unless they are provided
with adequate protection through insurance or adequate indemnification against inordinate risks of claims and actions against them arising
out of their service to and activities on behalf of the Company;
WHEREAS,
the Board of Directors of the Company (the “Board”) has determined that, in order to attract and retain qualified
individuals, the Company will attempt to maintain on an ongoing basis, at its sole expense, liability insurance to protect persons serving
the Company and its subsidiaries from certain liabilities;
WHEREAS,
the uncertainties relating to such insurance and to indemnification have increased the difficulty of attracting and retaining such persons;
WHEREAS,
the Board has determined that the increased difficulty in attracting and retaining such persons is detrimental to the best interests
of the Company’s shareholders and that the Company should act to assure such persons that there will be increased certainty of
such protection in the future;
WHEREAS,
it is reasonable, prudent and necessary for the Company contractually to obligate itself to indemnify, and to advance expenses on behalf
of, such persons to the fullest extent permitted by applicable law and the Articles so that they will serve or continue to serve the
Company free from undue concern that they will not be so indemnified; and
NOW,
THEREFORE, in consideration of Indemnitee’s agreement to serve as a director or officer from and after the date hereof, the parties
hereto agree as follows:
1.
Indemnity of Indemnitee. The Company hereby agrees to hold harmless and indemnify Indemnitee to the fullest extent permitted by
applicable law and the Articles (as hereinafter defined). In furtherance of the foregoing indemnification, and without limiting the generality
thereof:
(a)
Proceedings Other Than Proceedings by or in the Right of the Company. Indemnitee shall be entitled to the rights of indemnification
provided in this Section 1(a) if, by reason of Indemnitee’s Corporate Status (as hereinafter defined), the Indemnitee is,
or is threatened to be made, a party to or participant in any Proceeding (as hereinafter defined) other than a Proceeding by or in the
right of the Company. Pursuant to this Section 1(a), Indemnitee shall be indemnified against all Expenses (as hereinafter defined),
judgments, penalties, fines and amounts paid in settlement actually and reasonably incurred by Indemnitee, or on Indemnitee’s behalf,
in connection with such Proceeding or any claim, issue or matter therein, if the Indemnitee acted in good faith and in a manner the Indemnitee
reasonably believed to be in or not opposed to the best interests of the Company, and with respect to any criminal Proceeding, had no
reasonable cause to believe the Indemnitee’s conduct was unlawful, provided, however, no indemnification under this subsection
shall be made in respect of any claim, issue or matter as to which the Indemnitee shall have been adjudicated by final judgment by a
court of competent jurisdiction to be liable to the Company for willful neglect, willful default or actual fraud in the performance of
his/her duty to the Company.
(b)
Proceedings by or in the Right of the Company. The Company shall indemnify the Indemnitee if the Indemnitee is a party to or threatened
to be made a party to or is otherwise involved in any Proceeding by or in the right of the Company to procure a judgment in its favor
against all Expenses which are actually and reasonably incurred by the Indemnitee in connection with such a Proceeding, if the Indemnitee
acted in good faith and in a manner the Indemnitee reasonably believed to be in, or not opposed to, the best interests of the Company;
except that no indemnification under this subsection shall be made in respect of any claim, issue or matter as to which the Indemnitee
shall have been adjudicated by final judgment by a court of competent jurisdiction to be liable to the Company for willful neglect, willful
default or actual fraud in the performance of Indemnitee’s duty to the Company, unless and only to the extent that the court in
which such Proceeding was brought shall determine upon application that, despite the adjudication of liability but in view of all the
circumstances of the case, the Indemnitee is fairly and reasonably entitled to indemnity for such amounts which such court shall deem
proper, in each case, to the maximum extent permitted by the Articles.
(c)
Indemnification for Expenses of a Party Who is Wholly or Partly Successful. Notwithstanding any other provision of this Agreement,
to the extent that Indemnitee is, by reason of Indemnitee’s Corporate Status, a party to and is successful, on the merits or otherwise,
in any Proceeding, Indemnitee shall be indemnified to the maximum extent permitted by applicable law and the Articles against all Expenses
actually and reasonably incurred by Indemnitee or on Indemnitee’s behalf in connection therewith. If Indemnitee is not wholly successful
in such Proceeding but is successful, on the merits or otherwise, as to one or more but less than all claims, issues or matters in such
Proceeding, the Company shall indemnify Indemnitee against all Expenses actually and reasonably incurred by Indemnitee or on Indemnitee’s
behalf in connection with each successfully resolved claim, issue or matter. For purposes of this Section and without limitation, the
termination of any claim, issue or matter in such a Proceeding by dismissal, with or without prejudice, shall be deemed to be a successful
result as to such claim, issue or matter.
2.
Additional Indemnity. In addition to, and without regard to any limitations on, the indemnification provided for in Section
1 of this Agreement, the Company shall and hereby does indemnify and hold harmless Indemnitee to the fullest extent permitted by
applicable law and the Articles against all Expenses, judgments, penalties, fines and amounts paid in settlement (including all interest,
assessments and other charges paid or payable in connection with or in respect thereof) actually and reasonably incurred by Indemnitee
or on Indemnitee’s behalf if, by reason of Indemnitee’s Corporate Status, Indemnitee is, or is threatened to be made, a party
to or participant in any Proceeding (including a Proceeding by or in the right of the Company to procure a judgement in its favor); provided,
however, that (i) no indemnification against such Expenses, judgments, penalties, fines and amounts shall be made in respect of any claim,
issue or matter in any such Proceeding as to which Indemnitee shall have been finally adjudged by a court of competent jurisdiction to
be liable to the Company for willful default, willful neglect or actual fraud in the performance of Indemnitee’s duty to the Company,
and (ii) that the Company shall not be obligated to make any payment to Indemnitee that is finally determined (under the procedures,
and subject to the presumptions, set forth in Sections 6 and 7 hereof) to be unlawful.
3.
Contribution.
(a)
To the fullest extent permissible under applicable law and the Articles, whether or not the indemnification provided in Sections 1
and 2 hereof is available, in respect of any threatened, pending or completed action, suit or proceeding in which the Company
is jointly liable with Indemnitee (or would be if joined in such action, suit or Proceeding), the Company shall pay, in the first instance,
the entire amount of any judgment or settlement of such action, suit or proceeding without requiring Indemnitee to contribute to such
payment and the Company hereby waives and relinquishes any right of contribution it may have against Indemnitee. The Company shall not
enter into any settlement of any action, suit or proceeding in which the Company is jointly liable with Indemnitee (or would be if joined
in such action, suit or proceeding) unless such settlement provides for a full and final release of all claims asserted against Indemnitee.
(b)
Without diminishing or impairing the obligations of the Company set forth in the preceding subparagraph, if, for any reason, Indemnitee
shall elect or be required to pay all or any portion of any judgment or settlement in any threatened, pending or completed action, suit
or proceeding in which the Company is jointly liable with Indemnitee (or would be if joined in such action, suit or proceeding), the
Company shall contribute to the amount of Expenses, judgments, fines and amounts paid in settlement actually and reasonably incurred
and paid or payable by Indemnitee in proportion to the relative benefits received by the Company and all officers, directors or employees
of the Company, other than Indemnitee, who are jointly liable with Indemnitee (or would be if joined in such action, suit or proceeding),
on the one hand, and Indemnitee, on the other hand, from the transaction from which such action, suit or proceeding arose; provided,
however, that the proportion determined on the basis of relative benefit may, to the extent necessary to conform to law, be further adjusted
by reference to the relative fault of the Company and all officers, directors or employees of the Company other than Indemnitee who are
jointly liable with Indemnitee (or would be if joined in such action, suit or proceeding), on the one hand, and Indemnitee, on the other
hand, in connection with the events that resulted in such expenses, judgments, fines or settlement amounts, as well as any other equitable
considerations which the Law may require to be considered. The relative fault of the Company and all officers, directors or employees
of the Company, other than Indemnitee, who are jointly liable with Indemnitee (or would be if joined in such action, suit or proceeding),
on the one hand, and Indemnitee, on the other hand, shall be determined by reference to, among other things, the degree to which their
actions were motivated by intent to gain personal profit or advantage, the degree to which their liability is primary or secondary and
the degree to which their conduct is active or passive.
(c)
To the fullest extent permissible under applicable law and the Articles, the Company hereby agrees to fully indemnify and hold Indemnitee
harmless from any claims of contribution which may be brought by officers, directors or employees of the Company, other than Indemnitee,
who may be jointly liable with Indemnitee.
(d)
To the fullest extent permissible under applicable law and the Articles, if the indemnification provided for in this Agreement is unavailable
to Indemnitee for any reason whatsoever, the Company, in lieu of indemnifying Indemnitee, shall contribute to the amount incurred by
Indemnitee, whether for judgments, fines, penalties, excise taxes, amounts paid or to be paid in settlement and/or for Expenses, in connection
with any claim relating to an indemnifiable event under this Agreement, in such proportion as is deemed fair and reasonable in light
of all of the circumstances of such Proceeding in order to reflect (i) the relative benefits received by the Company and Indemnitee as
a result of the event(s) and/or transaction(s) giving cause to such Proceeding; and/or (ii) the relative fault of the Company (and its
directors, officers, employees and agents) and Indemnitee in connection with such event(s) and/or transaction(s).
(e)
The Company shall not enter into any settlement of any Proceeding in which the Company is jointly liable with Indemnitee (or would be
if joined in such Proceeding) unless such settlement provides for a full and final release of all claims asserted against Indemnitee.
4.
Indemnification for Expenses of a Witness. Notwithstanding any other provision of this Agreement, to the extent that Indemnitee
is, by reason of his Corporate Status, a witness, or is made (or asked to) respond to discovery requests, in any Proceeding to which
Indemnitee is not a party or is threatened to be a party, Indemnitee shall, to the fullest extent permissible under applicable law and
the Articles, be indemnified against all Expenses actually and reasonably incurred by Indemnitee or on Indemnitee’s behalf in connection
therewith.
5.
Advancement of Expenses.
(a)
Notwithstanding any other provision of this Agreement, and to the fullest extent not prohibited by applicable law and the Articles, the
Company shall advance all Expenses incurred by or on behalf of Indemnitee in connection with any Proceeding by reason of Indemnitee’s
Corporate Status within thirty (30) days after the receipt by the Company of a statement or statements from Indemnitee requesting such
advance or advances from time to time, whether prior to or after final disposition of such Proceeding. Such statement or statements shall
reasonably evidence the Expenses incurred by Indemnitee and shall include or be preceded or accompanied by a written undertaking by or
on behalf of Indemnitee to repay any Expenses advanced if it shall ultimately be determined that Indemnitee is not entitled to be indemnified
against such Expenses. Any advances and undertakings to repay pursuant to this Section 5 shall be unsecured and interest free.
Advances shall include any and all reasonable Expenses incurred (or reasonably expected by Indemnitee to be incurred by Indemnitee within
three months) pursuing an Enforcement Proceeding (as such term is defined in Section 7 below), including Expenses incurred preparing
and forwarding statements to the Company to support the advances claimed. For the purposes of this paragraph, assume all references to
a “Proceeding” in the definition of Expenses refer to an Enforcement Proceeding). To the fullest extent permitted by applicable
law, the Indemnitee shall not be required to reimburse the Company such amounts advanced until a final determination has been made with
respect to Indemnitee’s entitlement to indemnification under any such Enforcement Proceeding pursuant to Section 6(d). This
Section 5(a) shall not apply to any claim made by Indemnitee for which an indemnification, hold harmless or exoneration payment
is excluded pursuant to Section 9, but shall apply to any Proceeding referenced in Section 9(b) prior to a final determination
that Indemnitee is liable therefor.
(b)
The Company will be entitled to participate in the Proceeding at its own expense.
(c)
The Company shall not settle any action, claim or Proceeding (in whole or in part) which would impose any Expense, judgment, liability,
fine, penalty or limitation on Indemnitee without Indemnitee’s prior written consent.
6.
Procedures and Presumptions for Determination of Entitlement to Indemnification. The parties agree that the following procedures
and presumptions shall apply in the event of any question as to whether Indemnitee is entitled to indemnification under this Agreement:
(a)
To obtain indemnification under this Agreement, Indemnitee shall submit to the Board a written request, including therein or therewith
such documentation and information as is reasonably available to Indemnitee and is reasonably necessary to determine whether and to what
extent Indemnitee is entitled to indemnification. Notwithstanding the foregoing, any failure of Indemnitee to provide such a request
to the Company, or to provide such a request in a timely fashion, shall not relieve the Company of any liability that it may have to
Indemnitee unless, and to the extent that, such failure actually and materially prejudices the interests of the Company.
(b)
Upon written request by Indemnitee for indemnification pursuant to the first sentence of Section 6(a) hereof, a determination
with respect to Indemnitee’s entitlement thereto shall be made in the specific case by one of the following four methods, which
shall be at the election of the Board: (1) by a majority vote of the Disinterested Directors, even though less than a quorum, (2) by
a committee of disinterested directors designated by a majority vote of the disinterested directors, even though less than a quorum,
(3) if there are no disinterested directors or if the disinterested directors so direct, by Independent Counsel in a written opinion
to the Board, a copy of which shall be delivered to the Indemnitee, or (4) if so directed by the Board, by the shareholders of the Company.
For purposes hereof, disinterested directors are those members of the Board who are not parties to the action, suit or proceeding in
respect of which indemnification is sought by Indemnitee.
(c)
If the determination of entitlement to indemnification is to be made by Independent Counsel pursuant to Section 6(b) hereof, the
Independent Counsel shall be selected as provided in this Section 6(c). The Independent Counsel shall be selected by the Board.
Indemnitee may, within ten (10) days after such written notice of selection shall have been given, deliver to the Company a written objection
to such selection; provided, however, that such objection may be asserted only on the ground that the Independent Counsel so selected
does not meet the requirements of “Independent Counsel” as defined in Section 13 of this Agreement, and the
objection shall set forth with particularity the factual basis of such assertion. Absent a proper and timely objection, the person so
selected shall act as Independent Counsel. If a written objection is made and substantiated, the Independent Counsel selected may not
serve as Independent Counsel unless and until such objection is withdrawn or a court of competent jurisdiction has determined that such
objection is without merit. If, within twenty (20) days after submission by Indemnitee of a written request for indemnification pursuant
to Section 6(a) hereof, no Independent Counsel shall have been selected and not objected to, either the Company or Indemnitee
may petition a court of competent jurisdiction for resolution of any objection which shall have been made by the Indemnitee to the Company’s
selection of Independent Counsel and/or for the appointment as Independent Counsel of a person selected by the court or by such other
person as the court shall designate, and the person with respect to whom all objections are so resolved or the person so appointed shall
act as Independent Counsel under Section 6(b) hereof. The Company shall pay any and all reasonable fees and expenses of Independent
Counsel incurred by such Independent Counsel in connection with acting pursuant to Section 6(b) hereof, and the Company shall
pay all reasonable fees and expenses incident to the procedures of this Section 6(c), regardless of the manner in which such Independent
Counsel was selected or appointed.
(d)
In making a determination with respect to entitlement to indemnification hereunder, the person or persons or entity making such determination
shall presume that Indemnitee is entitled to indemnification under this Agreement. Anyone seeking to overcome this presumption shall
have the burden of proof and the burden of persuasion by clear and convincing evidence. Neither the failure of the Company (including
by its directors or independent legal counsel) to have made a determination prior to the commencement of any action pursuant to this
Agreement that indemnification is proper in the circumstances because Indemnitee has met the applicable standard of conduct, nor an actual
determination by the Company (including by Disinterested Directors or Independent Counsel) that Indemnitee has not met such applicable
standard of conduct, shall be a defense to the action or create a presumption that Indemnitee has not met the applicable standard of
conduct.
(e)
Indemnitee shall be deemed to have acted in good faith if Indemnitee’s action is based on the records or books of account of the
Enterprise, including financial statements, or on information supplied to Indemnitee by the officers of the Enterprise (as hereinafter
defined) in the course of their duties, or on the advice of legal counsel for the Enterprise or on information or records given or reports
made to the Enterprise by an independent certified public accountant or by an appraiser or other expert selected with reasonable care
by the Enterprise. In addition, the knowledge and/or actions, or failure to act, of any director, officer, agent or employee of the Enterprise
shall not be imputed to Indemnitee for purposes of determining the right to indemnification under this Agreement. Whether or not the
foregoing provisions of this Section 6(e) are satisfied, it shall in any event be presumed that Indemnitee has at all times acted
in good faith and in a manner he reasonably believed to be in or not opposed to the best interests of the Company. Anyone seeking to
overcome this presumption shall have the burden of proof and the burden of persuasion by clear and convincing evidence.
(f)
If the person, persons or entity empowered or selected under Section 6 to determine whether Indemnitee is entitled to indemnification
shall not have made a determination within sixty (60) days after receipt by the Company of the request therefor, the requisite determination
of entitlement to indemnification shall be deemed to have been made and Indemnitee shall be entitled to such indemnification absent (i)
a misstatement by Indemnitee of a material fact, or an omission of a material fact necessary to make Indemnitee’s statement not
materially misleading, in connection with the request for indemnification, or (ii) a prohibition of such indemnification under applicable
law; provided, however, that such 60-day period may be extended for a reasonable time, not to exceed an additional thirty (30) days,
if the person, persons or entity making such determination with respect to entitlement to indemnification in good faith requires such
additional time to obtain or evaluate documentation and/or information relating thereto; and provided, further, that the foregoing provisions
of this Section 6(f) shall not apply (i) if the determination of entitlement to indemnification is to be made by the shareholders
pursuant to Section 6(b) of this Agreement and if (A) within fifteen (15) days after receipt by the Company of the request for
such determination, the Board or the Disinterested Directors, if appropriate, resolve to submit such determination to the shareholders
for their consideration at an annual general meeting thereof to be held within seventy-five (75) days after such receipt and such determination
is made thereat, or (B) an extraordinary general meeting of shareholders is called within fifteen (15) days after such receipt for the
purpose of making such determination, such meeting is held for such purpose within sixty (60) days after having been so called and such
determination is made thereat, or (ii) if the determination of entitlement to indemnification is to be made by Independent Counsel pursuant
to Section 6(c) of this Agreement
(g)
If it is so determined that Indemnitee is entitled to indemnification, payment to Indemnitee shall be made within ten (10) days after
such determination. Indemnitee shall cooperate with the person, persons or entity making such determination with respect to Indemnitee’s
entitlement to indemnification, including providing to such person, persons or entity upon reasonable advance request any documentation
or information which is not privileged or otherwise protected from disclosure and which is reasonably available to Indemnitee and reasonably
necessary to such determination. Any Independent Counsel, member of the Board or shareholder of the Company shall act reasonably and
in good faith in making a determination regarding the Indemnitee’s entitlement to indemnification under this Agreement. Any costs
or expenses (including attorneys’ fees and disbursements) incurred by Indemnitee in so cooperating with the person, persons or
entity making such determination shall be borne by the Company (irrespective of the determination as to Indemnitee’s entitlement
to indemnification) and the Company hereby indemnifies and agrees to hold Indemnitee harmless therefrom.
(h)
The Company acknowledges that a settlement or other disposition short of final judgment may be successful if it permits a party to avoid
expense, delay, distraction, disruption and uncertainty. In the event that any action, claim or proceeding to which Indemnitee is a party
is resolved in any manner other than by adverse judgment against Indemnitee (including, without limitation, settlement of such action,
claim or proceeding with or without payment of money or other consideration) it shall be presumed that Indemnitee has been successful
on the merits or otherwise in such action, suit or proceeding. Anyone seeking to overcome this presumption shall have the burden of proof
and the burden of persuasion by clear and convincing evidence.
(i)
The Company agrees to pay the reasonable fees and expenses of Independent Counsel and to fully indemnify and hold harmless such Independent
Counsel against any and all Expenses, claims, liabilities and damages arising out of or relating to this Agreement or its engagement
pursuant hereto.
(j)
The termination of any Proceeding or of any claim, issue or matter therein, by judgment, order, settlement or conviction, or upon a plea
of nolo contendere or its equivalent, shall not (except as otherwise expressly provided in this Agreement) of itself adversely affect
the right of Indemnitee to indemnification or create a presumption that Indemnitee did not act in good faith and in a manner which he
reasonably believed to be in or not opposed to the best interests of the Company or, with respect to any criminal Proceeding, that Indemnitee
had reasonable cause to believe that his conduct was unlawful.
7.
Remedies of Indemnitee.
(a)
In the event that (i) a determination is made pursuant to Section 6 of this Agreement that Indemnitee is not entitled to indemnification
under this Agreement, (ii) advancement of Expenses is not timely made pursuant to Section 5 of this Agreement, (iii) no determination
of entitlement to indemnification is made pursuant to Section 6(b) of this Agreement within thirty (30) days after receipt by
the Company of the request for indemnification, (iv) payment of indemnification is not made pursuant to this Agreement within ten (10)
days after receipt by the Company of a written request therefor or (v) a contribution payment is not made in a timely manner pursuant
to Section 3 of this Agreement, (vi) payment of indemnification is not made within ten (10) days after a determination has been
made that Indemnitee is entitled to indemnification or such determination is deemed to have been made pursuant to Section 6 of
this Agreement or (vii) payment to Indemnitee pursuant to any hold harmless or exoneration rights under this Agreement or otherwise is
not made in accordance with this Agreement, Indemnitee shall be entitled to an adjudication in an appropriate court of in Delaware, or
in any other court of competent jurisdiction, of Indemnitee’s entitlement to such indemnification. Indemnitee shall commence such
proceeding seeking an adjudication within one hundred eighty (180) days following the date on which Indemnitee first has the right to
commence such proceeding pursuant to this Section 7(a). The Company shall not oppose Indemnitee’s right to seek any such
adjudication. Alternatively, Indemnitee, at Indemnitee’s option, may seek an award in arbitration to be conducted by a single arbitrator
pursuant to the Commercial Rules of the American Arbitration Association. Except as set forth herein, the Commercial Rules of the American
Arbitration Association shall apply to any such arbitration. The Company shall not oppose Indemnitee’s right to seek any such adjudication
or award in arbitration. Such adjudication or arbitration proceeding is referred to herein as “Enforcement Proceeding.”
(b)
In the event that a determination shall have been made pursuant to Section 6(b) of this Agreement that Indemnitee is not entitled
to indemnification, any judicial proceeding commenced pursuant to this Section 7 shall be conducted in all respects as a de novo
trial on the merits, and Indemnitee shall not be prejudiced by reason of the adverse determination under Section 6(b).
(c)
If a determination shall have been made pursuant to Section 6(b) of this Agreement that Indemnitee is entitled to indemnification,
the Company shall be bound by such determination in any judicial proceeding commenced pursuant to this Section 7, absent (i) a
misstatement by Indemnitee of a material fact, or an omission of a material fact necessary to make Indemnitee’s misstatement not
materially misleading in connection with the application for indemnification, or (ii) a prohibition of such indemnification under applicable
law.
(d)
In the event that Indemnitee, pursuant to this Section 7, seeks a judicial adjudication of his rights under, or to recover damages
for breach of, this Agreement, or to recover under any directors’ and officers’ liability insurance policies maintained by
the Company, the Company shall pay on his behalf, in advance, any and all expenses (of the types described in the definition of Expenses
in Section 13 of this Agreement) actually and reasonably incurred by him in such judicial adjudication, regardless of whether
Indemnitee ultimately is determined to be entitled to such indemnification, advancement of expenses or insurance recovery.
(e)
The Company shall be precluded from asserting in any judicial proceeding commenced pursuant to this Section 7 that the procedures
and presumptions of this Agreement are not valid, binding and enforceable and shall stipulate in any such court that the Company is bound
by all the provisions of this Agreement. To the fullest extent permitted by law and the Articles, the Company shall indemnify Indemnitee
against any and all Expenses and, if requested by Indemnitee, shall (within ten (10) days after receipt by the Company of a written request
therefore) advance, to the extent not prohibited by law, such expenses to Indemnitee, which are incurred by Indemnitee in connection
with any action brought by Indemnitee for indemnification or advance of Expenses from the Company under this Agreement or under any directors’
and officers’ liability insurance policies maintained by the Company, if, in the case of indemnification, Indemnitee is wholly
successful on the underlying claims; if Indemnitee is not wholly successful on the underlying claims, then such indemnification shall
be only to the extent Indemnitee is successful on such underlying claims or otherwise as permitted by applicable law and the Articles,
whichever is greater.
(f)
Notwithstanding anything in this Agreement to the contrary, no determination as to entitlement to indemnification under this Agreement
shall be required to be made prior to the final disposition of the Proceeding.
8.
Non-Exclusivity; Survival of Rights; Insurance; Primacy of Indemnification; Subrogation.
(a)
The rights of indemnification as provided by this Agreement shall not be deemed exclusive of any other rights to which Indemnitee may
at any time be entitled under applicable law, the Articles, any agreement, a vote of shareholders, a resolution of directors or otherwise,
of the Company. No amendment, alteration or repeal of this Agreement or of any provision hereof shall limit or restrict any right of
Indemnitee under this Agreement in respect of any action taken or omitted by such Indemnitee in his Corporate Status prior to such amendment,
alteration or repeal. No right or remedy herein conferred is intended to be exclusive of any other right or remedy, and every other right
and remedy shall be cumulative and in addition to every other right and remedy given hereunder or now or hereafter existing at law or
in equity or otherwise. The assertion or employment of any right or remedy hereunder, or otherwise, shall not prevent the concurrent
assertion or employment of any other right or remedy.
(b)
To the extent that the Company maintains an insurance policy or policies providing liability insurance for directors, officers, employees,
or agents or fiduciaries of the Company or of any other corporation, partnership, joint venture, trust, employee benefit plan or other
enterprise that such person serves at the request of the Company, Indemnitee shall be covered by such policy or policies in accordance
with its or their terms to the maximum extent of the coverage available for any director, officer, employee, agent or fiduciary under
such policy or policies. If, at the time of the receipt of a notice of a claim pursuant to the terms hereof, the Company has director
and officer liability insurance in effect, the Company shall give prompt notice of the commencement of such proceeding to the insurers
in accordance with the procedures set forth in the respective policies. The Company shall thereafter take all necessary or desirable
action to cause such insurers to pay, on behalf of the Indemnitee, all amounts payable as a result of such proceeding in accordance with
the terms of such policies.
(c)
In the event of any payment under this Agreement, the Company shall be subrogated to the extent of such payment to all of the rights
of recovery of Indemnitee, who shall execute all papers required and take all action necessary to secure such rights, including execution
of such documents as are necessary to enable the Company to bring suit to enforce such rights.
(d)
The Company shall not be liable under this Agreement to make any payment of amounts otherwise indemnifiable hereunder if and to the extent
that Indemnitee has otherwise actually received such payment under any insurance policy, contract, agreement or otherwise.
(e)
The Company’s obligation to indemnify or advance Expenses hereunder to Indemnitee who is or was serving at the request of the Company
as a director, officer, employee or agent of any other corporation, partnership, joint venture, trust, employee benefit plan or other
enterprise shall be reduced by any amount Indemnitee has actually received as indemnification or advancement of expenses from such other
corporation, partnership, joint venture, trust, employee benefit plan or other enterprise.
9.
Exception to Right of Indemnification. Notwithstanding any provision in this Agreement, the Company shall not be obligated under
this Agreement to make any indemnity in connection with any claim made against Indemnitee:
(a)
for which payment has actually been made to or on behalf of Indemnitee under any insurance policy or other indemnity provision, except
with respect to any excess beyond the amount paid under any insurance policy or other indemnity provision; or
(b)
for an accounting of profits made from the purchase and sale (or sale and purchase) by Indemnitee of securities of the Company within
the meaning of Section 16(b) of the Securities Exchange Act of 1934, as amended, or similar provisions of state statutory law or common
law;
(c)
except as provided in Section 7(e) of this Agreement, in connection with any Proceeding (or any part of any Proceeding) initiated
by Indemnitee, including any Proceeding (or any part of any Proceeding) initiated by Indemnitee against the Company or its directors,
officers, employees or other indemnitees, unless (i) the Board of the Company authorized the Proceeding (or any part of any Proceeding)
prior to its initiation or (ii) the Company provides the indemnification, in its sole discretion, pursuant to the powers vested in the
Company under applicable law; or
(d)
which results from Indemnitee’s willful default, willful neglect or actual fraud or any other acts, omissions or transactions for
which Indemnitee is prohibited from receiving indemnification under applicable law or the Articles.
10.
Duration of Agreement. All agreements and obligations of the Company contained herein shall continue during the period Indemnitee
is an officer or director of the Company (or is or was serving at the request of the Company as a director, officer, employee or agent
of another corporation, partnership, joint venture, trust or other enterprise) and shall continue for five (5) years thereafter or, if
longer, so long as Indemnitee shall be subject to any Proceeding (or any proceeding commenced under Section 7 hereof) by reason
of his Corporate Status, whether or not he is acting or serving in any such capacity at the time any liability or expense is incurred
for which indemnification can be provided under this Agreement. This Agreement shall be binding upon and inure to the benefit of and
be enforceable by the parties hereto and their respective successors (including any direct or indirect successor by purchase, merger,
consolidation or otherwise to all or substantially all of the business or assets of the Company), assigns, spouses, heirs, executors
and personal and legal representatives.
11.
Security. To the extent requested by Indemnitee and approved by the Board of the Company, the Company may at any time and from
time to time provide security to Indemnitee for the Company’s obligations hereunder through an irrevocable bank line of credit,
funded trust or other collateral. Any such security, once provided to Indemnitee, may not be revoked or released without the prior written
consent of the Indemnitee.
12.
Enforcement.
(a)
The Company expressly confirms and agrees that it has entered into this Agreement and assumes the obligations imposed on it hereby in
order to induce Indemnitee to serve as an officer or director of the Company, and the Company acknowledges that Indemnitee is relying
upon this Agreement in serving as an officer or director of the Company.
(b)
This Agreement constitutes the entire agreement between the parties hereto with respect to the subject matter hereof and supersedes all
prior agreements and understandings, oral, written and implied, between the parties hereto with respect to the subject matter hereof.
13.
Definitions. For purposes of this Agreement:
(a)
“Articles” means the memorandum and articles of association of the Company, as amended, restated or supplemented from
time to time.
(b)
“Corporate Status” describes the status of a person who is or was a director, officer, employee, agent or fiduciary
of the Company or of any other corporation, partnership, joint venture, trust, employee benefit plan or other enterprise that such person
is or was serving at the express written request of the Company.
(c)
“Disinterested Director” means a director of the Company who is not and was not a party to the Proceeding in respect
of which indemnification is sought by Indemnitee.
(d)
“Enterprise” shall mean the Company and any other corporation, partnership, joint venture, trust, employee benefit
plan or other enterprise that Indemnitee is or was serving at the express written request of the Company as a director, officer, employee,
agent or fiduciary.
(e)
“Expenses” shall include all reasonable attorneys’ fees, retainers, court costs, transcript costs, fees of experts,
witness fees, travel expenses, duplicating costs, printing and binding costs, telephone charges, postage, delivery service fees and all
other disbursements or expenses of the types customarily incurred in connection with prosecuting, defending, preparing to prosecute or
defend, investigating, participating, or being or preparing to be a witness in a Proceeding, or responding to, or objecting to, a request
to provide discovery in any Proceeding. Expenses also shall include Expenses incurred in connection with any appeal resulting from any
Proceeding and any federal, state, local or foreign taxes imposed on the Indemnitee as a result of the actual or deemed receipt of any
payments under this Agreement, including without limitation the premium, security for, and other costs relating to any cost bond, supersedeas
bond, or other appeal bond or its equivalent. Expenses, however, shall not include amounts paid in settlement by Indemnitee or the amount
of judgments or fines against Indemnitee.
(f)
“Independent Counsel” means a law firm, or a member of a law firm, that is experienced in matters of corporation law
and neither presently is, nor in the past five (5) years has been, retained to represent: (i) the Company or Indemnitee in any matter
material to either such party (other than with respect to matters concerning Indemnitee under this Agreement, or of other indemnitees
under similar indemnification agreements), or (ii) any other party to the Proceeding giving rise to a claim for indemnification hereunder.
Notwithstanding the foregoing, the term “Independent Counsel” shall not include any person who, under the applicable standards
of professional conduct then prevailing, would have a conflict of interest in representing either the Company or Indemnitee in an action
to determine Indemnitee’s rights under this Agreement. The Company agrees to pay the reasonable fees of the Independent Counsel
referred to above and to fully indemnify such counsel against any and all Expenses, claims, liabilities and damages arising out of or
relating to this Agreement or its engagement pursuant hereto.
(g)
“Proceeding” includes any threatened, pending or completed action, suit, arbitration, alternate dispute resolution
mechanism, investigation, inquiry, administrative hearing or any other actual, threatened or completed proceeding, whether brought by
or in the right of the Company or otherwise and whether civil, criminal, administrative or investigative, in which Indemnitee was, is
or will be involved as a party or otherwise, by reason of the fact that Indemnitee is or was an officer or director of the Company, by
reason of any action taken by him or of any inaction on his part while acting as an officer or director of the Company, or by reason
of the fact that he is or was serving at the request of the Company as a director, officer, employee, agent or fiduciary of another corporation,
partnership, joint venture, trust or other Enterprise; in each case whether or not he is acting or serving in any such capacity at the
time any liability or expense is incurred for which indemnification can be provided under this Agreement; including one pending on or
before the date of this Agreement, but excluding one initiated by an Indemnitee pursuant to Section 7 of this Agreement to enforce
his rights under this Agreement.
(h)
“Enforcement Proceeding” shall mean an adjudication or arbitration proceeding initiated by Indemnitee.
14.
Severability. The invalidity or unenforceability of any provision hereof shall in no way affect the validity or enforceability
of any other provision. Without limiting the generality of the foregoing, this Agreement is intended to confer upon Indemnitee indemnification
rights to the fullest extent permitted by applicable law and the Articles. In the event any provision hereof conflicts with any applicable
law or the Articles, such provision shall be deemed modified, consistent with the aforementioned intent, to the extent necessary to resolve
such conflict.
15.
Modification and Waiver. No supplement, modification, termination or amendment of this Agreement shall be binding unless executed
in writing by both of the parties hereto. No waiver of any of the provisions of this Agreement shall be deemed or shall constitute a
waiver of any other provisions hereof (whether or not similar) nor shall such waiver constitute a continuing waiver.
16.
Notice by Indemnitee. Indemnitee agrees promptly to notify the Company in writing upon being served with or otherwise receiving
any summons, citation, subpoena, complaint, indictment, information or other document relating to any Proceeding or matter which may
be subject to indemnification covered hereunder. The failure to so notify the Company shall not relieve the Company of any obligation
which it may have to Indemnitee under this Agreement or otherwise unless and only to the extent that such failure or delay materially
prejudices the Company.
17.
Notices. All notices and other communications given or made pursuant to this Agreement shall be in writing and shall be deemed
effectively given: (a) upon personal delivery to the party to be notified, (b) when sent by confirmed electronic mail or facsimile if
sent during normal business hours of the recipient, and if not so confirmed, then on the next business day, (c) five (5) days after having
been sent by registered or certified mail, return receipt requested, postage prepaid, or (d) one (1) day after deposit with a nationally
recognized overnight courier, specifying next day delivery, with written verification of receipt. All communications shall be sent:
(a)
To
Indemnitee at the address set forth below Indemnitee’s signature hereto.
(b)
To
the Company at:
Firstborn
Top Capital
398
S Mill Avenue,
Suite
306,
Tempe,
AZ 85284
Attn:
____________________
Telephone
No.: ____________
E-mail:
___________________
or
to such other address as may have been furnished to Indemnitee by the Company or to the Company by Indemnitee, as the case may be.
18.
Counterparts. This Agreement may be executed in two or more counterparts, each of which shall be deemed an original, but all of
which together shall constitute one and the same Agreement. This Agreement may also be executed and delivered by facsimile signature
and in two or more counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same
instrument.
19.
Headings. The headings of the paragraphs of this Agreement are inserted for convenience only and shall not be deemed to constitute
part of this Agreement or to affect the construction thereof.
20.
Interpretation. This Agreement shall be construed as a whole and in accordance with its fair meaning and any ambiguities shall
not be construed for or against either party. The words “execution”, “signed”, and “signature” herein shall
be deemed to include electronic signatures, including any electronic signatures as defined in the Electronic Transactions Act (Revised)
(the “Electronic Signature Act”), or the keeping of records in electronic form including any electronic record, as defined
in the Electronic Signature Act, each of which shall be of the same legal effect, validity and enforceability as a manually executed
signature or the use of paper-based recordkeeping systems, as the case may be, to the extent and as provided for in any applicable law,
including without limitation the Electronic Signature Act; provided, however that sections 8 and 19(3) of the Electronic Signature Act
shall not apply to this agreement or the execution or delivery thereof.
21.
Governing Law and Consent to Jurisdiction. This Agreement shall be governed by, construed and enforced in accordance with the
Laws of the State of Delaware without regard to the conflict of laws principles thereof. All Actions arising out of or relating to this
Agreement shall be heard and determined exclusively in the Chancery Court of the State of Delaware (or in any other court in the State
of Delaware or any appellate court thereof) (the “Specified Courts”). Each party hereto hereby (a) submits to the
exclusive jurisdiction of any Specified Court for the purpose of any Action arising out of or relating to this Agreement brought by any
party hereto and (b) irrevocably waives, and agrees not to assert by way of motion, defense or otherwise, in any such Action, any claim
that it is not subject personally to the jurisdiction of the above-named courts, that its property is exempt or immune from attachment
or execution, that the Action is brought in an inconvenient forum, that the venue of the Action is improper, or that this Agreement or
the transactions contemplated hereby may not be enforced in or by any Specified Court. Each party agrees that a final judgment in any
Action shall be conclusive and may be enforced in other jurisdictions by suit on the judgment or in any other manner provided by applicable
law. “Action” means any notice of noncompliance or violation, or any claim, demand, charge, action, suit, litigation,
audit, settlement, complaint, stipulation, assessment or arbitration, or any request (including any request for information), inquiry,
hearing, proceeding or investigation, by or before any governmental authority.
SIGNATURE
PAGE TO FOLLOW
IN
WITNESS WHEREOF, the parties hereto have executed this Agreement as a deed on and as of the day and year first above written.
COMPANY
By:
Name:
Title:
INDEMNITEE
Name:
Address:
In the presence of:
Name:
Address:
Occupation:______________________________________________
EX-10.7
EX-10.7
Filename: ex10-7.htm · Sequence: 9
Exhibit 10.7
Firstborn
Top Capital
2026
OMNIBUS equity incentive PLAN
SECTION
1.
ESTABLISHMENT,
OBJECTIVES AND DURATION
1.1.
ESTABLISHMENT. Subject to the approval of the shareholders of ARC Group Acquisition
I Corp. (the “Company”), the Company has established the BlueCrest Investment, Inc. 2026 Omnibus Equity Incentive
Plan (the “Plan”), as set forth herein, conditioned upon and effective as of the closing of the transactions contemplated
by the Share Purchase Agreement (“Effective Date”). Following the Effective Date, references to the Company shall
be construed as references to BlueCrest Investment, Inc., a British Virgin Islands business company, and the Plan shall be administered
subject to the Company’s memorandum and articles of association and the BVI Business Companies Act, as amended from time to time.
1.2.
PURPOSE. The purpose of the Plan is to enhance shareholder value by linking long-term
incentive compensation to the financial performance of the Company and to further align Participants’ financial rewards with the
financial rewards realized by the Company and its shareholders. The Plan is also a vehicle to attract and retain key personnel. To accomplish
the foregoing, the Plan provides that the Company may grant Incentive Share Options, Nonqualified Share Options, Share Appreciation Rights,
Restricted Shares, Restricted Share Units, Performance Shares and/or Performance Units.
1.3.
DURATION. The Plan shall remain in effect, subject to the right of the Company’s
Board of Directors to amend or terminate the Plan at any time pursuant to Section 14, until the earlier of ten (10) years following its
Effective Date or the date that all Shares subject to the Plan shall have been purchased or granted according to the Plan’s provisions.
1.4.
APPROVAL BY SHAREHOLDERS. The Plan has been adopted by the Board of Directors subject
to approval by the shareholders of the Company at an extraordinary general meeting of shareholders held following the adoption by the
Board. Awards may be granted prior to shareholder approval, but no Award may be exercised or settled until the Plan is approved by the
shareholders, and if the Plan is not so approved within twelve (12) months before or after the Effective Date, the Plan and all Awards
granted under the Plan shall be null and void.
SECTION
2.
DEFINITIONS
Whenever
used in the Plan, the following capitalized terms shall have the meanings set forth below:
2.1.
“ARTICLES” means the memorandum and articles of association of the Company,
as amended, restated or supplemented from time to time.
2.2.
“AWARD” means, individually or collectively, a grant under the Plan
of Nonqualified Share Options, Incentive Share Options, Share Appreciation Rights, Restricted Shares, Restricted Share Units, Performance
Shares, or Performance Units.
2.3.
“AWARD AGREEMENT” means a written (or electronic) document setting
forth the terms and provisions applicable to an Award granted to the Participant under the Plan, which need not be executed unless required
by the Committee, and is a condition to the grant of an Award hereunder.
2.4.
“BOARD” means the Board of Directors of the Company.
2.5.
“CHANGE IN CONTROL” means the occurrence of a “change in the
ownership,” a “change in the effective control” or a “change in the ownership of a substantial portion of the
assets” of the Company, as determined in accordance with this Section 2.5. In determining whether an event shall be considered
a “change in the ownership,” a “change in the effective control” or a “change in the ownership of a substantial
portion of the assets” of the Company, the following provisions shall apply:
(a)
A “change in the ownership” of the Company shall occur on the date on which any one person, or more than one person acting
as a group (within the meaning of Section 13(d)(3) or 14(d)(2) of the Securities Exchange Act of 1934, as amended (a “Person”)),
acquires ownership of the equity securities of the Company that, together with the equity securities held by such Person, constitutes
more than 50% of the total fair market value or total voting power of the Company, as determined in accordance with Treas. Reg. §1.409A-3(i)(5)(v).
If a Person is considered either to own more than 50% of the total fair market value or total voting power of the equity securities of
the Company, or to have effective control of the Company within the meaning of subsection (B), and such Person acquires additional equity
securities of the Company, the acquisition of additional equity securities by such Person shall not be considered to cause a “change
in the ownership” of the Company.
(b)
A “change in the effective control” of the Company shall occur on either of the following dates:
(i)
The date on which any Person acquires (or has acquired during the 12-month period ending on the date of the most recent acquisition by
such Person) ownership of equity securities of the Company possessing 30% or more of the total voting power of the Company’s equity
securities, as determined in accordance with Treas. Reg. §1.409A-3(i)(5)(vi). If a Person is considered to possess 30% or more of
the total voting power of the Company’s equity securities, and such Person acquires additional equity securities of the Company,
the acquisition of additional equity securities by such Person shall not be considered to cause a “change in the effective control”
of the Company; or
(ii)
The date on which a majority of the members of the Board of Directors of the Company is replaced during any 12-month period by directors
whose appointment or election is not endorsed by a majority of the members of the Board of Directors before the date of the appointment
or election, as determined in accordance with Treas. Reg. §1.409A-3(i)(5)(vi).
(c)
A “change in the ownership of a substantial portion of the assets” of the Company shall occur on the date on which any one
Person acquires (or has acquired during the 12-month period ending on the date of the most recent acquisition by such Person) assets
from the Company that have a total gross fair market value equal to or more than 40% of the total gross fair market value of all of the
assets of the Company immediately before such acquisition or acquisitions, as determined in accordance with Treas. Reg. §1.409A-3(i)(5)(vii).
A transfer of assets shall not be treated as a “change in the ownership of a substantial portion of the assets” when such
transfer is made to an entity that is controlled by the holders of the Company’s equity securities, as determined in accordance
with Treas. Reg. §1.409A-3(i)(5)(vii)(B).
(d)
For the purposes of this Plan and this Section 2.5, the following acquisitions shall not constitute a Change in Control: (i) an acquisition
by the Company or entity controlled by the Company, or (ii) an acquisition by an employee benefit plan (or related trust) sponsored or
maintained by the Company or any entity controlled by the Company.
The
above definition of “Change in Control” shall be interpreted by the Board, in good faith, and to comply with Code Section
409A.
2.6
“CHIEF EXECUTIVE OFFICER” or “CEO” shall mean the chief executive officer of the Company or his
or her designee.
2.7.
“CODE” means the Internal Revenue Code of 1986, and all regulations
and formal guidance issued thereunder, as amended from time to time, or any successor legislation thereto.
2.8.
“COMMITTEE” means the Compensation Committee of the Board, or such
other committee as shall be appointed by the Board as provided in Section 3 to administer the Plan, or in the absence of either, the
Board.
2.9.
“COMPANY” means ARC Group Acquisition I Corp., a British Virgin Islands
business company, and any successor to all or substantially all of the assets or shares of such entity as provided in Section 17. Following
the Effective Date, references to the Company shall be construed as references to BlueCrest Investment, Inc., a British Virgin Islands
business company. The Company is subject to the BVI Business Companies Act and the Articles.
2.10.
“BVI BUSINESS COMPANIES ACT” means the BVI Business Companies Act,
as amended, revised or re-enacted from time to time, and all regulations and statutory instruments made thereunder.
2.11.
“DIRECTOR” means any individual who is a member of the Board or the
board of directors of any Subsidiary.
2.12.
“DISABILITY” means, unless otherwise provided in the Award Agreement
or in an employment, change of control or similar agreement in effect between the Participant and the Company or a Subsidiary, the Participant
is unable to engage in any substantial gainful activity by reason of any medically-determinable physical or mental impairment which can
be expected to result in death or can be expected to last for a continuous period of not less than 12 months; or, by reason of any medically-determinable
physical or mental impairment which can be expected to result in death or can be expected to last for a continuous period of not less
than 12 months, receiving income replacement benefits for a period of not less than 3 months under an accident and health plan covering
employees of the Company or a Subsidiary.
2.13.
“EFFECTIVE DATE” means the date specified in Section 1.1.
2.14.
“EMPLOYEE” means any employee of the Company or any Subsidiary.
2.15.
“EXCHANGE ACT” means the Securities Exchange Act of 1934, and all rules
and formal guidance issued thereunder, as amended from time to time, or any successor act thereto.
2.16.
“FAIR MARKET VALUE” means, with respect to the relevant date, the fair
market value of the Shares for such date, as determined by the Committee in good faith and, if applicable, in compliance with Code Section
409A or, in the case of ISOs, Code Section 422(b)(4). In the case of NSOs or SARs, this may include but is not limited to any of the
following valuation methods if the Shares are duly listed on a national securities exchange or on The Nasdaq Stock Market:
(i) the closing price
of a Share on such date, or, if there are no sales on such date, on the next preceding day on which there were sales,
(ii) the last sale before or the first sale after the grant,
(iii) the closing price on the trading day before or the trading day of the grant,
(iv) the arithmetic mean of the high and low prices on the trading day before or the trading day of the grant, or
(v)
an average selling price during a specified period that is within 30 days before or 30 days after the applicable valuation date; provided
that the average selling price method described in this clause (v) is irrevocably approved by the Committee for use with the applicable
Award before the beginning of the specified period (for this purpose, the term average selling price refers to the arithmetic mean of
the high and low selling prices on all trading days during the specified period, or the average of such prices over the specified period
weighted based on the volume of trading of such Share on each trading day during such specified period); and provided, further,
that the Committee must designate the Participant who will be granted the Award, the number of Shares that are subject to the Award,
and the method for determining the exercise price or base price including the period over which the averaging will occur, before the
beginning of the specified averaging period.
Such
price shall be subject to adjustment as provided in Section 4.3.
2.17.
“INCENTIVE SHARE OPTION” or “ISO”
means the right to purchase Shares pursuant to terms and conditions that are intended to qualify as, and that satisfy the requirements
applicable to, an incentive stock option within the meaning of Code Section 422, as described in Section 6.
2.18.
“NaMED EXECUTIVE OFFICERS” means the CEO, the Chief Financial Officer,
and each of the three most highly compensated executive officers of the Company other than the
CEO and Chief Financial Officer, at the end of the most recently completed financial year of the Company.
2.19.
“NONQUALIFIED SHARE OPTION” or “NSO”
means the right to purchase Shares pursuant to terms and conditions that are not intended to be, or do not qualify as, an Incentive Share
Option as described in Section 6.
2.20.
“OPTION” means an Incentive Share Option or a Nonqualified Share Option,
as described in Section 6.
2.21.
“OPTION PRICE” means the per Share purchase price of a Share purchased
pursuant to an Option.
2.22.
“PARTICIPANT” means an Employee, prospective Employee, Director, or
consultant, advisor or contractor to the Company or any Subsidiary who has outstanding an Award granted under the Plan and includes those
former Employees and former Directors who have certain post-termination rights under the terms of an Award.
2.23.
“PERFORMANCE PERIOD” means the time period during which performance
goals must be achieved with respect to an Award, as determined by the Committee.
2.24.
“PERFORMANCE SHARE” means an Award granted to a Participant that entitles
the Participant to delivery of Shares upon achievement of performance goals, as described in Section 9.
2.25.
“PERFORMANCE UNIT” means an Award that entitles the Participant to
a cash payment upon achievement of performance goals, as described in Section 9.
2.26.
“PERIOD OF RESTRICTION” means the period or periods during which the
transfer of an Award or the Shares is limited in some way (based on the passage of time, the achievement of performance goals, or upon
the occurrence of other events as determined by the Committee, at its discretion), and the Award or Shares are subject to a substantial
risk of forfeiture, as provided in Sections 8 and 9.
2.27.
“PERSON” shall mean an individual or a corporation, partnership, limited liability company, association, trust, unincorporated
organization, or other legal entity or organization.
2.28.
“PLAN” means this Firstborn Top Capital 2026 Omnibus Equity Incentive
Plan, as set forth herein.
2.29.
“RESTRICTED SHARES” means an Award of Shares subject to vesting conditions,
which is granted to a Participant pursuant to Section 8.
2.30.
“RESTRICTED SHARE UNIT” or “RSUs”
shall mean a right to receive Shares or cash upon vesting pursuant to Section 8.
2.31.
“SERVICE” shall mean the performance of services for the Company (or any Subsidiary) within the meaning of Code Section
409A, except to the extent otherwise specifically provided in the Award Agreement.
2.32.
“SETTLED” shall mean, with respect to an Award, when the Award is fully exercised, vested, forfeited, canceled, expired
or otherwise terminated in accordance with the terms of such Award.
2.33.
“SHARE” or “SHARES”
means Class A ordinary shares, par value $0.0001 per share of the Company.
2.34.
“SHARE APPRECIATION RIGHT” or “SAR”
means a right, designated as an SAR, to receive the appreciation in the Fair Market Value of Shares pursuant to the terms of Section
7.
2.35.
“SHARE PURCHASE AGREEMENT” means that certain share purchase agreement by and among ARC Group Acquisition I Corp.,
Firstborn Top Capital Sdn. Bhd., the shareholders of Firstborn Top Capital Sdn. Bhd. and a representative each of ARC Group Acquisition
I Corp. and Firstborn Top Capital Sdn. Bhd. dated ______________.
2.36.
“SUBSIDIARY” means any corporation or other entity in a chain of corporations
or other entities in which each corporation or other entity has a controlling interest in another corporation or entity in the chain,
commencing with the Company; provided, however, that with respect to any ISO, the term “Subsidiary” means any entity
during any period in which it is a “parent corporation” (as that term is defined in Code Section 424(e)) with respect to
the corporation or a “subsidiary corporation” (as that term is defined in Code Section 424(f)) with respect to the Company.
2.35
“VESTING TRANCHE” shall mean the portion of an Award that vests or with respect to which restrictions lapse on a certain
date due to attainment of specified vesting conditions as stated in the Award Agreement or Plan.
SECTION
3.
ADMINISTRATION
3.1.
PLAN ADMINISTRATION. The Committee shall administer the Plan. The Committee shall
consist of not fewer than two Directors who are non-Employee Directors of the Company, within the meaning of Rule 16b-3 of the Exchange
Act; and “independent directors” for purposes of the rules of the exchange on which the Shares are traded. The Board may,
from time to time, remove members from, or add members to, the Committee, or may function as the Committee. Any vacancies on the Committee
shall be filled by members of the Board. Acts of a majority of the Committee at which a quorum is present, or acts reduced to or approved
in writing by unanimous consent of the members of the Committee, shall be valid acts of the Committee.
3.2.
AUTHORITY OF THE COMMITTEE. Except as limited by applicable law, including the
BVI Business Companies Act, or by the Articles, and subject to the provisions herein, the Committee shall have full power to select Participants
to participate in the Plan; determine the sizes and types of Awards; determine the terms and conditions of Awards in a manner consistent
with the Plan; construe and interpret the Plan and any agreement or instrument entered into under the Plan; establish, amend, or waive
rules and regulations consistent with the terms of the Plan for the Plan’s administration; and amend the terms and conditions of
any outstanding Award to the extent such terms and conditions are within the sole discretion of the Committee as provided in the Plan
and subject to Section 14; provided that the Committee shall not have the authority to amend any Option or SAR to reduce its Option
Price or base price except in accordance with Sections 4.3 and 4.4. Further, the Committee shall make all other determinations which
may be necessary or advisable for the administration of the Plan, including establishing administrative methods for the exercise of Options
and SARs. No authority conferred under the Plan shall be exercised in a manner that would cause the Company to act outside the powers,
restrictions or procedures set out in the Articles or the BVI Business Companies Act. The Committee’s determinations, interpretations
and actions under the Plan need not be uniform and may be made selectively among Participants and their estates and beneficiaries.
3.3.
DECISIONS BINDING. All determinations and decisions made by the Committee (or its
delegate) pursuant to the provisions of the Plan and all related orders and resolutions of the Board shall be final, conclusive and binding
on all Persons, including the Company, its shareholders, Employees, Directors, Participants, and their estates and beneficiaries.
3.4.
DELEGATION BY COMMITTEE. Unless prohibited by applicable law, the Articles or the applicable rules of a stock exchange, the Committee
may delegate all or some of its responsibilities and powers to any one or more of its members. The Committee also may delegate some or
all of its administrative duties to any officer of the Company and may delegate some or all of its administrative powers to the CEO.
The Committee may delegate to the CEO the authority to grant Awards under the Plan to Participants and potential Participants who are
not Directors or Named Executive Officers of the Company or any Subsidiaries, provided that the terms and conditions of such Awards
shall be set forth in an Award Agreement approved in substantial form by the Committee prior to the grant of said Awards, the Committee
in its delegation shall specify the maximum Shares that may be awarded to one Participant pursuant to such delegation in any calendar
year, and the CEO shall report any such grants to the Committee at its next meeting. In the case of any such delegation, references in
this Plan to the “Committee” shall include any such delegate, as applicable. The Committee hereby delegates to each of the
Company’s Corporate Secretary and Chief Legal Officer (or his or her equivalent) the authority to document any and all Awards made
by the Committee and/or the CEO under the Plan. The Committee may revoke any such allocation or delegation at any time.
3.5.
INFORMATION TO BE FURNISHED TO COMMITTEE. The records of the Company and Subsidiaries as to an Employee’s, Director’s
or Participant’s employment, termination of employment, performance of Services, termination of Services, leave of absence, reemployment
and compensation shall be conclusive on all persons unless determined to be manifestly incorrect. Participants and other persons entitled
to benefits under the Plan must, as a condition to the receipt or settlement of any Award hereunder, furnish the Committee with such
evidence, data or information as the Committee reasonably considers desirable to carry out the terms of the Plan.
3.6.
INDEMNIFICATION. In addition to such other rights of indemnification that they have as members of the Board or the Committee,
the Company shall indemnify the members of the Committee (and any delegates of the Committee, as permitted under Section 3.4), to the
extent permitted by applicable law and the Articles, against reasonable expenses (including, without limitation, attorney’s fees)
actually and necessarily incurred in connection with the defense of any action, suit or proceeding, or in connection with any appeal,
to which they or any of them may be a party by reason of any action taken or failure to act under or in connection with the Plan or any
Award awarded hereunder, and against all amounts paid by them in settlement thereof (provided such settlement is approved to the
extent required by and in the manner provided by the Articles relating to indemnification of the members of the Board) or paid by them
in satisfaction of a judgment in any such action, suit or proceeding, except in relation to such matters as to which it is adjudged in
such action, suit or proceeding that such Committee member or members (or their delegates) did not act in good faith and in a manner
reasonably believed to be in or not opposed to the best interests of the Company; provided, however, that no such indemnification may
be made in respect of any matter arising out of such Committee member’s or members’ willful default, willful neglect or actual
fraud.
SECTION
4.
SHARES
SUBJECT TO THE PLAN AND MAXIMUM AWARDS
4.1.
SHARES AVAILABLE FOR AWARDS.
(a)
The Shares available for Awards shall be authorized and unissued Shares or treasury Shares, if and to the extent permitted by the BVI
Business Companies Act and the Articles. The aggregate number of Shares that may be issued or used for reference purposes under the Plan
or with respect to which Awards, including but not limited to ISOs, may be granted shall not exceed twenty percent (20%) of the Company’s
total issued and outstanding Shares from time to time (the “Share Reserve”) subject to adjustment as provided in Section
4.3 for any share split made on or immediately after the Effective Date. This Plan is considered an “evergreen” plan, since
the shares covered by Awards which have been exercised or terminated shall be available for subsequent grants under the Plan and the
number of Awards available to grant increases as the number of issued and outstanding Shares increases. The Share Reserve shall in all
events be subject to further adjustment as provided in Section 4.3. In no event shall fractional Shares be issued under the Plan unless
the Articles and the BVI Business Companies Act permit the Company to issue fractional Shares and the Committee determines to do so.
For clarity, the Share Reserve in this Section 4.1(a) is a limitation on the number of Shares that may be issued pursuant to this Plan.
Shares may be issued in connection with a merger or acquisition as permitted by NASDAQ Listing Rule 5635(c) or other applicable exchange
rule, and any such issuance will not reduce the number of Shares available for issuance under this Plan. No Shares shall be issued under
the Plan unless the Board or Committee, as applicable, has determined that the consideration for such Shares is adequate and that the
issuance complies with the BVI Business Companies Act, the Articles and all applicable securities exchange rules.
(b)
Upon:
(i)
a payout of a SAR, RSU, or Performance Unit Award under this Plan in the form of cash; or
(ii)
a cancellation, termination, expiration without exercise, forfeiture, or lapse for any reason, of any Award under this Plan, the number
of Shares underlying any such Award that were not issued as a result of any of the foregoing actions shall again be available for the
purposes of Awards under the Plan. In addition, in the case of any Award granted in substitution for an award of a company or business
acquired by the Company or a Subsidiary, Shares issued or issuable in connection with such substitute Award shall not be counted against
the number of Shares reserved under the Plan but shall be available under the Plan by virtue of the Company’s assumption of the
plan or arrangement of the acquired company or business.
All
Restricted Share Awards which vest, and all Shares issued in settlement of an Option, SAR, Restricted Share Award, Restricted Share Unit,
or Performance Share Award, or withheld for payment of the Option Price or any tax imposed when the Award is exercised or settled, shall
reduce the total number of Shares available under the Plan and shall not again be available for the grant of any Award hereunder.
Notwithstanding
the foregoing, when a share-settled SAR is exercised under the Plan, the total number of Shares subject to the SAR shall not be available
for subsequent issuance under the Plan, regardless of the number of Shares used to settle the SAR.
4.2.
INDIVIDUAL PARTICIPANT LIMITATIONS. The Board may provide for a limit on the dollar
value or maximum aggregate number of Shares underlying Awards that may be granted to any one Named Executive Officer of the Company or
any Subsidiary in any financial year, subject to adjustment as provided in Section 4.3.
4.3.
ADJUSTMENTS. (a) Recapitalization. Notwithstanding any other provision of
the Plan, if the Company is involved in a corporate transaction or any other event which affects the Shares (including, without limitation,
any recapitalization, reclassification, reverse or forward share split, share dividend, extraordinary cash dividend, split-up, spin-off,
combination or exchange of shares), then the Committee shall make or provide for such adjustments to Awards to prevent the dilution or
enlargement of rights of the Awards as follows:
(i)
The Committee shall take action to adjust the number and kind of Shares that are issuable under the Plan and the maximum limits for each
type of Award;
(ii)
The Committee shall take action to adjust the number and kind of Shares subject to outstanding Awards;
(iii)
The Committee shall take action to adjust the Exercise Price or base price of outstanding Options and Share Appreciation Rights; and
(iv)
The Committee shall make any other equitable adjustments.
Only
whole Shares shall be issued in making the above adjustments. Further, the number of Shares available under the Plan or the number of
Shares subject to any outstanding Awards shall be the next lower number of Shares, so that fractions are rounded downward. Any adjustment
to or assumption of ISOs under this Section shall be made in accordance with Code Section 424. If the Company issues any rights to subscribe
for additional Shares pro rata to holders of outstanding Shares of the class or classes of shares then set aside for the Plan, then each
Participant shall be entitled to the same rights on the same basis as holders of outstanding Shares with respect to such portion of the
Participant’s Award as is exercised on or prior to the record date for determining shareholders entitled to receive or exercise
such rights.
(b)
Reorganization. If the Company is part of any reorganization involving merger, consolidation, acquisition of the Share or acquisition
of the assets of the Company, the Committee, in its discretion, may decide that:
(i)
any or all outstanding Awards shall pertain to and apply, with appropriate adjustment as determined by the Committee, to the securities
of the resulting corporation to which a holder of the number of Shares subject to each such Award would have been entitled;
(ii)
any or all outstanding Options or SARs shall become immediately fully exercisable (to the extent permitted under federal or state securities
laws) and shall remain exercisable for the remaining term of the Options or SARs under the terms of the Plan;
(iii)
any or all Options or SARs shall become immediately fully exercisable (to the extent permitted under federal or state securities laws)
and shall be terminated after giving at least 30 days’ notice to the Participants to whom such Options or SARs have been granted;
and/or
(iv)
any or all unvested Awards and/or Awards on which restrictions have not yet lapsed shall become immediately fully vested, nonforfeitable
and payable.
(c)
Limits on Adjustments. Any issuance by the Company of shares of any class other than the Shares of the Company, or securities
convertible into shares of any class, shall not affect, and no adjustment by reason thereof shall be made with respect to, the number
or price of Shares subject to any Award, except as specifically provided otherwise in this Plan. The grant of Awards under the Plan shall
not affect in any way the right or authority of the Company to make adjustments, reclassifications, reorganizations or changes of its
capital or business structure or to merge, consolidate or dissolve, or to liquidate, sell or transfer all or any part of its business
or assets. All adjustments that the Committee makes under this Plan shall be conclusive.
4.4.
PROHIBITION ON REPRICING. Anything else contained herein to the contrary notwithstanding,
except as provided in Section 4.3, the Committee shall not amend any Option or SAR to reduce its Option Price or base price, and shall
not issue to any Participant a new Award in exchange for the surrender and cancellation of any other Award, if such new Award has an
Option Price or base price (as applicable) lower than that of the Award for which it is exchanged, or take any other action that would
have the effect of reducing the Option Price or base price of an Option or SAR.
SECTION
5.
ELIGIBILITY
AND PARTICIPATION
5.1.
ELIGIBILITY. Persons eligible to participate in the Plan include current and future
Employees (including officers), consultants, advisors or contractors to the Company or a Subsidiary, and Directors, as designated by
the Committee; provided that persons who have been offered employment by or an engagement with the Company or a Subsidiary may
not receive any payment or exercise any right relating to an Award until such person begins employment or service with the Company or
Subsidiary; and provided, further, however, that ISOs may only be granted to current or prospective U.S. Employees. All
non-U.S. Employees will be granted NSOs.
5.2.
PARTICIPATION. Subject to the provisions of the Plan, the Committee shall determine
and designate, from time to time, the Participants to whom Awards shall be granted, the terms of such Awards, and the number of Shares
subject to such Award.
SECTION
6.
SHARE
OPTIONS
6.1.
GRANT OF OPTIONS AND AWARD AGREEMENT. Options shall constitute contractual rights
only and shall not constitute Shares or confer any shareholder rights unless and until Shares are issued to the Participant and the Participant
is entered in the Company’s register of members in accordance with the BVI Business Companies Act and the Articles.
(a)
Option Grant. Subject to the terms and provisions of the Plan and the Articles, Options may be granted to one or more Participants
in such number, upon such terms and provisions, and at any time and from time to time, as determined by the Committee, in its sole discretion.
The Committee may grant either Nonqualified Share Options or Incentive Share Options and shall have complete discretion in determining
the number of Options of each granted to each Participant, subject to the limitations of Section 4.
(b)
Award Agreement. Each Award shall be evidenced by an Award Agreement, effective as of the grant date, which shall specify the
Option Price, the term of the Option, the number of Shares subject to the Option, and such other provisions as the Committee shall determine,
and which are not inconsistent with the terms and provisions of the Plan. The Award Agreement shall also specify whether the Option is
to be treated as an ISO within the meaning of Code Section 422. If such Option is not designated as an ISO, such Option shall be deemed
an NSO. No ISO may be granted to any person more than 10 years after the Effective Date of the Plan.
6.2.
OPTION PRICE. The Committee shall designate the Option Price for each Share subject
to an Option under the Plan; provided that such Option Price shall not be less than 100% of the Fair Market Value of Shares subject
to an Option on the date the Option is granted, and which Option Price may not be subsequently decreased by the Committee except pursuant
to Section 4.3 and in compliance with Code Section 409A; provided further that Shares cannot in any event be issued at less than
par value and with respect to a Participant who owns, directly or indirectly, more than 10% of the total combined voting power of all
classes of shares of the Company or any Subsidiary, the Option Price of Shares subject to an ISO shall be at least 110% of the Fair Market
Value of such Shares on the ISO’s grant date.
6.3.
TERM OF OPTIONS. Each Option granted to a Participant shall expire at such time
as the Committee shall determine at the time of grant, but in no event shall be exercisable later than the tenth (10th) anniversary
of the grant date. Notwithstanding the foregoing, with respect to ISOs, in the case of a Participant who owns, directly or indirectly,
more than 10% of the total combined voting power of all classes of the shares of the Company or any Subsidiary, no such ISO shall be
exercisable later than the fifth (5th) anniversary of the grant date.
6.4.
EXERCISE OF OPTIONS. Options granted under this Section 6 shall be exercisable
at such times and be subject to such restrictions and conditions as the Committee shall in each instance approve, which need not be the
same for each Award or for each Participant, and shall be set forth in the applicable Award Agreement, subject to Section 10. Notwithstanding
the preceding sentence, the Fair Market Value of Shares to which ISOs are exercisable for the first time by any Participant during any
calendar year may not exceed $100,000. Any ISOs that become exercisable in excess of such amount shall be deemed NSOs to the extent of
such excess. The Committee, in its sole discretion and at any time, may establish procedures setting a minimum number of Shares that
must be exercised at any one time.
6.5.
EXERCISE AND PAYMENT. Options granted under this Section 6 shall be exercised by
the delivery of a written (or electronic) notice of exercise to the Company, setting forth the number of Shares with respect to which
the Option is to be exercised, accompanied by full payment for the Shares and all applicable tax withholding. The Option Price and applicable
tax withholding upon exercise of any Option shall be payable to the Company in full either:
(a)
in cash or its equivalent,
(b)
by tendering previously acquired whole Shares (held for any minimum period needed to avoid adverse impacts to the Company’s earnings
for financial reporting purposes), valued at their Fair Market Value at the time of exercise, with such documentation as the Committee
may require, or
(c)
a combination of (a) and (b).
In
addition, payment of the Option Price and applicable tax withholding may be payable by one or more of the following methods upon written
consent from the Committee if such method will not result in a charge to the Company’s earnings for financial reporting purposes:
(d)
by a “net exercise” in which whole Shares that otherwise would be acquired on exercise are withheld (valued at their Fair
Market Value at the time of exercise),
(e)
by tendering other Awards payable under the Plan, or
(f)
by cashless exercise through delivery of irrevocable instructions to a broker to promptly deliver to the Company the amount of proceeds
from a sale of all or a portion of the whole Shares being exercised.
To
the extent the Option Price and applicable tax withholding would require the sale or delivery of a fractional Share, any Shares sold
or delivered shall be rounded down to the next whole Share and the Participant shall pay the remainder using method (a) above. As soon
as practicable after receipt of a written (or electronic) notification of exercise and full payment, the Company shall deliver, electronically
or in paper form, the Shares to the Participant and, where required by the BVI Business Companies Act, shall enter the Participant in
the register of members as the holder of such Shares. No Participant shall have any rights of a shareholder with respect to Shares subject
to an Option, including any right to receive dividends, to vote, or to participate in the equity of the Company, until such Option has
been exercised and payment made in full as provided herein and the Participant has become the holder of record of the Shares in accordance
with the BVI Business Companies Act and the Articles.
SECTION
7.
SHARE
APPRECIATION RIGHTS
7.1.
GRANT OF SARS AND AWARD AGREEMENT.
(a)
SAR Grant. Subject to the terms and conditions of the Plan and the Articles, SARs may be granted to Participants and at any time
and from time to time, as determined by the Committee, in its sole discretion. The Committee shall have complete discretion in determining
the number of SARs granted to each Participant (subject to Section 4) and, consistent with the provisions of the Plan, in determining
the terms and conditions pertaining to such SARs. The Committee shall designate, at the time of grant, the base price of the SAR, which
base price shall be at least equal to the Fair Market Value of a Share on the grant date of the SAR. Base prices of SARs shall not subsequently
be decreased by the Committee, except pursuant to Section 4.3, provided always that SARs cannot in any event be granted at less than
the par value of the Shares they refer to. The Committee, in its sole discretion, may provide a maximum dollar limit on the total aggregate
payment due under a SAR.
(b)
Award Agreement. Each Award shall be evidenced by an Award Agreement that shall specify the base price, the term of the SAR, and
such other provisions as the Committee shall determine, and which are not inconsistent with the terms and provisions of the Plan.
7.2.
TERM OF SARS. The term of a SAR granted under the Plan shall be determined by the
Committee, in its sole discretion; provided, however, that unless otherwise designated by the Committee, such term shall not exceed
ten (10) years from the grant date.
7.3.
EXERCISE OF SARS. SARs shall be exercisable at such times and be subject to such
restrictions and conditions as the Committee shall in each instance approve, which need not be the same for each Award or for each Participant
and shall be set forth in the applicable Award Agreement, subject to Section 10. The Committee, in its sole discretion and at any time,
may establish procedures setting a minimum number of Shares with respect to which the SAR must be exercised at any one time.
7.4.
EXERCISE AND PAYMENT. SARs granted under this Section 7 shall be exercised by the
delivery of a written (or electronic) notice of exercise to the Company, setting forth the number of Shares with respect to which the
SAR is to be exercised, accompanied by full payment for all applicable tax withholding. The applicable tax withholding upon exercise
of any SAR shall be payable to the Company in full in the same manner as set forth in Section 6.5 above. As soon as administratively
practicable following exercise of a SAR, a Participant shall be entitled to receive payment from the Company in an amount determined
by multiplying:
(a)
The excess of the Fair Market Value of a Share on the date of exercise over the base price per Share; by
(b)
The number of Shares with respect to which the SAR is exercised.
At
the sole discretion of the Committee, exercisable at any time, the payment upon SAR exercise may be in cash, in Shares of equivalent
value, or in some combination thereof.
SECTION
8.
RESTRICTED
SHAREs and RESTRICTED SHARE UNITS
8.1.
GRANT OF RESTRICTED SHARES OR RSUS AND AWARD AGREEMENT.
(a)
Grant of Restricted Shares/Restricted Share Units. Subject to the terms and provisions of the Plan and the Articles, the Committee,
at any time and from time to time, may grant Restricted Shares or RSUs to Participants in such amounts as the Committee shall determine
in its sole discretion. The Committee shall have complete discretion in determining the number of Shares underlying each Award (subject
to Section 4) and, consistent with the provisions of the Plan, in determining the terms and conditions, including the vesting, pertaining
to such Award. The Committee may designate an RSU as payable in cash, in Shares, or a combination thereof.
(b)
Award Agreement. Each Award shall be evidenced by an Award Agreement that shall specify the vesting for each Vesting Tranche,
the number of Shares granted, and such other provisions as the Committee shall determine pursuant to Section 8.3 or otherwise, and which
shall not be inconsistent with the terms and provisions of the Plan.
8.2.
TRANSFERABILITY OF RESTRICTED shares. Except as provided in this Section 8, a Restricted
Share granted herein may not be sold, transferred, pledged, assigned, or otherwise alienated or hypothecated, voluntarily or involuntarily,
until (i) they vest with respect to their Vesting Tranche, or (ii) upon earlier satisfaction of any other conditions, as specified by
the Committee in its sole discretion (subject to Section 10) and set forth in the Award Agreement.
8.3.
settlement of award. Except as otherwise provided in Section 17.5 or in any Award
Agreement, and subject to any deferral elected pursuant to Section 12.2, the Company shall retain the certificates representing Restricted
Shares in the Company’s possession, or may deposit or transfer such Restricted Shares electronically to a custodian designated
by the Committee, until such time as all conditions and/or restrictions applicable to such Restricted Shares have been satisfied. As
soon as administratively practicable after a Restricted Share Award or RSU Award vests (for example, as part of a Vesting Tranche), Shares
covered by the portion of such Restricted Share Award that vested, or in the case of RSUs cash and/or Shares covered by such vested RSU
that vested, shall be delivered (in the case of Shares, electronically or in paper form) to the Participant.
8.4.
SHAREHOLDER RIGHTS. Unless otherwise designated by the Committee in an Award Agreement:
(i) a Participant shall have no shareholder rights with respect to the Shares subject to an RSU Award, including voting and cash dividend
rights, and (ii) the Participant shall have voting rights but shall not have cash dividend rights with respect to Shares subject to a
Restricted Share Award, until they vest (e.g., as part of a Vesting Tranche) and the Participant has received and become a holder of
record of the Shares; provided, however, that in the event that any dividend constitutes a derivative security or an equity security
pursuant to the rules under Section 16 of the Exchange Act, such dividend shall be added to the Restricted Share Award and subject to
the same vesting conditions and Vesting Tranches as are applicable to the Restricted Shares with respect to which the dividend is paid.
SECTION
9.
PERFORMANCE
UNITS AND PERFORMANCE SHARES
9.1.
GRANT OF PERFORMANCE UNITS/SHARES AND AWARD AGREEMENT.
(a)
Grant of Performance Unit/Shares. Subject to the terms of the Plan and the Articles, Performance Units and/or Performance Shares
may be granted to Participants in such amounts and upon such terms, and at any time and from time to time, as shall be determined by
the Committee in its sole discretion, which shall not be inconsistent with the terms and provisions of the Plan and shall be set forth
in an Award Agreement.
(b)
Award Agreement. Each Award shall be evidenced by an Award Agreement that shall specify the initial value of the Award, the performance
goals and the Performance Period, as the Committee shall determine, and which are not inconsistent with the terms and provisions of the
Plan.
9.2.
VALUE OF PERFORMANCE UNITS/SHARES. Each Performance Share shall represent the Participant’s
right to receive a Share (subject to Section 9.4) upon satisfaction of performance goals established by the Committee. Each Performance
Unit shall represent the Participant’s right to receive a cash payment equal to the value of the Performance Unit (as determined
by the Committee on the grant date, and subject to Section 9.4), upon satisfaction of the performance goals established by the Committee.
The Committee shall set performance goals in its sole discretion which, depending on the extent to which they are met, will determine
the number and/or value of Performance Shares and/or Performance Units that will be paid out to the Participant. For purposes of this
Section 9, the time period during which the performance goals must be met shall be called a Performance Period.
9.3.
EARNING OF PERFORMANCE UNITS/SHARES. Subject to the terms of the Plan, after the
applicable Performance Period has ended, the holder of Performance Units and/or Performance Shares shall be entitled to receive payment
on his or her Performance Units and/or Performance Shares earned by the Participant over the Performance Period, based on the extent
to which the corresponding performance goals have been achieved, as determined by the Committee. The Committee shall have the sole discretion
to adjust the determination of the degree of attainment of the preestablished performance goals.
9.4.
FORM AND TIMING OF PAYMENT OF PERFORMANCE UNITS/SHARES. Except as provided below,
and subject to any deferral elected pursuant to Section 12.2, payment of earned Performance Units and/or Performance Shares shall be
made in a single lump sum as soon as reasonably practicable following the close of the applicable Performance Period. Any Shares paid
to a Participant may be subject to any restrictions deemed appropriate by the Committee.
9.5.
PERFORMANCE MEASURES. The performance goals to be used for purposes of such grants shall be established by the Committee in writing
and stated in terms of the attainment of specified levels of or percentage changes in any one or more of the following measurements:
revenue; primary or fully-diluted earnings per Share; earnings before interest, taxes, depreciation, and/or amortization; pretax income;
operating income; cash flow from operations; total cash flow; return on equity; return on capital; return on assets; net operating profits
after taxes; economic value added; capital expenditures; expense levels; share price; debt levels; market share; total shareholder return
or return on sales; or any individual performance objective which is measured solely in terms of quantitative targets related to the
Company or the Company’s business; any other measurement approved by the Committee, in its sole discretion; or any combination
thereof. In addition, such performance goals may be based in whole or in part upon the performance of the Participant or the Company
or a Subsidiary, or a division and/or other operational unit thereof under one or more of such measures.
9.6.
SHAREHOLDER RIGHTS. Unless otherwise designated by the Committee in the Award Agreement,
the Participant shall have no shareholder rights with respect to the Shares subject to the Performance Share Award, including voting
and cash dividend rights, until after the Award has vested and the Participant has received and become a holder of record of the Shares;
provided, however, that in the event that any dividend constitutes a derivative security or an equity security pursuant to the
rules under Section 16 of the Exchange Act, such dividend shall be added to the Award and subject to the same accrual, forfeiture, and
payout restrictions as apply to the underlying Award with respect to which the dividend is paid.
SECTION
10.
VESTING
AND FORFEITURES
10.1.
Vesting. As part of making any Award, the Committee may determine the time and
conditions under which the Award will vest and may specify partial vesting in one or more Vesting Tranches. Vesting may, in the Committee’s
discretion, be based solely upon continued employment or Service for a specified period of time or may be based upon the achievement
of specific performance goals as described in Section 9.5 above, which shall be established by the Committee in its discretion. For all
purposes of this Plan, “vesting” of an Award shall mean:
(a)
In the case of an Option or SAR, the time at which the Participant has the right to exercise the Award.
(b)
In the case of Restricted Shares, all conditions for vesting, as stated in the Award Agreement or Plan, are satisfied.
(c)
In the case of Restricted Share Units, all conditions for vesting, as stated in the Award Agreement or Plan, are satisfied.
(d)
In the case of Performance Shares or Performance Units, the time at which the Participant has satisfied the requirements to receive payment
on such Performance Shares or Performance Units, which shall not be less than one year from the grant date, except as otherwise provided
in Section 10.2.
Vesting
need not be uniform among Awards granted at the same time or to persons similarly situated. Vesting requirements shall be set forth in
the applicable Award Agreement.
10.2.
VESTING ON TERMINATION OF EMPLOYMENT. Unless otherwise approved by the Committee either at the time of grant or at some later
date in accordance with Code Sections 409A and 422, upon the termination of the Participant’s employment or Service with the Company
and its Subsidiaries, all outstanding Awards shall be cancelled and no longer exercisable on the date of the termination. To the extent
that the Committee approves extended vesting or exercise provisions, such provisions need not be uniform among all Awards issued pursuant
to the Plan, and may reflect distinctions based on the reasons for such termination.
10.3.
ACCELERATION OF VESTING. The Committee may, in its sole discretion, accelerate
the vesting, in whole or in part, with respect to any Award, but no such acceleration shall be effective unless evidenced by a writing
signed by a duly authorized officer of the Company. The Committee may, in its sole discretion, delegate to the CEO its power to accelerate
the vesting of an Award granted to Participants who are not Directors or Named Executive Officers of the Company or any Subsidiaries.
In addition, the Committee may impose additional conditions on Awards, by inclusion of appropriate provisions in the document evidencing
or governing any such Award.
10.4.
EXTENSION OF EXERCISE PERIOD. The Committee may, in its sole discretion, subject to the terms of the Plan, exercisable either
at the time an Award is granted or at any time while the Award remains outstanding, extend the period of time for which the Option or
SAR is to remain exercisable following the Participant’s termination of employment or Service from the limited exercise period
otherwise in effect for that Option or SAR to such greater period of time as the Committee shall deem appropriate, but in no event beyond
the expiration of the maximum Option or SAR term permitted under this Plan, and/or to permit the Option or SAR to be exercised, during
the applicable post-termination exercise period, not only with respect to the number of vested Shares for which such Option or SAR is
exercisable at the time of the Participant’s termination of Service but also with respect to one or more additional installments
in which the Participant would have vested had the Participant continued in Service. Such an extension may result in recharacterization
of an ISO as a NSO.
SECTION
11.
TRANSFERABILITY
OF AWARDS; BENEFICIARY DESIGNATION
11.1.
LIMITS ON TRANSFERABILITY OF AWARDS.
(a)
Except as otherwise provided below, Awards may be exercisable only by the Participant during the Participant’s lifetime, and Awards
shall not be transferable other than by will or the laws of descent and distribution. Any purported transfer of any Award or any interest
therein that does not comply with the terms of this Plan shall be null and void and confer no rights of any kind upon the purported transferee.
(b)
The Committee may, in its discretion, permit a Participant to transfer any Award other than an ISO to any family member of such Participant,
subject to such restrictions and limitations as the Committee may provide; provided, however, that any such Award shall remain
subject to all vesting, forfeiture, and other restrictions provided herein and in the Award Agreement to the same extent as if it had
not been transferred; and provided further that in no event shall any transfer for value be permitted. For purposes of this Section
11.1(b), the terms “family member” and “transfer for value” have the same meaning as in the General Instructions
to SEC Form S-8, or such other form as the SEC may promulgate in replacement thereof.
(c)
To the maximum extent permitted by law, no Award shall be subject, in whole or in part, to attachment, execution or levy of any kind;
provided, however, that nothing contained herein shall affect the right of setoff set forth in Section 13.3.
(d)
Nothing contained in this Section 11.1 shall preclude a Participant from transferring Restricted Shares that have vested or Shares that
are issued in settlement of an Option, SAR, RSU, or Award of Performance Shares or Performance Units, subject to the remaining provisions
of this Plan, the Articles and applicable law, including any transfer requirements, restrictions or procedures under the BVI Business
Companies Act and the Articles and any requirement that the transferee be entered in the register of members.
11.2.
DESIGNATION OF BENEFICIARY. Each Participant under the Plan may, from time to time,
name any beneficiary or beneficiaries (who may be named contingently or successively) to whom any benefit under the Plan is to be paid
in case of his or her death before he or she receives any or all of such benefit. Each such designation shall revoke all prior designations
by the same Participant, shall be in a form prescribed by the Company, and will be effective only when filed by the Participant in writing
(or electronically, if permitted by the Committee) with the Secretary of the Company (or its designee) during the Participant’s
lifetime. In the absence of any such designation, benefits remaining unpaid at the Participant’s death shall be paid to the Participant’s
estate.
SECTION
12.
DEFERRALS;
COMPLIANCE WITH SECTION 409A
12.1.
PROHIBITION ON DEFERRALS OF OPTIONS, SARS, AND RESTRICTED SHAREs. No Participant
shall have the right to defer the amount of Shares or cash payable upon the exercise or settlement of any Option or SAR, or the transfer
of any Restricted Shares upon the vesting thereof.
12.2.
DEFERRALS OF Restricted share units, PERFORMANCE UNITS AND PERFORMANCE SHARES.
The Committee may permit a Participant to defer such Participant’s receipt of the payment of cash or the delivery of Shares that
would otherwise be due to such Participant upon the satisfaction of any requirements or goals with respect to Restricted Share Units,
Performance Units or Performance Shares. If any such deferral election is required or permitted, the Committee shall, in its sole discretion,
establish rules and procedures for such payment deferrals, subject to the following:
(a)
A deferral election may be made only at one of the following two times:
(i)
In the case of an Award that cannot vest (other than by reason of death, Disability, or a Change in Control) earlier than the first anniversary
of the date of grant, not later than the earlier of thirty (30) days after the date of grant or one (1) year prior to the earliest date
on which the Award may vest.
(ii)
In the case of an Award that is subject to a Performance Period of not less than one (1) year, and the vesting of which is subject to
the attainment of Performance Criteria that are established within the first ninety (90) days of the Performance Period and that are
not substantially certain of being achieved at the time of grant, not later than six (6) months prior to the end of the Performance Period.
(b)
A deferral election shall state the time and manner of payment. Payment must either be on a specified date, at the time of the Participant’s
separation from Service with the Company and its Subsidiaries (as defined in Code Section 409A), death, or Disability, or upon the occurrence
of a Change in Control. Notwithstanding the foregoing:
(i)
An amount payable by reason of a separation from Service to an Employee who is a “key employee” of the Company, as defined
in Code Section 409A, shall not be paid until six (6) months after the separation from Service, and any portion of such amount that would
otherwise be payable during such six (6)month period shall be paid instead at the end of such period;
(ii)
Payment of any amount that the Company reasonably determines would not be deductible by reason of Code Section 162(m) shall be deferred
until the earlier of the earliest date on which the Company reasonably determines that the deductibility of the payment will not be so
limited, or the year following the separation from Service.
(iii)
Any payment that the Company reasonably determines will violate a term of a loan agreement to which the Company is a party, or other
similar contract to which the Company is a party, and such violation will cause material harm to the Company shall be deferred until
the earliest date at which the Company reasonably anticipates that the making of the payment will not cause such violation, or such violation
will not cause material harm to the Company;
(iv)
Any payment that the Company reasonably anticipates that will violate Federal securities laws or other applicable law will be deferred
until the earliest date at which the Company reasonably anticipates that the making of the payment will not cause such violation; and
(v)
The Committee may permit Participants to elect to further defer payments, provided that any such election is made not less than
one (1) year prior to the date on which the payment would otherwise be made, and that the deferral is for a period of at least five (5)
years.
(c)
No payment that a Participant has elected to defer pursuant to this Section 12.2 may be paid at any earlier date, except in accordance
with procedures adopted by the Committee in compliance with Code Section 409A.
12.3.
COMPLIANCE WITH SECTION 409A. The provisions of this Plan, including but not limited
to this Section 12, are intended to comply with the restrictions of Code Section 409A, and, notwithstanding the Participant consent requirements
of Section 14.1, the Committee reserves the right to amend any provision of this Plan, or any outstanding Award, to the extent necessary
to comply with Section 409A.
SECTION
13.
RIGHTS
AND OBLIGATIONS OF PARTIES
13.1.
NO GUARANTEE OF EMPLOYMENT OR SERVICE RIGHTS. Nothing in the Plan shall interfere
with or limit in any way the right of the Company or any Subsidiary to terminate any Participant’s employment or Service at any
time, nor confer upon any Participant any right to continue in the employ or Service of the Company or any Subsidiary.
For
purposes of the Plan, temporary absence from employment or Service because of illness, vacation, approved leaves of absence, and transfers
of employment or Service among the Company and its Subsidiaries, shall not be considered to terminate employment or Service or to interrupt
continuous employment or Service. Conversion of a Participant’s employment relationship to a Service arrangement, and vice versa,
shall not result in termination of previously granted Awards (although it may result in an ISO being recharacterized as an NSO).
13.2.
PARTICIPATION. No Employee or Director shall have the right to be selected to receive
an Award under the Plan, or, having been so selected, to be selected to receive a future Award.
13.3.
RIGHT OF SETOFF AND CLAW-BACK. The Company or any Subsidiary may, to the extent
permitted by applicable law (including Code Section 409A), deduct from and set off against any amounts the Company or Subsidiary may
owe to the Participant from time to time, including amounts payable in connection with any Award, owed as wages, fringe benefits, or
other compensation owed to the Participant, such amounts as may be owed by the Participant to the Company or a Subsidiary, although the
Participant shall remain liable for any part of the Participant’s payment obligation not satisfied through such deduction and setoff.
All Awards (including any proceeds, gains or other economic benefit the Participant actually or constructively receives upon receipt
or exercise of any Award) will be subject to any Company claw-back policy, as set forth in such claw-back policy or the Award Agreement.
By accepting any Award granted hereunder, the Participant agrees to any deduction, claw-back or setoff under this Section 13.
13.4.
SECTION 83(B) ELECTION. No election under Section 83(b) of the Code (to include
in gross income in the year of transfer the amounts specified in Code Section 83(b)) or under a similar provision of the laws of a jurisdiction
outside the U.S. may be made, unless expressly permitted by the terms of the Award Agreement or by action of the Committee in writing
before the making of such election. In any case in which a Participant is permitted to make such an election in connection with an Award,
the Participant shall notify the Company of such election within ten (10) days of filing notice of the election with the Internal Revenue
Service or other governmental authority, in addition to any filing and notification required pursuant to regulations issued under Code
Section 83(b) or other applicable provision.
13.5.
DISQUALIFYING DISPOSITION NOTIFICATION. If any Participant shall make any disposition
of Shares delivered pursuant to the exercise of an Incentive Share Option under the circumstances described in Code Section 421(b) (relating
to certain disqualifying dispositions), such Participant shall notify the Company of such disposition within ten (10) days thereof.
SECTION
14.
AMENDMENT,
MODIFICATION, AND TERMINATION
14.1.
AMENDMENT, MODIFICATION, AND TERMINATION. Except as otherwise provided in this
Section 14.1 and subject to Section 14.2, at any time the Board may wholly or partially amend, modify, suspend or terminate the Plan
or the Committee’s authority to grant Awards under the Plan without the consent of shareholders or Participants. However, without
the approval of the Company’s shareholders given twelve months before or after the action by the Board if such shareholder approval
is required by any federal or state law or regulation or the rules of any share exchange or automated quotation system on which the Shares
may then be listed or quoted, no action of the Board may (i) increase the limit on the Share Reserve, (ii) reduce the exercise price
per share of any outstanding Option or SAR granted under this Plan, (iii) cancel any Option or SAR in exchange for cash, another Award
or an Option or SAR with a price per share that is less than the price per share of the original Option or SAR, or (iv) materially modify
the requirements as to eligibility for participation in this Plan. The Committee shall have no authority to waive or modify any other
Award term after the Award has been granted to the extent that the waived or modified term was mandatory under the Plan.
14.2.
AWARDS PREVIOUSLY GRANTED. No termination, amendment, suspension, or modification
of the Plan, other than to the extent necessary to comply with applicable U.S. or foreign laws, shall adversely affect in any material
way any Award previously granted under the Plan, without the written (or electronic) consent of the Participant holding such Award.
SECTION
15.
WITHHOLDING
15.1.
The Company and its Subsidiaries shall have the power and the right to deduct or withhold from amounts due to the Participant by the
Company or the Subsidiary, or require a Participant to remit to the Company or the Subsidiary as a condition of any Award, an amount
(in cash or in kind, subject to the approval of the Company) equal to the minimum Federal, State and local taxes, domestic or foreign,
required by law or regulation to be withheld with respect to any taxable event arising as a result of the Plan, provided that any withholding
or net settlement in Shares shall comply with the BVI Business Companies Act, the Articles and any applicable solvency, distribution,
purchase or redemption requirements. Notwithstanding the above, in the case of Options or SARs, such tax withholding shall be accomplished
as set forth in Section 6.5 and 7.4. With respect to an Award of Restricted Shares or RSU, the Participant may direct that any withholding
of Federal, State and local taxes, domestic or foreign, resulting from vesting of such Award be accomplished in any manner set forth
in Section 6.5. If the date of the vesting of any Award, other than an Option or SAR, held by Participant who is subject to the Company’s
policy regarding trading of its Shares by its officers and directors and Shares (the “original vesting date”) is not within
a “window period” applicable to the Participant, as determined by the Company in accordance with such policy, then withholding
shall be at the applicable statutory withholding amount accomplished by one or more of the methods provided for in Section 6.5(a) or
(f).
SECTION
16.
SUCCESSORS
All
obligations of the Company under the Plan with respect to Awards granted hereunder shall be binding on any successor to the Company,
whether the existence of such successor is the result of a direct or indirect merger, consolidation, purchase of all or substantially
all of the business and/or assets of the Company or otherwise.
SECTION
17.
MISCELLANEOUS
17.1.
UNFUNDED PLAN. The Plan is intended to constitute an “unfunded” plan
for incentive and deferred compensation. With respect to any payments not yet made to a Participant or the obligation to deliver Shares
pursuant to an Award, nothing contained in the Plan or any Award shall give any such Participant any rights that are greater than those
of a general creditor of the Company; provided that the Committee may authorize the creation of trusts and deposit therein cash,
Shares, other Awards or other property, or make other arrangements to meet the Company’s obligations under the Plan. Such trusts
or other arrangements shall be consistent with the “unfunded” status of the Plan unless the Committee otherwise determines
with the consent of each affected Participant.
17.2.
AWARDS TO PARTICIPANTS OUTSIDE THE UNITED STATES. The Committee may modify the
terms of any Award under the Plan made to or held by a Participant who is then resident or primarily employed outside the U.S. in any
manner deemed by the Committee to be necessary or appropriate in order that the Award shall conform to laws, regulations, and customs
of the country in which the Participant is then resident or primarily employed, or so that the value and other benefits of the Award
to the Participant, as affected by foreign tax laws and other restrictions applicable as a result of the Participant’s residence
or employment abroad, shall be comparable to the value of such an Award to a Participant who is resident or primarily employed in the
U.S.. Such authorization shall extend to and include establishing one or more separate sub-plans which include provisions not inconsistent
with the Plan that comply with statutory or regulatory requirements imposed by the foreign country or countries in which the Participant
resides. If determined advisable by the Committee, an Award may be modified under this Section in a manner that is inconsistent with
the express terms of the Plan, so long as such modifications will not contravene any applicable law or result in actual liability under
Section 16(b) of the Exchange Act for the Participant whose Award is modified.
17.3.
GENDER AND NUMBER; HEADINGS. Except where otherwise indicated by the context, any
masculine term used herein also shall include the feminine; the plural shall include the singular and the singular shall include the
plural. Headings are included for the convenience of reference only and shall not be used in the interpretation or construction of any
such provision contained in the Plan.
17.4.
SEVERABILITY. In the event any provision of the Plan shall be held illegal or invalid
for any reason, the illegality or invalidity shall not affect the remaining parts of the Plan, and the Plan shall be construed and enforced
as if the illegal or invalid provision had not been included.
17.5.
REQUIREMENTS OF LAW. The granting of Awards and the issuance of Shares under the
Plan shall be subject to all applicable laws, rules, and regulations, including, without limitation, the BVI Business Companies Act and
the Articles, and to such approvals by any governmental agencies or national securities exchanges as may be required. If at any time
on or after the Effective Date, the Committee, in its discretion, shall determine that the requirements of any applicable law (including,
without limitation, U.S. federal or state securities laws and British Virgin Islands law) should fail to be met, no Shares issuable under
Awards and no Options or SARs shall be exercisable until the Committee has determined that these requirements have again been met. The
Committee may suspend the right to exercise an Option or SAR at any time when it determines that allowing the exercise and issuance of
Shares would violate any federal or state securities or other laws or the BVI Business Companies Act or the Articles, and may provide
that any time periods to exercise the Option or SAR are extended during a period of suspension. With respect to “Insiders,”
transactions under this Plan are intended to comply with all applicable conditions of Rule 16b-3 under the Exchange Act. To the extent
any provision of the Plan or action by the Committee fails to so comply, it shall be deemed null and void, to the extent permitted by
law and deemed advisable by the Committee. Each Award Agreement and each certificate representing securities granted pursuant to the
Plan (including securities issuable pursuant to the terms of derivative securities) may bear such restrictive legend(s) as the Company
deems necessary or advisable under applicable law, including federal and state securities laws and British Virgin Islands law. If the
date of the vesting of any Award, other than an Option or SAR, held by Participant who is subject to the Company’s policy regarding
trading of its Shares by its officers and directors and Shares (the “original vesting date”) is not within a “window
period” applicable to the Participant, as determined by the Company in accordance with such policy, then the vesting of such Award
shall not occur on such original vesting date and shall instead occur on the first day of the next “window period” applicable
to the Participant pursuant to such policy.
17.6.
ADDITIONAL RESTRICTIONS ON TRANSFERS. The Committee may impose such restrictions
on any Shares acquired pursuant to an Award, including Restricted Shares, Performance Shares, or Shares received upon exercise of an
Option or SAR or under an RSU, as it may deem advisable and as are consistent with the Articles, the BVI Business Companies Act and applicable
securities laws. Subject to the approval of the Board or the CEO, an Option or SAR may be transferred pursuant to the terms of a domestic
relations order, official marital settlement agreement or other divorce or separation instrument as permitted by the Code and regulations
issued thereunder, and provided that if an Option is an ISO such option may be deemed a non-statutory share option as a result of such
transfer. Any transfer of Shares shall be effective only in accordance with the Articles and applicable law.
17.7.
GOVERNING LAW. The Plan and any agreements hereunder shall be administered, interpreted
and enforced under the internal laws of the British Virgin Islands without regard to conflicts of laws thereof. To the extent any provision
of the Plan or any Award Agreement is inconsistent with the Articles or the BVI Business Companies Act, the Articles and the BVI Business
Companies Act shall prevail, and the Plan or Award Agreement shall be construed, amended or limited to the minimum extent necessary to
comply with British Virgin Islands law.
EX-10.8
EX-10.8
Filename: ex10-8.htm · Sequence: 10
Exhibit
10.8
Executive
Employment Agreement
This
EXECUTIVE EMPLOYMENT AGREEMENT (“Agreement”) is made as of [_________] (the “Effective Date”),
by and between Firstborn Top Capital Sdn Bhd. (together with its successors and assigns, the “Company”), and [____________]
(“Executive”). As the context of this Agreement so requires, Executive and the Company are sometimes individually
referred to herein as a “Party” and collectively as the “Parties.”
RECITALS
WHEREAS,
the Company desires to employ Executive, and Executive desires to be employed by the Company, as the Company’s [●].
NOW,
THEREFORE, in consideration of the foregoing recitals, the mutual covenants and conditions herein, and other good and valuable consideration,
the receipt and adequacy of which is hereby acknowledged, the parties hereby agree as follows:
AGREEMENT
1. Employment
and Term. The Company hereby agrees to employ Executive, and Executive hereby accepts
employment by the Company, on the terms and conditions hereinafter set forth. Executive’s
term of employment by the Company under this Agreement (the “Term”) shall
commence on the Effective Date and end on the date on which the term of employment is terminated
in accordance with Section 5. Executive shall be employed under a contract of service for
purposes of Malaysian law, and this Agreement shall be read subject to the Employment Act
1955, the Industrial Relations Act 1967 and all other applicable Malaysian employment, social
security, tax and data protection laws, as amended from time to time.
2. Position,
Duties and Responsibilities, Location, and Commuting.
(a) Position
and Duties. During the Term, the Company shall employ Executive as [●]. Executive
shall report directly to, and subject to the specific direction of, the Company’s Board
of Directors (the “Board”). Executive shall have general overall authority
and responsibility for [description of duties]. Executive shall also have such other duties,
powers, and authority as are commensurate with his or her position as [●] and such
other duties and responsibilities that are commensurate with his or her positions as specifically
delegated to him or her from time to time by the Board.
(b) Exclusive
Services and Efforts. Executive agrees to devote his or her efforts, energies, and skill
to the discharge of the duties and responsibilities attributable to his or her position and,
except as set forth herein, agrees to devote all of his or her professional time and attention
to the business and affairs of the Company. Executive shall be entitled to engage in service
on the board of directors of one (1) not-for-profit organization to the extent such service
does not interfere with the performance of his or her duties and responsibilities to the
Company, as determined by the Company in its sole reasonable discretion.
1
(c) Compliance
with Company Policies. Executive shall be subject to the charter, policies, practices,
procedures and rules of the Company, including those policies and procedures set forth in
the Company’s Code of Conduct and Ethics, all of which shall form an integral part
of the terms of this Agreement. Executive’s violation of the terms of such documents
shall be considered a breach of the terms of this Agreement.
(d) Location
of Employment. Executive’s principal office, and principal place of employment,
shall be at the Company’s offices in Malaysia; provided that Executive may be required
under business circumstances to travel outside of such location in connection with performing
his or her duties under this Agreement.
3. Salary
and Incentives.
(a) Base
Salary. During the Term, the Company shall pay to Executive a monthly salary of RM[Amount]
(“Base Salary”). The Compensation Committee of the Board (the “Committee”)
may increase the Base Salary, in its sole discretion, taking into account Company and individual
performance objectives; provided that any reduction in Base Salary shall not be made except
with Executive’s prior written consent and in compliance with applicable Malaysian
law, and the Base Salary shall in no event be less than the applicable statutory minimum
wage.
(b) Annual
Cash Bonus. During the Term, Executive may be eligible to receive an annual cash bonus,
on terms and conditions as determined by the Committee in its sole discretion, taking into
account Company and individual performance objectives.
(c) Transaction
Incentive Bonus. The Executive may be eligible and receive a certain incentive bonus
provided on terms and conditions as approved by the Committee, taking into account Company
and Company growth objectives.
(d) Statutory
Contributions & Monthly Tax Deduction. The Company
shall make necessary statutory contribution to the Employees Provident Fund (EPF), the Social
Security Organisation (SOCSO) and the Employee’s Insurance Scheme (EIS) in accordance
with the prevailing statutory requirements. The Company shall deduct such sums as may be
required from your monthly salary for the contribution of EPF, SOCSO, scheduled monthly income
tax deductions (PCB) and other similar contributions and/or payments as required by law.
(e) Long-Term
Incentive Award. During the Term, Executive shall be eligible to participate in the Company’s
long-term incentive plan, on terms and conditions as determined by the Committee in its sole
discretion taking into account Company and individual performance objectives.
4. Employee
Benefits and Perquisites.
(a) Benefits.
Executive shall be entitled to participate in such health, group insurance, welfare, pension,
and other employee benefit plans, programs, and arrangements as are made generally available
from time to time to other employees of the Company, subject to Executive’s satisfaction
of all applicable eligibility conditions of such plans, programs, and arrangements. Nothing
herein shall be construed to limit the Company’s ability to amend or terminate any
employee benefit plan or program in its sole discretion.
2
(b) Fringe
Benefits, Perquisites, and Annual Leave. During the Term, Executive shall be entitled
to participate in all fringe benefits and perquisites made available to other employees of
the Company, subject to Executive’s satisfaction of all applicable eligibility conditions
to receive such fringe benefits and perquisites. In addition, Executive shall be eligible
for up to [14 days] of Annual Leave (“Annual Leave”) per calendar year
in accordance with the Company’s vacation and Annual Leave policy, inclusive of vacation
days and excluding medical leaves and standard paid Company holidays, in the same manner
as Annual Leave days for employees of the Company generally accrue; provided that Executive
shall receive no less than the minimum annual leave, paid public holidays, sick leave, hospitalization
leave, maternity/paternity benefits and other statutory benefits required under applicable
Malaysian law. Further, such Annual Leave shall be less than the statutory minimum based
on the tenure under the Employment Act 1955.
(c) Reimbursement
of Expenses. The Company shall reimburse Executive for all reasonable pre-approved business
and travel expenses incurred in the performance of his or her job duties, promptly upon presentation
of appropriate supporting documentation and otherwise in accordance with and subject to the
expense reimbursement policy of the Company.
(d) Maternity/Paternity
Leave. During the Term, the Executive shall be eligible to ninety eight (98) consecutive
days of paid Maternity Leave for an eligible female Executive and seven (7) consecutive days
of paid Paternity Leave for an eligible male Executive.
5. Termination.
(a) General.
The Company may terminate Executive’s employment only in accordance with this Agreement
and applicable Malaysian law, including any requirement for just cause or excuse, due inquiry,
procedural fairness and/or statutory notice or payment in lieu of notice, as applicable.
Executive may terminate his or her employment in accordance with this Agreement and applicable
Malaysian law; provided, however, that the Company and the Executive are required to provide
to the other party at least sixty (60) days’ written notice of intent to terminate
employment for any reason unless the Company specifies an earlier date of termination or
in lieu thereof, payment in lieu of such notice, and provided further that where a longer
notice period or greater benefit is required by applicable Malaysian law, such longer notice
period or greater benefit shall apply. For purposes of this Agreement, the following terms
have the following meanings:
(i) “Accrued
Benefits” shall mean: (i) accrued but unpaid Base Salary through the Termination
Date; (ii) reimbursement for any unreimbursed pre-approved reasonable business expenses incurred
through the Termination Date; (iii) accrued but unused Annual Leave days; and (iv) all other
payments, benefits, or fringe benefits to which Executive shall be entitled as of the Termination
Date under the terms of any applicable compensation arrangement or benefit, equity, or fringe
benefit plan or program or grant; all payable within thirty (30) days following the Termination
Date.
3
(ii) “Cause”
shall mean: (i) a breach by Executive of his or her fiduciary duties to the Company; (ii)
Executive’s breach of this Agreement, which, if curable, remains uncured or continues
after ten days’ notice by the Company thereof; (iii) the commission of any criminal
offence under applicable law or any other criminal act involving embezzlement, misappropriation
of money, fraud, theft, or bribery; (iv) illegal or controlled substance abuse or insobriety
by Executive; (v) Executive’s material negligence or dereliction in the performance
of, or failure to perform Executive’s duties of employment with the Company, which
remains uncured or continues after ten days’ notice by the Company thereof; (vi) Executive’s
refusal or failure to carry out a lawful directive of the Company or any member of the Board
or any of their respective designees, which directive is consistent with the scope and nature
of Executive’s responsibilities; or (vii) any conduct, action or behavior by Executive
that is, or is reasonably expected to be, materially damaging to the Company, whether to
the business interests, finance or reputation; provided that, where required by Malaysian
law, the Company shall conduct a due inquiry and provide Executive with a reasonable opportunity
to be heard before any dismissal for misconduct. In addition, Executive’s employment
shall be deemed to have terminated for Cause if, on the date Executive’s employment
terminates, facts and circumstances exist that would have justified a termination for Cause,
even if such facts and circumstances are discovered after such termination.
(iii) “Just
Cause” shall mean a material breach by the Company of its obligations under this
Agreement, upon which Executive notifies the Board in writing of such material breach within
thirty (30) days of such occurrence, and such material breach shall have not been cured within
thirty (30) days after the Board’s receipt of written notice thereof from Executive.
(iv) “Termination
Date” shall mean the date on which Executive’s employment hereunder terminates
in accordance with this Agreement.
(b) Termination
Without Cause or Termination by Executive for Just Cause. In the event that Executive’s
employment hereunder is terminated by the Company without Cause or by Executive for Just
Cause, Executive shall be entitled to receive the Accrued Benefits. In addition, commencing
on the first payroll date following the date that is sixty (60) days following the Termination
Date, the Company shall continue to pay Executive his or her Base Salary, in accordance with
customary payroll practices and subject to applicable withholding, statutory contributions
and income taxes (the “Severance Payments”), for [six (6) months] (the
“Severance Period”); provided, however, that the Severance Payments shall
be conditioned upon the execution, non-revocation, and delivery of a general release of claims
by Executive, in a form reasonably satisfactory to the Company, within sixty (60) days following
the Termination Date. In the event that Executive fails to timely execute and deliver such
a release, the Company shall have no obligation to pay Severance Payments under this Agreement.
(c) All
Other Terminations. In the event that Executive’s employment hereunder is terminated
by the Company for Cause, by Executive without Just Cause, or due to Executive’s death
or disability, Executive shall be entitled to receive the Accrued Benefits.
(d) Return
of Company Property. Upon termination of Executive’s employment for any reason
or under any circumstances, Executive shall promptly return any and all of the property of
the Company and any affiliates (including, without limitation, all computers, keys, credit
cards, identification tags, documents, data, confidential information, work product, and
other proprietary materials).
4
(e) Post-Termination
Cooperation. Executive agrees and covenants that, following the Term, he or she shall,
to the extent requested by the Company, cooperate in good faith with the Company to assist
the Company in the pursuit or defense of (except if Executive is adverse with respect to)
any claim, administrative charge, or cause of action by or against the Company as to which
Executive, by virtue of his or her employment with the Company or any other position that
Executive holds that is affiliated with or was held at the request of the Company, has relevant
knowledge or information, including by acting as the Company’s representative in any
such proceeding and, without the necessity of a subpoena, providing truthful testimony in
any jurisdiction or forum. The Company shall reimburse Executive for his or her reasonable
out-of-pocket expenses incurred in compliance with this Section.
6. Other
Tax Matters & Statutory Contributions.
(a) The
Company shall be entitled to withhold and make payment/ contribution of all applicable Malaysian
income tax, monthly tax deductions (PCB), Employees Provident Fund (EPF), Social Security
Organisation (SOCSO), Employment Insurance System (EIS), Human Resources Development Corporation
levy where applicable, workmen’s compensation contributions and other statutory contributions
as may be required by law with respect to compensation payable to Executive pursuant to this
Agreement. No deduction from wages shall be made except as permitted by applicable Malaysian
law or with Executive’s written authorization where required.
(b) Notwithstanding
anything herein to the contrary, this Agreement is intended to be interpreted and applied
so that the payment of the benefits set forth herein shall comply with the requirements regarding
the deferred annuity under the Income Tax Act 1967, as amended (the “ITA 1967”).
(c) All
reimbursements and in-kind benefits provided under this Agreement shall be made or provided
in accordance with the requirements of ITA 1967. To the extent that any reimbursements are
taxable to Executive, such reimbursements shall be paid to Executive on or before the last
day of Executive’s taxable year following the taxable year in which the related expense
was incurred. Reimbursements shall not be subject to liquidation or exchange for another
benefit and the amount of such reimbursements that Executive receives in one taxable year
shall not affect the amount of such reimbursements that Executive receives in any other taxable
year.
7. Non-Solicitation.
(a) During
the Term and for twelve (12) months following the Termination Date (the “Restricted
Period”), Executive shall not misuse or disclose Confidential Information, trade
secrets or personal data of the Company, and shall not, by using such Confidential Information
or trade secrets, directly solicit any customer, supplier or material business relation with
whom Executive had material dealings during the twelve (12) months preceding the Termination
Date. This Section is intended to protect the Company’s confidential information, trade
secrets and legitimate business interests and shall not be construed as restraining Executive
from exercising any lawful profession, trade or business in contravention of Section 28 of
the Contracts Act 1950.
(b) During
the Restricted Period, Executive will not, and will cause his or her affiliates not to, directly
or indirectly, through or in association with any third party (1) solicit, induce, recruit,
or encourage any employees or independent contractors of or consultants to the Company to
terminate their relationship with the Company or take away or hire such employees, independent
contractors, or consultants or (2) attempt to do any of the foregoing, either for Executive’s
own purposes or for any other third party.
5
8. Nondisclosure
and Nonuse of Confidential Information.
(a) Executive
acknowledges that: (i) the Confidential Information (as hereinafter defined) is a valuable,
special, and unique asset of the Company, the unauthorized disclosure or use of which could
cause substantial injury and loss of profits and goodwill to the Company; (ii) Executive
is in a position of trust and subject to a duty of loyalty to the Company, and (iii) by reason
of his or her employment and service to the Company, Executive will have access to the Confidential
Information. Executive, therefore, acknowledges that it is in the Company’s legitimate
business interest to restrict Executive’s disclosure or use of Confidential Information
for any purpose other than in connection with Executive’s performance of Executive’s
duties for the Company, and to limit any potential misappropriation of such Confidential
Information by Executive.
(b) Executive
will not disclose or use at any time, either during the Term or thereafter, any Confidential
Information (as hereinafter defined) of which Executive is or becomes aware, whether or not
such information is developed by him or her, except to the extent that such disclosure or
use is directly related to and required by Executive’s performance in good faith of
duties assigned to Executive by the Company or has been expressly authorized by the Board;
provided, however, that this sentence shall not be deemed to prohibit Executive from complying
with any subpoena, order, judgment, or decree of a court or governmental or regulatory agency
of competent jurisdiction (an “Order”); provided, further, however, that
(i) Executive agrees to provide the Company with prompt written notice of any such Order
and to assist the Company, at the Company’s expense, in asserting any legal challenges
to or appeals of such Order that the Company in its sole discretion pursues, and (ii) in
complying with any such Order, Executive shall limit his or her disclosure only to the Confidential
Information that is expressly required to be disclosed by such Order. Executive will take
all appropriate steps to safeguard Confidential Information and to protect it against disclosure,
misuse, espionage, loss, and theft. Executive shall deliver to the Company at the Termination
Date, or at any time the Company may request, all memoranda, notes, plans, records, reports,
electronic information, files and software, and other documents and data (and copies thereof)
relating to the Confidential Information or the Work Product (as hereinafter defined) of
the business of the Company which Executive may then possess or have under his or her control.
(c) As
used in this Agreement, the term “Confidential Information” means information
that is not generally known to the public (including the existence and content of this Agreement)
and that is used, developed, or obtained by the Company in connection with its business,
including, but not limited to, information, observations, and data obtained by Executive
while employed by the Company or any predecessors thereof (including those obtained prior
to the date of this Agreement) concerning (i) the business or affairs of the Company (or
such predecessors), (ii) products or services, (iii) fees, costs and pricing structures,
(iv) designs, (v) analyses, (vi) drawings, photographs and reports, (vii) computer software
and hardware, including operating systems, applications and program listings, (viii) flow
charts, manuals and documentation, (ix) databases and data, (x) accounting and business methods,
(xi) inventions, devices, new developments, methods, and processes, whether patentable or
unpatentable and whether or not reduced to practice, (xii) customers and clients (and all
information with respect to such persons) and customer or client lists, (xiii) suppliers
(and all information with respect to such persons) or supplier lists, (xiv) other copyrightable
works, (xv) all production methods, processes, technology, and trade secrets, and (xvi) all
similar and related information in whatever form. Confidential Information will not include
any information that has been published in a form generally available to the public prior
to the date Executive proposes to disclose or use such information. Confidential Information
will not be deemed to have been published merely because individual portions of the information
have been separately published, but only if all material features comprising such information
have been published in combination.
6
(d) Executive
shall comply with the Personal Data Protection Act 2010 and all Company policies relating
to the collection, processing, use, disclosure, retention and security of personal data.
Executive shall process personal data only for lawful employment or business purposes authorized
by the Company and shall promptly notify the Company of any actual or suspected unauthorized
access, disclosure, loss or misuse of personal data.
9. Property;
Inventions and Patents.
(a) Property.
Executive agrees that all inventions, innovations, improvements, technical information, systems,
software developments, methods, designs, analyses, drawings, reports, service marks, trademarks,
trade names, logos, products, equipment, and all similar or related information and materials
(whether patentable or unpatentable) (collectively, “Inventions”) which
relate to the Company’s actual or anticipated business, research and development, or
existing or future products or services and which are conceived, developed, or made by Executive
(whether or not during usual business hours and whether or not alone or in conjunction with
any other person) while employed (and for the Restricted Period if and to the extent such
Inventions result from any work performed for the Company, any use of the Company’s
premises or property or any use of the Company’s Confidential Information) by the Company
(including those conceived, developed, or made prior to the date of this Agreement) together
with all patent applications, letters patent, trademark, brands, tradename and service mark
applications or registrations, copyrights, and reissues thereof that may be granted for or
upon any of the foregoing (collectively referred to herein as, the “Work Product”),
belong in all instances to such member of the Company. Executive will promptly disclose such
Work Product to the Company and perform all actions reasonably requested by the Company (whether
during or after the Term) to establish and confirm the Company’s ownership of such
Work Product (including, without limitation, the execution and delivery of assignments, consents,
powers of attorney, and other instruments) and to provide reasonable assistance to the Company
(whether during or after the Term) in connection with the prosecution of any applications
for patents, trademarks, brands, trade names, service marks, or reissues thereof or in the
prosecution or defense of interferences relating to any Work Product. Executive recognizes
and agrees that the Work Product, to the extent copyrightable, constitutes works created
in the course of employment and shall vest in the Company to the fullest extent permitted
under the Copyright Act 1987 and other applicable Malaysian intellectual property laws and
that to the extent Work Product constitutes such works, the Work Product is the exclusive
property of the Company, and all right, title, and interest in the Work Product vests in
the Company. To the extent Work Product does not automatically vest in the Company, the Work
Product, and all of Executive’s right, title, and interest in Work Product, including
without limitation every priority right, is hereby assigned to the Company.
7
(b) Cooperation.
Executive shall, during the Term and at any time thereafter, assist and cooperate fully with
the Company in obtaining for the Company the grant of a certificate of patent, copyrights,
and any other intellectual property rights relating to the Work Product in Malaysia and/or
such other countries as the Company may designate. With respect to Work Product, Executive
shall, during the Term and at any time thereafter, execute all applications, statements,
instruments of transfer, assignment, conveyance or confirmation, or other documents, furnish
all such information to the Company and take all such other appropriate lawful actions as
the Company requests that are necessary to establish the Company’s ownership of such
Work Product. Executive will not assert or make a claim of ownership of any Work Product,
and Executive will not file any applications for patents or copyright or trademark registration
relating to any Work Product.
(c) No
Designation as Inventor; Waiver of Moral Rights. Executive agrees that the Company shall
not be required to designate Executive as the inventor or author of any Work Product. Executive
hereby irrevocably and unconditionally waives and releases, to the extent permitted by applicable
law, all of Executive’s rights to such designation and any rights concerning future
modifications to any Work Product. To the extent permitted by applicable law, Executive hereby
waives all claims to moral rights in and to any Work Product.
(d) Pre-Existing
and Third-Party Materials. Executive will not, in the course of employment with the Company,
incorporate into or in any way use in creating any Work Product any pre-existing invention,
improvement, development, concept, discovery, works, or other proprietary right or information
owned by Executive or in which Executive has an interest without the Company’s prior
written permission. Executive hereby grants the Company a nonexclusive, royalty-free, fully-paid,
perpetual, irrevocable, sublicensable, worldwide license to make, have made, modify, use,
sell, copy, and distribute, and to use or exploit in any way and in any medium, whether or
not now known or existing, such item as part of or in connection with such Work Product.
Executive will not incorporate any invention, improvement, development, concept, discovery,
intellectual property, or other proprietary information owned by any party other than Executive
into any Work Product without the Company’s prior written permission.
(e) Attorney-in-Fact.
Executive hereby irrevocably designates and appoints the Company and its duly authorized
officers and agents as Executive’s agent and attorney-in-fact, to act for and on Executive’s
behalf to execute and file any such applications and to do all other lawfully permitted acts
to further the prosecution and issuance of patents, copyright, trademark, and mask work registrations
with the same legal force and effect as if executed by Executive, if the Company is unable
because of Executive’s unavailability, dissolution, mental or physical incapacity,
or for any other reason, to secure Executive’s signature for the purpose of applying
for or pursuing any application for any United States, Malaysia or foreign patents or mask
work or copyright or trademark registrations covering the Work Product owned by the Company
pursuant to this Section.
10. Enforcement.
Because Executive’s services are special, unique, and extraordinary and because Executive
has access to Confidential Information and Work Product, the parties hereto agree that money
damages would be an inadequate remedy for any breach of this Agreement. Therefore, in the
event of a breach or threatened breach of this Agreement, the Company, or any of its successors
or assigns may, in addition to other rights and remedies existing in their favor at law or
in equity, apply to any court of competent jurisdiction for specific performance and/or injunctive
or other relief in order to enforce, or prevent any violations of, the provisions hereof
(without posting a bond or other security).
8
11. Assurances
by Executive. Executive represents and warrants to the Company that he or she may enter
into and fully perform all of his or her obligations under this Agreement and as an employee
of the Company without breaching, violating, or conflicting with (i) any judgment, order,
writ, decree, or injunction of any court, arbitrator, government agency, or other tribunal
that applies to Executive or (ii) any agreement, contract, obligation, or understanding to
which Executive is a party or may be bound.
12. Termination
or Repayment of Severance Payments. In addition to the foregoing, and not in any way
in limitation thereof, or in limitation of any right or remedy otherwise available to the
Company, if Executive violates any provision of this Agreement, any obligation of the Company
to pay Severance Payments shall be terminated and of no further force or effect, and Executive
shall promptly repay to the Company any Severance Payments previously made to Executive,
in each case, without limiting or affecting Executive’s obligations under this Agreement
the Company’s other rights and remedies available at law or equity.
13. Notices.
Except as otherwise specifically provided herein, any notice, consent, demand, or other communication
to be given under or in connection with this Agreement shall be in writing and shall be deemed
duly given when delivered personally, when transmitted by facsimile transmission, one day
after being deposited with Federal Express, registered post or other nationally recognized
overnight delivery service, or three days after being mailed by first class mail, charges
or postage prepaid, properly addressed, if to the Company, at its principal office, and,
if to Executive, at his or her address set forth following his or her signature below. Either
party may change such address from time to time by notice to the other.
14. Governing
Law and Jurisdiction. This Agreement shall be governed by and construed and interpreted
in accordance with the laws of Malaysia, without giving effect to any choice of law rules
or other conflicting provision or rule that would cause the laws of any jurisdiction to be
applied. Subject to any mandatory jurisdiction of the Malaysian labor authorities, Industrial
Court or other competent statutory tribunal, the courts of Malaysia shall have jurisdiction
over any dispute arising out of or in connection with this Agreement. In the event of any
contest or dispute relating to this Agreement or the termination of Executive’s employment
hereunder, each of the parties shall bear its own costs and expenses. Nothing in this Agreement
shall exclude or restrict any right or remedy available to Executive under the Employment
Act 1955, the Industrial Relations Act 1967 or any other applicable Malaysian law.
15. Amendments;
Waivers. This Agreement may not be modified or amended or terminated except by an instrument
in writing, signed by Executive and a duly authorized representative of the Company (other
than Executive). By an instrument in writing similarly executed (and not by any other means),
either party may waive compliance by the other party with any provision of this Agreement
that such other party was or is obligated to comply with or perform; provided, however, that
such waiver shall not operate as a waiver of, or estoppel with respect to, any other or subsequent
failure. No failure to exercise and no delay in exercising any right, remedy, or power hereunder
shall operate as a waiver thereof, nor shall any single or partial exercise of any right,
remedy, or power hereunder preclude any other or further exercise thereof or the exercise
of any other right, remedy, or power provided herein or by law or in equity. To be effective,
any written waiver must specifically refer to the condition(s) or provision(s) of this Agreement
being waived.
9
16. Inconsistencies.
In the event of any inconsistency between any provision of this Agreement and any provision
of any Company arrangement, the provisions of this Agreement shall control, unless Executive
and the Company otherwise agree in writing that expressly refers to the provision of this
Agreement that is being waived.
17. Assignment.
This Agreement is personal to Executive and without the prior written consent of the Company
shall not be assignable by Executive. The obligations of Executive hereunder shall be binding
upon Executive’s heirs, administrators, executors, assigns, and other legal representatives.
This Agreement shall be binding upon and shall inure to the benefit of and be enforceable
by the Company’s successors and assigns.
18. Voluntary
Execution; Representations. Executive acknowledges that (a) he or she has consulted with
or has had the opportunity to consult with independent counsel of his or her own choosing
concerning this Agreement and has been advised to do so by the Company, and (b) he or she
has read and understands this Agreement, is competent and of sound mind to execute this Agreement,
is fully aware of the legal effect of this Agreement, and has entered into it freely based
on his or her own judgment and without duress.
19. Headings.
The headings of the Sections and subsections contained in this Agreement are for convenience
only and shall not be deemed to control or affect the meaning or construction of any provision
of this Agreement.
20. Construction.
The language used in this Agreement shall be deemed to be the language chosen by the parties
to express their mutual intent, and no rule of strict construction shall be applied against
any party.
21. Beneficiaries/References.
Executive shall be entitled, to the extent permitted under applicable law, to select and
change a beneficiary or beneficiaries to receive any compensation or benefit hereunder following
Executive’s death by giving written notice thereof. In the event of Executive’s
death or a judicial determination of his or her incompetence, references in this Agreement
to Executive shall be deemed, where appropriate, to refer to his or her beneficiary, estate,
or other legal representative.
22. Survivorship.
Except as otherwise set forth in this Agreement, the respective rights and obligations of
the parties shall survive any termination of Executive’s employment.
23. Severability.
It is fully the desire and intent of the parties hereto that the provisions of this Agreement
be enforced as permissible under the laws and public policies applied in each jurisdiction
in which enforcement is sought. Accordingly, if any particular provision of this Agreement
shall be adjudicated by a court of competent jurisdiction or arbitrator to be invalid, prohibited,
or unenforceable for any reason, such provision, as to such jurisdiction, shall be ineffective,
without invalidating the remaining provisions of this Agreement or affecting the validity
or enforceability of such provision in any other jurisdiction. Notwithstanding the foregoing,
if such provision could be more narrowly drawn so as not to be invalid, prohibited, or unenforceable
in such jurisdiction, it shall, as to such jurisdiction, be so narrowly drawn, without invalidating
the remaining provisions of this Agreement or affecting the validity or enforceability of
such provision in any other jurisdiction.
24. Counterparts.
This Agreement may be executed in any number of counterparts, each of which shall be deemed
an original, but all such counterparts shall together constitute one and the same instrument.
Signatures delivered by facsimile or PDF shall be effective for all purposes.
25. Entire
Agreement. This Agreement contains the entire agreement of the parties and supersedes
all prior or contemporaneous negotiations, correspondence, understandings and agreements
between the parties, regarding the subject matter of this Agreement.
[Remainder
of this page is intentionally left blank]
10
Firstborn Top Capital
By:
[Name]
Title:
[Title]
EXECUTIVE:
By:
[Name]
[Signature
Page to Employment Agreement]
EX-99.1
EX-99.1
Filename: ex99-1.htm · Sequence: 11
Exhibit
99.1
Firstborn
Top Capital, a Licensed Private Financing Company in Malaysia, to Become Publicly Traded Via Business Combination with ARC Group
Acquisition I Corp
~
Transaction values Firstborn Top Capital at pro forma enterprise value of approximately $1,091.2 million ~
~
Firstborn Top Capital is a licensed private financing company committed to providing responsible, transparent and accessible financial
solutions to individuals and businesses across Malaysia ~
~
Executive Director, Ow Ruey Shen, will continue to lead Firstborn Top Capital ~
~
Transaction provides Firstborn Top Capital the capital to accelerate growth throughout Malaysia, then Southeast Asia ~
~
Business combination expected to close in the first quarter of 2027 ~
~
All Firstborn Top Capital shareholders to sell 100% of their equity to ARC Group Acquisition I Corp ~
Kuala
Lumpur, Malaysia, September 10, 2026 (GLOBE NEWSWIRE) — ARC Group Acquisition I Corp (“ARCL”) (Nasdaq: ARCL,
ARCLR, ARCLW), a special purpose acquisition company, today announced that it has entered into a definitive share purchase agreement
with Firstborn Top Capital Sdn. Bhd., a Malaysian private limited company (“Firstborn Top Capital” or the “Company”),
pursuant to which Firstborn Top Capital will become a wholly-owned subsidiary of ARCL. Upon completion of the transaction, ARCL will
be renamed BlueCrest Investment, Inc. and is expected to be listed on the Nasdaq Global Market under the new ticker symbol “BCIN.”
Firstborn
Top Capital is a licensed private financing company committed to providing responsible, transparent and accessible financial solutions
to individuals (vehicle, property, personal expense, share/IPO financing, loan consolidation, etc.) and corporations (working capital,
capex, contract financing, M&A, share financing, loan consolidation, etc.). Firstborn Top Capital offers one-working-day approval
and a transparent business and revenue model offering fixed monthly interest, with the annualized rate depending on collateral, no hidden
fees or upfront costs, and loan terms up to five years. Upon the closing of the transaction, Firstborn Top Capital will continue to be
led by its Executive Director, Mr. Ow Ruey Shen, an experienced senior corporate executive in Malaysia. After the transaction
closing, BlueCrest Investment, Inc. will continue to be led by Datuk Dr. Doris Wong Sing Ee, Chief Executive Officer and Executive Director.
Datuk
Dr. Wong is a seasoned corporate leader with more than 20 years of management experience spanning multiple sectors including oil and
gas, property development, solar energy, engineering, advertising, food and beverage, and raw materials. She also currently serves as
Chief Executive Officer and Executive Director of Bio Green Med Solution, Inc. (Nasdaq: BGMS), a Nasdaq-listed diversified enterprise,
and as Executive Director of Metronic Global Berhad. Datuk Dr. Wong brings deep expertise in business development, strategic
consultancy, and corporate advisory, with a particular focus on mergers and acquisitions and joint ventures across Malaysia, Singapore,
China, Japan, Thailand, and Indonesia. She holds a Doctor of Business Administration specializing in ESG from HELP University, Malaysia.
Mr.
Ow, Executive Director of Firstborn Top Capital, commented, “This is a transformative milestone for Firstborn Top Capital. Combining
with ARC Group Acquisition I Corp and becoming a publicly traded company on the Nasdaq Global Market under the BlueCrest Investment banner
will provide us with the capital, visibility, and platform to accelerate our growth strategy to expand our lending operations throughout
Malaysia and, ultimately, across Southeast Asia. We remain committed to delivering responsible, transparent, and accessible financial
solutions, and this transaction positions us to do so on a much larger scale.”
Datuk
Dr. Doris Wong, Chief Executive Officer of ARC Group Acquisition I Corp, added, “After evaluating numerous potential business combination
targets, Firstborn Top Capital stood out for its revenue model, strong management team, and compelling growth trajectory in Malaysia’s
licensed private financing market. Firstborn Top Capital’s one-working-day approval process, transparent fee structure, and diversified
loan portfolio across both individual and corporate borrowers demonstrate exactly the kind of operationally sound, high-growth business
we set out to find. We are confident that this combination, with the Nasdaq listing and the resources of the public markets behind it,
will unlock significant value for shareholders and position BlueCrest Investment as a leading financial services platform in Southeast
Asia.”
Transaction
Overview
Under
the terms of the proposed transaction, ARC Group Acquisition I Corp will purchase 100% of the issued and outstanding ordinary shares
of Firstborn Top Capital such that Firstborn Top Capital will become a wholly-owned subsidiary of ARC Group Acquisition I Corp. In the
process, Firstborn Top Capital will become a publicly traded entity under the name “BlueCrest Investment, Inc.” The transaction
reflects an implied pro forma enterprise value at closing of approximately $1,091.2 million assuming ARCL raises $5 million in
PIPE financing and assuming 0% redemption from $120.8 million in ARCL’s trust account. The combined company intends to use the
proceeds for market expansion, lending infrastructure development, and marketing capability development.
At
the closing of the proposed transaction, approximately 12.4% of the outstanding shares of the combined company is expected to be held
by public investors, with existing Firstborn Top Capital shareholders owning approximately 82.39%. The boards of directors of ARC Group
Acquisition I Corp and Firstborn Top Capital have approved the transaction. The proposed transaction will also require the approval of
the shareholders of ARC Group Acquisition I Corp and is subject to other customary closing conditions. The proposed transaction is expected
to close during first quarter 2027. Additional information about the proposed transaction, including a copy of the share purchase agreement
and investor presentation, will be provided in a Current Report on Form 8-K to be filed by ARC Group Acquisition I Corp today with the
Securities and Exchange Commission (“SEC”) and available at www.sec.gov.
Advisors
ARC
Group Limited is acting as sole financial advisor to ARC Group Acquisition I Corp and ARC Group Securities, LLC is acting as its sole
capital markets advisor.
Rimon
P.C. is acting as U.S. legal counsel to ARC Group Acquisition I Corp and Forbes Hare serves as BVI counsel. Rohamat & Ling (Malayasia)
is acting as legal counsel to Firstborn Top Capital.
About
Firstborn Top Capital Sdn. Bhd.
Founded
in 2019, Firstborn Top Capital Sdn. Bhd. is a licensed private financing company based in Malaysia, committed to providing responsible,
transparent, and accessible financing solutions to individuals and businesses across the country. The Company offers a comprehensive
suite of credit products for individuals, including vehicle financing, property-backed loans, personal expense financing, share and IPO
financing, and loan consolidation, as well as tailored corporate financing solutions encompassing working capital facilities, capital
expenditure financing, contract financing, M&A financing, share financing, and debt consolidation. Firstborn Top Capital distinguishes
itself through its streamlined one-working-day credit approval process, a transparent and predictable revenue model featuring fixed monthly
interest rates (annualized based on collateral value), no hidden fees or upfront costs, and flexible loan terms of up to five years.
For more information, please visit https://firstborntopcapital.com.my.
About
ARC Group Acquisition I Corp
ARC
Group Acquisition I Corp (Nasdaq: ARCL) is a blank check company formed for the purposes of effecting a merger, capital share exchange,
asset acquisition, share purchase, reorganization, or similar business combination with one or more energy and/or sustainable natural
resource companies. On May 1, 2026, ARCL consummated its initial public offering of 12,075,000 units which includes the full exercise
of the over-allotment option of 1,575,000 additional units granted to ARC Group Securities LLC, as representative of the underwriters
in ARCL’s initial public offering generating total gross proceeds of $120,750,000.
Non-GAAP
Financial Measures
This
press release includes certain non-GAAP financial measures that are not prepared in accordance with generally accepted accounting principles
in the United States (“GAAP”) and that may be different from non-GAAP financial measures used by other companies. ARC Group
Acquisition I Corp and Firstborn Top Capital Sdn. Bhd. believe that the use of these non-GAAP financial measures provides an additional
tool for investors to use in evaluating ongoing operating results and trends of Firstborn Top Capital. These non-GAAP measures should
not be considered in isolation from, or as an alternative to, financial measures determined in accordance with GAAP. Additionally, to
the extent that forward-looking non-GAAP financial measures are provided, they are presented on a non-GAAP basis without reconciliations
of such forward-looking non-GAAP measures due to the inherent difficulty in forecasting and quantifying certain amounts that are necessary
for such reconciliation.
Important
Information About the Proposed Business Combination and Where to Find It
For
additional information on the proposed transaction, see ARCL’s Current Report on Form 8-K, which will be filed concurrently with
this press release. In connection with the proposed transaction, ARCL intends to file relevant materials with the SEC, including a registration
statement on Form S-4 with the Securities Exchange Commission (SEC), which will include a proxy statement/prospectus, and will file other
documents regarding the proposed transaction with the SEC. ARCL’s shareholders and other interested persons are advised to read,
when available, the preliminary proxy statement/prospectus and the amendments thereto and the definitive proxy statement and documents
incorporated by reference therein filed in connection with the proposed transaction, as these materials will contain important information
about Firstborn Top Capital and ARCL and the proposed transaction. Promptly after the Form S-4 is declared effective by the SEC, ARCL
will mail the definitive proxy statement/prospectus and a proxy card to each shareholder entitled to vote at the meeting relating to
the approval of the proposed transaction and other proposals set forth in the proxy statement/prospectus. Before making any voting
or investment decision, investors and shareholders of ARCL are urged to carefully read the entire registration statement and proxy statement/prospectus,
when they become available, and any other relevant documents filed with the SEC, as well as any amendments or supplements to these documents,
because they will contain important information about the proposed transaction. The documents filed by ARCL with the SEC may be obtained
free of charge at the SEC’s website at www.sec.gov, or by directing a request to ARC Group Acquisition I Corp, 398 S. Mill
Avenue, Suite 306, Tempe, Arizona 85284.
Participants
in the Solicitation
ARC
Group Acquisition I Corp and certain of its directors, executive officers and other members of management and employees may, under SEC
rules, be deemed to be participants in the solicitation of proxies from ARCL’s shareholders in connection with the proposed transaction.
A list of the names of those directors and executive officers and a description of their interests in ARCL will be included in the proxy
statement/prospectus for the proposed transaction when available at www.sec.gov. Information about ARCL’s directors and
executive officers and their ownership of ARCL ordinary shares is set forth in ARCL’s final prospectus dated April 29, 2026 and
filed with the SEC on April 30, 2026, as modified or supplemented by any Form 3 or Form 4 filed with the SEC since the date of such filing.
Other information regarding the interests of the participants in the proxy solicitation will be included in the proxy statement/prospectus
pertaining to the proposed transaction when it becomes available. These documents can be obtained free of charge from the source indicated
above.
Firstborn
Top Capital Sdn. Bhd. and its directors and executive officers may also be deemed to be participants in the solicitation of proxies from
the shareholders of ARCL in connection with the proposed transaction. A list of the names of such directors and executive officers and
information regarding their interests in the proposed transaction will be included in the proxy statement/prospectus for the proposed
transaction. Additional information regarding the participants in the proxy solicitation and a description of their direct and indirect
interests is included in the proxy statement/prospectus filed with the SEC on Form S-4. Shareholders, potential investors and other interested
persons should read the proxy statement/prospectus carefully when it becomes available before making any voting or investment decisions.
You may obtain free copies of these documents from the sources indicated above.
Cautionary
Statement Regarding Forward-Looking Statements
Certain
statements contained in this press release constitute “forward-looking statements” within the meaning of U.S. federal securities
laws. Forward-looking statements may include, but are not limited to, statements with respect to (i) trends in the Malaysian lending
industry, including changes in technology and competition related to Firstborn Top Capital’s products; (ii) Firstborn Top Capital’s
growth prospects and its market size; (iii) Firstborn Top Capital projected financial and operational performance including relative
to its competitors; (iv) new financial products and technology that Firstborn Top Capital may introduce in the future; (v) the potential
transaction, including the implied enterprise value, the expected post-closing ownership structure and the likelihood and ability of
the parties to consummate the potential transaction successfully; (vi) the risk the proposed transaction may not be completed in a timely
manner or at all, which may adversely affect the price of ARCL’s securities; (vii) the failure to satisfy the conditions to the
consummation of the proposed transaction, including the approval of the proposed transaction by the shareholders of ARC Group Acquisition
I Corp; (viii) the effect of the announcement or pendency of the proposed transaction on ARCL’s or Firstborn Top Capital’s
business relationships, performance and business generally; (ix) the outcome of any legal proceedings that be instituted against ARCL
or Firstborn Top Capital related to the proposed transaction or any agreement related thereto; (x) the ability to maintain the listing
of ARCL on Nasdaq; (xi) the price of ARCL’s securities, including volatility resulting from changes in the competitive and regulated
industry in which Firstborn Top Capital operates, variations in performance across competitors, changes in laws and regulations affecting
Firstborn Top Capital’s business and changes in the combined capital structure; (xii) the ability to implement business plans,
forecasts, and other expectations after the completion of the proposed transaction and identify and realize additional opportunities;
and (xiii) other statements regarding ARCL’s or Firstborn Top Capital’s expectations, hopes, beliefs, intentions and strategies
regarding the future.
In
addition, any statements that refer to projections forecasts or other characterizations of future events or circumstances, including
any underlying assumptions are forward-looking statements. The words “anticipate,” “believe,” “continue,”
“could,” “estimate,” “expect,” “intends,” “outlook,” “may,” “might,”
“plan,” “possible,” “potential,” “predict,” “project,” “should,”
“would,” and similar expressions may identify forward-looking statements, but the absence of these words does not mean that
a statement is not forward-looking. Forward-looking statements are predictions, projections and other statements about future events
that are based on current expectations and assumptions and, as a result, are subject to risks and uncertainties.
You
should carefully consider the risks and uncertainties described in the “Risk Factors” section of ARC Group Acquisition I
Corp final prospectus dated April 29, 2026 and filed with the SEC on April 30, 2026 for its initial public offering and, the proxy statement/prospectus
relating to the proposed transaction, which is expected to be filed by ARC Group Acquisition I Corp with the SEC, other documents filed
by ARC Group Acquisition I Corp from time to time with SEC, and any risk factors made available to you in connection with ARC Group Acquisition
I Corp, Firstborn Top Capital, and the proposed transaction. These forward-looking statements involve a number of risks and uncertainties
(some of which are beyond the control of Firstborn Top Capital and ARC Group Acquisition I Corp) and other assumptions, that may cause
the actual results or performance to be materially different from those expressed or implied by these forward-looking statements. ARCL
and Firstborn Top Capital caution that the foregoing list of factors is not exclusive.
No
Offer or Solicitation
This
press release relates to a proposed transaction between ARC Group Acquisition I Corp and Firstborn Top Capital Sdn. Bhd., and does not
constitute a proxy statement or solicitation of a proxy and does not constitute an offer to sell or a solicitation of an offer to buy
the securities of ARC Group Acquisition I Corp or Firstborn Top Capital, nor shall there be any sale of any such securities in any state
or jurisdiction in which such offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities
laws of such state or jurisdiction.
Contacts
ARC
Group Acquisition I Corp
398
S. Mill Avenue, Suite 306
Tempe,
Arizona 85284
Attn:
Datuk Dr. Doris Wong Sing Ee
Chief
Executive Officer
Tel:
(928) 625-0928
GRAPHIC
GRAPHIC
Filename: ex99-1_001.jpg · Sequence: 12
Binary file (10207 bytes)
Download ex99-1_001.jpg
GRAPHIC
GRAPHIC
Filename: ex99-1_002.jpg · Sequence: 13
Binary file (4972 bytes)
Download ex99-1_002.jpg
XML — IDEA: XBRL DOCUMENT
XML
Filename: R1.htm · Sequence: 30
v3.26.1
Cover
Sep. 10, 2026
Document Type
8-K
Amendment Flag
false
Document Period End Date
Sep. 10, 2026
Entity File Number
001-43253
Entity Registrant Name
ARC
Group Acquisition I Corp
Entity Central Index Key
0002073515
Entity Tax Identification Number
00-0000000
Entity Incorporation, State or Country Code
D8
Entity Address, Address Line One
398
S Mill Avenue
Entity Address, Address Line Two
Suite 306
Entity Address, City or Town
Tempe
Entity Address, State or Province
AZ
Entity Address, Postal Zip Code
85284
City Area Code
(928)
Local Phone Number
625-0928
Written Communications
false
Soliciting Material
false
Pre-commencement Tender Offer
false
Pre-commencement Issuer Tender Offer
false
Entity Emerging Growth Company
true
Elected Not To Use the Extended Transition Period
false
Units, each consisting of one Class A ordinary share, par value $0.0001 per share, one warrant, and one right to acquire 1/4
Title of 12(b) Security
Units, each consisting of
one Class A ordinary share, par value $0.0001 per share, one warrant, and one right to acquire 1/4
Trading Symbol
ARCLU
Security Exchange Name
NASDAQ
Class A ordinary shares included as part of the Units
Title of 12(b) Security
Class A ordinary shares
included as part of the Units
Trading Symbol
ARCL
Security Exchange Name
NASDAQ
Rights included as part of the Units
Title of 12(b) Security
Rights included as part
of the Units
Trading Symbol
ARCLR
Security Exchange Name
NASDAQ
Warrants, each warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share
Title of 12(b) Security
Warrants, each warrant exercisable
for one Class A ordinary share at an exercise price of $11.50 per share
Trading Symbol
ARCLW
Security Exchange Name
NASDAQ
X
- Definition
Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.
+ References
No definition available.
+ Details
Name:
dei_AmendmentFlag
Namespace Prefix:
dei_
Data Type:
xbrli:booleanItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Area code of city
+ References
No definition available.
+ Details
Name:
dei_CityAreaCode
Namespace Prefix:
dei_
Data Type:
xbrli:normalizedStringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.
+ References
No definition available.
+ Details
Name:
dei_DocumentPeriodEndDate
Namespace Prefix:
dei_
Data Type:
xbrli:dateItemType
Balance Type:
na
Period Type:
duration
X
- Definition
The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.
+ References
No definition available.
+ Details
Name:
dei_DocumentType
Namespace Prefix:
dei_
Data Type:
dei:submissionTypeItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Address Line 1 such as Attn, Building Name, Street Name
+ References
No definition available.
+ Details
Name:
dei_EntityAddressAddressLine1
Namespace Prefix:
dei_
Data Type:
xbrli:normalizedStringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Address Line 2 such as Street or Suite number
+ References
No definition available.
+ Details
Name:
dei_EntityAddressAddressLine2
Namespace Prefix:
dei_
Data Type:
xbrli:normalizedStringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Name of the City or Town
+ References
No definition available.
+ Details
Name:
dei_EntityAddressCityOrTown
Namespace Prefix:
dei_
Data Type:
xbrli:normalizedStringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Code for the postal or zip code
+ References
No definition available.
+ Details
Name:
dei_EntityAddressPostalZipCode
Namespace Prefix:
dei_
Data Type:
xbrli:normalizedStringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Name of the state or province.
+ References
No definition available.
+ Details
Name:
dei_EntityAddressStateOrProvince
Namespace Prefix:
dei_
Data Type:
dei:stateOrProvinceItemType
Balance Type:
na
Period Type:
duration
X
- Definition
A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection b-2
+ Details
Name:
dei_EntityCentralIndexKey
Namespace Prefix:
dei_
Data Type:
dei:centralIndexKeyItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Indicate if registrant meets the emerging growth company criteria.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection b-2
+ Details
Name:
dei_EntityEmergingGrowthCompany
Namespace Prefix:
dei_
Data Type:
xbrli:booleanItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Securities Act
-Number 7A
-Section B
-Subsection 2
+ Details
Name:
dei_EntityExTransitionPeriod
Namespace Prefix:
dei_
Data Type:
xbrli:booleanItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.
+ References
No definition available.
+ Details
Name:
dei_EntityFileNumber
Namespace Prefix:
dei_
Data Type:
dei:fileNumberItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Two-character EDGAR code representing the state or country of incorporation.
+ References
No definition available.
+ Details
Name:
dei_EntityIncorporationStateCountryCode
Namespace Prefix:
dei_
Data Type:
dei:edgarStateCountryItemType
Balance Type:
na
Period Type:
duration
X
- Definition
The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection b-2
+ Details
Name:
dei_EntityRegistrantName
Namespace Prefix:
dei_
Data Type:
xbrli:normalizedStringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection b-2
+ Details
Name:
dei_EntityTaxIdentificationNumber
Namespace Prefix:
dei_
Data Type:
dei:employerIdItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Local phone number for entity.
+ References
No definition available.
+ Details
Name:
dei_LocalPhoneNumber
Namespace Prefix:
dei_
Data Type:
xbrli:normalizedStringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 13e
-Subsection 4c
+ Details
Name:
dei_PreCommencementIssuerTenderOffer
Namespace Prefix:
dei_
Data Type:
xbrli:booleanItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 14d
-Subsection 2b
+ Details
Name:
dei_PreCommencementTenderOffer
Namespace Prefix:
dei_
Data Type:
xbrli:booleanItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Title of a 12(b) registered security.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection b
+ Details
Name:
dei_Security12bTitle
Namespace Prefix:
dei_
Data Type:
dei:securityTitleItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Name of the Exchange on which a security is registered.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection d1-1
+ Details
Name:
dei_SecurityExchangeName
Namespace Prefix:
dei_
Data Type:
dei:edgarExchangeCodeItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 14a
-Subsection 12
+ Details
Name:
dei_SolicitingMaterial
Namespace Prefix:
dei_
Data Type:
xbrli:booleanItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Trading symbol of an instrument as listed on an exchange.
+ References
No definition available.
+ Details
Name:
dei_TradingSymbol
Namespace Prefix:
dei_
Data Type:
dei:tradingSymbolItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Securities Act
-Number 230
-Section 425
+ Details
Name:
dei_WrittenCommunications
Namespace Prefix:
dei_
Data Type:
xbrli:booleanItemType
Balance Type:
na
Period Type:
duration
X
- Details
Name:
us-gaap_StatementClassOfStockAxis=ARCLU_UnitsEachConsistingOfOneClassOrdinaryShareParValue0.0001PerShareOneWarrantAndOneRightToAcquire14Member
Namespace Prefix:
Data Type:
na
Balance Type:
Period Type:
X
- Details
Name:
us-gaap_StatementClassOfStockAxis=ARCLU_ClassOrdinarySharesIncludedAsPartOfUnitsMember
Namespace Prefix:
Data Type:
na
Balance Type:
Period Type:
X
- Details
Name:
us-gaap_StatementClassOfStockAxis=ARCLU_RightsIncludedAsPartOfUnitsMember
Namespace Prefix:
Data Type:
na
Balance Type:
Period Type:
X
- Details
Name:
us-gaap_StatementClassOfStockAxis=ARCLU_WarrantsEachWarrantExercisableForOneClassOrdinaryShareAtExercisePriceOf11.50PerShareMember
Namespace Prefix:
Data Type:
na
Balance Type:
Period Type: